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General introduction and outline of the thesis 
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Black Sigatoka disease of banana, caused by 
Pseudocercospora fijiensis 
 
Banana, the top fruit of the world and an important staple 
The genus Musa contains banana plants with edible fruits, which are among the oldest 
domesticated crops. Archaeological studies indicated that the domestication process of bananas 
and plantains probably started around 7,000 years ago in Southeast Asia (D'Hont et al. 2012; 
Perrier et al. 2011). The modern geographical distribution of Musa spp. includes the tropical 
and subtropical areas of the Americas, Africa, the Caribbean Islands, Melanesia, the Pacific 
islands and Southeast Asia (mainland and islands). Bananas are among the most important crops 
worldwide and rank highly on the list of valuable agricultural commodities (Ploetz 2000; Ploetz 
et al. 2015). The 2012 – 2013 banana market review from the Food and Agriculture 
Organization of the United Nations (FAO), stated that the global production of bananas was 
around 106.7 millions of tons.  
The global banana export reached 16.5 million tons with a gross production value of 
US $29.7 billion (FAO 2014a, b). Ecuador is the largest exporter in the world, exporting 5.19 
million tons (MT) in 2012, followed by the Philippines with 2.6 MT, Guatemala with 1.98 MT, 
Costa Rica with 1.88 MT and Colombia with 1.83 MT (FAO 2014a, b) (Figure 1). The main 
importers of banana in 2012 were the United States of America and countries of the European 
Union with 4.4 MT and 4.3 MT, respectively (FAO 2014a). Other important markets are Russia, 
Japan and China (FAO 2014b). 
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Figure 1. Main banana exporting countries in 2012, data taken from FAOSTAT. 
 
The global banana export represents only 15.5% of the total banana production. The 
remaining 84.5% represents the banana production for domestic markets and local 
consumption. This underscores the importance of the banana fruit as a major fruit in many 
tropical and subtropical countries. Cooking bananas are a starchy staple food crop for 
approximately 500 million people (Collins 2014), such as in Uganda where it is a major staple 
food as well as an important cash commodity for communities (Shively & Hao 2012). Bananas 
are also very important in the local markets of Asia. Virtually all banana production from India 
and China are destined for local markets (Ploetz et al. 2015). Many banana varieties for local 
consumption are nutritious - rich in minerals and vitamins A, C and B6 - relative cheap and 
easy to produce (Ekesa et al. 2012; INIBAP 1998). In developing countries in Latin America, 
the banana trade is an important source of income. For example, in Ecuador, 95% of the total 
production is exported and represents almost 60% of the agricultural gross domestic product 
(GDP; US$ 1.9 billion in 2009). In fact, bananas are the second export product of Ecuador after 
oil (Vega 2011). They are an important factor in the economy, strengthening the rural 
communities in the coastal region (Vega 2011). In Ecuador, the majority of producers are 
smallholders with 71% working on up to 20 hectares. In 2009, 2.5 million Ecuadorians, 
Ecuador Philippines Guatemala Costa Rica Colombia
Value 5198703 2646380 1986761 1885909 1834936
0
1000000
2000000
3000000
4000000
5000000
6000000
To
n
n
e
s
Main banana exporting countries 2012
Chapter 1 
10 
representing 17.5% of the population, were directly or indirectly involve in the banana industry 
(Vega 2011). Different banana and plantain varieties are easy to spot in local markets, where 
they are cheap and provide an accessible source of energy, minerals and vitamins. A similar 
pattern emerges in African developing countries. From the total agricultural output of Uganda, 
25% of the value concerns bananas and top-ranks the per capita consumption in the world (0.70 
kg.person-1.day-1) (Shively et al 2012). Comparable developments are observed in the eastern 
parts of the Democratic Republic of Congo where bananas (plantains and cooking bananas) 
constitute the second main starchy staple food after cassava, with a consumption rate of around 
0.37 - 0.48 kg.person-1.day-1 (Ekesa et al. 2012). 
Banana plants are monocotyledons of the order Zingiberales. Most edible bananas 
belong to the Eumusa (Musa) section of the family Musaceae with seedless diploid, triploid or 
tetraploid genetic configurations derived from two founding species, Musa acuminata (the wild 
diploid, fertile A-genome donor) and M. balbisiana (the wild diploid, fertile B-genome donor), 
either alone or in various combinations (D'Hont et al. 2012; Perrier et al. 2011). The subgroup 
Cavendish comprises triploid sterile hybrids (AAA) derived from M. acuminata and is the most 
significant banana group representing 28% of global banana consumption and nearly all of the 
worldwide banana export. The plantain subgroup (AAB), important in African and Latin 
America, is accountable for 21% of the global fruit production (Ploetz et al. 2015). Commercial 
bananas are typically produced in large monocultures, which results in increased disease threats. 
Smallholders frequently grow different banana cultivars in mixed cropping systems resulting 
in complicated management, but with significantly lower disease pressure (Ploetz et al. 2015; 
Zadoks & Schein 1979). Like in any agricultural production system, but particularly in 
perennial crops, many abiotic and biotic factors as well as managerial activities affect banana 
production, including soil structure (physical and chemical), irrigation, fertilization, drainage 
systems, pesticides, fruit bag covering, bunch support, debudding and dehanding. Many 
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smallholders lack the resources to control these factors (Ploetz et al. 2015). Despite regional 
fluctuations, the most important diseases in banana crops are caused by fungi followed by - in 
descending importance order – bacterial and viral disease, nematode and insect pests (Ploetz et 
al. 2015).  
Globally, the most important disease in banana production is the so-called black 
Sigatoka, or black leaf streak disease, caused by Pseudocercospora fijiensis (Morelet) 
(Deighton 1976), previously Mycosphaerella fijiensis Morelet (1969) (Churchill 2011b). Other 
important diseases are Panama disease caused by Fusarium oxysporum f. sp. cubense (FOC), 
yellow Sigatoka disease caused by Pseudocercospora musae, anthracnose caused by 
Colletotrichum musae, Banana Streak Virus (BSV) and the burrowing nematode Radopholus 
similis (Blomme et al. 2011; Ploetz et al. 2015). The relatively rapid, long-distance 
dissemination of diseases is thought to be associated with anthropogenic movement of infested 
material, specially by “suckers” (Ploetz et al. 2015). Banana suckers are lateral shoots 
developing from the rhizome of the mother plant that are used to vegetative propagate the plant 
by the growers. Before the era of tissue culture, this was the one and only way to reproduce the 
plant and it greatly contributed to the global dissemination of FOC (Ordoñez et al. 2015). The 
currently most important re-emerging banana disease is FOC caused by the genetic lineage 
vegetative compatibility group 01213, colloquially called Tropical Race 4 (TR4). Other 
emerging diseases are the bacterial diseases, namely Banana Xanthomonas Wilt (BXW) and 
blood disease caused by Ralstonia haywardii subspecies celebensis. These emerging diseases 
and some other important diseases like eumusae leaf spot (Mycosphaerella eumusae), freckle 
(Phyllosticta maculata and allied species) (Wong et al. 2012), banana lesion nematode 
(Pratylenchus goodeyi) and Banana Bunchy Top Virus (BBTV) have relative narrow 
geographical distributions, but may incur major losses (Ploetz et al. 2015). For the majority of 
these diseases, effective quarantine measures and the use of clean seed material are the only 
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available and hence, essential measures to reduce their dispersal. Other diseases - primarily the 
foliar blights, including the Sigatoka complex - and (insect and nematode) pests are manageable 
by using pesticides. However, reducing efficacies are a major concern as the major commercial 
banana varieties - including Cavendish - are (very) susceptible to a plethora of diseases (Ploetz 
et al. 2015). 
The importance of black Sigatoka disease 
Among the banana diseases, black Sigatoka is by far the major problem in the banana 
industry, causing serious leaf defoliation and indirect post-harvest fruit quality problems due to 
premature ripening of the fruit, turning it unacceptable for export (Ploetz 2000). The main 
control measure involves frequent fungicide applications, which has a very high environmental 
and economic burden (Risède et al. 2010). As such, black Sigatoka has a major effect on 
subsistence production of banana and plantain since most of the smallholders are unable to 
afford these fungicides (Ploetz 2000). Meanwhile the public opinion, debating the fungicide 
usage and the increasing negative environmental impacts, demands safer food and 
environmental friendly crop management. This justified demand has an increasing impact on 
global exporting regulations, directing towards reduced pesticide use in commercial banana 
production (Risède et al. 2010), which primarily comprises the highly susceptible Cavendish 
type monocultures. 
Hence, one of the major issues in black Sigatoka control has been the excessive and 
unplanned fungicide use in many banana farms worldwide. This uncurbed use facilitated 
resistance development in the pathogen population, thereby reducing the efficacy of disease 
management and hence, maximizing the number of fungicide applications, such as presently in 
Costa Rica. In the 1990’s, 30 applications per year were sufficient for disease control, but in 
2007 the frequency had increased to over 50 treatments. Another example is Cameroon with 12 
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treatments increasing to nearly 50 applications per year between 1990 and 2008 (Lapeyre et al. 
2010b). In Ecuador, the average number of applications was 10 – 12 in the 1990’s, which 
increased up to approximately 30 applications per year in 2016 (CIBE, unpublished data). 
Consequently, these excessive fungicide applications do contribute to negative impacts on the 
environment and occupational health of workers in banana plantations and rural villages nearby, 
as mentioned in the World Health Organization report (Beaglehole et al. 2003; van Wendel de 
Joode et al. 2016). In 2006-2008, the international project ‘Pesticide Reduction Program for 
Bananas (PRPB)’ sponsored by the Common Fund for Commodities and coordinated by 
Wageningen University and Research, analysed global pesticide use in banana producing 
countries (Risède et al. 2010), which revealed that the majority of the currently applied 
fungicides is targeting P. fijiensis. In addition, a clear correlation was detected between black 
Sigatoka incidence, annual rainfall (more rain = more P. fijiensis spores = more fungicide 
applications) and the risk of reduced efficacy of fungicides, which forced farmers to shift to 
contact fungicides. Since contact fungicides lack a curative effect their application frequency is 
higher, which increases the chemical load in banana production (Risède et al. 2010). This 
vicious circle of required intensification of fungicide applications and increasing resistance in 
P. fijiensis populations towards systemic fungicides threatens fruit production and underscores 
the need for new molecules and application strategies to sustainably manage black Sigatoka in 
banana.  
 
Disease symptoms 
P. fijiensis symptoms start to appear 14 to 20 days after inoculation with red-brown 
specks (~0.25 mm diameter) at the lower leaf surface (Long 1979; Marín et al. 2003). These 
specks rapidly enlarge into reddish-brown streaks running parallel to the leaf veins that then 
develop into larger dark-brown to black composite streaks, which are indeed visible at both leaf 
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surfaces, but appear larger on the abaxial side (Long 1979). The streaks eventually form 
fusiform or elliptical spots that coalesce and form a water-soaked border with a yellow halo that 
eventually merge to cause extensive leaf necrosis (Figure 2). The time period from the first 
symptom to the streaks and subsequently necrotic spots varies depending on the cultivar and 
the severity of the infection (Marín et al. 2003). The symptom description of P. fijiensis 
infection is summarized in Tables 1 and 2 (Fouré 1985; Marín et al. 2003; Meredith & Lawrence 
1969).  
 
 
Figure 2. Banana plant infected with Pseudocercospora fijiensis in a greenhouse experiment. 
The plant shows the typical symptoms of the disease, streaks, elliptical necrotic lesions with 
water-soaked border and a chlorotic yellow halo and extensive necrosis. Mark in arrows are 
some of the stage of the disease based on Fouré description (Fouré 1985).  
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Table 1. Black Sigatoka symptoms on banana (Meredith & Lawrence 1969). 
Common name Stage Description 
Speck Stage 1 
First visible lesion. Reddish brown specks in the lower surface of 
the leaf (<0.25 mm). Abundant near the margin of the leaf. 
Usually first appear in the third, fourth or older leaves. 
First Streak stage Stage 2 
Streaks elongate to form narrow reddish brown streaks up to 20 
mm long and 2 mm wide. The long axis is parallel to the leaf 
venation. Frequently they are densely aggregated in a band 
several centimetres wide. Specks that overlap, form large, 
compound streaks. 
Second Streak 
stage 
Stage 3 
The streaks may elongate slightly. The colour changes from 
reddish brown to dark brown or almost black. They are clearly 
visible in the upper surface of the leaf.  
First Spot stage Stage 4 
The streaks broaden and become fusiform or elliptical. The spot 
is characterized by the development of a light brown, water-
soaked border around the spot.  
Second Spot 
stage 
Stage 5 
The dark brown or black central area of the spot becomes 
depressed and the water-soaked border becomes more 
pronounced. A slight yellowing of the leaf tissue surrounding the 
water-soaked border may occur.  
Third Spot stage Stage 6 
The centre of the spot dehydrates, becoming light grey or buff-
coloured and further depresses. The spot is bordered by a well 
define dark brown or black rim. There is a bright yellow 
transitional zone between the spot and the green healthy leaf 
tissue. After the leaf collapsed and withered, spots remain clearly 
visible.  
 
 
Table 2. Black Sigatoka symptoms describe by Fouré taken from Marín et al 2003 (Fouré 
1985; Marín et al. 2003). 
Common name Stage (Fouré) Description 
Mark Stage 1a Depigmentation mark (whitish or yellow). Only on lower surface 
Speck Stage 1b Red-brown speak on lower surface of the leaf  
Dash/Lesion Stage 2 Red-brown streaks on both side of the leaf surface 
Streak Stage 3 Wider streaks. Colour starts changing from red to dark brown. 
Spot Stage 4 Dark brown (lower) to black (upper) spots. 
Burn Stage 5 Black spot with chlorotic halo. Lesion is slightly depressed. 
Necrosis Stage 6 
Centre of the spot dries out and becomes whitish to grey. Spot is 
surrounded by a dark brown to black border and further 
depressed.  
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The Pseudocercospora fijiensis life cycle 
The life cycle of P. fijiensis starts with leaf infection by either ascospores or conidia. 
After a period of epiphytic growth of two to three days, germ tubes penetrate the leaf through 
the stomata (Lapeyre et al. 2010b). The first symptoms will generally appear 14-20 days after 
penetration of the leaf. Conidia form at early stages (stage 2 to 4) of the disease development 
and are splash-dispersed over short-range distances. Ascospores develop at stage 6 and become 
airborne and show long-range distance dispersal up to an estimated mean distance of 614 meters 
with a maximum distance of 1000 meters (Lapeyre et al. 2010b; Rieux et al. 2014). 
 
Figure 3. Pseudocercospora fijiensis life cycle reprinted from Agrios (2005) as shown in 
Churchill (2011). 
 
General introduction  
17 
 
The first conidiophores of P. fijiensis develop on the abaxial surface of the leaf during 
stage 2 or 3 and continue to develop until stage 5. Conidia production is almost continuous 
between stage 3 and stage 5. Conidiophores emerge individually or in diverging fascicles of 
two to eight stalks from the stomata of the abaxial surface of the leaf (within the boundary of 
the lesion). Few conidiophores emerge from stomata on the adaxial surface of the lesion 
(Meredith & Lawrence 1969). Conidia are pale greenish or olivaceous in colour and obclavate 
to cylindro-obclavate in form. Conidia contain one to 10 septae that form a straight or mildly 
curved propagule, with a short obconically truncate base. Conidia have a visible and slightly 
thickened hilum 1.5-3 µm of diameter and an obtuse tip, 20-132 µm long, of 2.5-5 µm diameter 
at the broadest point near to the base, tapering to 1.5-3 µm diameter at the tip (Meredith & 
Lawrence 1969). 
The sexual reproduction starts with the development of spermogonia at stage 3 or 4 at 
the lower leaf surface. Spermogonia with spermatia become abundant at stage 4 (Meredith & 
Lawrence 1969). On the abaxial surface, spermogonia develop frequently in the substomatal 
cavity of stomata from which one or more conidiophores emerge. Mature spermogonia contain 
hyaline, rod-shape spermatia that act as gametes in fertilization of the pseudothecia that emerge 
in stage 5 and 6 (Meredith & Lawrence 1969). Pseudothecia are present at both sides of the 
lamina, but more frequent on the adaxial surface. The pseudothecia are scattered, immersed, 
piercing the epidermis by a narrow or moderately thick papillate ostiole, globose with 50-85 
µm of diameter. Their wall is composed of three or more layers of dark brown polygonal cells 
and they contain numerous asci that are bitunicate, obclavate, and contain eight two-celled 
hyaline fusoid-clavate ascospores (dimensions 11.5-15.6 x 2.5-5.0 µm, Figure 4), with the 
larger cell uppermost in the ascus (Meredith & Lawrence 1969).  
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Figure 4. Pseudocercospora fijiensis ascospores in cryogenic Scanning Electron Microscope 
(CRY-SEM).  
 
Pseudocercospora fijiensis genetics  
Pseudocercospora fijiensis is a haploid, ascomycete fungus, belonging to the family 
Mycosphaerellaceae, order Capnodiales, class Dothideomycetes, and phylum Ascomycota. The 
fungus has an asexual and sexual reproduction cycle driven by a bipolar heterothallic mating 
system (Churchill 2011b). The dissemination of P. fijiensis most likely started in Southeast Asia 
and since then has spread to the major tropical and subtropical banana growing areas of the 
world (Churchill 2011b; Long 1979; Robert et al. 2012). This has been supported by a number 
of population genetic analyses that indicate Southeast Asia, between Papua New Guinea and 
the Solomon Islands (Carlier et al. 1996; Halkett et al. 2010; Hayden et al. 2003; Rivas et al. 
2004b) as the centre of origin. Consequently, founder effects and bottleneck phenomena were 
detected in populations outside Southeast Asia, which are potentially the main determinants of 
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the global population structure (Carlier et al. 1996; Fahleson et al. 2009; Halkett et al. 2010; 
Manzo-Sanchez et al. 2008; Rivas et al. 2004b; Zandjanakou-Tachin et al. 2009). This is 
consistent with the stochastic nature of the disease spreading at continental and local scales in 
contrast to a steady advance of an epidemic front, although some populations within countries 
show a continuous range expansion as an epidemic front (Halkett et al. 2010). 
The underlying mechanism for stochastic disease development at local or continental 
scale could result from either airborne spores or from the transport of infected plant material 
(Halkett et al. 2010; Rivas et al. 2004b; Zandjanakou-Tachin et al. 2009). Most of the P. 
fijiensis populations are not in gametic disequilibrium, resulting in high gene diversity levels. 
This supports the hypothesis that random-mating – in accord with a heterothallic bipolar mating 
system, similar to the related Zymoseptoria tritici (Conde-Ferraez et al. 2007; Goodwin & 
Kema 2014; Kema et al. 1996; Waalwijk et al. 2002) exists within the population and 
underlines the important role of ascospore dissemination (Carlier et al. 1996; Halkett et al. 
2010; Rieux et al. 2014; Rivas et al. 2004b). The colonization patterns are also supported by 
genetic studies from a historical perspective. For example, the first report of P. fijiensis in Latin 
America was in Honduras and Costa Rica (Guzmán et al. 2013), which is congruent with the 
highest gene diversity levels found in these countries (Rivas et al. 2004b). In other Latin 
American countries the genetic diversity is considered medium to low in comparison with Costa 
Rica and Honduras (Perea et al. 2005). In Africa, the point of entry is more ambiguous since 
the genetic diversity levels are comparable throughout most countries (Fahleson et al. 2009; 
Rivas et al. 2004b; Zandjanakou-Tachin et al. 2009). 
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Black Sigatoka disease management relies on fungicides 
 As mentioned above, black Sigatoka management in banana is difficult as the majority 
of commercial banana varieties is highly susceptible to P. fijiensis. In contrast to a plethora of 
other crops, plant breeding in banana is also limited and hence, cultivars with improved 
resistance to P. fijiensis hardly enter the market. In any case, the Cavendish subgroup, which is 
a major constituent of the global banana production, is extremely susceptible to black Sigatoka. 
Therefore, disease control relies either entirely on fungicides or production moves to sub-
optimal environments that slow down disease development, such as the high altitude desert area 
of Piura, Peru.  
In the banana industry two groups of fungicides are applied to control P. fijiensis. 
These are categorized according to their phytomobility into the plant tissue and characterized 
as contact and systemic fungicides. Contact fungicides remain at the leaf surface. Systemic or 
penetrating fungicides on the other hand are able to penetrate the plant tissue. The most widely 
applied systemic fungicides for black Sigatoka control are those belonging to the chemical 
families benzimidazoles, triazoles, morpholines and strobilurins (Pérez 2006).  
The benzimidazoles were the first modern site-specific penetrating fungicides used for 
fungi pathogen control (Latin 2011). This group includes benomyl and thiabendazole.  
In the 1980s, triazole (azoles) fungicides were introduced. They belong to the 
Demethylation Inhibitor fungicides (DMIs) that obstruct the lanosterol 14α-demethylase which 
catalyses the removal of a methyl group from lanosterol. This is an essential enzyme of the 
ergosterol biosynthesis pathway (Cañas et al. 2009; Pietila et al. 2006). The lanosterol 14α-
demethylase enzyme is encoded by the cyp51 gene.  
Morpholine fungicides are well known by the compound Tridemorph that was first 
approved in 1969 (Pérez 2006). Tridemorph inhibits the Δ8 – Δ7 isomerase and the C14 
reductase in the ergosterol metabolic pathway.  
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The first strobilurin fungicide was introduced to the global market in 1997 (Knight et 
al. 2002). The quinol oxidation inhibitors (QoIs), or strobilurins, block the respiration pathway 
by inhibiting the cytochrome bc1 complex in mitochondria (Peres et al. 2014). By 2000, 
resistant P. fijiensis isolates emerged on banana production farms in Costa Rica (Amil et al. 
2007).  
The newest compounds introduced in the market are “second generation” 
carboxamides. These fungicides are classified by the Fungicide Resistance Action Committee 
(FRAC) as Succinate Dehydrogenase Inhibitors class or SDHIs. Their fungicidal activity is 
based on the disruption of the mitochondrial tricarboxylic acid cycle (TCA) through inhibition 
of the Succinate Dehydrogenase enzyme (SDH). At the molecular level, carboxamides inhibit 
ubiquinone reduction by binding to the ubiquinone binding site (Qp site) of the SDH enzyme 
(Scalliet et al. 2012). 
 
Scope of the thesis 
 This study aims to elucidate the molecular mechanisms on adaptation to a major class 
of fungicides, the sterol demethylation-inhibitors (DMIs), that are globally used in the disease 
management of black Sigatoka caused by P. fijiensis.  
 Chapter 1 provides a general introduction to the subject with a description of the 
importance of banana as a food and fruit crop, the causal agent of black Sigatoka - P. fijiensis -
and its lifestyle and the disease expression and management.  
 Chapter 2 describes the history of black Sigatoka disease management and the role of 
fungicides and the decline in efficacy with a focus on the situation in Costa Rica, which is 
exemplary for other important banana growing regions.  
 Chapter 3 contains a global phenotypic and genotypic analysis of P. fijiensis isolates 
to describe and understand reduced efficacy to DMI fungicides and the relationship with 
Pfcyp51 gene and promoter modifications and associated CYP51 protein three-dimensional 
modifications.  
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 Chapter 4 summarizes a functional analysis of the Pfcyp51 gene and describes 
promoter swapping experiments between wild type and resistant P. fijiensis isolates to analyse 
the role of repeat elements - present in the Pfcyp51 promoters of resistant P. fijiensis strains - 
in the expression of the gene and its relation to reduced efficacy.  
 Chapter 5 addresses the question whether the Pfcyp51 gene is the only determining 
factor in reduced DMI efficacy by an unbiased mapping approach where two resistant isolates 
are crossed to a sensitive strain resulting in two P. fijiensis mapping populations that were 
genotyped and phenotyped for DMI sensitivity. In both populations, a causal genetic region of 
250,660 bp is identified that contains 53 putative genes, including the Pfcyp51. 
Chapter 6 discusses the experimental outcomes of the preceding chapters, puts these 
in a broad context and concludes that Pfcyp51 gene and promoter modulation is largely 
responsible for the reduced DMI efficacy in black Sigatoka disease management. The impact 
and implications of these findings are discussed for the development of future sustainable 
disease control strategies.  
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Introduction 
Bananas are among the most important crops worldwide (Ploetz 2000; Ploetz et al. 
2015). The 2012 – 2013 banana market review from the Food and Agriculture Organization of 
the United Nations (FAO), stated that the global production of bananas was around 106.7 
millions of tons. Global export reached 16.5 million tons with a gross production value of US 
$29.7 billion (FAO 2014a, b). Nonetheless, global export of banana represents only 15.5% of 
the total banana production. The remaining 84.5% represents banana production for local 
consumption. This stresses the importance of the banana fruit as a staple food in many tropical 
and subtropical developing countries. It is believed that banana is a starchy staple food for 
approximately 500 million people (Collins 2014). Many banana varieties for local consumption 
are relative cheap and easy to produce. Sadly, many of these varieties are susceptible to black 
Sigatoka disease, an important leaf defoliation disease that is caused by the dothideomycete 
fungus Pseudocercospora fijiensis (previously Mycosphaerella fijiensis) (Arango et al. 2016). 
The disease causes substantial direct and indirect losses due to defoliation and consequently 
reduced yields as well as due to premature ripening of the fruit, turning them into an unfit 
commodity for the export, respectively (Ploetz 2000). The main control measure involves 
frequent fungicide applications with a very high environmental and economic burden (Chong 
et al. 2016b; Chong et al. 2016c; Risède et al. 2010). As such, black Sigatoka has a major effect 
on subsistence production of banana and plantain since most of the smallholders are unable to 
afford the costs of these fungicides (Ploetz 2000). One of the major issues in black Sigatoka 
control has been the excessive and unplanned fungicide use in many banana farms worldwide 
(Lapeyre et al. 2010b). This uncurbed usage promoted resistance development within the 
pathogen population. Over time, resistance levels increased to such extent that the number of 
fungicide applications are now near maximum levels (Chong et al. 2016b). This can be well 
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illustrated by the history of the control of the disease in Costa Rica, which is one of the major 
banana export countries that had to deal with the disease soon after its incursion in Central 
America (Marín et al. 2003). The extent and well documented record of the disease 
management by the National Banana Corporation (CORBANA) enables a critical review of 
contemporary black Sigatoka management, further substantiating and underscoring the need for 
alternative disease management practices and strategic decisions towards sustainable and 
environmentally friendly banana production. 
 
Black Sigatoka management through time 
A historic picture of black Sigatoka management 
Black Sigatoka disease was first report in Fiji in 1963 (Rhodes 1964) and arrived to 
Costa Rica in 1979 (Lapeyre et al. 2010b; Rivas et al. 2004b). When black Sigatoka arrived 
another pathogen Pseudocercospora musae (previously Mycosphaerella musicola), also known 
as yellow Sigatoka, was already present in the banana farms in Costa Rica (Stover 1962). Much 
of the strategies for the control for black Sigatoka disease have been adapted from the control 
of yellow Sigatoka. For example, the use of protectant fungicide begins with the arrival of P. 
musae to Central America in 1934. The United Fruit Company begins applying Bordeaux 
mixture (CuSO4 + Ca(OH)2) for the control (Stover, 1990). In 1941, Leach did a great deal 
when he identifies that the unfurling heart leaf (“candela or cigar”) is the major target for the 
ascospores of P. musae and later P. fijiensis. He also probed that it is physically impossible for 
protectant fungicides to reach ascospores in the hart leaf since this leaf is constantly expanding 
and exposing under surface of the leaf cylinder. By 1946 Leach published his research on 
bananas leaf spot diseases in Gross Michel cultivar (Leach 1946). Another important control 
strategy, the use of oil sprays for the control, was discover by Guille and Guyot in 1956 (Guyot 
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& Guillé 1954; Stover 1990). Table 1 shows a time line history of the chemical control of the 
so call banana leaf spots diseases, yellow and black Sigatoka. Eventually, black Sigatoka 
displaced yellow Sigatoka in most of the banana production areas around the world becoming 
the omnipresent banana pathogen (Guzmán et al. 2013). 
Since the 1950s the export banana trade has been dominated by the banana 
“Cavendish” varieties (D'Hont et al. 2012; Langhe et al. 2009), which are very susceptible to 
P. fijiensis. Hence, fungicides are major disease control agents in addition to a range of cultural 
practices. The latter includes the application of mineral oil, which has been practiced since the 
1950s (Klein 1960)(Marin et al 2003) and slows down disease development (Pérez 2006; Stover 
1990). Moreover, mineral oil became an important carrier for many fungicides. In many ways, 
mineral oil is a main component of conventional control, they protect and reduce the fungicide 
volume by forming a homogeneous mist that distributes active ingredients on the leaf, prevents 
evaporation and improves, in the case of many systemic fungicides, the penetration of the plant 
tissue. 
Prior to 1970’s, almost all fungicides were protectants (Ma & Michailides 2005). 
Ethylene bis-dithiocarbamates, such as maneb and mancozeb were introduced in the market in 
1950 and 1958, respectively, and have been widely used for black Sigatoka control. 
Dithiocarbamates have a nonspecific mode of action (moa) with the thiol group blocking 
respiration and other important metabolic process (Gullino et al. 2010; Pérez 2006). 
Chlorothalonil is another compound that is still frequently used, only with water as oil mixtures 
are phytotoxic (Pérez 2006). It is a derivate of the phthalimides, which thiol group interferes 
with the glutathione pathway, A-coenzyme and 2-mercaptoethanol thereby reducing all 
metabolic activity of the fungal cell. 
The benzimidazoles were the first modern site-specific fungicides for disease control 
(Latin 2011). They include benomyl and thiabendazole that are still being used for the control 
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of crown rot of the harvested and packed fruit. Benomyl, a methyl benzimidazole carbamate, 
was introduced in 1968 and inhibits fungal growth by binding to the β-tubulin thereby 
disrupting fungal cell division (Cañas et al. 2006). However, point mutations at positions 198 
of the β-tubulin gene lead to one amino acid (aa) change, which provokes complete resistance 
in P. fijiensis populations without any apparent fitness penalty (Cañas et al. 2006; Pérez 2006). 
The first triazole fungicide, propiconazole, was introduced for black Sigatoka control 
in 1984 (Stover 1990). It belongs to the group of sterol demethylation-inhibitors (DMIs) that 
inhibit the lanosterol 14α-demethylase (CYP51), an essential enzyme of the ergosterol 
biosynthesis pathway (Cañas et al. 2009). This enzyme catalyses the removal of a methyl group 
from lanosterol in fungi, allowing the sterol metabolism to proceed to the production of 
ergosterol. Triazoles inhibit the CYP51 function by binding to the heme cofactor in the active 
site of the enzyme. Henceforth, sterol metabolism is hampered due the accumulation of 14-α-
methyl-3,6-diol, a toxic sterol produced by the ∆-5,6-desaturase encoded by the gene ERG3, 
which affect membrane integrity and leads to growth inhibition and cell death (Lupetti et al. 
2002; Pietila et al. 2006; Shapiro et al. 2011). Several studies have shown a correlation between 
the loss of sensitivity to triazoles and point mutations in the cyp51 gene (Cañas et al. 2009; 
Lepesheva & Waterman 2004). In P. fijiensis such mutations are abundant and resistance is also 
due to overexpression of the Pfcyp51, as a result of promoter insertions (Chong et al. 2010; 
Chong et al. 2016b; Díaz-Trujillo et al. 2016a) 
The morpholine fungicides are represented by tridemorph that was approved for black 
Sigatoka control in 1969. It inhibits the Δ8–Δ7 isomerase and the C14 reductase in the 
ergosterol metabolic pathway and its translocation is essentially trans-laminar (Pérez 2006). 
Therefore, it has a limited risk of resistance development in the pathogen population. Despite 
this advantage, its efficacy for black Sigatoka control is not as good as the azole fungicides 
(Pérez 2006). 
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The first quinol oxidation inhibitor (QoI), or strobilurin was introduced in 1997 (Amil 
et al. 2007; Knight et al. 2002). It blocks the respiration pathway by interfering with the 
cytochrome bc1 complex in the mitochondria (Pérez 2006; Sierotzki et al. 2000). Due to their 
entirely new chemistry and enormous efficacy, strobilurins quickly became one of the most 
important agricultural fungicides accounting for >20% of the global fungicide market within 
the first ten years after their introduction (Fernández et al. 2010). However, by 2000, isolates 
of P. fijiensis with resistance to the QoIs were already common on some farms in the production 
zones of Costa Rica (Amil et al. 2007), and in 2008, P. fijiensis populations at three commercial 
plantations in Costa Rica were almost fixed for strobilurin resistance (Arango et al. 2016). The 
resistance to these compounds is mediated by a point mutation in the Pfcytb gene that leads to 
a change of a glycine for an alanine at position 143 (G143A) of the protein (Sierotzki et al. 
2000). 
Finally, the latest fungicides for black Sigatoka management that entered the market 
are the “second generation” carboxamides or succinate dehydrogenase inhibitors (SDHIs). First 
generation carboxamides were discovered in the mid 1960’s for the control of basidiomycetes. 
Their fungicidal activity is based on the disruption of the mitochondrial tricarboxylic acid cycle 
(TCA) through inhibition of the succinate dehydrogenase (SDH) enzyme. At the molecular 
level, carboxamides inhibit ubiquinone reduction by binding to the ubiquinone binding site (Qp 
site) of the SDH enzyme (Scalliet et al. 2012). New molecules with a wider spectrum of activity 
were discovered recently (Leroux et al. 2010) but are not yet generally applied. 
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Table 1. Historical time line of the evolution and important events in the chemical control of 
black Sigatoka  
Year  Black Sigatoka strategies evolution and important events Reference 
1934 
Arrival of Pseudocercospora musae (Mycosphaerella musicola), also called 
yellow Sigatoka, to Americas and the beginning of the use of Bordeaux 
mixture. 
Stover 1962 
1941 
Leach identifies the unfurling cigar (heart) leaf as the major target for the 
Pseudocercospora musae spores. He also proves that the heart leaf cannot 
be protected by contact fungicides.  
Leach 1946 
1946 
Leach publishes his discoveries in "Banana leaf spot (Mycosphaerella 
musicola) on the Gros Michel variety in Jamaica: “Investigations on the 
aetiology of the disease and the principles of control by spraying". 
Leach 1946 
1950 
The first dithiocarbamate, Maneb, was introduced for yellow Sigatoka 
control. 
Stover 1990 
1956 Guille and Guyot discovered oil sprays. Guyot & Guillé 1954 
1958 
Introduction of the dithiocarbamate mancozeb (Dithane) for the control of 
yellow Sigatoka. Maneb successfully controls leaf spot diseases together 
with copper applications by aircraft. 
Stover 1990 
1960 
Klein publishes the first forecasting method of oil spray in Honduras. He 
shows that oil controls the streak disease stage and that the stages of the 
disease can be used as a decision moment for fungicide application. 
Klein 1960 
1962 Discovery that oil-in-water mixtures are more effective than oil alone. Stover 1990 
1963 First report of black Sigatoka in Fiji.  Rhodes 1964  
1967 
DuPont sent the first systemic fungicide (the first benzimidazole), compound 
number 1991 or Benlate (benomyl), to be evaluated in Honduras. In the same 
year Calixin (tridemorph) was also tested in Honduras.  
Stover 1990 
1972 
 The second forecasting method was developed in Guadalupe by Ganry 
and Meyer, who divided the disease symptoms in five stages. They 
correlated disease development with temperature and evaporation 
rates. This was the first system introducing oil and systemic fungicides 
(Benlate).  
 Black Sigatoka is discovered in Honduras and from there it dispersed 
throughout Latin America and the Caribbean.  
Ganry & Meyer 1972 
 
Guzmán et al 2013 
1973 
First epidemic of black Sigatoka disease in Honduras. Benlate was 
effectively and extensively used for disease control. First use of in-oil 
mixtures and later in “cocktails” (different mode of action fungicide 
mixtures) with Mancozeb. 
Stover 1990 
1976 
First fungicide resistance appeared against Benlate in Honduras, followed 
by a serious outbreak of black Sigatoka. 
Stover 1990 
1979 
Chlorothalonil was introduced, but was unable to provide adequate control 
under conductive conditions for the disease (heavy rain promoting abundant 
ascospore production). 
Stover 1990 
1980 
The Fungicide Resistance Action Committee (FRAC) was founded as an 
organization designed to discuss resistance problems and to formulate plans 
for cooperative efforts to avoid or manage fungicide resistance. 
http://www.frac.info/about-
frac/why-frac- 
1981 
Dithane, Benlate and Calixin were reintroduced to control black Sigatoka. 
At that time protectant fungicides were used combined with cocktails during 
rainy periods and almost exclusively in dry periods. 
Stover 1990 
1983 
First report of black Sigatoka in Cameroon. The symptom development 
method was modified to six stages by Fouré.  
Fouré 1985, Stover 1990 
1984 
The first triazole fungicide propiconazole belonging to the DMI group was 
introduced together with a forecasting method to control black Sigatoka. 
Stover 1990 
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Year  Black Sigatoka strategies evolution and important events Reference 
1986 
Flusilazole fungicide is introduced for black Sigatoka control. Propiconazole 
and flusilazole were extremely effective having curative effect when applied 
14 days after the cigar leaf unfurled. Both compounds were extremely 
persistent in the leaf (up to 60 days after application) and were applied as 
oil-in-water emulsions. The decision supports system (forecasting) and the 
use of triazoles reduced the number of application cycles for black Sigatoka 
control from 35 - 45 to 20. 
Stover 1990 
1987 
Guidelines were established to reduce the development of resistance in 
Pseudocercospora fijiensis to azoles and included no year-round 
applications (max. 4 - 8 cycles over six month).  
Stover 1990 
1988 
Fungicide resistance monitoring methods were discussed/described during 
the first meeting on the use of DMI fungicides. 
Stover 1990 
1997 The first quinol oxidation inhibitor (QoI) or strobilurin was introduced. Amil et al 2007 
2000 
Resistance to the QoIs already common on some farms in the productions 
zones of Costa Rica. 
Amil et al 2007 
2003 
 Reduced efficacy of DMIs towards P. fijiensis is prevalent in many 
countries. 
 FRAC Banana Working Group is established.  
Marín et al 2003 
 
http://www.frac.info/about-
frac/why-frac- 
2004 Anilinopyrimidines are introduced.  Guzmán 2007 
2006 
DMI sensitivity is not “restored” after refraining from application over a 
period of four years in Costa Rica. 
Guzmán 
2008 
P. fijiensis populations in Costa Rica are nearly fixed for QoI resistance (92-
100%). 
Arango et al 2016 
2009 
 Correlation between reduced efficacy of triazoles and point mutations 
in the Pfcyp51 gene discovered. 
 Overexpression of the Pfcyp51 gene is found in Costa Rican samples 
from 2009. 
Cañas et al 2009 
 
Chong et al 2012, Díaz et al 2016 
(Chapter 3 and 4) 
2010 
 Irrespective of the country of origin in Latin America, the baseline 
sensitivity for boscalid, fluopyram and isopyrazam is high. 
 Black Sigatoka incursion in Martinique.  
http://www.frac.info/docs/default-
source/working-groups/banana-
group/group/2010-meeting-
minutes---english.pdf?sfvrsn=4 
Ioos et al 2011 
2012 Black Sigatoka incursion in Guadalupe. Guzmán et al 2013 
2016 First genetic mapping of DMI resistance in P. fijiensis. Chong et al 2016c (Chapter 5) 
 
 
DMIs as major control agents for black Sigatoka management 
Currently, the DMIs are the major control agents for black Sigatoka in banana. The P. 
fijiensis DMI baseline sensitivity in Costa Rica has been continuously rising: In 2003, Marín et 
al., reported an average EC50 for propiconazole of 0.15 mg.L
-1 with a maximum value of 0.5 
mg.L-1 in Costa Rica populations (Marín et al. 2003). Díaz et al., (2016) showed an increase 
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among four resistant Costa Rican isolates sampled in 2009 to an average of 1.10 mg.L-1 with a 
maximum value of 1.53 mg.L-1 and recently Chong et al. (2016) determined an EC50 average 
of 5.8 mg.L-1 and a maximum value of 18.4 mg.L-1 among 107 P. fijiensis isolates from 2014 
(Chong et al. 2016b). This shows that the EC50 between 2003 and 2014 gradually increased 
with an average of 1.4 fold per year. For example, based on 2009 the measured average was 1.1 
mg.L-1 and predicted by calculation, is 1.12 mg.L-1. Therefore, the increment is predictable and 
it is currently 38 times higher than in 2003. Evidently, one can argue that the locations and 
sample numbers need to be considered but the sensitivity shift is clear. 
As mentioned above, Costa Rica has a long history of black Sigatoka control with a 
high number of fungicides applications per year (Lapeyre et al. 2010a; Marín et al. 2003). The 
observed DMI baseline sensitivity shift correlates with the increasing amounts of applied 
fungicides, which increased from 30 in the 1990’s up to 50 treatments by 2007 and up to 53 in 
2015 on the San Pablo plantation (Figure 1). In a global survey for DMI efficacy, Chong et al., 
(2016) recently reported that EC50 values among Costa Rican P. fijiensis isolates are 
representative for the selective pressure exerted by DMIs fungicides on the pathogen 
population. Interestingly, at least for the case of “San Pablo”, the actual number of DMI cycles 
reduced over time from seven to four applications per year in 1998 and 2014, respectively, but 
overall the number of DMI cycles was approximately 10 between 2003 and 2010. From 2014 
to 2015, there was a sudden rise in the number of DMI cycles (from four to seven; Figure 2) 
that maybe a consequence of the frequency of less sensitive isolates with high EC50 values in 
the “San Pablo” population (sample taken in 2014, Figure 3) (Chong et al. 2016b). This suggests 
that the selective pressure in previous years was sufficient to turn the major part of the 
population into resistant strains by 2014.  
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Figure 1. An overview of different chemicals used to control black Sigatoka at the San Pablo 
plantation in Limon, Costa Rica, in 1998 and during the period 2003-2015. Numbers over the 
coloured bars indicate the annual frequency of applications per chemical group. The numbered 
diamonds over the bars indicate the total number of fungicide cycles per year (One cycle can 
include several fungicides in mixtures). 
 
 
Figure 2. An overview of the number of DMI applications for the control black Sigatoka at the 
San Pablo plantation in Limon, Costa Rica, in 1998 and during the period 2003-2015. 
 
 
Figure 3. The average sensitivity, measured as EC50, of 49 randomly collected mono-
ascosporic Pseudocercospora fijiensis strains from the San Pablo - Limon, Costa Rica - 
population to three DMI fungicides in 2014. Strains with an EC50 values >1 mg.L
-1 are 
considered resistant (Chapter 3) (Chong et al. 2016b). 
7
10 10 12 8 10 9 10 10
4 5 5 4
7
2 3 1 2 2 2 2 23 2 3 3 2 2 2 1 1 3 1 2 2
11 12
17 17 16 16 16
22 23 21
10 9
12 13
4 6 6 6 4 5
7 8 5 3 4 41 1 1 1
18
25 24 22
30
26 25 26 25
36
39 41 37
32
39
50 50 50 52
46
52
55
50 48
51 53 50
53
0
10
20
30
40
50
60
1998 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015
Fu
n
gi
ci
d
e
 C
yc
le
s
Year
DMI Benzimidazoles QoI Amines Pyrimidines SDHI Contact fungicides Total Cycles
7
10 10
12
8
10
9
10 10
4
5 5
4
7
0
2
4
6
8
10
12
14
1998 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015
D
M
I f
u
n
gi
ci
d
e 
cy
cl
es
Year
5.39
3.91
4.71
0
1
2
3
4
5
6
7
8
Difenoconazole Epoxiconazole Propiconazole
E
C
5
0
m
g
.L
-1
An historical treatise and critical review 
33 
It is important to mention that the aforementioned reduction of DMI cycles at “San 
Pablo” between 2011 to 2014 was driven by forecast information (weather and disease 
development) and economic considerations, but not by the reduced efficacy of the compounds. 
In addition, ceasing DMI applications for a period of four years hardly changed the frequency 
of resistant strains in the population. This suggests no fitness penalty for reverting to sensitivity. 
Previous studies in P. fijiensis have not shown significant differences in incubation period, 
latency period, conidial sporulation and severity between DMI sensitive and resistant isolates 
(Romero 1999). Hence, the use of DMI free periods will likely not contribute to population 
shifts towards sensitivity. On the contrary, by the end of the four years without DMIs fungicides 
the frequency of DMI resistant strains increased in both treatments (Figure 4), which might, 
however, also result from the immigration/gene flow from the DMI experimental plots (plots 
of 50 ha with 200 ha borders between experimental plots) since the airborne P. fijiensis 
ascospores can travel at least hundreds of meters (Guzmán 2007; Lapeyre et al. 2010b; Rieux 
et al. 2014). The increased use of mancozeb, azoxystrobin and tridemorph compensated for 
reduced cycles with DMIs, but exerted – of course – significant selective pressure for these 
fungicides (azoxystrobin and tridemorph), and has resulted in P. fijiensis populations that are 
nearly fixed for strobilurin resistance, surely compared to the wild type (wt) population of San 
Carlos (Arango et al., 2016).  
The historical records (2001 – 2015) for DMI sensitivity monitoring (discriminatory 
dose 0.1 mg.L-1) of ascospores germ tube lengths from different Costa Rican banana regions 
enable a comparison of wt site San Carlos with commercial banana plantations (Figure 5). In 
general, the loss of sensitivity curve fluctuates, but seems to stabilize in the last 5 years, which 
can be explained by the implementation of better control (with mixtures of different target-site 
specific and protectant fungicides) and management strategies during recent years. 
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Nonetheless, germ tube lengths monitoring experiments have unequivocally shown the reduced 
efficacy of DMIs for Costa Rican P. fijiensis populations (Chong et al. 2016b). 
 
 
 
Figure 4. The infection index of Pseudocercospora fijiensis on Cavendish banana at the San 
Pablo plantation – Limón, Costa Rica - in plots that were either treated with DMIs or that 
underwent alternative treatments without DMIs from 1998 to 2001 (Guzmán 2007). 
 
 
Evidently, it is possible that the contrast in sensitivity levels is determined by the two 
monitoring procedures - EC50 based on mycelial growth in 96-well plates vs. ascospores germ 
tube lengths - or by the physiological differences of the tested tissues (mycelium vs. 
ascospores). For example, ascospore monitoring procedures are evaluated with two or three 
doses at 48 hours with a considerable number of samples (on average 100 spores per treatment 
with more than three repetitions). However, only three doses preclude observing accurate 
response levels, despite the representative number of ascospores per population. Alternatively, 
some fungicidal effects might be expressed at stages after 48 hours. Calvo et al. (1997) showed 
that the germ tube of propiconazole resistant ascospores continued growing after 48 hours, 
while those of some sensitive ascospores stopped growing after 48 hours (Calvo et al. 1997). 
In contrast, mono-ascosporic colonies are evaluated with eight different doses and after five to 
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10 days incubation with mycelium pieces in 96-well microtiter tests (Chong et al. 2016b), a 
method that is very common for other fungi, such as the related Zymoseptoria tritici where 
thousands of isolates are monitored on an annual basis by various laboratories 
(http://www.frac.info/monitoring-methods). Hence, this method is more precise to determine 
overall sensitivity of an individual strain, but requires a range of preliminary experiments for 
standardization and statistical analyses as well as sufficient samples to represent a given 
population. Despite the different levels, however, the shift of base line sensitivity is recorded 
independent of these two methodologies, which is also apparent by analysing the P. fijiensis 
populations in commercial farms with the wt population at San Carlos (Figure 6; Chong et al., 
2016). In the commercial banana farms the percentage of inhibited ascospores tends to decrease. 
Ascospore germ tubes inhibition in the range of 50-70% (Figure 6) might result individuals 
with moderate sensitivity to DMIs or to tolerance, as defined by normal development despite 
substantial abiotic stress. Interestingly, we noticed that there is always a very low percentage 
of isolates from the control population with high levels of DMI resistance as well as very 
sensitive ascospores from overall resistant populations at commercial farms. This supports the 
hypothesis that there are always sensitive isolates that escape disease control or resistant isolates 
that are able to survive and reproduce in a non-selective environment (Latin 2011; Vincellin 
2014). We have not observed such blurred classes for strobilurin resistance in the same 
populations (Arango et al., 2016). 
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Figure 6. Comparison of the inhibition of Pseudocercospora fijiensis ascospore germ-tube 
lengths at 0.1 mg.L-1 as a measure of sensitivity to the DMI fungicides propiconazole, 
difenoconazole and epoxiconazole in either control sites at commercial Cavendish plantations 
in the main producing area in Limón (red bars) and San Carlos (green bars) Costa Rica. 
Populations with >70% inhibited ascospores are considered as sensitive, whereas those with 
inhibition percentage between 50% and 70% are supposed to be tolerant and <50% inhibited 
ascospores populations are presumably resistant.   
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Clearly, one of the most important questions about the selection pressure that DMI 
fungicide exerts on P. fijiensis populations is about the actual doses that reach the fungus. The 
translation from laboratory efficacy trails to field conditions is difficult and hardly tested. 
However, we have performed inoculation trails with P. fijiensis isolates of various resistance 
levels – as determined in the laboratory - and showed that some resistant strains were equally 
fit in greenhouse trials using field doses of DMIs (DMI doses of 400 mg.L-1 Figure 7).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Phenotyping DMI sensitive and resistant Pseudocercospora fijiensis strains on 
Cavendish (var. Grand Naine) under greenhouse conditions. Plants were treated prior 
inoculation with two DMIs (propiconazole, Tilt, and difenoconazole, Sico) or with the water 
control (no fungicide application). Plots show a rapid development of infected leaf area by the 
resistant strain R2. Resistant strain R1 developed much slower but caused significantly more 
disease than the sensitive control (S2), Disease development was monitored between 7 and 49 
days after inoculation (dai). 
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In general, most farmers follow the technical instructions of the manufacturers as 
printed on the label of the commercial fungicides, but the effective dose also depends on the 
“carrier”, mineral oil or oil in water emulsions with different emulsifiers. Fischer (1991) 
reported that a mix of propiconazole in emulsion has a foliar level recovery of 90% compared 
to just 43% in mineral oil, although the latter had a significantly better leaf coverage than 
emulsions, particularly under moderate dew conditions. 
Details on final DMI doses under field conditions are available in the – rare - Ciba-
Geigy Tilt technical dossier from 1991. It provides one of the most complete descriptions of 
the application, leaf penetration and inside leaf degradation of the product. This important 
information should be available for each fungicide that is commercialized for black Sigatoka 
control. For example, oil in water emulsion was the best combination for leaf penetration from 
13 mg.L-1 of fungicide inside the leaf at the first hour down to a final dose of 2 mg.L-1 at 96 
hours after application. However, the most stable application was the mix with oil that despite 
a relatively low leaf penetration - at the first hour after application 5 mg.L-1 – maintained a 
concentration of 6 mg.L-1 for the next 11 hours and finally of 4 mg.L-1 between 24 and 96 hours. 
Finally, a water formulation showed a penetration of 6 mg.L-1 at the first hour, which dropped 
to only 0.5 mg.L-1 at 96 hours. In general, the major fungicide part that penetrated the lamina 
disappears within 12 hours (biological degradation, dilution), but a residual low level of the 
active ingredient remains in the tissue for more than four days (Ciba-Geigy 1991). Still, it is 
worth mentioning that doses on the leaf are usually 1 to 1.5 times higher during the first 12 
hours (the persistence of the fungicide on the leaf highly depends of the type of carrier) (Ciba-
Geigy 1991). Hence, considering these results, the actual propiconazole doses that most 
pathogen spores and colonies face will be 1-5 mg.L-1 at least for some days (Ciba-Geigy 1991), 
provided an appropriate distribution on/in the leaf. We, therefore, conclude that the empiric 
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dose of 1 mg.L-1 as a threshold for propiconazole resistance in laboratory efficacy trials has a 
solid support from leaf penetration experiments. 
 
Cultural practices to reduce black Sigatoka impact 
The control of the critical levels of black Sigatoka in banana plantations is driven by 
reducing direct costs- such as reduced yield potential – and indirect costs, due to reduced 
quality. The latter is far more important as the disease triggers early ripening, which makes the 
fruit unfit for export (Ploetz et al. 2015). Hence, the extraordinary control measures are required 
to deliver a marketable product that survives the demanding logistic chain (Guzmán et al. 2013; 
Ploetz et al. 2015). The favourable weather conditions for black Sigatoka development include 
high relative humidity (95 – 100%) with temperatures around 27°C and intermittent rain fall 
(Long 1979; Marín et al. 2003). The common agronomic factors that affect disease 
development include production site selection, banana variety selection, planting date, soil 
fertility and acidity, plant spacing, irrigation practices and field drainage (Vincellin 2014). As 
mentioned above, the underlying issues of black Sigatoka management is the fact that 95% of 
the export trade comprises highly susceptible “Cavendish” clones that essentially form one big 
monoculture around the globe (Ploetz et al. 2015). Hence, the reduction of on-farm inoculum 
is one of the most important cultural practices, which can be achieved by removing leaf tissue 
with mature pseudothecia that release ascospores. This practice is known as “deleafing”, 
“detipping” or “surgery” (Marín et al. 2003). The detached foliage will rapidly decompose on 
the plantation floor, but still may provide inoculum. Therefore, decomposition is stimulated by 
adding products, such as urea, which altogether can reduce the infectiousness by 50% (Marín 
et al. 2003). Water logging is a potential threat to banana plantations under tropical conditions 
and, hence, appropriate drainage, plant spacing or drip-irrigation are crucial for optimal plant 
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development and to reduce excessive humidity that supports disease development (Marín et al. 
2003). 
 
The commonest fungicides and spraying programs for black Sigatoka 
management  
Overall, the international banana industry just uses two kinds of fungicides for black 
Sigatoka management that are categorized according to their phytomobility, either contact or 
penetrant fungicides (Table 2). Contact fungicides remain on the surface of the leaf and they 
are only redistributed by precipitation, irrigation and dew. Penetrant fungicides, on the other 
hand are absorbed into the plant tissue and can be subdivided into acropetal, local penetrant or 
systemic penetrants (Latin 2011). In acropetal penetration compounds are moving between cells 
along with the water potential gradient. They are xylem mobile and therefore translocated 
upward towards the leaf tips and margins. Local penetrants diffuse into the wax/cuticle layer 
where they are bound and immobilized. Systemic penetrants move inter- and intracellularly 
with the live protoplast and follow a sugar density gradient (Latin 2011). The main 
contemporary compounds currently used for black Sigatoka management are contact fungicides 
such as mancozeb and chlorothalonil, and the acropetal penetrant fungicides such as the DMIs 
propiconazole, epoxiconazole, difenoconazole and tebuconazole. Despite the overall resistance 
development strobilurins such as azoxystrobin, pyraclostrobin and trifloxystrobin are still in 
use, likely due to their “greening effect” (Bennett & Arneson 2003; Pérez 2006). Finally, 
tridemorph (amine) has been also very important for the control of black Sigatoka, particularly 
in mixtures with protectants or systemic fungicides. Table 2 describes all the fungicides that 
have been recommended by the Fungicide Resistance Action Committee (FRAC) for the 
control of black Sigatoka. Usually, several fungicides are prepared as “cocktails” that are 
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composed of two or three fungicides with different modes of action. Generally, a mix is 
composed by one or two systemic fungicides and a protectant, for instance a DMI, an amine 
and mancozeb. Occasionally, QoIs (depending of the level of resistance in the population) or 
SDHIs are used instead of DMIs. QoIs are most of the time mix with amines or pyrimidines. 
Due to the epidemiology of the disease, with an almost continuum of ascospore production 
(Lapeyre et al. 2010b; Marín et al. 2003), contact fungicides remain a very important 
component of the tank mixes, sometimes combined with new or specialty products such as 
vegetable wax and various biologicals (Table S1). 
At present, weekly spray schedules are required with around four applications per 
month (depending of the rain fall). This is significant more than e.g. the San Pablo applications 
schedule in 1998 that comprised three applications per month in general and two applications 
from May to August. At that time, most fungicides were applied alone and systemic fungicides 
were applied in a six-month period, alternating weekly with another moa or contact fungicide. 
In 2003, applications were raised to five per month in some periods and most fungicides were 
mixed in “cocktails”; either systemic/protectant or protectant/protectant tank mixtures, 
although these protectants were also applied alone. Then, from 2008 onwards, spray schedules 
were more or less the same with four applications per months using systemic fungicides applied 
in mixtures and alternating moa’s over a six-month period. The number of applications was 
increased to five per month in 2009 which is unaltered since then. A summary of the application 
cycles and the specific systemic groups being applied is shown in Figure 1. Table S1 provides 
the actual San Pablo fungicide application schedule during 2015. 
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Table 2. Fungicides used in black Sigatoka control ordered by their chemical classifications 
(FRAC 2013, 2015). 
 
*Some trade names also include mixes with other active ingredients. 
Chemical class 
Fungicide use 
in banana 
Fungicide trade 
name* 
Description  
Contact 
fungicides 
Benzene derivatives chlorothalonil 
Bravo, Bronco, 
Daconil 
This compound interferes with the glutathione pathway, a 
coenzyme and 2-mercaptoethanol reducing thiol-group 
based metabolism in the cell. 
Carbamates Mancozeb  Dithane 
Mancozeb is placed in the subclass of carbamate pesticides 
called dithiocarbamates. As a cholinesterase inhibitor, it 
affects the nervous system. 
Systemic 
fungicides 
Demethylation 
inhibitors (DMI) 
bitertanol Baycor 
These compounds inhibit the lanosterol 14α-demethylase, 
an essential enzyme of the ergosterol biosynthesis pathway.  
difenoconazole Score, Sico 
epoxiconazole Opus  
fenbuconazole  Indar 
myclobutanil Rally, Sisthane 
propiconazole  Tilt, Bumper 
tebuconazole  Silvacur 
tetraconazole Eminente 
triadimenol 
 Bulldock, 
Caporal,  
Amine fungicides 
spiroxamine  Impulse 
Amines are ergosterol synthesis inhibitions. Tridemorph 
inhibits the Δ8 – Δ7 isomerase and the C14 reductase in the 
ergosterol metabolic pathway.  
fenpropimorph  Volley 
fenpropidin Seeker 750 
tridemorph 
Calixin, 
Musaclean 
Qo inhibitors (QoI) 
azoxystrobin Amistar, Bankit 
Quinol oxidation inhibitors (QoIs) or strobilurins, block the 
respiration pathway by inhibiting the cytochrome bc1 
complex in mitochondria.  
pyraclostrobin  Comet 
trifloxystrobin Tega 
Anilinopyrimidines 
(AP) 
pyrimethanil Siganex 
AP’s inhibit the methionine biosynthesis. It should only be 
used in mixtures and in full alternation. To reduce selection 
pressure, the total number of applications is limited to eight 
per year and these should not represent more than 50% of 
total number of sprays. 
Benzimidazoles 
(BCM) 
benomyl Benlate 
Fungicides with high systemic and curative activity that allow 
long intervals between applications. Resistant P. fijiensis 
strains were detected two years after first application. 
carbendazim Curacarb 
 thiophanate  Cycosin 
thiabendazole Mertect 
thiophanate-
methyl 
Nucilate, 
Thiophol, Topsin. 
N-
Phenylcarbamates 
dietofencarb,  Powmyl 
No sensitivity data are yet available. A maximum of 33% of 
the total number of sprays can be applied with N-
Phenylcarbamates. 
SDHI fungicides 
boscalid Cumora 
Irrespective of the country of origin in Latin America, the 
baseline sensitivity for boscalid, fluopyram and isopyrazam 
is high. 
 
fluopyram Luna  
isopyrazam Reflect 
Guanidines dodine Syllit 
Irrespective of the country of origin in Latin America, the 
baseline sensitivity for dodine is variable. However, in 
Ecuador baseline sensitivity did not significantly change after 
two years of applications.  
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Molecular analyses of fungicide resistance in P. fijiensis 
One of the main adaptations to environmental changes or selection pressure is the 
genetic variation of the target organism, which modulates and complicates sustainable disease 
control. Site-specific compounds often select for total resistance due to point mutations - often 
referred as “major gene” resistance or “monogenic” resistance - that renders these compounds 
ineffective (Latin 2011), including the mechanisms for resistance to benzimidazoles and 
strobilurins. Eventually, mutant alleles will dissipate in the population conferring partial or total 
resistance to a particular fungicide (Grünwald et al. 2003), whereby the epidemiology of the 
organism can amplify the effect and rate of dissemination (Aouini et al., 2016). The target of 
DMIs is lanosterol 14α-demethylase that is encoded by Pfcyp51 (Cañas et al. 2009). Recent 
studies revealed a correlation between propiconazole resistance and point mutations in the 
Pfcyp51 gene (Cañas et al. 2009; Chong et al. 2010; Lepesheva & Waterman 2004). The effect 
of point mutations in the Pfcyp51 gene was also related with cross resistance to epoxiconazole 
and difenoconazole  (Chong et al. 2016b). The plethora of Pfcyp51 mutations has resulted in a 
total of 28 aa substitutions (Chong et al. 2016b). From this 28 aa substitutions, positions 136, 
313, 380, 381 and 460 – 463 have been associated with loss of sensibility to DMI (Cañas et al. 
2009; Chong et al. 2016b). These amino acid changes are nearby central positions of the 
lanosterol 14α-demethylase, surrounding the Substrate Recognition Site (SRS) (e.g. positions 
Y136, A313, 381) and inside a loop close to the L α helix (e.g. Y460 to Y463) (Cañas et al. 
2009; Chong et al. 2016b; Lepesheva & Waterman 2004). The large variation in genetic 
isoforms complicates the analysis of the enzyme and the corresponding degrees of resistance. 
Pfcyp51 promoter insertions were recently discovered as a driving mechanism for Pfcyp51 
expression contributing to quantitative variation for reduced DMI sensitivity (Chong et al., 
2016a, 2016b; Diaz et al., 2016). Similar mechanisms were identified in Aspergillus fumigatus 
isolates that are resistant to medical azole fungicides (Mellado et al. 2007; Snelders et al. 2012; 
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Verweij et al. 2013). Interestingly, none of the DMI sensitive strains found in a global survey 
contained promoter insertions, while they were very common in tolerant and resistant strains 
and correlated with the levels of resistance to DMIs (Chong et al. 2016b). Overexpression of 
cyp51 also correlated with promoter insertions in Venturia inaequalis and Blumeriella jaapii 
(Schnabel and Jones 2000, Ma et al. 2006), but their frequency in P. fijiensis is unparalleled. In 
B. jaapii, the overexpression results from upstream insertions of various truncated derivatives 
of LINE-like retrotransposons (Ma et al. 2006). However, the underlying mechanism and 
function of these repeated elements remains to be deciphered (Schnabel and Jones 2000, Ma et 
al. 2006; Diaz et al., 2016) and might involve blocking proper binding of expression reducing 
components or generate binding sites for positive regulators that enhance the promoter.  
 
Supervised black Sigatoka control aided by disease forecasting systems  
Forecasting systems have been essential tools for the control of black Sigatoka by 
using climatic and biological descriptors for the prediction of the severity of the disease 
(Guzmán 2007; Lapeyre et al. 2010b; Marín et al. 2003). These severity predictions are used 
for the timely application of the fungicide (Guzmán 2007; Lapeyre et al. 2010b). This allows a 
supervised rather than a calendar driven application, which supports efficient use of fungicides 
and modulates their application depending on necessary doses or frequencies. As mention 
above, most of the control strategies in black Sigatoka have been adapted from control programs 
that were developed for the milder yellow Sigatoka, which is caused by the fungus P. musae. 
The first forecasting for oil sprays was determined by symptom severity of controls that were 
only treated with oil (Stover 1990). Later, weather variables, such as temperature and 
evaporation rates, were additionally used to optimize fungicide applications by Ganry and 
Meyer (1972), including the use of oil and systemic fungicides (benomyl) and using a 0-5 scale 
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for symptom severity classes for yellow Sigatoka (Ganry & Meyer 1972; Stover 1990). After 
the incursion of black Sigatoka in Cameroon in 1983 the symptom development score was 
extended by Fouré with an additional severity class (stage 6) (Fouré 1985; Stover 1990). 
Despite the overall success of these forecasting programs in a more supervised control 
of black Sigatoka for many years, they never took into account the cost of fungicide resistance. 
Since they only can be used with highly curative systemic fungicides (single target) the 
development of fungicide resistance interfered with their efficacy, leading to progressive 
abandoning of this rational strategy in favour of the systematic use of contact fungicides that 
must be applied every week (Lapeyre et al. 2010b). Hence, notwithstanding the fact that 
forecasting programs are still being used – in oil mixtures and based on different chemistries - 
as a decision making tool, there is a need for optimized and modernized programs to further 
fungicide efficiency in black Sigatoka control (Lapeyre et al. 2010b). 
 
The way forward: integrating molecular DMI resistance parameters in 
disease management  
Biological parameters such as the ‘Stage of Evolution of Disease’ (SED), the 
‘Youngest Leaf bearing Streaks’ (YLSt), The ‘Youngest Leaf Spotted’ (YLS) and the ‘Number 
of Functional Leaves at Harvest’ (NLH) are very important for decision making and the 
evaluation of the efficacy of control strategies (Lapeyre et al. 2010b). Sensitivity monitoring 
procedures of the ascospores germ-tube inhibition have also been use for decision making, 
especially for the evaluation of the efficacy of control. Nonetheless, the information retrieved 
by this methodology is too superficial. Since is not possible to recover any molecular 
information from this method the information about the mechanism behind the resistance is 
lost. A more professional methodology has to be implemented integrating the molecular 
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information to understand the origin of the resistance. The currently available molecular 
information on modulation of the Pfcyp51 gene, which seems the main driver for reduced 
sensitivity (Chong et al., 2016c), is a potential add-on for optimizing forecasting programs and 
hence, disease control. Quantitative information on overall P. fijiensis population 
characteristics (EC50 values, number of promoter inserts that can be monitored by simple PCR, 
but also cross resistance, multi drug resistance, fitness and virulence) in the target and 
neighbouring plantations - immigration and gene flow - can be used to predict the success of 
spraying cycles. The costs of generating these data is substantial due to sample/material 
preparation, but it provides a much broader view on the evolution of P. fijiensis populations 
that can be monitored and used to alert potential problems with reduced efficacy and hence 
inherent and increasing direct and indirect costs. With the continuously reducing costs for 
genome-based information, the use of this type of detailed information will positively 
contribute to optimize disease control. Governments and research institutes need to prepare 
themselves for advancing black Sigatoka management through interdisciplinary approaches 
using the latest technologies and alternative products to diversify and innovate control 
strategies. It is rather disturbing that monitoring of fungicide sensitivity in e.g. wheat is highly 
professionalized and entirely sequence based, but that black Sigatoka management is still using 
old-fashioned worn-out procedures that do not provide any insight in underlying mechanisms 
and thus prevent modernizing and rationalizing disease control. For instance, the lack of cross 
resistance between pyraclostrobin and azoxystrobin in P. fijiensis is nicely supported by a 
simple PCR test with specific molecular markers for the G143A substitution in the Pfcytb gene 
(Sepúlveda & Torres 2016). Such a quick scan is also possible for DMIs as we determined that 
aa changes at positions 313, 136 and 463 (or even combinations of these substitutions) are the 
most important substitutions causing reduced efficacy. In addition, promoter insertions can be 
visualized by a simple PCR and are important alerts for reduced efficacy of DMIs as recently 
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demonstrated for Costa Rica (Figure 8) (Diaz et al., 2016). Ideally, qPCR tests should be run 
directly on DNA preps from infected leaves to rapidly quantify and type DMI resistance in 
pathogen populations (Singh & Mustapha 2013). Eventually and evidently, sequence based 
technologies will revolutionize the discovery of underlying mechanisms of reduced sensitivities 
of disease control agents and will contribute to modern and optimized disease management. 
 
Figure 8. Example of PCR amplification of the Pfcyp51 promoter in Pseudocercospora fijiensis 
isolates from different populations. Isolate CIRAD86 (C86) was used as indicative control for 
the presence of one promoter element, and isolates Z8.12 and CA5_16 as controls with three 
and six repeat elements, respectively. The number of repeat elements in each control sample is 
showed over the corresponding band. The other strains originate from banana plantations under 
fungicide disease management and represent various promoter length variants. 
 
Comparing the use of DMI sensitivity data in the control of the fungal 
wheat pathogen Zymoseptoria tritici and Pseudocercospora fijiensis 
P. fijiensis and Z. tritici are two of the most economically important pathogens of 
banana and wheat, respectively (Cook et al. 2013; Dean et al. 2012; Kema 2009). The analogy 
between these related dothideomycetes (Arango et al. 2016) is key to the use of Z. tritici as a 
model for the molecular studies in P. fijiensis (Kema 2009; Stergiopoulos et al. 2014). There 
are also striking similarities and dissimilarities with regard to the evolution of DMI resistance 
in both species, which will increase the understanding of the phenomenon and how to deal with 
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it under practical conditions. Both diseases are foliar blights caused by species with striking 
similarities in lifestyle: a heterothallic bipolar mating system with both asexual and sexual 
reproduction that enables these pathogens to complete several sexual cycles per year, resulting 
in genetically very diverse and versatile populations (Arzanlou et al. 2010). Yet, despite 
numerous speculations, recent data have shown that the basis on the plant pathogen interaction 
is a classic gene-for-gene model with avirulence effectors and host receptors (Aouini 2016; 
Arango et al. 2016; Stergiopoulos et al. 2010). For both diseases, DMIs are the cornerstone of 
disease management (Cools & Fraaije 2013). The evolution of DMI sensitivity in Z. tritici is a 
continuous threat to growers and the agrochemical industry and therefore represents the best 
studied system in agriculturally important plant pathogenic fungi (Cools & Fraaije 2013). 
Similar to P. fijiensis, shifts in DMI sensitivity in Z. tritici populations have been gradual by 
nature and are therefore commonly attributed to polygenic mechanisms, including (i) alteration 
in the cyp51 sequence, (ii) overexpression of the cyp51gene and (iii) ATP-binding cassette 
transporters and major facilitators, resulting in fungicide efflux (Chong et al. 2016c; Cools & 
Fraaije 2013; Cools et al. 2013; Cowen 2008). 
With regard to modulation of the cyp51 gene, many - similar - mutations have been 
identified for P. fijiensis and Z. tritici (Cañas et al. 2009; Chong et al. 2016b; Cools & Fraaije 
2013). In the cyp51 gene for 36 amino aa substitutions were identified in Z. tritici and 28 aa in 
P. fijiensis. Some of these, identical, substitutions have been instrumental for DMI resistance 
(Chong et al. 2016b; Cools & Fraaije 2013). For example, the substitution Y136F in P. fijiensis 
is equivalent to Y137F in Z. tritici, and both are also linked with reduced DMI sensitivity in 
Penicillium italicum, Uncinula necator and Blumeria graminis f. sp. hordei (Albertini et al. 
2003; Cools & Fraaije 2013; Délye et al. 1997). A substitution at Y136, or its equivalent in 
other species, is the most frequently observed modification of CYP51 in pathogenic fungi 
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(Cools et al. 2013). Interestingly, the equivalent position in Z. tritici, Y137F, although common 
in strain from the 1990s, has now virtually disappeared from the population. Cools and Fraaije 
(2013) associate this phenomenon with the disappearance of triadimenol, a fungicide that was 
commonly used in 1970s (Cools & Fraaije 2013). Substitution Y136F in P. fijiensis represents 
a 17.47% share in a recent global survey among 269 isolates and is primarily present in Costa 
Rica (2014) and Colombia (2012) (Chong et al. 2016b). It was also identified in two isolates 
from the Dominican Republic and in one strain from Cameroon (2014), but is absent in 
Ecuadoran isolates (2011) as well as strains from Martinique and Guadalupe (2013) (Chong et 
al. 2016b). Given the example of Z. tritici, it is of interest to study whether these differences 
can also be attributed to the use of particular fungicides in these countries. Substitutions V136A 
and I381V are correlated with reduced sensitivities to tebuconazole in Z. tritici (Cools et al. 
2013). Positional changes at 380 and 381 in P. fijiensis tend to be rare, and were most prevalent 
in strains from Costa Rica and the Dominican Republic (Chong et al. 2016b). It would be of 
interest to test such isolates for sensitivity towards tebuconazole, but thereby considering that 
isolates that overexpress Pfcyp51 are less susceptible and show reduced variation in their 
response (overexpression is not selected for based on specific DMI fungicides) (Cools & Fraaije 
2013). Hence, any phenotypic test with tebuconazole should be conducted with a strain carrying 
substitutions at position 380 or 381, but with a wild type promoter. 
Other similitudes are found in substitutions around positions 313 and 460 to 463 
(Cools et al. 2013). In Z. tritici modulation of position 312 is rare, but aa changes at position 
313 are ubiquitous in P. fijiensis (Chong et al. 2016b; Cools & Fraaije 2013). In both species 
we have identified numerous aa changes that do not have any apparent relation with DMI 
sensitivity and could either result from compensating mutation events, contingent evolution or 
exert pressure for the selection of important substitutions (Chong et al. 2016b; Cools & Fraaije 
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2013). CYP51 complementation experiments in Saccharomyces cerevisiae or P. fijiensis 
transformation experiments can be used to analyse the importance of these substitutions (Cools 
& Fraaije 2013; Díaz-Trujillo et al. 2016a). The collected data in both species clearly indicate 
that accumulation of mutations in the cyp51 gene in drive reduced sensitivity to DMI fungicides 
(Cools et al. 2013). The environmental exposure of other fungi, including the human pathogen 
A. fumigatus, and the reduced efficacy of (medical) DMIs is a worrying situation with far 
reaching consequences for patients and potential risks for occupational health of workers in the 
agricultural sector (Risède et al. 2010; Snelders et al. 2012; Verweij et al. 2009). 
Overexpression of the cyp51 gene has been also reported in both species (Chong et al. 
2010; Cools et al. 2012; Díaz-Trujillo et al. 2016a). In Z. tritici a 120 bp insertion in the 
promoter region correlates with a 10 to 40-fold overexpression of the cyp51 gene (Cools et al. 
2012). Similarly, promoter insertions in Pfcyp51 cause an overexpression resulting in decreased 
sensitivity to DMIs (Díaz-Trujillo et al. 2016a). However, promoter insertions are very rare in 
Z. tritici but, contrastingly, common in P. fijiensis where the actual insertion is a repeat of a 
normal Pfcyp51 promoter element of 19 bp that is repeated many times at position 103, 
upstream of the coding region of the Pfcyp51 gene (Chong et al. 2016b; Díaz-Trujillo et al. 
2016a). A similar tandem repeat associated reduction of DMI sensitiveness was observed in A. 
fumigatus (Mellado et al. 2007; Snelders et al. 2012; Verweij et al. 2013). The size, nature and 
location of the promoter inserts in Z. tritici and P. fijiensis are distinct and unique and therefore 
likely not related or due to a similar mechanism. Nevertheless, the fact that promoter insertions 
arose in three fungi that are commonly treated with DMIs raises important questions on their 
origin and role in order to improve their management both in agriculture as well as the clinical 
practice. 
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Finally, the role of transporters– either major facilitators (MFS) or ATP-binding 
cassette (ABC) transporters – in reduced efficacy due to increased efflux of active ingredients 
of fungicides has been reported in several plant and human pathogens, including Candida 
albicans, A. fumigatus and Z. tritici (Cools et al. 2013; Cowen 2008; Stergiopoulos et al. 2002; 
Zwiers 2002). Until now there is no report on increased expression of membrane transporters 
in P. fijiensis. All current evidence points to cyp51 as the major regulator of DMI sensitivity 
(Chong et al. 2016c). Recently, Chong et al. (2016b) followed an unbiased genetic mapping 
approach to identify genomic regions involved in DMI sensitivity, which identified one major 
genetic window containing Pfcyp51 on putative chromosome 7. However, the aforementioned 
genetic window contained at least 52 other genes, including a putative ABC transporter that 
cannot be ruled out to affect DMI sensitivity and await functional analysis (Chong et al. 2016c). 
 
The P. fijiensis – banana interaction and its epidemiology impact on black 
Sigatoka disease 
As pointed out above, recent studies have shown that the P. fijiensis homologue of the 
Cladosporium fulvum Avr4 effector is recognized by the tomato Cf4 resistance gene 
(Stergiopoulos et al., 2010; Arango et al., 2016). Moreover, the allelic variation at this PfAvr4 
locus is limited to just six variants (Stergiopoulos et al., 2014). Since Calcutta 4 (M. acuminata 
ssp. burmannica, a wild diploid banana) showed a typical hypersensitive response to P. fijiensis 
isolates carrying PfAvr4, it is considered that wild banana germplasm carries homologues of 
Cf4 that can be used in either classical breeding or genetic engineering approaches (Arango et 
al., 2016). Similar to the situation in Z. tritici, a basic understanding of the pathosystem will 
eventually lead to enhanced breeding efforts that will lead to the discovery of new resistance 
genes for black Sigatoka management. Thus far, this is not seriously addressed and hence, all 
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breeding efforts rely on just natural infection. A more targeted approach taking into account the 
achievements in other similar pathosystems, such as the wheat-Z. tritici pathosystem (Mirzadi 
Gohari et al. 2015), will greatly advance breeding output and efficiency, which eventually will 
exploit natural host resistance as a major factor for disease control. Surprisingly, this is hitherto 
virtually neglected as a breeding target in banana.  
 
The long road to a sound black Sigatoka disease management 
First of all, it is important to note that black Sigatoka is primarily a problem in large 
monoculture export plantations that are dominated by “Cavendish” clones. However, the 
disease is definitely also of importance for non-export countries such as India and Brazil that 
either grow increasing volumes of “Cavendish” clones, or a suite of different varieties with 
greater appreciation by the consumer, respectively. Backyard farmers’ crops may be affected 
by the disease as well, but need a completely different approach through targeted small-holder 
oriented programs. These are increasingly driven by commercial breeding companies, as for 
other tropical crops, including potatoes, cucurbits and peppers, see also 
http://www.accesstoseeds.org. In any case, host resistance is a cornerstone for appropriate, 
effective disease management and this philosophy is absent in the global banana industry, where 
black Sigatoka is considered as a disease one can deal with due to the fungicide solution, despite 
the enormous costs (on average at least 1,000 – 1,500 USD.ha-1.year-1). However, any political 
decision or consumer preference to reduce the chemical load in banana production or a legal 
abandonment of aerial spraying will directly affect the industry and call for more sustainable 
ways to control the disease. Instead of short-sightedness, the industry needs strategy and vision. 
This warrants increased efforts to professionalize breeding programs supported by sound 
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scientific data. The recent suite of papers on black Sigatoka disease management and biology 
contribute to this raising awareness (Chong et al. 2016b; Chong et al. 2016c; Díaz-Trujillo et 
al. 2016a).  
The current review and the research referred to clearly indicate that the ceiling of 
chemical control of black Sigatoka is approaching or has been reached in some cases. One can 
simply not spray banana crops on a daily basis. Hence, alternative products with different moa´s 
and broader, multisite targets are indispensable for continued disease control. Meanwhile, 
sensitivity monitoring has to undergo a major shift towards scientifically oriented strategies 
using the latest technologies rather than old-fashioned worn-out methodologies that exist purely 
at the expense of production zones in the developing world. The continuously increasing 
resistance to systemic fungicides in the field is a clear wake-up call for the industry that now 
progressively falls back on protectants that are both environmentally unfriendly and threaten 
occupational health of farm workers, employees and surrounding villagers (van Wendel de 
Joode et al. 2016). Hence, governments, industry and the logistic chain players have to 
acknowledge and consider their responsibilities and undertake actions to ensure the trialling 
and release of new systemic fungicides and their integration with appropriate control strategies. 
In addition, the power of the retail sector and eventually of primarily Western consumers has 
to be leveraged with programs that constructively connect actors in banana production and the 
trade and simultaneously dovetails programs to support sound and sustainable banana 
production with justified wages for all chain participants. A low price in Western supermarkets 
at the expense of low wage countries is old fashioned, unjustified and conflicts with the current 
view on the distribution of wealth and harmonized good agricultural practice. However, 
strategic changes and solutions - such as diversified resistant banana germplasm - will only 
slowly surface, simply because these will take time and require substantial budgets to 
An historical treatise and critical review 
55 
materialize. Technically, major improvements of disease control methods can rapidly be 
achieved by (enabling the) adoption of new discoveries and using these in overall decision 
support systems as outlined above (Lapeyre, 2010; Risède et al., 2010). For instance, disease 
forecasting programs will work appropriately under suboptimal conditions for black Sigatoka 
disease development such as the dry tropics (Lapeyre, 2010). The challenge is to translate these 
to the wet tropics where P. fijiensis thrives and continuously undergoes sexual reproduction 
turning it into an extremely versatile pathogen. There, continuous monitoring of the fungicide 
sensitivity is one of the major tools for the timely and accurate modulation of forecasting and 
control strategies, which can be aided by the application of accurate and rapid molecular 
monitoring tools such as PCR-based technologies that will extend the timeframe for an adequate 
supervised response. Lessons from other crops should be learned in banana cropping thereby 
assuring a continued and justified access to food and fruit. 
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Supporting information 
Table S1.- Example of fungicide application data sheet for the San Pablo plantation in Costa 
Rica.  
DIRECCIÓN DE INVESTIGACIONES-CORBANA ASISTENCIA TÉCNICA EN EL MANEJO DE LA SIGATOKA NEGRA REGISTRO DE ASPERSIONES 
  Farm: San Pablo Este          Year: 2015 
      Program Operation Oil Oil Cycle  $ (Irrigation)   
Week Date Fungicide Mix Date Mix L/ha Mz Nu. D.C. 
ha 
cycle 
/ha/pdo
. 
Observatio
ns 
52/14         142.5 26.0 50       
System. 
aplic.: 
Triaz.= 7, 
Aminas= 13, 
Benz.= 0 
                      
Pyri.= 4, 
Carboxa= 1 
y Estrob.= 2. 
Total= 13 
1 28-Dec Dithane 1,75+3+NF Dec 28 
D1,75+N
F 
3 0.92 1 6     
MaxiBoost 
(0,6) / 161 
ha 
1 3-Jan Dithane 1,75+4+NF Jan 3 
D1,75+N
F 
4 0.92 2 6     
TechnoZn 
(1) / 157 ha 
3 12-Jan CSiCa2+9 (Calixin + Sico) 12 CSiCa2 9 1.00 3 9     155 ha 
4 21-Jan 
Volley (fenpropimorph) + 
Dithane 1+1,9+8 
22 
CVo(1)1,
9 
8 1.00 4 10     152 ha  
5 27-Jan Dithane 1,75+3+NF 27 
D1,75+N
F 
3 0.92 5 5     
TecnokZn 
(1) / 147 ha 
(renov c. 14-
19) 
5 31-Jan Dithane 1,75+3+NF 31 
D1,75+N
F 
2 0.92 6 4     
Phytocrop 
(1) / 147 ha 
7 9-Feb 
Opus (epoxiconazole) 
Impulse (Spiroxamide) 
Dithane 1,9+9 
Feb. 8 
COpIm1,
9 
9 1.00 7 8     
Adel x progr 
/ 148 ha 
8 18-Feb 
Impulse(Spiroxamide) 
Siganex (AP) Dithane 1,9+9 
18 
CImSx1,
9 
9 1.00 8 10     147 ha 
9 24-Feb Dithane 1,75+3+NF 24 
D1,75+N
F 
3 0.92 9 6     
TecnokZn 
(1) 
10 1-Mar Dithane 1,75+3+NF Mar. 3 
D1,75+N
F 
4 0.92 10 7     
Atra x clima / 
MaxiBoost 
(0,6) 
11 10-Mar 
CVo 0,85+1,9+6 
(fenpropimorph + 
mancozeb) 
10 
CVo0,85
+1,9 
7 1.00 11 7       
11 14-Mar Dithane 1,75+2+NF 14 
D1,75+N
F 
2 0.92 12 4     
TecnokZn 
(1) 
12 21-Mar 
CSx1,9+6 (pyrimethanil + 
mancozeb) 
21 CSx1,9 6 1.00 13 7       
13 26-Mar Dithane 1,75+3+NF 26 
D1,75+N
F 
3 0.92 14 5     
NutriProtect
or (0,51) 
14 31-Mar Dithane 1,75+3+NF 31 
D1,75+N
F 
2 0.92 15 5     Psac (1) 
15 9-Apr 
CTiCa1,9+7 (mancozeb +tilt 
+tridemorph) 
Apr. 9-
12 
CTiCa1,
9 
7.5 1.00 16 9     
Ti= Tilt / Atra 
x clima / Día 
12, aceite 8 
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DIRECCIÓN DE INVESTIGACIONES-CORBANA ASISTENCIA TÉCNICA EN EL MANEJO DE LA SIGATOKA NEGRA REGISTRO DE ASPERSIONES 
  Farm: San Pablo Este          Year: 2015 
      Program Operation Oil Oil Cycle  $ (Irrigation)   
Week Date Fungicide Mix Date Mix L/ha Mz Nu. D.C. 
ha 
cycle 
/ha/pdo
. 
Observatio
ns 
16 15-Apr 
Dithane 1,75+2+NF 
(Mancozeb) 
18 
CImSx1,
9 
8 1.00 17 9     
Reprog x 
atra y clima 
17 23-Apr 
Dithane 1,75+2+NF 
(Mancozeb) 
23 
D1,75+N
F 
2 0.92 18 5     
Día 25 renov 
2014: Sx+5 
(19,5 ha) / 
FolivFe (1) 
18 28-Apr 
DBg1,5+1 
(Mancozeb) 
28 
DBg1,5+
1 
0 0.79 19 5     
Psac 
(1)=$4,80 
19 3-May 
D43Br1,35+0,5 
(Dithane + Bravo) 
May 3 D43Br 0 0.10 20 5     
1,35+0,5 / 
TecnoZn (1) 
20 8-May 
Br1,2  
(Chlorothalonil) 
10 
D1,75+N
F 
2 0.92 21 7     
Atra y reprog 
x clima  
21 20-May 
Regnum Calixin Dithane 1,9 
+ 9 
21 
CRgCa1
,9 
9 1.00 22 11     Atra x clima   
22 30-May 
Impulse Siganex Dithane 
1,9+8 
30 
CImSx1,
9 
8 1.00 23 9       
23 4-Jun Dithane 1,75+2+NF Jun. 4 
D1,75+N
F 
2 0.92 24 5     Psac (1) 
24 9-Jun Dithane 1,75+2+NF 9 
D1,75+N
F 
2 0.92 25 5       
            
25 14-Jun Dithane 1,75+2+NF 14 
Po1,35+
NF 
2 0.00 26 5     
x falta de 
Dith 60 /  
27 20-Jun Dithane 1,75+2+NF 28 
CSvIm1,
9 
9 1.00 27 14     
Banazeb/Re
prog x 
clima/Rep 
espec 16-17 
S (Sx0,25, 
19 ha) 
29 9-Jul 
Cumora Siganex Banazeb 
2+9 
Jul. 14 CCuSx2 9 1.00 28 16   1 - 5 Atra x clima 
29 13-Jul 
Bb1,75+2+NF 
(Mancozeb) 
18 
Bb1,75+
NF 
2 0.92 29 4     
Bb=Banazeb
(mancozeb)/
MaxiB+Psac 
(0,5+0,56) 
30 23-Jul 
BbNTZn1,5+1,5+4+NF 
(Mancozeb) 
24 
BbNZn+
NF 
4 0.92 30 6 92   
NZnP (cera) 
(1,5) / Atra x 
clima 
31 1-Aug Volley (1) Banaz 2+9 Agu. 1 
CVo1+1,
9 
9 1.00 31 8       
33 10-Aug Sico Calixin Banaz 1,9+9 11 
CSiCa1,
9 
9 1.00 32 10   5 - 12    
33 16-Aug BbNZn1,5+2+3+NF 17 
BbNZn+
NF 
4 0.86 33 6     
Atra x 
clima/NZn:1 
v x 
proveedor/B
bNF1,75+0,
3:1 v 
34 22-Aug Dithane 1,75+3+NF 22 
Bb1,75+
NF 
3 0.92 34 5     Psac (1) 
35 26-Aug Dithane 1,75+3+NF 26 
Bb1,75+
NF 
2 0.92 35 4     
TechnoCa 
(1) 
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DIRECCIÓN DE INVESTIGACIONES-CORBANA ASISTENCIA TÉCNICA EN EL MANEJO DE LA SIGATOKA NEGRA REGISTRO DE ASPERSIONES 
  Farm: San Pablo Este          Year: 2015 
      Program Operation Oil Oil Cycle  $ (Irrigation)   
Week Date Fungicide Mix Date Mix L/ha Mz Nu. D.C. 
ha 
cycle 
/ha/pdo
. 
Observatio
ns 
36 3-Sep 
Impulse Siganex Banaz 
1,9+8 
Set. 3 
CImSx1,
9 
8 1.00 36 8       
37 8-Sep BbNZn1,5+2+3+NF 10 
BbNZn+
NF 
5 0.79 37 7     
NTZnP (2) / 
Sin Mist 
Control 
38 17-Sep Volley Banaz 1,9+7 17 CVo1,9 7 1.00 38 7   14   
39 22-Sep Bb1,75+3+NF 22 BbPhCu 3 0.26 39 5     
0,50 + PhCu 
0,53 
39 27-Sep Bb1,75+3+NF 27 
Bb1,75+
NF 
3 0.79 40 5     Tecamin (1) 
41 5-Oct Tilt Calixin Banaz 1,9 +8 Oct. 6 
CTiCa1,
9 
8 0.92 41 9   6 - 15   
41 10-Oct BbNZn1,5+2+3+NF 10 
BbNZn+
NF 
2 0.79 42 4       
42 15-Oct Bb1,75+3+NF 15 
Bb1,75+
NF 
3 0.92 43 5     
FolCa+Ever
est 
43 23-Oct Volley Banaz 1,9+7 23 CVo1,9 7 1.00 44 8     
Naturamin 
(150 g) 
44 29-Oct BbNZn1,5+2+3+NF 29 
BbNZn+
NF 
2 0.79 45 6       
45 4-Nov 
Bb2+2 
(Macozeb) 
Nov. 4-
5 
Bb2 2 0.92 46 6     
Prueba con 
fruta sin 
bolsa y agua 
de reuso 
46 10-Nov Bb1,75+3+NF 10-12 
Bb1,75+
NF 
2 0.92 47 6     
TechnoCa+
NitK (1+1) / 
Atra x clima / 
12: aceite 3 
48 16-Nov Bb1,75+3+NF 17 
Bb1,75+
NF 
4 0.92 48 6       
48 25-Nov 
Regnum Siganex Banaz 1,9 
+ 8 
26 
CRgSx1,
9 
8 1.00 49 9     Atra x clima 
49 5-Dec Opus Impulse Banaz 1,9+8 Dec. 4 
COpIm1,
9 
8 1.00 50 9       
50 11-Dec Bb1,75+2+NF 10 
Bb1,75+
NF 
2 0.92 51 6       
51 15-Dec BbNZn1,5+1,5+2+MC 15 
BbNZn+
MC 
2 0.79 52 5       
52 20-Dec Bb1,75+2+NF (0,20) 23-24 
CImSx1,
9 
8 1.00 53 8     
Reprog x 
clima y 
atraso 
CCa=Calixin + Dithane, Rg= Regnum, CSx=Siganex + Dithane, D=Dithane, 
Br=Bravo 
            
Sistém. 
aplic.:Triaz.= 
7, Aminas= 
18, Benz.= 0 
        
Subtotal
: 
251.5 47.1 53       
Pyri.= 6, 
Carboxa= 1 
y Estrob.= 2. 
Total= 21 
    Total: 298.6         
  
 
 
 
 
 
 
 
Chapter 3 
Global analysis of reduced sensitivity to azole fungicides 
in the banana black Sigatoka pathogen 
Pseudocercospora fijiensis 
Pablo Chong1,11, Josué Ngando Essoh2,10, Rafael Arango3, L. C. Paul Keizer4, Ioannis 
Stergiopoulos5, Michael F. Seidl6, Mauricio Guzman7, Jorge Sandoval7, Paul E. 
Verweij8, Gabriel Scalliet9, Helge Sierotzski9, Luc de Lapeyre de Bellaire10, Pedro W. 
Crous6,12, Jean Carlier11, Sandrine Cros10, Harold J. G. Meijer13, Esther Lilia Peralta1 
and Gert H. J. Kema6,13 
Chapter 3 
60 
Abstract 
Pseudocercospora fijiensis is the causal agent of black Sigatoka or black leaf streak disease of 
bananas and plantains. Due to the overall susceptibility of the main export Cavendish bananas, 
black Sigatoka management largely relies on fungicides, predominantly on multisite inhibitors 
and azoles, which belong to the sterol demethylation-inhibitors (DMIs) that target the 
lanosterol 14α-demethylase enzyme CYP51. We examined the azole sensitivity of 592 field 
isolates of P. fijiensis collected from various banana production zones in Colombia, Costa 
Rica, the Dominican Republic, Ecuador, the Philippines, Guadalupe, Martinique and 
Cameroon. Continuous sensitivity ranges towards the DMIs fungicides difenoconazole, 
epoxiconazole and propiconazole was observed with clear patterns of cross-sensitivity. 
Genotyping by sequencing was applied to study the overall genetic diversity in a geographical 
subset of 155 P. fijiensis strains, which revealed a distinct clustering based on the geographical 
origins of the isolates, with clear subclades for African, Latin American and the Caribbean 
isolates. Finally, sequence analyses of the CYP51 encoding gene Pfcyp51 in 266 isolates 
showed a wide suite of mutations. Twenty-eight independent point mutations result in amino 
acid (aa) substitutions with nine of them correlating with reduced sensitivity to DMIs. 
Moreover, we identified nine novels regionally disseminated aa substitutions. The majority of 
the substitutions correlated with reduced sensitivity to DMIs are in the proximity or affect the 
putative substrate-binding site based on in silico predictions of the CYP51 protein models. In 
addition, up to six – sometimes unique - insertions in the Pfcyp51 promoter could be found in 
strains displaying reduced azole sensitivity. Such promoter insertions correlate with reduced 
DMI sensitivity and, frequently contain repeated elements with a palindromic core. Wild type 
strains from unsprayed bananas in Ecuador, Colombia and Cameroon did not contain any 
promoter insertions. Our study is the first global analysis of fungicide resistance in P. fijiensis, 
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and provides a lead to understand DMI sensitivity reduction, and enables the development of 
better black Sigatoka management strategies, but also calls for the deployment of a wider range 
of solutions for a sustainable control of this unparalleled banana threat.  
 
Introduction 
Banana is an important staple food (plantain AAB, 2n=3x=33; cooking banana ABB, 
2n=3x=33)(D'Hont et al. 2012; Perrier et al. 2011) and the most popular fruit (dessert banana 
usually AA or AAA, 2n=2x=22 and 3n=3x=33, respectively)(Ploetz et al. 2015) around the 
world. Commercial banana production is dominated by “Cavendish” cultivars that almost 
exclusively comprise the export trade (95%), but that are also increasingly important for 
domestic markets in many countries, such as India and China (Ploetz et al. 2015). Moreover, 
Cavendish plantations are actively developed in the Middle-East and East Africa as an 
important cash crop (Shively & Hao 2012; Zeitoun et al. 2012). The success of Cavendish 
clones is largely explained by their resistance to Panama disease that wiped out “Gros Michel” 
banana cultivar in Central America in the previous century. However, banana production using 
“Cavendish” clones also facilitates the dissemination of a new Panama disease causing strain 
of the soil-borne Fusarium oxysporum f.sp. cubense (the so-called Tropical Race 4 strain, 
(Ordoñez et al. 2015)) that threatens global banana production. A major foliar blight affecting 
global banana and plantain production is black Sigatoka or black leaf streak disease, which is 
caused by the dothideomycete fungus Pseudocercospora fijiensis (previously Mycosphaerella 
fijiensis). Contrary to Panama disease, P. fijiensis colonizes and destroys the foliage by 
developing characteristic necrotic spots that eventually coalesce in large blotches that destroy 
the leaves (Figure S1), thereby initiating physiological adaptations that results in premature 
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fruit ripening, which is a major secondary post-harvest loss (Stover & Simmonds 1987). Due 
to the extreme susceptibility of “Cavendish” bananas, black Sigatoka is considered as the 
costliest banana disease requiring extraordinary fungicide input that threatens the environment 
and affects the occupational health of plantation workers (Risède et al. 2010; van Wendel de 
Joode et al. 2016). The increasing fungicide applications (Chong et al. 2016a; de Lapeyre de 
Bellaire 2009) exert an enormous selection pressure on P. fijiensis populations that gradually 
affect the efficacy of the applied fungicides. Sterol demethylation-inhibitors (DMIs) are the 
commonest applied systemic fungicides for black Sigatoka management (Cañas et al. 2009). 
These fungicides interfere with the catalytic site of the lanosterol 14α-demethylase enzyme, 
also known as CYP51 (Cañas et al. 2009), which is a key player in ergosterol biosynthesis by 
catalysing the demethylation of lanosterol via its heme bound iron atom in the substrate 
recognition site (SRS) (Akins & Sobel 2009; Lepesheva & Waterman 2004; Warrilow et al. 
2013). The continuous and massive use of DMI fungicides has contributed to the selection of 
reduced sensitivity and eventual resistance in P. fijiensis populations (Cañas et al. 2009; 
Chong et al. 2016a; Churchill 2011a; Guzmán et al. 2013; Marín et al. 2003; Ploetz 2000). 
Selection and concurrent spread into and across P. fijiensis populations highly depends on the 
applied fungicides and the properties of the pathogen population (Lapeyre et al. 2010b; Robert 
et al. 2012; Vincellin 2014). The link between DMI fungicides overuse and the occurrence of 
reduced efficacy and concurring genetic variation at the target site has been demonstrated in 
many fungal species (Becher & Wirsel 2012; Cools et al. 2013; Villani et al. 2016; Warrilow 
et al. 2013). The commonest observed genetic mechanisms of DMI resistance are non-
synonymous point mutations in the coding region of the cyp51 gene resulting in modified 
versions of the CYP51 protein, and changes in the cyp51 gene promoter resulting in elevated 
expression levels (Akins & Sobel 2009; Albarrag et al. 2011; Albertini et al. 2003; Bean et al. 
2009; Bolton et al. 2016; Cools et al. 2012; Cools et al. 2013; Délye et al. 1997; Díaz-Trujillo 
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et al. 2016a; Dyer et al. 2000; Eddouzi et al. 2013; Hamamoto et al. 2000; Ma et al. 2006; 
Mellado et al. 2007; Schnabel & Jones 2000; Verweij et al. 2013). Point mutations in the 
cyp51 coding region mostly result in amino acid (aa) changes within the six SRS (SRS1-6) 
regions (Cañas et al. 2009; Lepesheva & Waterman 2004), which are peptide chains regions 
at the protein core that interact with the target substrate. The mentioned substitutions do not 
inactivate the enzyme but compromise fungicide binding affinity (Cools et al. 2012; 
Lepesheva & Waterman 2004). The most common substitutions in the P. fijiensis cyp51 gene 
(Pfcyp51) are at positions Y136 and A313, inside the putative SRS1 and SRS4 respectively, 
and substitutions Y461 and Y463 (Cañas et al. 2009; Chong et al. 2010). Interestingly, P. 
fijiensis isolates from Costa Rica with an accumulated number of mutations in the Pfcyp51 
gene also contain promoter insertions (Díaz-Trujillo et al. 2016a). The insertions in the 
Pfcyp51 promoter are composed of repeated elements. Promoter replacement analysis showed 
that these repeats alone are responsible for increased EC50 values (Díaz-Trujillo et al. 2016a).  
Although there is information regarding the genetic variation of P. fijiensis at specific 
geographical locations (Halkett et al. 2010; Hayden et al. 2003; Robert et al. 2012), the 
relationship between genetic diversity with DMI usage is currently lacking. Here, we analyse 
the molecular effects underlying reduced sensitivity and resistance towards DMI fungicides 
by phenotyping the azole sensitivity of 592 isolates. These data are further supported by 
sequencing the Pfcyp51 gene and promoter region of a 266 isolate subset, collected worldwide 
from major banana producing countries. Furthermore, we show a positive correlation between 
increased DMI applications, the presence of specific genetic modifications in the promoter 
and coding region mutations of Pfcyp51 and reduced azole sensitivity. We also modelled the 
impact of amino acid changes at the substrate recognition site of the PfCYP51 protein, 
indicating which mutations possibly contribute significantly to azole resistance. Our findings 
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support the hypothesis that DMIs exert a stringent selective pressure on P. fijiensis in banana 
plantations globally. 
 
Materials and methods 
Pseudocercospora fijiensis strains and inoculum 
 A suite of 592 P. fijiensis strains from major banana producing and indigenous regions in 
Africa, Asia and Latin America was collected and analysed in this study (Table 1). A random 
set of strains from this global collection was tested for confirm their specie identity based on 
the elongation factor-1α sequence, which was amplified with primers EF1-728F (5′-
CATCGAGAA GTTCGAGAAGG-3’) and EF1-986R (5′-TACTTGAAGGAACCCTTACC-
3’) (Carbone & Kohn 1999) and analysed using the NCBI genome database and the 
P.(Mycosphaerella) fijiensis v2.0, JGI genome portal. 
 Originally, 612 isolate were collected but we were unable to recover 20 P. fijiensis isolates 
from the collection preserved (Preserving solution: 50% of potato dextrose broth and 30% 
glycerol) at -80°C, and hence 592 P. fijiensis isolates were available for subsequent 
phenotyping. From this set 266 isolates were selected based in their DNA quality and their 
phenotyping for genotypic analyses, including strains from which we had genomic DNA 
(gDNA) or Pfcyp51 sequences available. Five sensitive isolates (X845, X846, X847, X849 
and X851) were used to compare the sequence variation among Pfcyp51 wild type genes but 
were not phenotype in this study. We regarded these strains as DMIs sensitive, based on 
available information for their response to propiconazole (Díaz-Trujillo et al. 2016a). 
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Table 1. Origins and characteristics of the Pseudocercospora fijiensis isolates used in this 
study. 
Country / 
collection 
Year of 
collection 
Isolates DMI 
sensitivity 
tested 
Pfcyp51 
Sequenced 
Population characteristics 
DMI and total fungicide 
application per year of 
collection 
Colombia 
CIB UBALMED 
late 2012 98 34 
Treated farms and a subset of 
13 isolates from non-treated 
zones 
DIM estimated application: 
7 cycles from a total of 32 
cycles 
Costa Rica 
CORBANA 
early 2014 107 33 Treated farms 
DIM estimated application: 
7 cycles from a total of 56 
cycles 
Dominican 
Republic 
CIRAD 
early 2013 25 23 Treated farms Data undetermined 
Ecuador 
CIBE-ESPOL 
early 2011 101 40 
Treated farms and a subset of 
25 isolates from non-treated 
zones 
DIM estimated application: 
13 cycles from a total of 30 
cycles 
Philippines 
PRI-WUR 
early 2013 98 28 Treated farms 
DIM estimated application: 
12 cycles from a total of 54 
cycles 
Guadalupe 
CIRAD 
early 2013 30 3 
Non-treated 
(low exposure) 
DIM estimated application: 
6 cycles from a total of 10 
cycles 
Martinique 
CIRAD 
early 2013 42 5 
Non-treated 
(low exposure) 
DIM estimated application: 
9 cycles from a total of 11 
cycles 
Cameroon 
CIRAD 
midst 2014 90 94 
Treated farms and a subset of 
25 isolates from non-treated 
zones 
DIM estimated application: 
7 cycles from a total of 45 
cycles 
Individual 
sensitive 
isolates* 
WUR  
2009 1 6 Non-treated Non-treated zones 
Total: 8 collections 592 266  
 
*(Indonesia, Gabon, Burundi, Taiwan, Philippines and Cameroon) 
 
Inoculum preparation 
Inocula were prepared by using the protocol of Peláez et al. (Peláez et al. 2006) with 
modifications. In short, a piece of mycelium (~0.5 cm2) from a 3-4 weeks old P. fijiensis 
colony grown on potato dextrose agar (PDA) medium was blended for 20 sec. at 6,000 rpm in 
an Ultra Turrax Tube Drive homogenizer (IKA, Staufen, Germany) using a sterile DT-20 tube 
(IKA, Staufen, Germany) in 15 ml of distilled water. Mycelial pieces were filtered through the 
Steriflip Vacuum-driven Filter System (Sterile 100 µm; Merck Millipore, Billerica, USA) and 
quantified in a Kova glasstic slide 10 with a grids coverslip microscope slide (Kova, 
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California, USA). The mycelial fragment concentration was adjusted to approximately 
5x105.ml-1.  
 
Fungicide testing 
Syngenta Crop Protection AG, Basel, Switzerland, provided technical grade quality 
fungicide samples of propiconazole and difenoconazole. Epoxiconazole was obtained from 
Sigma (Sigma Aldrich, Missouri, USA). The propiconazole and difenoconazol azoles were 
maintained as 50.000x stock solutions and epoxiconazole as a 20.000x stock solution in 
DMSO. Fifty μl of mycelium solution was mixed with 200 μl PDB medium supplemented 
with antifungal compounds in flat bottom transparent polystyrene non-coated 96-wells 
microtiter plates (Corning, New York, USA).  
Each strain was initially tested in duplicate, against seven concentrations (0.004, 
0.016, 0.04, 0.16, 0.64, 2.56 and 10.24 mg.L-1) for each fungicide and a water control. In a 
secondary screening, a selected subset - based on their geographical origin and sensitivity 
response - of 212 isolates was re-evaluated in at least three biological repetitions. Finally, a 
third test was performed for 21 DMI resistant P. fijiensis isolates (>10 mg.L-1 in the initial test) 
against extended final concentrations using 0, 0.64, 2.56, 10.24, 15.36, 20.48, 30.72, 40.96 
mg.L-1. In all experiments, the final concentration of DMSO was kept at 1% (v/v) and plates 
were incubated in the dark at 27°C for 10 days. Mycelium growth was determined after 
removing the cover of the plates using a micro plate reader Infinite® 200 PRO machine, 
TECAN, Switzerland, which was calibrated at room temperature (wavelength 690 nm, 
multiple reads per well in a 5x5 circle-filled form, bandwidth 9 µm, number of flashes 5 and 
1 mm exclusion from well walls). The concentration that resulted in 50% growth inhibition 
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(EC50) was determined by plotting the growth profiles from the OD readings, adjusted for the 
background. Monotone regression spline functions (Ramsay 1988) were applied to fit the 
curve profiles using GenStat 18th Edition software (VSN International, Hemel Hempstead, 
UK). The EC50 sensitivity threshold ranges for all fungicides were arbitrary chosen based on 
the clustering analyses of the 2log EC50 means standard error of the differences and the genetic 
information of the Pfcyp51 gene. The EC50 sensitivity thresholds selected for the strains 
grouping were: resistant >1 mg.L-1, tolerant from 0.1 to 0.99 mg.L-1 and sensitive <0.1 mg.L-
1. 
 
Pfcyp51 sequencing  
 The coding region of the Pfcyp51 gene and its promoter were amplified using the 
specific primers CYP51_Pfijien_F1 (5’-AAGGTCATATCGCAGG-3’) and 
CYP51_Pfijien_R1 (5’-GAATGTTATCGTGTGACA-3’). The PCR program consisted of an 
initial denaturation step at 94°C for 5 min, followed by 34 cycles of denaturation at 94°C for 
30 seconds, annealing at 55°C for 30 seconds and an extension at 68°C for 90 sec. A final 
extension step was performed at 72°C for 7 min. The expected amplicons ranged from 2 to 2,2 
Kb and were directly sequenced by Macrogen (Seoul, Korea) using the amplification primers 
and additional sequencing primers: CYP51_Pfijien_F2 (5’-ACAGAAACATCACCTCC-3’, 
CYP51_Pfijien_F3 (5’-ATTGCTTCACTTTCATCC-3’), CYP51_Pfijien_F4 (5’-
CTCTACCAC GATCTCGAC-3’) and CYP51_Pfijien_R2 (5’-GATATGGATATAGTTGT-
3’). For each strain the sequences were assembled using SeqMan (Lasergene v8 software from 
DNASTAR®). Contigs were aligned and analysed using CLC Genomic software version 7.5.2 
from Qiagen (Hilden, Germany). The wild type P. fijiensis strain CIRAD86 was used as 
reference to determine the number and type of mutations in each isolate. We used MEME 
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(Bailey & Elkan 1994), GLAM2 (Frith et al. 2008) and ESEfinder 3.0 (Cartegni et al. 2003) 
software to analyse the promoter region of Pfcyp51. 
 
Model building and docking studies 
The three-dimensional structures of seven PfCYP51 proteins (hybrid models) were 
predicted using YASARA software (http://www.yasara.org). The hybrid models, were 
predicted using a three-dimensional template of the CYP51 proteins from Aspergillus 
fumigatus (PDB code: 4UYM) (Hargrove et al. 2015), Saccharomyces cerevisiae (PDB code: 
4LXJ and 4K0F) (Monk et al. 2013), Homo sapiens (PDB code: 3JUS) (Strushkevich et al. 
To be publish) and Mycobacterium tuberculosis (PDB code: 2W0B) (Chen et al. 2009). From 
each template five variant models were generated. Each variant model was scored with the Z-
scores calculated from molecular dynamics force field energies. The variants with the best Z-
scores were selected to build the final hybrid models. The crystal structure of the lanosterol 
14α-demethylase (CYP51b) from A. fumigatus in complex with voriconazole was used as main 
template. The same software package was applied for simulating the docking of propiconazole 
in the SRSs of CYP51. The chemical structure of the tested fungicide propiconazole 
(PubChem code 43234), was retrieved from PubChem 
(http://pubchem.ncbi.nlm.nih.gov/compound/propiconazole). The global distance test was 
performed using default settings. Active side residues were defined as those within 7Å (Chen 
et al. 2010) of the substrate closest atom. The selected modelled genotypes are listed in Table 
S3.  
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DArTseq markers generation  
A set of 155 P. fijiensis isolates were selected based on origin and DNA quality and 
genotyped using DArTseq sequencing technology (www.diversityarrays.com/). DNA samples 
were processed in digestion/ligation reactions as described before (Kilian et al. 2012). The 
technology was optimized for P. fijiensis by replacing a single PstI-compatible adaptor with 
two separate adaptors corresponding to two different Restriction Enzyme (RE) overhangs. The 
PstI-compatible adapter was designed to include the Illumina flow cell attachment sequence, 
a sequencing primer sequence and a “staggered” varying length barcode region (Elshire et al. 
2011). The reverse adapter contained the flow cell attachment region and a MseI-compatible 
overhang sequence so that only “mixed fragments” (PstI-MseI) amplify effectively by PCR.  
Equimolar amounts of amplification products from each sample of the 96-well 
microtiter plate were bulked and applied to c-Bot (Illumina) bridge PCR followed by 
sequencing on an Illumina Hiseq2000 apparatus. Sequences generated from each lane were 
processed using proprietary DArT analytical pipelines (Kilian et al. 2012). In the primary 
pipeline, the fastq files were first processed to filter for poor quality sequences, applying more 
stringent selection criteria to the barcode region compared to the rest of the sequence resulting 
in reliable assignments of the sequences to specific samples. Approximately 2,000,000 
sequences per barcode/sample were identified and used in marker calling. Identical sequences 
were collapsed into “fastqcoll files” and subjected to a second pipeline for further quality 
selection criteria (Kilian et al. 2012). Finally, the score markers (presence/absence of 
restriction fragments) were represented in a 0/1 binary matrix for usage in the genetic 
similarity calculation.  
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Population clustering analyses  
To determine the genetic diversity of P. fijiensis, we utilized the DArTseq markers 
of the 155 isolates that originated from eight distinct geographical locations. DArTseq markers 
were quality filtered (Qpmr >2.7, Reproducibility =1, CallRate >0.66), resulting in 6,586 
polymorphic DArTseq markers. Based on the presence or absence profiles of these markers, 
the Jaccard-distance between isolates was determined using R (http://www.R-project.org) (R-
Development-Core-Team 2008). Subsequently, complete hierarchical clustering analysis was 
performed, as implemented in R (R-Development-Core-Team 2008). 
 
Analyses of P. fijiensis strains with the sensitivity trait  
For practical reasons, not all 592 isolates could be tested on three fungicides in 
replication, as is described above. A single estimate on all fungicides was made for 294 
isolates, while for 253 isolates the EC50 was estimated in triplicate (for the majority). Only 45 
isolates did not give a proper EC50 estimate to all fungicides. The data was first analysed with 
a full factorial ANOVA model comparing main effects and interactions for experimental 
factors isolates and fungicides. Prior to analysis the data were 2log-transformed to obtain 
homogeneity of variance and a better approximation by the normal distribution. The 
interaction space of this ANOVA with (3-1).(592-1) parameters, if significant, can be 
described with more succinct models.  
The Finlay-Wilkinson model (FW) (Eberhart & Russell 1966; Finlay & Wilkinson 
1963) describes the interaction between two factors in a more parsimonious nonlinear form. It 
models one of the factors as a product with a linear relation to the other. This relation can 
depend either on the fungicide or isolate with EC50; yijk = Fungicidei + bi x Isolatej + εijk or yijk 
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= Isolatei + bi x Fungicidej + εijk. This results in ‘sensitivities’ (bi) for fungicides or isolates 
indicated by the steepness of the slope. For isolates this results in nearly 600 lines as 
sensitivities of each isolate independently, while for fungicides it uses only three lines to 
describe the general sensitivity response towards each fungicide. Sensitivity above 1 means 
more sensitive and vice versa. 
 
Analyses of the sensitivity trait with Pfcyp51 mutations 
From a subset of 266 isolates, 23 substitutions, binary variables, were established and 
a promoter palindromic factor with 6 levels (Pfcyp51 sequencing). Included are the fungicide 
treatment and country as explanatory factors, with 3 and 8 levels. The FW estimates of the 
EC50 sensitivities were taken as the response or dependent variable in a regression model, with 
the mutations and promoter, country and fungicide are explanatory. To analyse main effects 
of the substitutions alone, these were first fitted with a step-forward approach to select the 
most explanatory ones without the expected moderating and/or confounded effect of the 
promoter or the other factors. These selected substitutions were subsequently subjected to an 
all-subset selection procedure, where we can decide which subset of significant substitutions 
forms the most stable combination. These most explanatory substitutions variables were used 
to refit the model, now with the promoter and fungicide factor added as main effects. In the 
next three steps, possible first order interaction terms with the mutations were added with 
forward selection followed by backward elimination. Each of these rounds tries iteratively to 
include subsequent interaction terms based on a forward inclusion ratio and overall 
significance and retains only the best fitting combinations. First among the mutations 
themselves, then mutations with promoter and finally mutations with fungicide and country. 
The model resulting from this process is refitted to arrive at a final model with backward 
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elimination to see if any previously included interaction terms have become superfluous. The 
23 mutations were pairwise tested for interaction with Fischer’s Exact test on independence, 
which can be used to judge the plausibility to accept or discard certain results from the 
subsequent model fitting. 
 
Results  
Pseudocercospora fijiensis specie confirmation 
Different species of the fungal genus Pseudocercospora cause very similar symptoms 
on banana. Moreover, these species also morphologically resemble P. fijiensis and can coexist 
in the same leaf (Arzanlou et al. 2008; Churchill 2011a), the so-called black Sigatoka complex. 
We assessed the potential occurrence of other Pseudocercospora species in our global 
collection of isolates. We selected 28 strains from the collection on the basis of their colony 
morphology to sequence the elongation factor-1α gene to confirm their identification. PCR 
amplification resulted in fragments for all strains and, based on blast analyses we identified 
these strains as P. fijiensis, suggesting that most of the strains in the global collection were 
correctly identified based on morphology and ascospore germination patterns (data not 
shown).  
 
Fungicide sensitivity of the P. fijiensis collection to DMIs  
The Pseudocercospora fijiensis collection was tested for sensitivity against three 
DMI fungicides; difenoconazole, epoxiconazole and propiconazole (Table S1). In general, we 
observed cross-resistance among all strains for these three compounds. In Figure S2a the raw 
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2log (EC50) versus fitted estimates illustrates this as a positive band. Fitting the full factorial 
model revealed that there was a modest interaction between isolate and fungicide (p=0.027) at 
the cost of a huge number of parameters. A simpler model is the FW model, which describes 
the interaction variation together with one of the main effects as a linear product. If this factor 
was the isolate, the angle of the relation, expressed the sensitivity for of each isolate towards 
the fungicide compared to 1. These sensitivities were not significant (p=0.24), instead used for 
the fungicides it expressed the sensitivity of each fungicide toward all isolates and had much 
more explanatory power (p<0.001). Figure S2b shows this FW model with 3 lines, based on 
the isolate means, shows clearly the interaction by the difenoconazole sensitivity line crossing 
the other two fungicides sensitivities which are nearly parallel, so behave additive. For that 
reason, the structure of the populations bases on their sensitivity response (resistant, tolerant 
or sensitive) might differ between products (Figure S2b and S3). In countries where banana 
production requires black Sigatoka management through frequent fungicide applications, viz. 
Costa Rica, Colombia and the Philippines, isolates with reduced sensitivity were clearly 
dominant, in decreasing and distinct order (Figure 1, Tables 2 and S1, S2). In countries such 
as Cameroon, the Dominican Republic and Ecuador where the use of DMIs is still relatively 
limited a majority of tolerant P. fijiensis isolates, was found (Tables 2 and S2). In contrast, all 
P. fijiensis isolates from Guadalupe and Martinique were sensitive (Tables 2 and S2). DMIs 
are used for disease control in both islands but since P. fijiensis recently arrived, the time of 
the exposure of the population to the DMIs have been short. The DMI sensitivity levels among 
P. fijiensis isolates found in Costa Rica are the lowest across all isolates, with no isolates 
classified in the sensitive category and isolates classified in the tolerant category ranging from 
one percent for propiconazole, two percent for difenoconazole and three percent for 
epoxiconazole with the rest of the isolates been resistant (Table S2).  
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Table 2. Fisher's protected least significant difference test showing the difference in sensitivity 
from Pseudocercospora fijiensis populations by origin. 
 
 
 
 
 
 
 
 
Figure 1. Observed sensitivity differences to three DMI fungicide (difenoconazole, 
epoxiconazole and propiconazole) among Pseudocercospora fijiensis strains from varying 
countries. Data are presented as the frequency of individual EC50 data that match against the 
EC50 means for the combined response to the tested DMIs (
2Log). 
Country mean 2log (EC50) hom. group Isolate count 
Guadalupe -6.015 a 30 
Martinique -5.833 a 42 
Ecuador -2.655 b 101 
Cameroon -2.655 b 90 
Dominican R. -0.924 c 25 
Colombia 0.220 d 95 
Philippines 0.388 e 98 
Costa Rica 2.010 f 111 
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The EC50 values for Costa Rican P. fijiensis isolates for the three DMIs were the 
highest. The majority of isolates in Philippines and Colombia were also resistant. Isolates from 
Ecuador, Dominican Republic and Cameroon were mostly tolerant. Nonetheless, sensitive and 
resistant strains were also represented (Figure 1 and Table S2). The lowest values were found 
in isolates originating from Guadalupe, Martinique and Cameroon. All isolates from untreated 
areas from Cameroon, Colombia and Ecuador were also sensitive. (Figure 1 and Table S2). 
Interestingly, Costa Rica population (one of the main banana exporting countries) and the 
populations from Guadalupe and Martinique (with low fungicide exposure) perfectly fit with 
the chosen thresholds for DMI resistance and sensitive, respectively (Figure 1 and Tables 2 
and S2). Other countries as Cameroon, Colombia and Ecuador have an almost continue set of 
values (Figure 1 and Table S2). The overall response of the global population is shown in 
Figure S2 and S3. The additional sensitivity analyses on 21 resistant strains with high 
fungicide dose (up to 40.96 mg.L-1, Figure S4) revealed that CaM10_6, CaM1_5 and CaM3_1 
from Costa Rica had extremely high EC50 values, especially in their response to 
difenoconazole and propiconazole (Figure S4).  
 
DArTseq genotyping  
 We analysed the genetic variation among 155 isolates of P. fijiensis (Figure 2) using 
hierarchical clustering based on 6,586 polymorphic DArTseq markers. We detected a clear 
clustering pattern reflecting the geographical origin of the samples. For example, most isolates 
from Cameroon cluster together in one group. The majority of isolates from Latin America 
and the Caribbean are genetically close, but also show the tendency to cluster together by 
country with some exceptions. The highest genetic diversity, demonstrated by many individual 
clusters, was detected in the Philippines, whereas the lowest genetic diversity was found in the 
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Dominican Republic. No clear pattern between the genetic variation and the degree of 
sensitivity to DMIs was found (Figure 2).  
 
 
Figure 2. Genetic diversity of 155 selected Pseudocercospora fijiensis isolates. a) Hierarchical 
clustering of 155 P. fijiensis isolates based on 6,586 polymorphic DArTseq markers (Jaccard 
distance; complete linkage clustering). Classification of individual isolates based on b) the 
country of origin of individual isolates and by c) DMI sensitivity. 
 
The Pfcyp51 diversity and genetic support for reduced sensitivity 
Based on dissimilarities in fungicide sensitivity patterns, 266 isolates were 
selected for amplification and sequencing of the Pfcyp51 gene, including the promoter 
region. Six wild type isolates were included as controls to determine the natural variation 
in Pfcyp51 sequences irrespective of fungicide sensitivity. We identified 60 unique 
genotypes with a total number of 28 mutations in the coding region of the Pfcyp51 gene 
(Figure 3 and Table S3) taking the sensitive strain CIRAD86 as a reference (Arango et al. 
2016). The aa changes were dispersed over 20 positions. Strikingly, all isolates shared a 
nonsynonymous mutation resulting in the amino acid change V106D (Figure 3). The 
number of mutations per position per country is summarized in Table 3.   
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Table 3. Changes in the CYP51 protein sequences of Pseudocercospora fijiensis isolates per 
country.  
Country/   aa 
subst. 
Colombia 
Costa 
Rica 
Cameroon 
Dom. 
Republic 
Ecuador Guadalupe Philippines Martinique 
Individual 
Isolates 
TOTAL 
(n) 34 33 94 23 40 3 28 5 6 266 
Promoter 
Insertion 
24 
(70.6%) 
26 
(78.8%) 
62  
(66%) 
17  
(74%) 
5  
(12%)  
0 
8 
(28.60%) 
0 0 
142 
(52.79%) 
T18I* 
34 
(100%) 
33 
(100%) 
0 
23  
(100%) 
40 
(100%) 
3 
 (100%) 
15 
(53.60%) 
5  
(100%) 
2  
(33.3%) 
156 
(57.99%) 
A19E* 1 (2.9%) 0 0 0 
1 
(2.5%) 
0 0 0 0 
2  
(0.74%) 
Y58F* 0 0 0 0 0 0 0 0 
1 
 (16.6%) 
1 
 (0.37%) 
I70M 0 0 0 0 0 0 
2  
(7.1%) 
0 0 
2  
(0.74%) 
D71E 0 0 0 0 0 0 
2 
 (7.1%) 
0 0 
2   
(0.74%) 
V106D* 
34 
(100%) 
33 
(100%) 
94 
 (100%) 
23 
 (100%) 
40 
(100%) 
3 
 (100%) 
28 
 (100%) 
5 
 (100%) 
5 
 (83.3%) 
268 
(99.63%) 
V116L* 0 0 0 0 0 0 0 0 
1 
 (16.6%) 
1 
 (0.37%) 
Y136F 
21 
(61.8%) 
19 
(57.6%) 
1 
 (1.06%) 
2 
 (8.70%) 
0 0 
4  
(14.3%) 
0 0 
47 
(17.47%) 
K171R* 0 0 0 0 0 0 
4 
 (14.3%) 
0 
1  
(16.6%) 
5 
 (1.86%) 
V260L 0 
2  
(6.1%) 
0 0 0 0 0 0 0 
2 
 (0.74%) 
I264T* 0 0 0 0 0 0 0 
1 
 (20%) 
0 
1  
(0.37%) 
A313G 
9 
(26.5%) 
19 
(57.6%) 
64 
(68.1%) 
19 
 (82.6%) 
33 
(82.5%) 
0 
27 
(96.4%) 
0 0 
172 
(63.94%) 
H380N 0 
3  
(9.1%) 
0 0 0 0 0 0 0 
3 
 (1.12%) 
A381G 
1 
 (2.9%) 
7 
(21.2%) 
0 
3 
 (13%) 
0 0 0 0 0 
11 
(4.09%) 
R418G* 0 0 0 
1 
 (4.3%) 
0 0 0 0 0 
1  
(0.37%) 
A446S* 0 0 0 0 0 0 
22 
(78.6%) 
0 
1  
(16.7%) 
23 
(8.55%) 
D460E 0 0 0 0 0 0 
15 
(53.6%) 
0 0 
15 
(5.58%) 
D460V 0 0 
49 
(52.1%) 
0 0 0 0 0 0 
49 
(18.22%) 
ΔY461 0 0 0 0 0 0 
2 
 (7.1%) 
0 0 
2 
 (0.74%) 
Y461D 
2 
 (5.9%) 
2  
(6%) 
0 0 
2 
 (5%) 
0 
2 
 (7.1%) 
0 0 
8 
 (2.97%) 
Y461N 2 (5.9%) 0 0 0 0 0 
15 
(53.6%) 
0 0 
17 
(6.32%) 
Y461S 0 0 0 0 0 0 
2 
 (7.1%) 
0 0 
2 
 (0.74%) 
G462A 0 
1 
 (3%) 
0 0 0 0 0 0 0 
1 
 (0.37%) 
G462D 0 0 
4 
 (4.3%) 
0 0 0 0 0 0 
4  
(1.49%) 
Y463D 
21 
(61.8%) 
22 
(66.7%) 
6 
 (6.4%) 
14 
 (60.9%) 
1 
 (2.5%) 
0 
6  
(21.4%) 
0 0 
70 
(26.02%) 
Y463H 
3 
 (8.8%) 
1 
 (3%) 
0 
2 
 (8.7%) 
10 
(25%) 
0 0 0 0 
16 
(5.95%) 
Y463N 0 
2 
 (6.1%) 
5 
 (5.3%) 
3  
(13%) 
20 
(50%) 
0 0 0 0 
31 
(11.52%) 
Y463S 0 
4 
(12.1%) 
0 
2 
 (8.7%) 
0 0 0 0 0 
6 
 (2.23%) 
*Amino acid substitutions found in sensitive isolates 
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Figure 3. Amino acid (aa) substitutions identified in the Pseudocercospora fijiensis 14α 
demethylase enzyme. In total 28 aa changes were observed, located at 20 positions in the 
sequence of Pfcyp51. The substitutions with red labels are in the vicinity of the substrate 
recognizing site (SRS). 
 
With the exception of Y136F, all amino acid substitutions derived from single 
base nonsynonymous mutations (Table S4). In Y136F, the wild type codon is TAC at 
position 405 bp and the altered codons are TTC and TTT, which are present in 29 isolates 
from different populations (Costa Rica, Cameroon, Colombia and Philippines) and in 11 
isolates from Costa Rica, respectively. This may suggest that codon TTT occurred from a 
consecutive mutation that emerged from the pre-existing codon variant TTC. The list of 
the codons for each substitution is summarized in Table S4. 
At a global scale, the most frequently observed aa changes are V106D (268), 
A313G (172), T18I (156), Y463D (70), Y136F (47) and Y461D (8) (Table 3). The largest 
number of specific mutations was present among Philippine isolates. Mutations resulting 
in I70M, D71E, D460E, ΔY461 and Y461S were unique for the Philippine population, 
whereas mutations leading to K171R and A446S were shared with a strain from Taiwan. 
However, unique mutations were also observed in other countries. For instance, V260L, 
H380N and G462A were exclusive for Costa Rica, whereas aa changes D460V and 
G462D were only found in Cameroon. Just a few mutations leading to aa changes were 
only found once, such as I264T in an isolate from Martinique and R418G in a strain from 
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the Dominican Republic (Table 3). In contrast, other mutations are ubiquitous such as 
T18I, present in all isolates from Latin America and the Caribbean and in 15 out of 28 
Philippine isolates. The same mutation existed in two sensitive wild type strains from the 
Philippines and Indonesia (Table 3), but was absent among African isolates.  
The number of aa changes per individual genotype varied from one to seven 
substitutions (Table S3). Most of the none sensitive analysed isolates gained four aa 
changes when compared with the reference strain. The most common combination was 
T18I/V106D/A313G/Y463D, present in genotypes G29 to G32, identified in 24 isolates 
from Colombia (2), Philippines (2), Ecuador (1), Costa Rica (5) and the Dominican 
Republic (14). Genotype G25, represented by one isolate from Cameroon, contained the 
modification Y136F (Table S3). Thirty-five isolates share only a single substitution 
(V106D), when compared with the CIRAD86 reference. The two and three-way 
combinations T18I + V106D, T18I + A19E + V106D, T18I + Y58F + V106D; T18I + 
V106D + I264T, T18I + V106D + R418G, T18I + V106D + A446S and, V106D + V116L 
+ A446S were all present in P. fijiensis isolates sensitive to DMIs. In contrast, 
substitutions Y136F, A313G, H380N, D460E, D460V, ΔY461, Y461D, Y461N, Y461S, 
G462A, G462D, Y463D, Y463H, Y463N and Y463S were only present in strains with 
reduced sensitivity to DMIs. Interestingly, genotypes G8, G12, G13, G14, G18, G19, G36, 
G41, G49, G52, G53, G57, G58 and G60 show a differential impact on the sensitivity for 
the three fungicide with EC50 values higher on propiconazole (Table S3).  
 
The chemical properties of the detected aa substitutions in the different genotypes are 
compared in Table S5. Most substitutions affect the hydrophobic or hydrophilic interactions, 
particularly T18I, A19E, V106D Y136F, I264T, A313G, A381G, R418G, A446S, D460V and 
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those at positions 461 and 463, which modulate hydrophobic or hydrophilic properties that are 
expected to influence the three-dimensional conformation of the protein. 
 
Protein models and docking studies 
 In order to understand the conformational effect of sensitivity related substitutions on 
the PfCYP51 protein, seven in silico models were built (template base on A. fumigatus, S. 
cerevisiae, H. sapiens and M. tuberculosis). The quality model Z-scores are summarized in 
Table S6. The Z-score of a protein is defined as the energy separation between the native fold 
and the average of an ensemble of misfolds in the units of the standard deviation of the 
ensemble (Zhang & Skolnick 1998). Figure 4 shows the secondary structure of the protein 
model based on the CYP51 of genotype G1 (reference strain CIRAD86). The model was 
compared with an early in silico model of P. fijiensis and the crystal structures of the CYP51 
from Trypanosoma cruzi and T. brucei (Cañas et al. 2009; Chen et al. 2010). Most of the 
structural CYP51 family protein elements: alpha helixes, beta sheets and the SRSs, were well 
conserved in the model. The exceptions are the absence of alpha helix F’ and F” and the 
presence of an extra alpha helix predicted from aa positions 452-458. Most importantly, the 
SRSs were recognizable in the in silico PfCYP51 model and suggest an open substrate channel 
between the alpha helix A’, the loop between alpha helix F and G (loop FG), and the loop 
between beta sheet 2_3 and beta sheet 2_2 (details of the active site and the channel in the 
model are visualized in Figure S5 and S6).  
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Figure 4. Schematic representations of CYP51. (A) Three-dimensional model based on 
Pseudocercospora fijiensis CIRAD86 (genotype G1). (B) PfCYP51 secondary structure 
model annotated based on Cañas et al. (2009) and Chen et al. (2010) (variation in nomenclature 
between authors is show in parentheses). Helix structures are shown as blue cylinders, ß sheets 
are indicated in red, turns in green and random coils in cyan. Main α helixes are depicted in 
capital letters and the putative substrate recognition sites (SRS) indicated as boxes. The 
changes in amino acids identified in Pfcyp51 are depicted as: (^) only in DMIs sensitive 
isolates, (*) only in resistant strains and (+) present in both. Residues that potentially locate 
within 7Å of the propiconazole docking site are labelled with blue triangles. 
A) 
B) 
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A global distance test was performed to measure the superposition similarity between 
two proteins by calculating the number of structurally equivalent pairs of C-alpha atoms that 
are within the specified distance. This revealed that the most similar model to the PfCYP51 
wild type was from the sensitive Bo_1 strain, originating from the indigenous P. fijiensis 
population in Bohol, Philippines (DMIs sensitive, genotype G10) with 85.61% of similarity, 
while the most dissimilar model was derived from strain CaM10_6, originating from the 
frequently sprayed Cartagena population in Costa Rica, (DMIs resistant, genotype G44) with 
76.95% of similarity (Table S7).  
 
Docking experiments  
In silico docking experiments show that propiconazole probably binds to the 
PfCYP51 active site by positioning the triazole ring close to the porphyrin plane with a 
nitrogen atom aligned to the iron atom in the heme group (Figures 5A and S5). Based on 3D 
modelling putative aa positions were identified that are located less than 7Å to the nearest 
propiconazole atom for the docked compound. The potential interacting aa’s are marked in 
Figure 4 and Table S7. Out of the 21 putative aa’s interacting with propiconazole, 19 are 
located inside the proposed SRSs (Cañas et al. 2009). Particularly, positions 136, 313, 380 and 
381 found in field isolates with reduce DMI sensitivity were predicted to be in direct 
interaction with propiconazole (Figure 5A). In the model of the sensitive strain Bo_1 although 
the amino acid substitutions were positioned outside the docking area, they induced three 
remarkable spatial changes in the active site chamber of the PfCYP51 (Table S7 and Figure 
5B). The models of strains with reduced sensitivities revealed specific changes in the active 
site conformation including direct changes to some of the propiconazole interacting aa’s. 
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All resistant models have five to eight positions with altered spatial locations and 
angles compared to the reference model, affecting DMI binding. Notably, the deletion at 
position 461 (∆461) in model M52_10 (genotype G60, Figure 5e) results in the shift of three 
aa’s near the docking area at positions, 524, 525 and 526. As a result, L523 is introduced into 
the docking site and pushes S526 to a distance of 8.13Å versus 4.05 Å in the model of sensitive 
strains, a distance not included in the putative range of interaction with the fungicide (Table 
S7). Sensitive strain Bo_1 has three positions with modulated spatial distance and angles in 
the PfCYP51 active site chamber (125, 380 and 384; Figure 5b).  
A particular orientational variation exist at position 125, which is present in all 
PfCYP51 models of resistant strains, and that harbours the entrance of the channel facilitating 
the entry to the enzyme core that comprises the active site (Figure S6). Contrary to this 
conformation, the model of the sensitive strain Bo_1 has a more exposed entrance at this 
position while the models of the resistant strains CaM10_6, M52_10 and M52_22 have a 
narrow access (Figure 5b, c and f). Other major changes are situated for position 383 (reference 
1.85Å close to propiconazole) and position 313. In the former case, positional changes seem 
to be due to aa substitutions at other positions. All predicted changes in the relative distance 
of aa’s near the docking area (reference <7Å) are summarized in Table S7. 
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Figure 5. Models of the active site of the PfCYP51 protein with amino acid modulations due 
to mutations. A) Reference model of the PfCYP51 of the reference Pseudocercospora fijiensis 
CIRAD86 showing the location of amino acids (aa) in the vicinity of the propiconazole 
docking area. With the exception of tyrosine at position 136, aa’s with a distance farther than 
5.4 Å from the docking area are removed for better visualization. The heme group is depicted 
in red, the propiconazole fungicide in blue and aa residues in green. B) Active site of P. 
fijiensis strain Bo_1 (in cyan) superimposed on the CIRAD86 reference. Active sites of CYP51 
resistant models (C) CaM10_6, (D) CaM10_21, (E) M52_10, (F) M52_22 and (G) Z4_16 (in 
magenta) superimposed on the CIRAD86 reference. In (D) position 381 was also included. 
Significant variations in distance, position or angle of the aa residuals are highlighted with 
light red or yellow discs. 
 
A) B) 
C) 
 
  
 
D) 
E) F) 
G) 
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Promoter Insertions 
From the 266 sequenced isolates, we found 142 isolates that have an insertion in the 
Pfcyp51 promoter (Tables 3 and S4), which have been correlated with reduced sensitivity to 
DMIs (Díaz-Trujillo et al. 2016a). For instance, the 25 P. fijiensis strains with the combination 
T18I + V106D + Y136F + Y463D (genotypes G22, G23 and G24) differed in DMI sensitivity, 
clearly reflected by the number of insertions in the promoters. Similarly, genotypes G35 and 
G36 (T18I + V106D + A313G + Y463N) do not differ in Pfcyp51 substitutions, nonetheless, 
the three G36 isolates with promoter insertions have higher EC50 values, which maximizes in 
those with three insertions (Table S3). 
A more detailed analysis of the promoter of the resistant strains identify a region of 
high variation, with insertions starting at position 2,121,774 of scaffold 7 in the genome 
sequence of the reference strain (Pseudocercospora fijiensis v2.0, JGI), ~103 bp upstream of 
the start codon of Pfcyp51 (antisense direction). In 98 isolates, the insertions substitute a 
stretch of 8 to 27 bp starting at position 103 or 102 bp upstream of the start codon, e.g. in the 
Philippine isolate T52_22 an 8 bp region is substituted by an insertion of 123 bp at position -
102 bp. 
Others have gained multiple substitutions, such as isolate CaM3_3 from Costa Rica, 
which has one 16 bp exchange for a 9 bp fragment at position -103 bp and a second substitution 
of 7 bp with a 76 bp fragment, localized at –94 bp (Table S8). In addition, 38 isolates contain 
an insertion at position 94 bp. Two isolates from Cameroon, strain P2S20 and P4S19, have a 
substitution followed by an insertion at position 157 bp upstream of the start codon. The 
Philippine isolates (M52_4, M52_9, M52_23 and U22_3) show a deletion of 8 bp, 
“CATGGACC”, in the promoter region beginning 97 bp upstream of the start codon. 
Generally, the majority of insertions at the -103 region comprise one or more copies or partial 
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copies of a 19 bp genomic element, “TAAATCTCGTACGATAGCA”. This element is present 
as a single element in the CIRAD86 reference and originally located a few nucleotides 
downstream in the promoter MYCFIscaffold_7:2121794 – 2121813, (-122 bp upstream of the 
Pfcyp51 start codon), indicated as element “A” in Figures 6 and 7.  
 
Figure 6. Logo made in MEME (Bailey & Elkan 1994) of the repeated inserts elements found 
in the promoter region of 142 Pseudocercospora fijiensis strains. Element “A” is common in 
all repeat candidates that were identified by the software. 
 
Despite the geographical differences of many isolates, we identified very similar 
insertions in the Pfcyp51 gene promoter. Overall, a limited number of substitutions and 
insertions were observed although at variable positions (Figure S7). Element “A” contains a 
core sequence of an eight base pair palindromic DNA fragment “TCGTACGA”, which is 
present in all variants, and at least twice in all isolates that contain an insertion (Figure 7; green 
arrows, Figure S7) and up to six copies in the Pfcyp51 promoter of resistant strains. Some 
isolates contain a partial construction of element “A” in their insertions, while others have a 
modified “A” element due to a few additional nucleotides. For example, Philippine isolate 
T52_22 possesses three copies of element “A” and one partial copy, resulting in four copies 
of the palindrome. In a similar way, the Ecuadorian isolates RCQS_3 and RCQS_16 possess 
one copy of the “A” element, but three of the palindromic sequences, two of them in partial 
stretches of “A” (Figure S7, Table S8). In total, the palindrome sequence is present up to six 
Element A 
Global analysis of the sensitivity to azole  
87 
times in resistant Pfcyp51 genotypes (Table S3). The smallest insertion, in isolate POS9 from 
Cameroon, encodes a single “A” element, but two copies of the palindrome (Figure 8).  
The presence of two or more palindromic insertions (three or more copies in total) 
correlates with strongly reduced DMI sensitivity (Tables S4 and S9). Interestingly, mutation 
Y136F only occurred in isolates with multiple promoter insertions (at least four or more 
palindromes “TCGTACGA” insertions). The detailed gene configurations of representative 
strains with reduced sensitivity are presented in Table S3 and Figure 8. 
Although geographically different isolates show very similar insertions in the 
Pfcyp51 gene promoter, we found an additional big and unique insertion in Philippine isolates. 
This 39 bp insertion, “TTCACCACCCTCGCATTCTTGGTCA-GTATAC-ATAGACCT”, 
indicated as the “B” element, is present in eight Philippine isolates (Figures 7, 8 and S5). The 
“B” element also encompasses a palindromic 6 bp DNA fragment “GTATAC” that, however, 
is not correlated with reduced sensitivity to DMIs. 
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Figure 7. Analysis of the insertions in the promoter region of the Pfcyp51 gene in 
Pseudocercospora fijiensis strains from various countries. Insertions are generally located 
from 94 to 103 bp upstream of the start codon of the gene. Element “A” is marked with blue 
together with the palindromic arrangement TCGTACGA marked in green. Alterations of 
element “A” are marked with red and partial constructions of the element with purple. Part of 
the novel insertion merely identified in Philippines isolates, element “B”, is marked with light 
yellow. Negative values at the right represent the position from the beginning of the insertion 
related to the start codon of the gene.
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Figure 8. Representation of the Pseudocercospora fijiensis Pfcyp51 gene. Genomic 
configuration of elements of the most representative resistant genotypes are shown with 
insertions in the promoter region of the Pfcyp51 gene. Vertical lines in the coding domain of 
the Pfcyp51 gene represent the different CYP51 codon position substitutions: 1) Reference 
genotype G1. 2) Resistant genotype G24. 3) Resistant genotype G23. 4) Resistant genotype 
G43 (Philippines). 5) Resistant genotype G42. 6) Resistant genotype G13. 7) Resistant 
genotype G25 and 8) Resistant genotype G18.  
 
The effect of Pfcyp51 mutations and fungicide sensitivity 
Substitutions A313G, Y136F, H380N, Y463D and D460V gave the main explanatory 
changes related to increasing EC50 values (Table 4) as the reference genotype was a susceptible 
one. Additional mutation candidates for a main effect were A381G, A446S, T18I, Y463N and 
D460E based on a ratio of 20 for inclusion compared to the mean square error (~p<0.00001). 
However, these were less consistent, so a combination among the substitutions could be more 
plausible. Retaining the first 5 mutations and adding the main effect of the Pfcyp51 promoter 
and the fungicide treatment resulted in even higher EC50 predictive power. Figure 9 shows that 
the number of insertions in the Pfcyp51 promoter corresponds with reduced fungicide 
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sensitivity, indicated by the number after the 5 binary position representing the mutational 
main effect and before the fungicide letter (P). The inclusion of the fungicide factor 
demonstrates the main effect of the treatment but not shown in Figure 9 as the difference were 
too small. 
Next all first order interactions were evaluated and added if significant. Followed by 
backward selection to check out the specific combinations that had most predictive power. 
Substitutions T18I, A381G, A446S are again indicated but now in combination with one or 
the other and a new mutation V106D is put forward in this context. Also the interaction Y136F 
with A313G, which are both already in the model as main effect, is still assessed as important. 
This combination increases again the sensitivity to the DMIs as can be seen from the parameter 
estimate, and seemingly this is attributed to Y136F as is also in the combination with A318G 
more sensitive. Finally, the addition of the promoter interaction with a mutation was all 
checked, however none was found to be very specific. This means that either the interaction 
with fungicide is already covered by a mutation or there was no specific mutation involved 
with the difenoconazole interaction. This last explanation is supported by the lack of 
significance for the alternative FW-model with sensitivities per isolate. Country is not there 
because the mutations are confounded with it, so country is included as last and the sensibility 
did not incur much from it. Figure 9 represents the effect of the accumulation of these crucial 
mutations by x-axis on propiconazole. In the left bottom is the sensitive reference ‘without’ 
mutation and the ‘simplest’ promoter of the Pfcyp5. The upper right has the most accumulated 
mutations as an additive effect together with the most insertions in the promoter that was 
present in the set of isolates. It shows the additive magnitude of the specific mutation 
combinations that was present on the 2log (EC50). 
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Table 4. Regression analyses of Pseudocercospora fijiensis Pfcyp51 mutations on azole 
efficacy. This table shows the fitted model with the relevant factors (amino acid substitutions 
and promoter insertions, F-test <0.001) that remains from 23 factors evaluated. Factors are in 
descendant order of importance base on the accumulated analyses of the variance ratio (v.r.). 
The threshold of including a variable was heuristically set to a v.r. ratio of 10, which gave 11 
factors as predictor for the loss of sensitivity to DMIs. This final model was checked by 
backward elimination to see if any previously included terms became superfluous. Table shows 
the degrees of freedom (d.f.), the sum of the squares (s.s), mean squares (m.s.) and variance 
ratio (v.r.). 
 
Accumulated analysis of variance 
Substitution change d.f. s.s. m.s. v.r. 
+ A313G 1 1876.24 1876.24 2489.04 
+ Y136F 1 2268.64 2268.64 3009.60 
+ H380N 1 508.66 508.66 674.79 
+ Y463D 1 116.14 116.14 154.07 
+ D460V 1 110.48 110.48 146.57 
+ Prom 5 205.53 41.11 54.53 
+ Fungi 2 64.44 32.22 42.74 
+ T18I.A381G 1 51.55 51.55 68.39 
+ V106D.A446S 1 148.27 148.27 196.70 
+ Y136F.A313G 1 222.94 222.94 295.75 
+ Y136F.A381G 1 44.60 44.60 59.17 
Residual 627 472.63 0.75  
      
Total 643 6090.13 9.47  
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Figure 9. Predicted interaction of the accumulation of specific CYP51 substitutions with the 
sensitivity response on propiconazole fungicide. The genotype number codes are represented 
by the presence/absence of substitutions (1/0 matrix) with the exception of the Pfcyp51 
palindromic promoter insertions that have six levels. The 11 number codes follow the chosen 
fungicide correlated model: 1) A313G, 2) Y136F, 3) H380N, 4) Y463D, 5) D460V, 6) Promoter 
insert numbers, 7) Fungicide, 8) T18I, 9) A381G, 10) V106D, and 11) A446S. The substitutions 
are placed from left to right in order of importance where the first one is the most interactive 
and the last one the least interactive. For practical reasons number code 7 has been labelled for 
the fungicide (P for propiconazole). For example, model resistant genotype code 001106P1110 
(marked in light red) has five substitutions: H380N, Y463D, T18I, A381G and V106D with six 
promoter palindromic inserts and it has been predicted as resistant (2LogEC50 >0) in the 
interaction with the fungicide propiconazole. 
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Discussion 
The use of antibacterial therapies and anti-fungal is common in human and veterinary 
medicine to complement the host immune response and restore well-being and health 
(Boogaerts et al. 2001). Therefore, antibiotics resistance raised global awareness (Unno et al. 
2010; Yang et al. 2014), as it threatens the lives of many patients and animals due to failing 
antibiotic treatments, resulting in the return or severity of many bacterial infections (Brauner et 
al. 2016). Reduced sensitivities to fungicides equally threaten lives of patients (Eddouzi et al. 
2013; Mitka 2011; Unno et al. 2010; Verweij et al. 2013) and animals, such as upon Aspergillus 
fumigatus infections causing aspergillosis, a lethal inflammatory disease without adequate 
antifungal treatment (Chowdhary et al. 2013; Verweij et al. 2013). The reduced effect of such 
treatments is mostly due to cyp51 mutations (Becher & Wirsel 2012; Cools et al. 2013).  
The control of plant pathogens also strongly relies on a limited set of fungicides, with 
mostly similar active ingredients (Cools et al. 2013). Azole fungicides are the cornerstone of 
contemporary managements strategies for many plant pathogens (Cools et al. 2013). In this 
paper we describe the occurrence and mechanisms of the reduced sensitivity of azole fungicides 
to the plant pathogenic fungus P. fijiensis, which may be one of the factors that leads to the 
increase of fungicide applications for black Sigatoka control in banana cultivation. The 
dispersal and magnitude of DMI fungicide resistance in P. fijiensis urges for an understanding 
of the underlying mechanisms in order to develop new control strategies. Here, we analysed an 
unparalleled set of P. fijiensis isolates obtained from populations in countries with varying 
practices (among them four of the top ten largest producers and exporters of banana), hence 
intensities of black Sigatoka management. This enables a global analysis and comparison of 
fungicide application and the occurrence of reduced DMI sensitivity in P. fijiensis and the prime 
genetic dynamics. The distribution of EC50’s for all isolates revealed a wide range of DMI 
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sensitivity, parallel for the tested fungicides, which can be considered as a continuous set of 
values (Figure S3). This disallowed clear cut-off values to discern statistically significantly 
different groups. Therefore, we introduced EC50 criteria to form three sensitivity groups. This 
permitted analyses based on the non-synonymous mutations in the Pfcyp51 gene, the promoter 
characteristics and the origin of the samples. Nonetheless, the result show differences in the 
structure of the populations based on their sensitivity response to each specific fungicide 
(although not significant), especially for difenoconazole. These differences may suggest the 
need for a better grouping criteria and differential thresholds levels choice per individual 
fungicide. All fungicide resistant strains were exclusively identified in commercial banana 
farms, especially from Costa Rica, Colombia and the Philippines, where banana production is 
economically very important and the number of fungicide applications per season is high 
(Figure 1 and Table S2).  
 
DMI sensitivity differences are associated with fungicide application practices 
Costa Rica has a long history of Sigatoka control associated with a continuously 
increasing number of fungicides applications per year (Chong et al. 2016a; Marín et al. 2003). 
For example, observed DMI baseline sensitivity shift correlates with the increasing amounts of 
applied fungicides, which raised from 30 in the 90’s up to 50 treatments by 2007 and up to 53 
in 2015 in San Pablo´s farm in Costa Rica (Chong et al. 2016a). In this case the actual number 
of DMI cycles reduced over time from seven to four applications per year in 1998 and 2014, 
respectively, but overall the number of DMI cycles was approximately 10 between 2003 and 
2010. In 2015, there was a sudden rise in the number of DMI cycles. This rise might be resulted 
by the frequency of strains with high EC50 values in the “San Pablo” population. This event 
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suggests that the selective pressure in previous years was sufficient to turn the major part of the 
population into resistant strains by 2014. In parallel, we isolated the most resistant strains from 
this country and have recently proven the association between their genetic constitution and 
DMI sensitivity (Díaz-Trujillo et al. 2016a). Hence, fungicide application intensity results in 
the recovery of resistant strains, e.g. 99% of the Costa Rican isolates had EC50 values higher 
than 1 mg.L-1 for propiconazole. In contrast, the majority of strains were sensitive in remote 
areas nearly secluded from fungicide applications. The resistant strains always carried Pfcyp51 
gene mutations. Recent findings for strobilurins suggested that these remote areas are 
genetically isolated from large commercial banana plantations, as indicated by their population 
genetic parameters (Arango et al. 2016). For DMIs, similar mechanisms seem to be operational. 
Hence, the rare occurrence of reduced sensitivity in overall sensitive populations seems to be 
largely due to genetic drift. 
 Although the actual number of DMI applications per location from which the strains 
were collected is in most cases untraceable it seems that the number of resistant isolates 
increases parallel with the number of fungicide applications (Figure 1 and Table S2) 
underpinning the selective pressure exerted by the intensive applications of DMIs. The 
relatively low percentage of resistant strains from Ecuador (difenoconazole 16.83%, 
epoxiconazole 8.91%, and propiconazole 21.78%) might reflect the particular climatic situation 
with long dry seasons at the coast, reducing black Sigatoka development and hence favouring 
control due to lower inoculum production. Therefore, the frequency of fungicide applications 
is lower (Marín et al. 2003), albeit that the number of applications is increasing since the 
sampling of the isolates in our study (2009-2010; Enrique Donoso, personal communication; 
CIBE, unpublished data). Hence, it would be worth monitoring the current population of P. 
fijiensis in Ecuador.  
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P. fijiensis incursions into Martinique and Guadalupe, two islands of the Caribbean 
close to the northern-east part of South America, happened only in 2010 and 2012, respectively 
(Guzmán et al. 2013; Ioos et al. 2011). For that reason, the exposure to the fungicide have been 
too short, hence the selective pressure is low, which accords with our results, as all P. fijiensis 
isolates are sensitive to DMIs. It has been found that these two populations are sensitive to other 
mode of action fungicide (data not shown). Thus, the favoured origin hypothesis is that these 
islands were colonized by wild-type P. fijiensis isolates. We can exclude the alternative 
hypothesis that the absence of continuous DMI selective pressure results in the loss of resistance 
alleles, due to apparent fitness costs of these alleles, which consequently reverts the population 
back to sensitivity. This effect was shown for Magnaporthe oryzae and Cercospora beticola, 
but remained unnoticed for many other fungi (Hollomon 2015), and we, therefore, consider it 
unlikely for P. fijiensis, particularly since we have identified wild-type strains in other non-
sprayed areas such as San Carlos in Costa Rica and Bohol in the Philippines (data not show) 
and in Cameroon, Colombia and Ecuador.  
P. fijiensis colonized Latin America and the Caribbean during multiple events, likely 
beginning around 40 years ago from Honduras and/or Costa Rica (Halkett et al. 2010; Lapeyre 
et al. 2010b; Rivas et al. 2004a). Such events are consequently accompanied by a reduction of 
genetic diversity through founder effects and bottleneck events (Carlier et al. 1996; Halkett et 
al. 2010; Hayden et al. 2003; Rivas et al. 2004b). Our results show that most isolates from Latin 
America and the Caribbean share the same genetic background (Figure 2). Since P. fijiensis 
ascospores cannot travel beyond a few hundred of meters, long distance dispersal is considered 
to be solely due to anthropogenic movement of contaminated material (Arango et al. 2016; 
Halkett et al. 2010; Marín et al. 2003; Ploetz et al. 2015; Rieux et al. 2014), which unveils 
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unparalleled risks for the banana sector as was also recently shown for the dissemination of the 
Tropical Race 4 strain of Panama disease (Ordoñez et al. 2015).  
 
The genetic structure of P. fijiensis populations and the wild type Pfcyp51 gene 
As indicated above, most Latin American and the Caribbean P. fijiensis isolates cluster 
in the genetic analysis, while isolates from Cameroon form a distinct clade (Figure 2). 
Interestingly, Philippine strains show the highest diversity. This is consistent with the current 
understanding of the genetic structure of P. fijiensis populations, showing that African and 
American populations originate from separated colonization events and that South East Asia – 
here represented by the Philippines – is the centre of origin (Carlier et al. 1996; Halkett et al. 
2010; Hayden et al. 2003; Rivas et al. 2004b). Intriguingly, this pattern continues at the Pfcyp51 
sequence level. For example, the substitution leading to T18I is present in all Latin American 
and the Caribbean and in 15 out of 34 Philippine strains, but lacks in the Cameroon population.  
Our sequencing data of the Pfcyp51 gene across all populations highlights a 
particularity of the CIRAD86 – originating from Cameroon - reference strain, which was 
selected for the first genetic linkage map and genome sequencing (Manzo-Sanchez et al. 2008). 
We now actually question the representativeness of this strain for the species as it encodes V106 
in Pfcyp51, whereas the sequences of all 268 genotyped isolates encode D106. With the 
suggested centre of origin in Southeast Asia, we propose that the wild-type genotype is D106 
rather than V106. In retrospect, this may indicate that the proposed additive role of V106D for 
DMI resistance is an artefact, based on a mutation in the hitherto reference CIRAD86. This 
underscores the need for more genomic information from strains that are selected in the centre 
of origin. 
Chapter 3 
98 
The selective pressure of DMI fungicides on P. fijiensis  
The genetic effects of the DMI application on P. fijiensis populations are solely targeted 
on modifications of the Pfcyp51 gene (Chong et al. 2016c). Most Pfcyp51 modulations paralleled 
with the DMI fungicide resistance response and are comparable to those identified in other 
organisms. Substitutions V136A and I381V are correlated with reduced sensitivities to 
triadimenol in Erysiphe necator and to tebuconazole in Zymoceptoria. tritici, respectively (Cools 
et al. 2013). The accumulation of mutations tend to confer increased resistance to DMI 
fungicides (Cools et al. 2013). Here, we were unable to determine such specific substitutions for 
any of the tested fungicides, which might be due to the high number of factors analysed 
(individual mutations, mutation combination and seven levels of promoter insertions) and hence, 
further studies may identify unique mutation/efficacy interactions.  
Sensitive strains also show variation in Pfcyp51 with a maximum of three mutations 
resulting in three aa changes. Overall, the maximum of aa substitutions was found in the 
Philippines population where some isolates accumulated up to seven aa substitutions in the 
coding region of the Pfcyp51 gene. Such a high degree of polymorphism in the cyp51 gene was 
previously reported for Oculimacula (Tapesia) acuformis and Oculimacula yallundae (Albertini 
et al. 2003). The substitutions resulting in A19E, I70M, D71E, V260L, I264T, H380N, R418G, 
D460E, D460V, Y461N, Y461S, ΔY461 and G462D were hitherto unknown in P. fijiensis, 
although other changes in positions 461 and 462 were reported to affect DMI sensitivity (Cañas 
et al. 2009; Chong et al. 2010; Díaz-Trujillo et al. 2016a). Substitutions A19E, Y58F, V116L, 
and R418G were solely detected in DMI sensitive isolates, suggesting that these represent natural 
random variation, which is uncorrelated with DMI sensitivity. Notably, substitution I264T - 
although also detected in a DMI sensitive isolate (EC50 slightly above sensitive mean) - was 
correlated with additive effects of reduced efficacy of the evaluated DMIs. Similarly, 
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substitutions T18I and A446S are present in both sensitive and resistant isolates, but also 
correlated with additive effects in strains with reduced sensitivity. These observed additive 
effects might be explained as compensatory substitutions for azole sensitivity as illustrated by 
aa changes at positions 459 to 461 in ZtCYP51, compensating the I381V substitution that was, 
by itself, enzymatically lethal as corroborated by complementation experiments in S. cerevisiae 
(Becher & Wirsel 2012). Nevertheless, these modifications urge for additional studies to 
elucidate their contribution to P. fijiensis survival.  
Substitutions A313G, Y136F, H380N, Y463D, and D460V are directly correlated with 
resistance (Table 4 and Figure 9). Similar substitutions were also found in Z. tritici (Cools et al. 
2013) and Y136F was linked with azole resistance in Penicillium italicum, Uncinula necator and 
Blumeria graminis f. sp. hordei (Albertini et al. 2003; Délye et al. 1997). A substitution at Y136, 
or its equivalent in other species, is the most frequently observed modification of CYP51 in 
pathogenic fungi (Cools et al. 2013). Interestingly, Y136F originated from two sequential 
codons. The original codon is TAC while the modified codons are TTC and TTT. The latter is 
unique for the Costa Rican population and might arose from a consecutive mutation emerging 
from the pre-existing TTC codon. This consecutive selection might result from prolonged DMI 
pressure and may represent a bias event towards optimized codon usage. Nonetheless it is worth 
to mention that P. fijiensis codon usage shows a relative preference for codon TTC 
(http://www.kazusa.or.jp/codon/). Codon usage in genes have been long investigated in 
Echericha coli, Sacharomices cerevisiae and Aspergillus nidulans where it correlated with 
highly expressed genes and more efficient translation (Dilucca et al. 2015; Lloyd & Sharp 1991; 
Trotta 2013). The Pfcyp51 gene overexpression in Costa Rican isolations (Chong et al. 2010) 
(Díaz-Trujillo et al. 2016a) might supports this hypothesis, however additional studies are 
needed to strengthen this hypothesis.  
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The importance of substitutions at positions 136, 313, 380, 381 and 460 to 463 are 
strengthened by PfCYP51 modelling. Everything is located in the SRS with the exception of 
positions 460 to 463. Changes in these aa positions however compromise the three-dimensional 
structure of the protein resulting in an affinity change. For example, models with the setting 
ΔY461, Y461N, G462A and Y463D, revealed significant distance and angle changes around 
position 524 to 526 (SRS6) (Figure 4, 5c - g, Table S7). The deletion of ΔY461 itself provoked 
a shift in positions 523 to 526 introducing the S523 into the active site and pushing S526 out of 
the selected range (>7Å).  
Position 125, at the entrance of the channel to the active site of the protein, was modified 
in all resistant strains (Figure S6). However, based on modelling, the effect is limited. Additional 
studies are required to elucidate how these changes affect fungicide entry or the catalytic centre 
structure. 
 
Promoter insertions 
The presence of repeated elements and insertions in the promoter region of Pfcyp51 
explains the overexpression of the gene (Díaz-Trujillo et al. 2016a). None of the sensitive strains 
contained insertions while they were very common in tolerant and resistant strains. In the current 
survey, promoter insertions positively correlated with the resistance to DMIs (Table 4 and Figure 
9). Also in A. fumigatus, cyp51 promoter insertions explain resistance to azole fungicides 
(Mellado et al. 2007). Interestingly, these insertions were also associated with non-synonymous 
mutations in the coding region (Mellado et al. 2007). Snelders et al. (2012) observed that an A. 
fumigatus isolate with two copies of a tandem repeat acquired an additional repeat during DMI 
treatment, supporting the hypothesis that genomic changes in the cyp51 gene are inducible 
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(Snelders et al. 2012). Analogously, in P. digitatum promoter insertions drive the expression of 
the cyp51 gene; a 126 bp insertion comprising five repeat elements is present in resistant strains 
while sensitive isolates only carry one repeat element (Hamamoto et al. 2000). Similarly, cyp51 
gene overexpression is also reported in Z. tritici, a close relative of P. fijiensis, where a 120 bp 
insertion in the promoter region correlates with a 10 to 40-fold overexpression (Cools et al. 2012) 
as well as in Venturia inaequalis and Blumeriella jaapii where the presence of upstream 
derivatives of LINE-like retrotransposons correlated with overexpression of the cyp51 gene (Ma 
et al. 2006; Schnabel & Jones 2000). All these discussed inserts vary in size and nature across 
species and are not located at equal positions and clearly result from independent events, which 
raise the question about their origin. They might be remains of transposable element activity, 
some of which contain powerful promoters (Cools et al. 2013). In P. digitatum the effect of a 
transposon element in the promoter region has been described to confer resistance to DMIs (Sun 
et al. 2013). In P. fijiensis three independent promoter insertions exist, at -103 bp, at -94 bp and 
at -157 bp from the start codon. The latter was only present in two isolates from Cameroon. 
However, all isolates with insertion contain tandem copies (or partial copies) of the “A” element 
and were at least DMIs “tolerant” (>0.1 mg.L-1) (Table S3 and Figure S7).  
The central core of the repeats are the palindromic arrangements. These motifs 
constitute an important group of regulatory elements in eukaryotes in which they act as cis-
elements (Knox & Keller 2015). Many transcription factors (TF) bind palindromic sequences 
with high affinity (Narlikar & Hartemink 2006; Qian et al. 2006). For example, the TF ADR1 
binds as a monomer to palindromic sequences to regulate the expression of S. cerevisiae ADH2 
gene (Thurkral et al. 1991). In Cercospora nicotianae the TF CRG1 binds to a palindrome 
sequence present in genes that confer resistance to cercosporin (Chung et al. 2003). The group 
of bZIP TFs target palindromic DNA sequences as dimers, thereby regulating e.g. secondary 
metabolism (Knox & Keller 2015). The importance of the palindromic sequences might explain 
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the existence of isolates with few full repeats and a partial “A” element insertion in Pfcyp51 
while they are categorized as DMI resistant (Figure 7 and S5).  
A second palindromic sequence, inserted in element B, was present in the Pfcyp51 
promoter of Philippine isolates. Due to the absence of intermediate strains, only containing the 
B element, the correlation with Pfcyp51 gene expression is not resolved. However, there was no 
significant expression difference of Pfcyp51 when compared with strains merely containing the 
A element (data not shown). 
In summary, element “A” and particularly its palindromic core is important for 
regulation of gene expression, most likely as a transcriptional enhancer (Bolton et al. 2016; 
Schnabel & Jones 2000). The mechanism and the components involved, however, remain to be 
elucidated. Future work will aim at the characterization of the mechanism and identification of 
the involved TFs and additional determinants (Bolton et al. 2016). Promoter insertions of 
element A tend to confer higher EC50 regardless of the fungicide and might be the reason why 
we were unable to determine specific substitutions for the tested fungicides. This might suggest 
that the effect of the promoter insertion can mascaraed the specific interaction between a 
substitution and a particular fungicide and induce at some degree cross-resistance among DMI 
fungicides. Interestingly, only tolerant or resistant strains show insertions in the promoter region. 
This suggest that the selection for overexpression only occur after the emergence of point 
mutations. Transformation studies have demonstrated that insertions alone do not increase the 
DMI resistant significantly (Díaz-Trujillo et al. 2016a). For this reason, we conclude that the 
main resistant factors are the mutations in the Pfcyp51 and that the insertions in the promoter 
region acts as an additive effect. 
Three isolates from Costa Rica, CaM10_6, CaM1_5 and CaM3_1, revealed 
extraordinary high EC50 values that remain unexplained solely by the Pfcyp51 promoter 
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configuration similar to those in other, less resistant isolates from Costa Rica. This suggests the 
presence of additional quantitative genetic components that directly or indirectly modulate 
resistance as observed in O. yallundae (Dyer et al. 2000). The construction of a genetic map of 
P. fijiensis based on crosses between fungicide resistant and sensitive isolates facilitates an 
unbiased identification of additional genes contributing to DMI fungicide resistance (Chong et 
al. 2016c) and provides insight into the recombination frequency of mutant alleles and the 
possible distribution mechanism of resistance alleles in populations. The current and associated 
studies (Chong et al. 2016a; Chong et al. 2016c; Díaz-Trujillo et al. 2016a) significantly 
contribute to the understanding of the origin and dissemination of DMI resistance mechanisms 
in P. fijiensis and facilitates the prediction of the efficacy of new generations of fungicides.  
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Supporting information 
Table S1. EC50 mean values per Pseudocercospora fijiensis isolate. Columns show: Country, 
isolate code, fungicide, 2 Logarithmic mean, lower and upper error of the difference values 
(Lsed and Used), observations (number of independent EC50 calculated values), standard error 
of the measurement (Sem), lower and upper confident intervals of the means and the back-
transformed EC50 mean values in mg.L
-1. Strains with EC50 values lower than 0.1 mg.L
-1 are 
indicated with a green background, values from 0.1 to 0.9 mg.L-1are shown in light yellow 
background and values higher than 1 mg.L-1 are shown in light red background. 
Country Isolate Fungicide 2Log(m) Lsed Used (n) Sem LMCI UMCI EC50  
Dominican Rep. A_10 Difenoconazole -3.525 -5.567 -1.482 3 0.520 -4.546 -2.504 0.087 
Dominican Rep. A_10 Epoxiconazole -4.238 -6.280 -2.195 3 0.520 -5.259 -3.217 0.053 
Dominican Rep. A_10 Propiconazole -2.484 -4.527 -0.442 3 0.520 -3.506 -1.463 0.179 
Dominican Rep. A_11 Difenoconazole 0.437 -1.606 2.479 3 0.520 -0.584 1.458 1.354 
Dominican Rep. A_11 Epoxiconazole -0.057 -2.100 1.985 3 0.520 -1.079 0.964 0.961 
Dominican Rep. A_11 Propiconazole 0.309 -1.733 2.352 3 0.520 -0.712 1.330 1.239 
Dominican Rep. A_12 Difenoconazole -7.164 -9.207 -5.122 3 0.520 -8.185 -6.143 0.007 
Dominican Rep. A_12 Epoxiconazole -6.334 -8.376 -4.292 3 0.520 -7.355 -5.313 0.012 
Dominican Rep. A_12 Propiconazole -5.956 -7.999 -3.914 3 0.520 -6.978 -4.935 0.016 
Dominican Rep. A_13 Difenoconazole 1.082 -0.960 3.124 3 0.520 0.061 2.103 2.117 
Dominican Rep. A_13 Epoxiconazole -0.107 -2.149 1.936 3 0.520 -1.128 0.915 0.929 
Dominican Rep. A_13 Propiconazole 0.153 -1.889 2.196 3 0.520 -0.868 1.174 1.112 
Dominican Rep. A_14 Difenoconazole -1.781 -3.824 0.261 3 0.520 -2.802 -0.760 0.291 
Dominican Rep. A_14 Epoxiconazole -2.274 -4.317 -0.232 3 0.520 -3.295 -1.253 0.207 
Dominican Rep. A_14 Propiconazole -1.780 -3.822 0.262 3 0.520 -2.801 -0.759 0.291 
Dominican Rep. A_15 Difenoconazole 0.877 -1.165 2.920 3 0.520 -0.144 1.899 1.837 
Dominican Rep. A_15 Epoxiconazole 0.221 -1.822 2.263 3 0.520 -0.801 1.242 1.165 
Dominican Rep. A_15 Propiconazole 0.650 -1.393 2.692 3 0.520 -0.372 1.671 1.569 
Dominican Rep. A_16 Difenoconazole -4.152 -6.194 -2.110 3 0.520 -5.173 -3.131 0.056 
Dominican Rep. A_16 Epoxiconazole -2.032 -4.074 0.011 3 0.520 -3.053 -1.010 0.245 
Dominican Rep. A_16 Propiconazole -1.632 -3.674 0.410 3 0.520 -2.653 -0.611 0.323 
Dominican Rep. A_7 Difenoconazole -2.646 -4.689 -0.604 3 0.520 -3.667 -1.625 0.160 
Dominican Rep. A_7 Epoxiconazole -4.329 -6.371 -2.287 3 0.520 -5.350 -3.308 0.050 
Dominican Rep. A_7 Propiconazole -1.882 -3.924 0.160 3 0.520 -2.903 -0.861 0.271 
Dominican Rep. A_8 Difenoconazole -2.057 -4.100 -0.015 3 0.520 -3.079 -1.036 0.240 
Dominican Rep. A_8 Epoxiconazole -3.478 -5.521 -1.436 3 0.520 -4.500 -2.457 0.090 
Dominican Rep. A_8 Propiconazole -1.459 -3.501 0.583 3 0.520 -2.480 -0.438 0.364 
Dominican Rep. A_9 Difenoconazole -1.630 -3.672 0.412 3 0.520 -2.651 -0.609 0.323 
Dominican Rep. A_9 Epoxiconazole -2.694 -4.736 -0.651 3 0.520 -3.715 -1.673 0.155 
Dominican Rep. A_9 Propiconazole -1.278 -3.321 0.764 3 0.520 -2.300 -0.257 0.412 
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Country Isolate Fungicide 2Log(m) Lsed Used (n) Sem LMCI UMCI EC50  
Colombia Almendros_1 Difenoconazole 0.809 -1.233 2.852 1 0.901 -0.959 2.578 1.752 
Colombia Almendros_1 Epoxiconazole -0.412 -2.454 1.630 1 0.901 -2.181 1.357 0.752 
Colombia Almendros_1 Propiconazole 1.061 -0.982 3.103 1 0.901 -0.708 2.830 2.086 
Colombia Almendros_2 Difenoconazole 2.569 0.527 4.612 1 0.901 0.801 4.338 5.936 
Colombia Almendros_2 Epoxiconazole 0.237 -1.806 2.279 1 0.901 -1.532 2.006 1.178 
Colombia Almendros_2 Propiconazole 1.581 -0.461 3.624 1 0.901 -0.187 3.350 2.993 
Colombia Almendros_3 Difenoconazole -0.173 -2.215 1.869 1 0.901 -1.942 1.596 0.887 
Colombia Almendros_3 Epoxiconazole -0.896 -2.939 1.146 1 0.901 -2.665 0.872 0.537 
Colombia Almendros_3 Propiconazole -0.267 -2.310 1.775 1 0.901 -2.036 1.502 0.831 
Colombia Almendros_4 Difenoconazole -1.589 -3.632 0.453 1 0.901 -3.358 0.180 0.332 
Colombia Almendros_4 Epoxiconazole -1.093 -3.135 0.949 1 0.901 -2.862 0.676 0.469 
Colombia Almendros_4 Propiconazole -0.406 -2.448 1.637 1 0.901 -2.174 1.363 0.755 
Colombia Almendros_8 Difenoconazole 2.898 0.855 4.940 1 0.901 1.129 4.666 7.452 
Colombia Almendros_8 Epoxiconazole 2.672 0.630 4.715 1 0.901 0.904 4.441 6.375 
Colombia Almendros_8 Propiconazole 2.759 0.716 4.801 1 0.901 0.990 4.528 6.768 
Philippines B11_10 Difenoconazole 0.645 -1.397 2.688 1 0.901 -1.123 2.414 1.564 
Philippines B11_10 Epoxiconazole 1.071 -0.972 3.113 1 0.901 -0.698 2.839 2.100 
Philippines B11_10 Propiconazole 1.600 -0.442 3.642 1 0.901 -0.169 3.369 3.031 
Philippines B11_11 Difenoconazole -0.976 -3.018 1.066 3 0.520 -1.997 0.045 0.508 
Philippines B11_11 Epoxiconazole -2.089 -4.131 -0.046 3 0.520 -3.110 -1.067 0.235 
Philippines B11_11 Propiconazole -0.542 -2.585 1.500 3 0.520 -1.564 0.479 0.687 
Philippines B11_12 Difenoconazole -0.836 -2.878 1.207 3 0.520 -1.857 0.186 0.560 
Philippines B11_12 Epoxiconazole -1.531 -3.574 0.511 3 0.520 -2.552 -0.510 0.346 
Philippines B11_12 Propiconazole -0.264 -2.306 1.778 3 0.520 -1.285 0.757 0.833 
Philippines B11_13 Difenoconazole -1.458 -3.501 0.584 3 0.520 -2.480 -0.437 0.364 
Philippines B11_13 Epoxiconazole -1.909 -3.952 0.133 3 0.520 -2.930 -0.888 0.266 
Philippines B11_13 Propiconazole 0.187 -1.856 2.229 3 0.520 -0.835 1.208 1.138 
Philippines B11_14 Difenoconazole -1.566 -3.609 0.476 1 0.901 -3.335 0.202 0.338 
Philippines B11_14 Epoxiconazole -1.599 -3.641 0.444 1 0.901 -3.367 0.170 0.330 
Philippines B11_14 Propiconazole -0.067 -2.110 1.975 1 0.901 -1.836 1.701 0.954 
Philippines B11_15 Difenoconazole 1.128 -0.914 3.170 1 0.901 -0.641 2.897 2.186 
Philippines B11_15 Epoxiconazole 0.639 -1.403 2.682 1 0.901 -1.129 2.408 1.558 
Philippines B11_15 Propiconazole 0.952 -1.091 2.994 1 0.901 -0.817 2.720 1.934 
Philippines B11_16 Difenoconazole 0.325 -1.718 2.367 1 0.901 -1.444 2.094 1.252 
Philippines B11_16 Epoxiconazole -1.187 -3.229 0.856 1 0.901 -2.955 0.582 0.439 
Philippines B11_16 Propiconazole 1.260 -0.782 3.302 1 0.901 -0.509 3.029 2.395 
Philippines B11_2 Difenoconazole 1.317 -0.725 3.360 1 0.901 -0.452 3.086 2.492 
Philippines B11_2 Epoxiconazole 1.781 -0.262 3.823 1 0.901 0.012 3.550 3.436 
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Country Isolate Fungicide 2Log(m) Lsed Used (n) Sem LMCI UMCI EC50  
Philippines B11_2 Propiconazole 2.175 0.132 4.217 1 0.901 0.406 3.943 4.514 
Philippines B11_5 Difenoconazole 2.456 0.414 4.498 3 0.520 1.435 3.477 5.487 
Philippines B11_5 Epoxiconazole 2.184 0.142 4.227 3 0.520 1.163 3.205 4.545 
Philippines B11_5 Propiconazole 2.122 0.080 4.164 3 0.520 1.101 3.143 4.353 
Philippines B11_7 Difenoconazole -0.487 -2.530 1.555 3 0.520 -1.508 0.534 0.713 
Philippines B11_7 Epoxiconazole -1.627 -3.669 0.416 3 0.520 -2.648 -0.606 0.324 
Philippines B11_7 Propiconazole 0.121 -1.922 2.163 3 0.520 -0.901 1.142 1.087 
Philippines B11_8 Difenoconazole 1.506 -0.536 3.549 1 0.901 -0.262 3.275 2.841 
Philippines B11_8 Epoxiconazole 1.355 -0.688 3.397 1 0.901 -0.414 3.124 2.558 
Philippines B11_8 Propiconazole 1.355 -0.687 3.397 1 0.901 -0.414 3.124 2.558 
Philippines B11_9 Difenoconazole 0.571 -1.471 2.613 1 0.901 -1.198 2.340 1.486 
Philippines B11_9 Epoxiconazole -0.401 -2.444 1.641 1 0.901 -2.170 1.367 0.757 
Philippines B11_9 Propiconazole 0.218 -1.825 2.260 1 0.901 -1.551 1.987 1.163 
Philippines B21_1 Difenoconazole -0.795 -2.837 1.248 1 0.901 -2.564 0.974 0.576 
Philippines B21_1 Epoxiconazole -0.480 -2.522 1.563 1 0.901 -2.248 1.289 0.717 
Philippines B21_1 Propiconazole 1.335 -0.708 3.377 1 0.901 -0.434 3.103 2.522 
Philippines B21_10 Difenoconazole 0.410 -1.633 2.452 1 0.901 -1.359 2.179 1.328 
Philippines B21_10 Epoxiconazole -0.132 -2.175 1.910 1 0.901 -1.901 1.637 0.912 
Philippines B21_10 Propiconazole 1.586 -0.456 3.628 1 0.901 -0.183 3.355 3.002 
Philippines B21_11 Difenoconazole 1.088 -0.954 3.131 1 0.901 -0.680 2.857 2.126 
Philippines B21_11 Epoxiconazole 0.598 -1.444 2.641 1 0.901 -1.171 2.367 1.514 
Philippines B21_11 Propiconazole 0.974 -1.068 3.017 1 0.901 -0.795 2.743 1.965 
Philippines B21_12 Difenoconazole 0.855 -1.187 2.897 1 0.901 -0.914 2.624 1.809 
Philippines B21_12 Epoxiconazole 1.847 -0.195 3.889 1 0.901 0.078 3.616 3.598 
Philippines B21_12 Propiconazole -1.016 -3.058 1.027 1 0.901 -2.785 0.753 0.495 
Philippines B21_13 Difenoconazole -1.097 -3.139 0.945 1 0.901 -2.866 0.672 0.467 
Philippines B21_13 Epoxiconazole -3.184 -5.227 -1.142 1 0.901 -4.953 -1.415 0.110 
Philippines B21_13 Propiconazole 0.204 -1.838 2.246 1 0.901 -1.565 1.973 1.152 
Philippines B21_2 Difenoconazole 0.041 -2.001 2.084 1 0.901 -1.727 1.810 1.029 
Philippines B21_2 Epoxiconazole 0.317 -1.726 2.359 1 0.901 -1.452 2.086 1.246 
Philippines B21_2 Propiconazole 1.185 -0.858 3.227 1 0.901 -0.584 2.953 2.273 
Philippines B21_3 Difenoconazole -0.213 -2.255 1.830 1 0.901 -1.981 1.556 0.863 
Philippines B21_3 Epoxiconazole -0.838 -2.880 1.204 1 0.901 -2.607 0.931 0.559 
Philippines B21_3 Propiconazole 0.664 -1.379 2.706 1 0.901 -1.105 2.432 1.584 
Philippines B21_4 Difenoconazole 2.864 0.821 4.906 1 0.901 1.095 4.633 7.279 
Philippines B21_4 Epoxiconazole 2.970 0.928 5.012 1 0.901 1.201 4.739 7.836 
Philippines B21_4 Propiconazole 0.592 -1.451 2.634 1 0.901 -1.177 2.360 1.507 
Philippines B21_5 Difenoconazole -2.006 -4.049 0.036 1 0.901 -3.775 -0.237 0.249 
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Country Isolate Fungicide 2Log(m) Lsed Used (n) Sem LMCI UMCI EC50  
Philippines B21_5 Epoxiconazole -1.278 -3.321 0.764 1 0.901 -3.047 0.490 0.412 
Philippines B21_5 Propiconazole -0.108 -2.150 1.935 1 0.901 -1.877 1.661 0.928 
Philippines B21_6 Difenoconazole -0.241 -2.283 1.802 1 0.901 -2.009 1.528 0.846 
Philippines B21_6 Epoxiconazole 1.012 -1.031 3.054 1 0.901 -0.757 2.780 2.016 
Philippines B21_6 Propiconazole -0.207 -2.250 1.835 1 0.901 -1.976 1.561 0.866 
Philippines B21_7 Difenoconazole 1.021 -1.022 3.063 1 0.901 -0.748 2.789 2.029 
Philippines B21_7 Epoxiconazole 1.025 -1.017 3.068 1 0.901 -0.743 2.794 2.036 
Philippines B21_7 Propiconazole -0.068 -2.111 1.974 1 0.901 -1.837 1.700 0.954 
Philippines B21_8 Difenoconazole 1.965 -0.077 4.008 1 0.901 0.196 3.734 3.905 
Philippines B21_8 Epoxiconazole 2.255 0.213 4.298 1 0.901 0.486 4.024 4.774 
Philippines B21_8 Propiconazole 0.747 -1.296 2.789 1 0.901 -1.022 2.515 1.678 
Philippines B21_9 Difenoconazole 2.421 0.378 4.463 1 0.901 0.652 4.190 5.354 
Philippines B21_9 Epoxiconazole 1.236 -0.806 3.279 1 0.901 -0.533 3.005 2.356 
Philippines B21_9 Propiconazole 2.528 0.486 4.570 1 0.901 0.759 4.297 5.768 
Colombia Bananal_1 Difenoconazole 0.703 -1.340 2.745 1 0.901 -1.066 2.472 1.628 
Colombia Bananal_1 Epoxiconazole 0.660 -1.382 2.703 1 0.901 -1.108 2.429 1.580 
Colombia Bananal_1 Propiconazole 1.185 -0.857 3.228 1 0.901 -0.584 2.954 2.274 
Colombia Bejuquillo_1 Difenoconazole -6.750 -8.792 -4.707 1 0.901 -8.519 -4.981 0.009 
Colombia Bejuquillo_1 Epoxiconazole -6.087 -8.130 -4.045 1 0.901 -7.856 -4.318 0.015 
Colombia Bejuquillo_1 Propiconazole -5.946 -7.989 -3.904 1 0.901 -7.715 -4.177 0.016 
Colombia Bejuquillo_2 Difenoconazole -6.561 -8.603 -4.518 3 0.520 -7.582 -5.539 0.011 
Colombia Bejuquillo_2 Epoxiconazole -6.057 -8.099 -4.015 3 0.520 -7.078 -5.036 0.015 
Colombia Bejuquillo_2 Propiconazole -5.236 -7.278 -3.194 3 0.520 -6.257 -4.215 0.027 
Colombia Bejuquillo_3 Difenoconazole -5.921 -7.963 -3.878 1 0.901 -7.689 -4.152 0.017 
Colombia Bejuquillo_3 Epoxiconazole -5.129 -7.172 -3.087 1 0.901 -6.898 -3.360 0.029 
Colombia Bejuquillo_3 Propiconazole -3.874 -5.916 -1.832 1 0.901 -5.643 -2.105 0.068 
Colombia Bejuquillo_4 Difenoconazole -7.447 -9.490 -5.405 1 0.901 -9.216 -5.679 0.006 
Colombia Bejuquillo_4 Epoxiconazole -6.075 -8.118 -4.033 1 0.901 -7.844 -4.307 0.015 
Colombia Bejuquillo_4 Propiconazole -5.606 -7.648 -3.564 1 0.901 -7.375 -3.837 0.021 
Colombia Bejuquillo_5 Difenoconazole -6.075 -8.117 -4.032 1 0.901 -7.843 -4.306 0.015 
Colombia Bejuquillo_5 Epoxiconazole -5.805 -7.847 -3.763 1 0.901 -7.574 -4.036 0.018 
Colombia Bejuquillo_5 Propiconazole -4.304 -6.346 -2.262 1 0.901 -6.073 -2.535 0.051 
Colombia Bejuquillo_6 Difenoconazole -6.266 -8.308 -4.224 1 0.901 -8.035 -4.497 0.013 
Colombia Bejuquillo_6 Epoxiconazole -5.937 -7.980 -3.895 1 0.901 -7.706 -4.168 0.016 
Colombia Bejuquillo_6 Propiconazole -4.865 -6.907 -2.822 1 0.901 -6.634 -3.096 0.034 
Colombia Bejuquillo_7 Difenoconazole -6.158 -8.200 -4.116 1 0.901 -7.927 -4.389 0.014 
Colombia Bejuquillo_7 Epoxiconazole -5.323 -7.366 -3.281 1 0.901 -7.092 -3.554 0.025 
Colombia Bejuquillo_7 Propiconazole -4.963 -7.005 -2.920 1 0.901 -6.731 -3.194 0.032 
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Philippines Bo_1 Difenoconazole -7.483 -9.525 -5.441 3 0.520 -8.504 -6.462 0.006 
Philippines Bo_1 Epoxiconazole -6.447 -8.490 -4.405 3 0.520 -7.468 -5.426 0.011 
Philippines Bo_1 Propiconazole -5.851 -7.893 -3.808 3 0.520 -6.872 -4.829 0.017 
Colombia Bonita_2 Difenoconazole -2.089 -4.131 -0.047 3 0.520 -3.110 -1.068 0.235 
Colombia Bonita_2 Epoxiconazole -2.749 -4.791 -0.706 3 0.520 -3.770 -1.727 0.149 
Colombia Bonita_2 Propiconazole -1.796 -3.839 0.246 3 0.520 -2.817 -0.775 0.288 
Colombia C080910 Difenoconazole -3.023 -5.066 -0.981 3 0.520 -4.044 -2.002 0.123 
Colombia C080910 Epoxiconazole -3.082 -5.125 -1.040 3 0.520 -4.103 -2.061 0.118 
Colombia C080910 Propiconazole -1.178 -3.221 0.864 3 0.520 -2.199 -0.157 0.442 
Colombia C120901 Difenoconazole -1.591 -3.633 0.452 1 0.901 -3.359 0.178 0.332 
Colombia C120901 Epoxiconazole -2.594 -4.636 -0.552 1 0.901 -4.363 -0.825 0.166 
Colombia C120901 Propiconazole -1.061 -3.104 0.981 1 0.901 -2.830 0.708 0.479 
Colombia C120906 Difenoconazole 2.761 0.719 4.804 1 0.901 0.993 4.530 6.781 
Colombia C120906 Epoxiconazole 3.072 1.030 5.115 1 0.901 1.304 4.841 8.411 
Colombia C120906 Propiconazole 2.924 0.881 4.966 1 0.901 1.155 4.692 7.587 
Colombia C120908 Difenoconazole 2.764 0.722 4.807 1 0.901 0.995 4.533 6.794 
Colombia C120908 Epoxiconazole 1.580 -0.462 3.623 1 0.901 -0.189 3.349 2.990 
Colombia C120908 Propiconazole 1.313 -0.729 3.355 1 0.901 -0.456 3.082 2.485 
Colombia C120909 Difenoconazole 2.568 0.525 4.610 1 0.901 0.799 4.336 5.928 
Colombia C120909 Epoxiconazole 0.394 -1.648 2.437 1 0.901 -1.375 2.163 1.314 
Colombia C120909 Propiconazole 2.464 0.422 4.507 1 0.901 0.696 4.233 5.519 
Colombia C120910 Difenoconazole    0    
>10.24 
Colombia C120910 Epoxiconazole 
   
0 
   
>10.24 
Colombia C120910 Propiconazole    0    
>10.24 
Colombia C120912 Difenoconazole 2.585 0.543 4.628 1 0.901 0.816 4.354 6.001 
Colombia C120912 Epoxiconazole -0.191 -2.234 1.851 1 0.901 -1.960 1.578 0.876 
Colombia C120912 Propiconazole 1.799 -0.244 3.841 1 0.901 0.030 3.568 3.479 
Colombia C120913 Difenoconazole    0    
>10.24 
Colombia C120913 Epoxiconazole 2.597 0.555 4.640 1 0.901 0.828 4.366 6.051 
Colombia C120913 Propiconazole    0    
>10.24 
Colombia C139 Difenoconazole -6.430 -8.473 -4.388 2 0.637 -7.681 -5.179 0.012 
Colombia C139 Epoxiconazole -6.116 -8.158 -4.074 2 0.637 -7.367 -4.865 0.014 
Colombia C139 Propiconazole -5.387 -7.429 -3.344 2 0.637 -6.638 -4.136 0.024 
Cameroon C86 Difenoconazole -7.862 -9.905 -5.820 2 0.637 -9.113 -6.612 0.004 
Cameroon C86 Epoxiconazole -7.217 -9.259 -5.175 2 0.637 -8.468 -5.966 0.007 
Cameroon C86 Propiconazole -6.681 -8.723 -4.638 2 0.637 -7.932 -5.430 0.010 
Costa Rica Ca10_13 Difenoconazole 2.486 0.444 4.529 2 0.637 1.236 3.737 5.604 
Costa Rica Ca10_13 Epoxiconazole 1.759 -0.283 3.801 2 0.637 0.508 3.010 3.385 
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Costa Rica Ca10_13 Propiconazole 1.990 -0.053 4.032 2 0.637 0.739 3.240 3.971 
Costa Rica Ca5_16 Difenoconazole 2.489 0.446 4.531 2 0.637 1.238 3.739 5.613 
Costa Rica Ca5_16 Epoxiconazole 0.328 -1.715 2.370 2 0.637 -0.923 1.578 1.255 
Costa Rica Ca5_16 Propiconazole 1.473 -0.569 3.515 2 0.637 0.222 2.724 2.776 
Costa Rica CaM1_1 Difenoconazole 2.583 0.541 4.625 7 0.341 1.914 3.252 5.992 
Costa Rica CaM1_1 Epoxiconazole 0.890 -1.153 2.932 6 0.368 0.168 1.612 1.853 
Costa Rica CaM1_1 Propiconazole 1.443 -0.600 3.485 7 0.341 0.774 2.111 2.718 
Costa Rica CaM1_10 Difenoconazole 2.263 0.221 4.305 4 0.451 1.379 3.147 4.800 
Costa Rica CaM1_10 Epoxiconazole 2.155 0.112 4.197 4 0.451 1.270 3.039 4.453 
Costa Rica CaM1_10 Propiconazole 1.974 -0.069 4.016 3 0.520 0.953 2.995 3.928 
Costa Rica CaM1_11 Difenoconazole 1.472 -0.571 3.514 2 0.637 0.221 2.722 2.774 
Costa Rica CaM1_11 Epoxiconazole 2.144 0.101 4.186 2 0.637 0.893 3.395 4.419 
Costa Rica CaM1_11 Propiconazole 1.702 -0.341 3.744 2 0.637 0.451 2.952 3.253 
Costa Rica CaM1_12 Difenoconazole 3.296 1.253 5.338 1 0.901 1.527 5.064 9.819 
Costa Rica CaM1_12 Epoxiconazole 1.695 -0.348 3.737 1 0.901 -0.074 3.464 3.237 
Costa Rica CaM1_12 Propiconazole 2.357 0.315 4.399 2 0.637 1.106 3.608 5.123 
Costa Rica CaM1_13 Difenoconazole    0    
>10.24 
Costa Rica CaM1_13 Epoxiconazole 
   
0 
   
>10.24 
Costa Rica CaM1_13 Propiconazole    0    
>10.24 
Costa Rica CaM1_14 Difenoconazole 2.732 0.690 4.775 1 0.901 0.964 4.501 6.645 
Costa Rica CaM1_14 Epoxiconazole 1.758 -0.285 3.800 1 0.901 -0.011 3.527 3.382 
Costa Rica CaM1_14 Propiconazole 1.966 -0.076 4.008 1 0.901 0.197 3.735 3.907 
Costa Rica CaM1_15 Difenoconazole 
   
0 
   
>10.24 
Costa Rica CaM1_15 Epoxiconazole 1.904 -0.138 3.947 1 0.901 0.135 3.673 3.743 
Costa Rica CaM1_15 Propiconazole 
   
0 
   
>10.24 
Costa Rica CaM1_16 Difenoconazole    0    
>10.24 
Costa Rica CaM1_16 Epoxiconazole 3.002 0.960 5.044 2 0.637 1.751 4.253 8.012 
Costa Rica CaM1_16 Propiconazole 2.952 0.910 4.995 1 0.901 1.183 4.721 7.739 
Costa Rica CaM1_2 Difenoconazole 2.031 -0.011 4.074 5 0.403 1.240 2.822 4.088 
Costa Rica CaM1_2 Epoxiconazole 1.515 -0.527 3.558 7 0.341 0.847 2.184 2.859 
Costa Rica CaM1_2 Propiconazole 2.503 0.460 4.545 5 0.403 1.712 3.294 5.668 
Costa Rica CaM1_3 Difenoconazole 2.429 0.386 4.471 6 0.368 1.707 3.151 5.384 
Costa Rica CaM1_3 Epoxiconazole 1.896 -0.146 3.938 7 0.341 1.228 2.565 3.722 
Costa Rica CaM1_3 Propiconazole 1.793 -0.250 3.835 7 0.341 1.124 2.461 3.464 
Costa Rica CaM1_4 Difenoconazole 1.646 -0.397 3.688 7 0.341 0.977 2.314 3.129 
Costa Rica CaM1_4 Epoxiconazole 1.957 -0.085 4.000 6 0.368 1.235 2.679 3.883 
Costa Rica CaM1_4 Propiconazole 2.215 0.173 4.258 6 0.368 1.493 2.937 4.644 
Costa Rica CaM1_5 Difenoconazole 3.706 1.664 5.749 3 0.520 2.685 4.728 13.054 
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Costa Rica CaM1_5 Epoxiconazole 2.372 0.329 4.414 4 0.451 1.487 3.256 5.176 
Costa Rica CaM1_5 Propiconazole 2.630 0.588 4.673 5 0.403 1.839 3.421 6.191 
Costa Rica CaM1_6 Difenoconazole 2.256 0.214 4.299 5 0.403 1.465 3.047 4.778 
Costa Rica CaM1_6 Epoxiconazole 2.225 0.182 4.267 5 0.403 1.434 3.016 4.675 
Costa Rica CaM1_6 Propiconazole 2.609 0.567 4.652 5 0.403 1.818 3.400 6.103 
Costa Rica CaM1_7 Difenoconazole 2.348 0.305 4.390 6 0.368 1.626 3.070 5.091 
Costa Rica CaM1_7 Epoxiconazole 2.654 0.612 4.697 6 0.368 1.932 3.376 6.296 
Costa Rica CaM1_7 Propiconazole 2.550 0.508 4.592 5 0.403 1.759 3.341 5.856 
Costa Rica CaM1_8 Difenoconazole 1.479 -0.563 3.522 6 0.368 0.757 2.201 2.788 
Costa Rica CaM1_8 Epoxiconazole 2.151 0.108 4.193 6 0.368 1.429 2.873 4.440 
Costa Rica CaM1_8 Propiconazole 0.949 -1.093 2.992 6 0.368 0.227 1.671 1.931 
Costa Rica CaM1_9 Difenoconazole 1.943 -0.099 3.986 2 0.637 0.693 3.194 3.846 
Costa Rica CaM1_9 Epoxiconazole 1.616 -0.427 3.658 1 0.901 -0.153 3.385 3.065 
Costa Rica CaM1_9 Propiconazole 2.568 0.526 4.611 2 0.637 1.318 3.819 5.931 
Costa Rica CaM10_16 Difenoconazole 2.588 0.546 4.631 3 0.520 1.567 3.610 6.014 
Costa Rica CaM10_16 Epoxiconazole 1.215 -0.828 3.257 3 0.520 0.193 2.236 2.321 
Costa Rica CaM10_16 Propiconazole 2.488 0.445 4.530 3 0.520 1.467 3.509 5.609 
Costa Rica CaM10_21 Difenoconazole 2.961 0.919 5.003 3 0.520 1.940 3.982 7.787 
Costa Rica CaM10_21 Epoxiconazole 3.330 1.287 5.372 1 0.901 1.561 5.098 10.054 
Costa Rica CaM10_21 Propiconazole 2.655 0.613 4.697 3 0.520 1.634 3.676 6.299 
Costa Rica CaM10_6 Difenoconazole 4.387 2.345 6.430 3 0.520 3.366 5.408 20.925 
Costa Rica CaM10_6 Epoxiconazole 2.655 0.613 4.697 6 0.368 1.933 3.377 6.298 
Costa Rica CaM10_6 Propiconazole 4.203 2.160 6.245 1 0.901 2.434 5.971 18.414 
Costa Rica CaM2_1 Difenoconazole 2.400 0.357 4.442 3 0.520 1.378 3.421 5.277 
Costa Rica CaM2_1 Epoxiconazole 1.324 -0.719 3.366 2 0.637 0.073 2.574 2.503 
Costa Rica CaM2_1 Propiconazole 1.264 -0.779 3.306 4 0.451 0.379 2.148 2.401 
Costa Rica CaM2_10 Difenoconazole 
   
0 
   
>10.24 
Costa Rica CaM2_10 Epoxiconazole 2.759 0.717 4.802 2 0.637 1.509 4.010 6.770 
Costa Rica CaM2_10 Propiconazole 2.874 0.832 4.917 2 0.637 1.624 4.125 7.333 
Costa Rica CaM2_11 Difenoconazole    0    
>10.24 
Costa Rica CaM2_11 Epoxiconazole 
   
0 
   
>10.24 
Costa Rica CaM2_11 Propiconazole    0    
>10.24 
Costa Rica CaM2_12 Difenoconazole 
   
0 
   
>10.24 
Costa Rica CaM2_12 Epoxiconazole    0    
>10.24 
Costa Rica CaM2_12 Propiconazole 
   
0 
   
>10.24 
Costa Rica CaM2_13 Difenoconazole    0    
>10.24 
Costa Rica CaM2_13 Epoxiconazole 
   
0 
   
>10.24 
Costa Rica CaM2_13 Propiconazole    0    
>10.24 
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Costa Rica CaM2_14 Difenoconazole    0    
>10.24 
Costa Rica CaM2_14 Epoxiconazole 2.784 0.742 4.827 2 0.637 1.534 4.035 6.889 
Costa Rica CaM2_14 Propiconazole 3.004 0.961 5.046 2 0.637 1.753 4.254 8.020 
Costa Rica CaM2_15 Difenoconazole 2.072 0.029 4.114 1 0.901 0.303 3.840 4.204 
Costa Rica CaM2_15 Epoxiconazole 1.939 -0.104 3.981 2 0.637 0.688 3.190 3.834 
Costa Rica CaM2_15 Propiconazole 2.337 0.294 4.379 2 0.637 1.086 3.587 5.051 
Costa Rica CaM2_16 Difenoconazole 3.255 1.213 5.298 1 0.901 1.487 5.024 9.549 
Costa Rica CaM2_16 Epoxiconazole 2.785 0.743 4.827 2 0.637 1.534 4.036 6.892 
Costa Rica CaM2_16 Propiconazole 2.737 0.694 4.779 2 0.637 1.486 3.988 6.666 
Costa Rica CaM2_2 Difenoconazole 3.015 0.972 5.057 2 0.637 1.764 4.265 8.082 
Costa Rica CaM2_2 Epoxiconazole 2.072 0.030 4.115 2 0.637 0.822 3.323 4.205 
Costa Rica CaM2_2 Propiconazole 2.022 -0.020 4.065 3 0.520 1.001 3.044 4.063 
Costa Rica CaM2_3 Difenoconazole 2.315 0.273 4.358 2 0.637 1.065 3.566 4.977 
Costa Rica CaM2_3 Epoxiconazole 2.349 0.306 4.391 3 0.520 1.328 3.370 5.094 
Costa Rica CaM2_3 Propiconazole 2.046 0.004 4.088 4 0.451 1.162 2.930 4.130 
Costa Rica CaM2_4 Difenoconazole 2.839 0.796 4.881 3 0.520 1.817 3.860 7.153 
Costa Rica CaM2_4 Epoxiconazole 2.204 0.161 4.246 3 0.520 1.183 3.225 4.607 
Costa Rica CaM2_4 Propiconazole 2.678 0.636 4.720 3 0.520 1.657 3.699 6.400 
Costa Rica CaM2_5 Difenoconazole    0    
>10.24 
Costa Rica CaM2_5 Epoxiconazole 2.843 0.800 4.885 1 0.901 1.074 4.611 7.173 
Costa Rica CaM2_5 Propiconazole 2.915 0.872 4.957 1 0.901 1.146 4.684 7.541 
Costa Rica CaM2_6 Difenoconazole    0    
>10.24 
Costa Rica CaM2_6 Epoxiconazole 2.402 0.359 4.444 1 0.901 0.633 4.171 5.285 
Costa Rica CaM2_6 Propiconazole 2.765 0.723 4.807 1 0.901 0.996 4.534 6.797 
Costa Rica CaM2_7 Difenoconazole 1.905 -0.138 3.947 1 0.901 0.136 3.674 3.745 
Costa Rica CaM2_7 Epoxiconazole 1.798 -0.245 3.840 2 0.637 0.547 3.048 3.476 
Costa Rica CaM2_7 Propiconazole 1.990 -0.052 4.033 2 0.637 0.740 3.241 3.974 
Costa Rica CaM2_8 Difenoconazole    0    
>10.24 
Costa Rica CaM2_8 Epoxiconazole 
   
0 
   
>10.24 
Costa Rica CaM2_8 Propiconazole    0    
>10.24 
Costa Rica CaM2_9 Difenoconazole 2.632 0.590 4.674 2 0.637 1.381 3.883 6.199 
Costa Rica CaM2_9 Epoxiconazole 2.138 0.095 4.180 2 0.637 0.887 3.388 4.401 
Costa Rica CaM2_9 Propiconazole 2.946 0.903 4.988 2 0.637 1.695 4.197 7.705 
Costa Rica CaM3_1 Difenoconazole 4.228 2.186 6.270 3 0.520 3.207 5.249 18.741 
Costa Rica CaM3_1 Epoxiconazole 1.941 -0.101 3.983 6 0.368 1.219 2.663 3.840 
Costa Rica CaM3_1 Propiconazole 3.050 1.007 5.092 5 0.403 2.259 3.841 8.280 
Costa Rica CaM3_10 Difenoconazole 
   
0 
   
>10.24 
Costa Rica CaM3_10 Epoxiconazole 2.611 0.568 4.653 1 0.901 0.842 4.379 6.108 
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Costa Rica CaM3_10 Propiconazole 3.302 1.260 5.345 1 0.901 1.533 5.071 9.864 
Costa Rica CaM3_11 Difenoconazole 2.236 0.194 4.279 2 0.637 0.986 3.487 4.712 
Costa Rica CaM3_11 Epoxiconazole 1.216 -0.827 3.258 2 0.637 -0.035 2.466 2.322 
Costa Rica CaM3_11 Propiconazole 2.764 0.722 4.807 2 0.637 1.514 4.015 6.794 
Costa Rica CaM3_12 Difenoconazole 2.739 0.697 4.782 1 0.901 0.971 4.508 6.678 
Costa Rica CaM3_12 Epoxiconazole 0.716 -1.326 2.759 2 0.637 -0.534 1.967 1.643 
Costa Rica CaM3_12 Propiconazole 2.179 0.137 4.222 2 0.637 0.929 3.430 4.529 
Costa Rica CaM3_13 Difenoconazole 2.831 0.788 4.873 1 0.901 1.062 4.599 7.114 
Costa Rica CaM3_13 Epoxiconazole 2.801 0.758 4.843 2 0.637 1.550 4.051 6.967 
Costa Rica CaM3_13 Propiconazole 3.057 1.014 5.099 1 0.901 1.288 4.825 8.320 
Costa Rica CaM3_14 Difenoconazole 1.248 -0.794 3.291 1 0.901 -0.520 3.017 2.376 
Costa Rica CaM3_14 Epoxiconazole 2.289 0.246 4.331 2 0.637 1.038 3.539 4.886 
Costa Rica CaM3_14 Propiconazole 2.215 0.172 4.257 1 0.901 0.446 3.983 4.642 
Costa Rica CaM3_15 Difenoconazole 
   
0 
   
>10.24 
Costa Rica CaM3_15 Epoxiconazole 1.692 -0.350 3.735 2 0.637 0.441 2.943 3.231 
Costa Rica CaM3_15 Propiconazole 
   
0 
   
>10.24 
Costa Rica CaM3_16 Difenoconazole 2.869 0.827 4.911 2 0.637 1.618 4.120 7.305 
Costa Rica CaM3_16 Epoxiconazole 2.133 0.090 4.175 2 0.637 0.882 3.383 4.386 
Costa Rica CaM3_16 Propiconazole 2.627 0.585 4.670 2 0.637 1.377 3.878 6.179 
Costa Rica CaM3_2 Difenoconazole 2.392 0.350 4.435 2 0.637 1.142 3.643 5.250 
Costa Rica CaM3_2 Epoxiconazole 1.526 -0.516 3.569 3 0.520 0.505 2.547 2.880 
Costa Rica CaM3_2 Propiconazole 2.092 0.049 4.134 4 0.451 1.207 2.976 4.263 
Costa Rica CaM3_3 Difenoconazole 1.679 -0.364 3.721 3 0.520 0.658 2.700 3.202 
Costa Rica CaM3_3 Epoxiconazole 0.022 -2.020 2.065 4 0.451 -0.862 0.907 1.016 
Costa Rica CaM3_3 Propiconazole 1.477 -0.566 3.519 4 0.451 0.592 2.361 2.783 
Costa Rica CaM3_4 Difenoconazole 3.145 1.103 5.188 1 0.901 1.376 4.914 8.847 
Costa Rica CaM3_4 Epoxiconazole 1.705 -0.337 3.747 4 0.451 0.821 2.589 3.261 
Costa Rica CaM3_4 Propiconazole 3.126 1.084 5.169 3 0.520 2.105 4.148 8.732 
Costa Rica CaM3_5 Difenoconazole 
   
0 
   
>10.24 
Costa Rica CaM3_5 Epoxiconazole 2.075 0.033 4.118 2 0.637 0.824 3.326 4.214 
Costa Rica CaM3_5 Propiconazole 3.190 1.147 5.232 1 0.901 1.421 4.958 9.123 
Costa Rica CaM3_6 Difenoconazole    0    
>10.24 
Costa Rica CaM3_6 Epoxiconazole 3.095 1.052 5.137 1 0.901 1.326 4.864 8.543 
Costa Rica CaM3_6 Propiconazole    0    
>10.24 
Costa Rica CaM3_7 Difenoconazole 1.739 -0.303 3.781 2 0.637 0.488 2.990 3.338 
Costa Rica CaM3_7 Epoxiconazole 1.467 -0.576 3.509 2 0.637 0.216 2.717 2.764 
Costa Rica CaM3_7 Propiconazole 0.726 -1.316 2.769 2 0.637 -0.525 1.977 1.654 
Costa Rica CaM3_8 Difenoconazole 2.078 0.036 4.121 2 0.637 0.828 3.329 4.223 
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Costa Rica CaM3_8 Epoxiconazole 1.687 -0.355 3.730 2 0.637 0.437 2.938 3.221 
Costa Rica CaM3_8 Propiconazole 1.583 -0.459 3.626 2 0.637 0.333 2.834 2.997 
Costa Rica CaM3_9 Difenoconazole 1.729 -0.313 3.771 2 0.637 0.478 2.980 3.315 
Costa Rica CaM3_9 Epoxiconazole 0.329 -1.714 2.371 2 0.637 -0.922 1.579 1.256 
Costa Rica CaM3_9 Propiconazole 0.931 -1.111 2.974 2 0.637 -0.320 2.182 1.907 
Costa Rica CaM7_10 Difenoconazole 2.833 0.791 4.875 3 0.520 1.812 3.854 7.126 
Costa Rica CaM7_10 Epoxiconazole 2.284 0.242 4.327 3 0.520 1.263 3.305 4.871 
Costa Rica CaM7_10 Propiconazole 1.114 -0.929 3.156 3 0.520 0.092 2.135 2.164 
Costa Rica CaM7_19 Difenoconazole 2.595 0.553 4.638 2 0.637 1.344 3.846 6.042 
Costa Rica CaM7_19 Epoxiconazole 2.141 0.098 4.183 3 0.520 1.119 3.162 4.410 
Costa Rica CaM7_19 Propiconazole 2.342 0.299 4.384 3 0.520 1.320 3.363 5.069 
Colombia Caribe_1 Difenoconazole 2.901 0.858 4.943 1 0.901 1.132 4.670 7.468 
Colombia Caribe_1 Epoxiconazole 2.435 0.393 4.478 1 0.901 0.667 4.204 5.409 
Colombia Caribe_1 Propiconazole 2.774 0.731 4.816 1 0.901 1.005 4.543 6.839 
Colombia Caribe_2 Difenoconazole 1.603 -0.439 3.646 3 0.520 0.582 2.624 3.038 
Colombia Caribe_2 Epoxiconazole 0.771 -1.272 2.813 3 0.520 -0.250 1.792 1.706 
Colombia Caribe_2 Propiconazole 0.195 -1.847 2.237 3 0.520 -0.826 1.216 1.145 
Colombia Caribe_3 Difenoconazole 2.510 0.467 4.552 3 0.520 1.488 3.531 5.694 
Colombia Caribe_3 Epoxiconazole 1.322 -0.720 3.364 3 0.520 0.301 2.343 2.500 
Colombia Caribe_3 Propiconazole 1.669 -0.373 3.712 3 0.520 0.648 2.690 3.181 
Colombia Caribe_4 Difenoconazole 0.205 -1.838 2.247 1 0.901 -1.564 1.973 1.152 
Colombia Caribe_4 Epoxiconazole -1.105 -3.147 0.938 1 0.901 -2.873 0.664 0.465 
Colombia Caribe_4 Propiconazole -0.271 -2.313 1.772 1 0.901 -2.039 1.498 0.829 
Dominican Rep. Dom_1 Difenoconazole -3.777 -5.820 -1.735 3 0.520 -4.799 -2.756 0.073 
Dominican Rep. Dom_1 Epoxiconazole -5.681 -7.723 -3.638 3 0.520 -6.702 -4.660 0.019 
Dominican Rep. Dom_1 Propiconazole -2.374 -4.417 -0.332 3 0.520 -3.396 -1.353 0.193 
Dominican Rep. Dom_10 Difenoconazole 0.779 -1.264 2.821 3 0.520 -0.243 1.800 1.716 
Dominican Rep. Dom_10 Epoxiconazole 0.863 -1.179 2.905 3 0.520 -0.158 1.884 1.819 
Dominican Rep. Dom_10 Propiconazole 1.242 -0.801 3.284 3 0.520 0.221 2.263 2.365 
Dominican Rep. Dom_12 Difenoconazole -2.578 -4.620 -0.535 3 0.520 -3.599 -1.557 0.168 
Dominican Rep. Dom_12 Epoxiconazole -2.366 -4.408 -0.324 3 0.520 -3.387 -1.345 0.194 
Dominican Rep. Dom_12 Propiconazole -0.324 -2.366 1.718 3 0.520 -1.345 0.697 0.799 
Dominican Rep. Dom_2 Difenoconazole 0.068 -1.975 2.110 3 0.520 -0.953 1.089 1.048 
Dominican Rep. Dom_2 Epoxiconazole -0.024 -2.067 2.018 3 0.520 -1.045 0.997 0.983 
Dominican Rep. Dom_2 Propiconazole -0.207 -2.249 1.835 3 0.520 -1.228 0.814 0.866 
Dominican Rep. Dom_3 Difenoconazole -0.151 -2.194 1.891 3 0.520 -1.172 0.870 0.901 
Dominican Rep. Dom_3 Epoxiconazole -0.250 -2.293 1.792 3 0.520 -1.272 0.771 0.841 
Dominican Rep. Dom_3 Propiconazole 0.403 -1.639 2.445 3 0.520 -0.618 1.424 1.322 
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Dominican Rep. Dom_4 Difenoconazole 0.325 -1.718 2.367 3 0.520 -0.697 1.346 1.252 
Dominican Rep. Dom_4 Epoxiconazole 0.346 -1.696 2.389 3 0.520 -0.675 1.367 1.271 
Dominican Rep. Dom_4 Propiconazole 0.855 -1.188 2.897 3 0.520 -0.166 1.876 1.808 
Dominican Rep. Dom_6 Difenoconazole -0.950 -2.992 1.093 3 0.520 -1.971 0.072 0.518 
Dominican Rep. Dom_6 Epoxiconazole -0.615 -2.657 1.428 3 0.520 -1.636 0.406 0.653 
Dominican Rep. Dom_6 Propiconazole 0.053 -1.989 2.095 3 0.520 -0.968 1.074 1.037 
Dominican Rep. Dom_7 Difenoconazole 0.264 -1.778 2.307 3 0.520 -0.757 1.285 1.201 
Dominican Rep. Dom_7 Epoxiconazole 0.277 -1.766 2.319 3 0.520 -0.745 1.298 1.211 
Dominican Rep. Dom_7 Propiconazole 0.561 -1.482 2.603 3 0.520 -0.460 1.582 1.475 
Dominican Rep. Dom_8 Difenoconazole -1.161 -3.204 0.881 3 0.520 -2.183 -0.140 0.447 
Dominican Rep. Dom_8 Epoxiconazole -0.824 -2.866 1.218 3 0.520 -1.845 0.197 0.565 
Dominican Rep. Dom_8 Propiconazole -0.009 -2.052 2.033 3 0.520 -1.030 1.012 0.994 
Dominican Rep. Dom_9 Difenoconazole -0.163 -2.206 1.879 3 0.520 -1.184 0.858 0.893 
Dominican Rep. Dom_9 Epoxiconazole -0.542 -2.585 1.500 3 0.520 -1.564 0.479 0.687 
Dominican Rep. Dom_9 Propiconazole 0.180 -1.862 2.222 3 0.520 -0.841 1.201 1.133 
Ecuador E_22 Difenoconazole -7.618 -9.660 -5.575 4 0.451 -8.502 -6.733 0.005 
Ecuador E_22 Epoxiconazole -6.926 -8.968 -4.883 3 0.520 -7.947 -5.904 0.008 
Ecuador E_22 Propiconazole -6.565 -8.608 -4.523 5 0.403 -7.356 -5.774 0.011 
Ecuador EC_1 Difenoconazole -7.756 -9.798 -5.714 4 0.451 -8.640 -6.872 0.005 
Ecuador EC_1 Epoxiconazole -6.993 -9.036 -4.951 3 0.520 -8.014 -5.972 0.008 
Ecuador EC_1 Propiconazole -6.062 -8.104 -4.020 4 0.451 -6.946 -5.178 0.015 
Ecuador EC_21 Difenoconazole -7.897 -9.940 -5.855 1 0.901 -9.666 -6.128 0.004 
Ecuador EC_21 Epoxiconazole -7.651 -9.694 -5.609 1 0.901 -9.420 -5.882 0.005 
Ecuador EC_21 Propiconazole -6.748 -8.790 -4.706 1 0.901 -8.517 -4.979 0.009 
Ecuador EC_5 Difenoconazole -7.084 -9.126 -5.041 4 0.451 -7.968 -6.199 0.007 
Ecuador EC_5 Epoxiconazole -6.813 -8.855 -4.771 4 0.451 -7.697 -5.929 0.009 
Ecuador EC_5 Propiconazole -6.470 -8.513 -4.428 4 0.451 -7.355 -5.586 0.011 
Ecuador ECM_1 Difenoconazole 0.528 -1.514 2.571 1 0.901 -1.240 2.297 1.442 
Ecuador ECM_1 Epoxiconazole -0.805 -2.847 1.237 1 0.901 -2.574 0.964 0.572 
Ecuador ECM_1 Propiconazole -0.372 -2.415 1.670 1 0.901 -2.141 1.397 0.773 
Ecuador ECQ_10 Difenoconazole -4.473 -6.515 -2.430 2 0.637 -5.723 -3.222 0.045 
Ecuador ECQ_10 Epoxiconazole -4.464 -6.506 -2.421 2 0.637 -5.714 -3.213 0.045 
Ecuador ECQ_10 Propiconazole -3.046 -5.089 -1.004 2 0.637 -4.297 -1.796 0.121 
Ecuador ECQ_20 Difenoconazole -5.572 -7.615 -3.530 2 0.637 -6.823 -4.322 0.021 
Ecuador ECQ_20 Epoxiconazole -5.624 -7.666 -3.581 2 0.637 -6.874 -4.373 0.020 
Ecuador ECQ_20 Propiconazole -4.753 -6.795 -2.710 2 0.637 -6.003 -3.502 0.037 
Ecuador ECU_18 Difenoconazole -3.258 -5.300 -1.215 1 0.901 -5.027 -1.489 0.105 
Ecuador ECU_18 Epoxiconazole -3.842 -5.884 -1.799 1 0.901 -5.610 -2.073 0.070 
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Ecuador ECU_18 Propiconazole -2.211 -4.253 -0.168 1 0.901 -3.979 -0.442 0.216 
Ecuador ECU_2 Difenoconazole -2.318 -4.360 -0.276 2 0.637 -3.569 -1.067 0.201 
Ecuador ECU_2 Epoxiconazole -3.238 -5.280 -1.195 2 0.637 -4.488 -1.987 0.106 
Ecuador ECU_2 Propiconazole -1.784 -3.826 0.259 2 0.637 -3.034 -0.533 0.290 
Ecuador EN_12 Difenoconazole -5.773 -7.816 -3.731 1 0.901 -7.542 -4.005 0.018 
Ecuador EN_12 Epoxiconazole -6.091 -8.134 -4.049 1 0.901 -7.860 -4.323 0.015 
Ecuador EN_12 Propiconazole -5.193 -7.235 -3.150 1 0.901 -6.962 -3.424 0.027 
Ecuador EN_2 Difenoconazole -7.012 -9.055 -4.970 2 0.637 -8.263 -5.762 0.008 
Ecuador EN_2 Epoxiconazole -6.420 -8.462 -4.377 2 0.637 -7.671 -5.169 0.012 
Ecuador EN_2 Propiconazole -5.695 -7.737 -3.652 2 0.637 -6.945 -4.444 0.019 
Ecuador ENB_52 Difenoconazole -7.302 -9.344 -5.259 2 0.637 -8.552 -6.051 0.006 
Ecuador ENB_52 Epoxiconazole -6.964 -9.006 -4.921 2 0.637 -8.215 -5.713 0.008 
Ecuador ENB_52 Propiconazole -6.283 -8.325 -4.241 3 0.520 -7.304 -5.262 0.013 
Ecuador ENB_6 Difenoconazole -5.503 -7.546 -3.461 1 0.901 -7.272 -3.734 0.022 
Ecuador ENB_6 Epoxiconazole -5.915 -7.957 -3.872 1 0.901 -7.683 -4.146 0.017 
Ecuador ENB_6 Propiconazole -4.623 -6.665 -2.580 1 0.901 -6.391 -2.854 0.041 
Ecuador ENB_7 Difenoconazole -3.890 -5.933 -1.848 1 0.901 -5.659 -2.122 0.067 
Ecuador ENB_7 Epoxiconazole -3.963 -6.005 -1.921 1 0.901 -5.732 -2.194 0.064 
Ecuador ENB_7 Propiconazole -4.075 -6.118 -2.033 1 0.901 -5.844 -2.307 0.059 
Ecuador ENP_8 Difenoconazole -6.269 -8.311 -4.226 1 0.901 -8.037 -4.500 0.013 
Ecuador ENP_8 Epoxiconazole -5.505 -7.547 -3.462 1 0.901 -7.273 -3.736 0.022 
Ecuador ENP_8 Propiconazole -4.712 -6.754 -2.670 1 0.901 -6.481 -2.943 0.038 
Ecuador ENR_4 Difenoconazole -7.240 -9.283 -5.198 1 0.901 -9.009 -5.471 0.007 
Ecuador ENR_4 Epoxiconazole -5.865 -7.907 -3.823 1 0.901 -7.634 -4.096 0.017 
Ecuador ENR_4 Propiconazole -5.714 -7.756 -3.672 1 0.901 -7.483 -3.945 0.019 
Ecuador ENV_5 Difenoconazole -7.481 -9.523 -5.438 1 0.901 -9.249 -5.712 0.006 
Ecuador ENV_5 Epoxiconazole -7.223 -9.265 -5.180 1 0.901 -8.992 -5.454 0.007 
Ecuador ENV_5 Propiconazole -6.054 -8.096 -4.011 1 0.901 -7.823 -4.285 0.015 
Ecuador ENV_9 Difenoconazole -7.966 -10.008 -5.923 1 0.901 -9.734 -6.197 <0.004 
Ecuador ENV_9 Epoxiconazole -7.332 -9.375 -5.290 3 0.520 -8.354 -6.311 0.006 
Ecuador ENV_9 Propiconazole -6.701 -8.743 -4.658 3 0.520 -7.722 -5.680 0.010 
Ecuador ESM_2 Difenoconazole -5.556 -7.599 -3.514 2 0.637 -6.807 -4.306 0.021 
Ecuador ESM_2 Epoxiconazole -5.125 -7.167 -3.082 2 0.637 -6.375 -3.874 0.029 
Ecuador ESM_2 Propiconazole -4.539 -6.581 -2.496 2 0.637 -5.789 -3.288 0.043 
Ecuador ESM_3 Difenoconazole -5.867 -7.910 -3.825 2 0.637 -7.118 -4.617 0.017 
Ecuador ESM_3 Epoxiconazole -5.596 -7.638 -3.553 2 0.637 -6.847 -4.345 0.021 
Ecuador ESM_3 Propiconazole -5.257 -7.300 -3.215 2 0.637 -6.508 -4.007 0.026 
Ecuador ESM_4 Difenoconazole -4.121 -6.163 -2.078 1 0.901 -5.889 -2.352 0.057 
Global analysis of the sensitivity to azole  
117 
Country Isolate Fungicide 2Log(m) Lsed Used (n) Sem LMCI UMCI EC50  
Ecuador ESM_4 Epoxiconazole -4.240 -6.282 -2.198 1 0.901 -6.009 -2.471 0.053 
Ecuador ESM_4 Propiconazole -4.205 -6.247 -2.162 1 0.901 -5.973 -2.436 0.054 
Colombia Esmeraldas_1 Difenoconazole 2.596 0.553 4.638 3 0.520 1.575 3.617 6.046 
Colombia Esmeraldas_1 Epoxiconazole 1.475 -0.567 3.517 3 0.520 0.454 2.496 2.780 
Colombia Esmeraldas_1 Propiconazole 2.080 0.037 4.122 3 0.520 1.058 3.101 4.227 
Colombia Esmeraldas_2 Difenoconazole 2.896 0.853 4.938 1 0.901 1.127 4.664 7.442 
Colombia Esmeraldas_2 Epoxiconazole 1.028 -1.014 3.070 1 0.901 -0.741 2.797 2.039 
Colombia Esmeraldas_2 Propiconazole 1.725 -0.317 3.768 1 0.901 -0.043 3.494 3.307 
Colombia Esmeraldas_3 Difenoconazole 1.650 -0.392 3.692 3 0.520 0.629 2.671 3.139 
Colombia Esmeraldas_3 Epoxiconazole 1.103 -0.939 3.145 3 0.520 0.082 2.124 2.148 
Colombia Esmeraldas_3 Propiconazole 1.067 -0.975 3.110 3 0.520 0.046 2.088 2.095 
Colombia Esmeraldas_4 Difenoconazole 0.626 -1.416 2.669 1 0.901 -1.142 2.395 1.544 
Colombia Esmeraldas_4 Epoxiconazole -0.231 -2.274 1.811 1 0.901 -2.000 1.537 0.852 
Colombia Esmeraldas_4 Propiconazole 1.048 -0.995 3.090 1 0.901 -0.721 2.816 2.067 
Colombia Esmeraldas_5 Difenoconazole 2.355 0.313 4.398 1 0.901 0.586 4.124 5.116 
Colombia Esmeraldas_5 Epoxiconazole 0.556 -1.486 2.598 1 0.901 -1.213 2.325 1.470 
Colombia Esmeraldas_5 Propiconazole 1.542 -0.500 3.585 1 0.901 -0.226 3.311 2.913 
Colombia Esperanza_4 Difenoconazole 2.331 0.288 4.373 1 0.901 0.562 4.099 5.031 
Colombia Esperanza_4 Epoxiconazole 2.067 0.025 4.110 1 0.901 0.299 3.836 4.191 
Colombia Esperanza_4 Propiconazole 3.047 1.004 5.089 1 0.901 1.278 4.815 8.263 
Ecuador ESS_2 Difenoconazole -6.654 -8.696 -4.611 2 0.637 -7.904 -5.403 0.010 
Ecuador ESS_2 Epoxiconazole -6.077 -8.119 -4.034 2 0.637 -7.327 -4.826 0.015 
Ecuador ESS_2 Propiconazole -5.952 -7.994 -3.909 2 0.637 -7.202 -4.701 0.016 
Ecuador ESS_4 Difenoconazole -3.932 -5.975 -1.890 1 0.901 -5.701 -2.164 0.065 
Ecuador ESS_4 Epoxiconazole -4.594 -6.636 -2.551 1 0.901 -6.362 -2.825 0.041 
Ecuador ESS_4 Propiconazole -5.460 -7.503 -3.418 1 0.901 -7.229 -3.692 0.023 
Ecuador ESS_6 Difenoconazole -6.794 -8.837 -4.752 1 0.901 -8.563 -5.026 0.009 
Ecuador ESS_6 Epoxiconazole -5.512 -7.554 -3.470 1 0.901 -7.281 -3.743 0.022 
Ecuador ESS_6 Propiconazole -6.337 -8.380 -4.295 1 0.901 -8.106 -4.569 0.012 
Ecuador ESS_7 Difenoconazole -7.459 -9.501 -5.416 1 0.901 -9.228 -5.690 0.006 
Ecuador ESS_7 Epoxiconazole -6.274 -8.316 -4.231 1 0.901 -8.043 -4.505 0.013 
Ecuador ESS_7 Propiconazole -6.466 -8.509 -4.424 1 0.901 -8.235 -4.697 0.011 
Colombia Estadero_1 Difenoconazole 
   
0 
   
>10.24 
Colombia Estadero_1 Epoxiconazole 2.392 0.349 4.434 1 0.901 0.623 4.160 5.248 
Colombia Estadero_1 Propiconazole 
   
0 
   
>10.24 
Colombia Estadero_2 Difenoconazole 1.380 -0.663 3.422 3 0.520 0.359 2.401 2.602 
Colombia Estadero_2 Epoxiconazole 0.025 -2.017 2.068 3 0.520 -0.996 1.047 1.018 
Colombia Estadero_2 Propiconazole 0.110 -1.932 2.152 3 0.520 -0.911 1.131 1.079 
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Colombia Estadero_3 Difenoconazole 1.469 -0.573 3.512 3 0.520 0.448 2.490 2.769 
Colombia Estadero_3 Epoxiconazole -0.903 -2.945 1.139 3 0.520 -1.924 0.118 0.535 
Colombia Estadero_3 Propiconazole 1.155 -0.887 3.197 3 0.520 0.134 2.176 2.227 
Colombia Estadero_4 Difenoconazole -0.090 -2.132 1.953 3 0.520 -1.111 0.931 0.940 
Colombia Estadero_4 Epoxiconazole -0.763 -2.805 1.280 3 0.520 -1.784 0.259 0.589 
Colombia Estadero_4 Propiconazole -0.025 -2.068 2.017 3 0.520 -1.047 0.996 0.983 
Colombia Estadero_5 Difenoconazole 2.144 0.101 4.186 3 0.520 1.123 3.165 4.419 
Colombia Estadero_5 Epoxiconazole -0.424 -2.466 1.619 3 0.520 -1.445 0.597 0.745 
Colombia Estadero_5 Propiconazole 2.208 0.166 4.251 3 0.520 1.187 3.229 4.621 
Colombia Frontera_2 Difenoconazole 0.955 -1.087 2.998 3 0.520 -0.066 1.976 1.939 
Colombia Frontera_2 Epoxiconazole -0.659 -2.701 1.383 3 0.520 -1.680 0.362 0.633 
Colombia Frontera_2 Propiconazole 1.230 -0.812 3.273 3 0.520 0.209 2.252 2.346 
Colombia Frontera_3 Difenoconazole 0.512 -1.530 2.555 3 0.520 -0.509 1.533 1.426 
Colombia Frontera_3 Epoxiconazole -0.642 -2.685 1.400 3 0.520 -1.663 0.379 0.641 
Colombia Frontera_3 Propiconazole 0.278 -1.764 2.320 3 0.520 -0.743 1.299 1.213 
Colombia Frontera_5 Difenoconazole 0.747 -1.296 2.789 1 0.901 -1.022 2.515 1.678 
Colombia Frontera_5 Epoxiconazole 0.152 -1.891 2.194 2 0.637 -1.099 1.402 1.111 
Colombia Frontera_5 Propiconazole 1.967 -0.075 4.009 3 0.520 0.946 2.988 3.910 
Colombia Frontera_6 Difenoconazole 2.499 0.456 4.541 1 0.901 0.730 4.268 5.652 
Colombia Frontera_6 Epoxiconazole -0.075 -2.117 1.968 1 0.901 -1.844 1.694 0.949 
Colombia Frontera_6 Propiconazole 2.444 0.401 4.486 1 0.901 0.675 4.212 5.440 
Colombia Frontera_7 Difenoconazole 2.316 0.274 4.358 1 0.901 0.547 4.085 4.979 
Colombia Frontera_7 Epoxiconazole 2.358 0.315 4.400 1 0.901 0.589 4.126 5.125 
Colombia Frontera_7 Propiconazole 2.724 0.682 4.767 1 0.901 0.955 4.493 6.608 
Colombia Galvis_1 Difenoconazole -0.852 -2.894 1.191 1 0.901 -2.620 0.917 0.554 
Colombia Galvis_1 Epoxiconazole -0.768 -2.810 1.275 1 0.901 -2.537 1.001 0.587 
Colombia Galvis_1 Propiconazole 1.397 -0.645 3.439 1 0.901 -0.372 3.166 2.633 
Colombia Galvis_2 Difenoconazole -1.426 -3.468 0.617 3 0.520 -2.447 -0.404 0.372 
Colombia Galvis_2 Epoxiconazole -2.364 -4.406 -0.321 3 0.520 -3.385 -1.342 0.194 
Colombia Galvis_2 Propiconazole -0.099 -2.141 1.944 3 0.520 -1.120 0.922 0.934 
Ecuador GCB_28 Difenoconazole -1.058 -3.100 0.984 2 0.637 -2.309 0.193 0.480 
Ecuador GCB_28 Epoxiconazole -2.424 -4.467 -0.382 2 0.637 -3.675 -1.173 0.186 
Ecuador GCB_28 Propiconazole -1.146 -3.188 0.897 2 0.637 -2.397 0.105 0.452 
Ecuador GCB_30 Difenoconazole -1.424 -3.467 0.618 2 0.637 -2.675 -0.173 0.373 
Ecuador GCB_30 Epoxiconazole -2.457 -4.499 -0.414 2 0.637 -3.708 -1.206 0.182 
Ecuador GCB_30 Propiconazole -2.207 -4.249 -0.165 2 0.637 -3.458 -0.956 0.217 
Ecuador GCB_7 Difenoconazole -2.888 -4.930 -0.845 2 0.637 -4.138 -1.637 0.135 
Ecuador GCB_7 Epoxiconazole -3.861 -5.903 -1.819 2 0.637 -5.112 -2.610 0.069 
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Ecuador GCB_7 Propiconazole -2.827 -4.870 -0.785 2 0.637 -4.078 -1.576 0.141 
Ecuador GCLg_18 Difenoconazole -1.025 -3.068 1.017 2 0.637 -2.276 0.225 0.491 
Ecuador GCLg_18 Epoxiconazole -2.233 -4.275 -0.190 2 0.637 -3.483 -0.982 0.213 
Ecuador GCLg_18 Propiconazole -1.202 -3.245 0.840 2 0.637 -2.453 0.048 0.435 
Ecuador GCMA_4 Difenoconazole -4.023 -6.065 -1.980 4 0.451 -4.907 -3.138 0.062 
Ecuador GCMA_4 Epoxiconazole -3.845 -5.887 -1.802 4 0.451 -4.729 -2.960 0.070 
Ecuador GCMA_4 Propiconazole -3.277 -5.320 -1.235 4 0.451 -4.162 -2.393 0.103 
Ecuador GCMS_7 Difenoconazole -3.138 -5.181 -1.096 3 0.520 -4.160 -2.117 0.114 
Ecuador GCMS_7 Epoxiconazole -3.859 -5.901 -1.816 3 0.520 -4.880 -2.838 0.069 
Ecuador GCMS_7 Propiconazole -2.636 -4.679 -0.594 3 0.520 -3.658 -1.615 0.161 
Ecuador GCSB_13 Difenoconazole -2.480 -4.522 -0.438 3 0.520 -3.501 -1.459 0.179 
Ecuador GCSB_13 Epoxiconazole -3.076 -5.119 -1.034 3 0.520 -4.097 -2.055 0.119 
Ecuador GCSB_13 Propiconazole -1.882 -3.924 0.161 3 0.520 -2.903 -0.861 0.271 
Ecuador GNA_1 Difenoconazole -0.349 -2.391 1.694 2 0.637 -1.599 0.902 0.785 
Ecuador GNA_1 Epoxiconazole -1.905 -3.947 0.138 2 0.637 -3.155 -0.654 0.267 
Ecuador GNA_1 Propiconazole 0.340 -1.702 2.383 2 0.637 -0.910 1.591 1.266 
Ecuador GNA_6 Difenoconazole 0.110 -1.932 2.153 2 0.637 -1.141 1.361 1.079 
Ecuador GNA_6 Epoxiconazole -2.038 -4.080 0.004 2 0.637 -3.289 -0.787 0.243 
Ecuador GNA_6 Propiconazole -1.388 -3.431 0.654 2 0.637 -2.639 -0.138 0.382 
Ecuador GND_18 Difenoconazole 0.460 -1.582 2.503 3 0.520 -0.561 1.482 1.376 
Ecuador GND_18 Epoxiconazole 0.179 -1.864 2.221 3 0.520 -0.843 1.200 1.132 
Ecuador GND_18 Propiconazole 1.497 -0.545 3.540 3 0.520 0.476 2.519 2.823 
Ecuador GNM_1 Difenoconazole 0.637 -1.406 2.679 1 0.901 -1.132 2.406 1.555 
Ecuador GNM_1 Epoxiconazole -0.992 -3.035 1.050 1 0.901 -2.761 0.776 0.503 
Ecuador GNM_1 Propiconazole -1.204 -3.246 0.839 1 0.901 -2.973 0.565 0.434 
Ecuador GNMe_1 Difenoconazole -1.155 -3.197 0.888 1 0.901 -2.923 0.614 0.449 
Ecuador GNMe_1 Epoxiconazole -0.849 -2.891 1.194 1 0.901 -2.618 0.920 0.555 
Ecuador GNMe_1 Propiconazole -1.607 -3.650 0.435 1 0.901 -3.376 0.161 0.328 
Ecuador GNP_3 Difenoconazole 1.438 -0.604 3.480 5 0.403 0.647 2.229 2.709 
Ecuador GNP_3 Epoxiconazole 0.668 -1.375 2.710 5 0.403 -0.123 1.459 1.589 
Ecuador GNP_3 Propiconazole 2.420 0.377 4.462 4 0.451 1.535 3.304 5.351 
Ecuador GSa_10 Difenoconazole -2.520 -4.562 -0.477 2 0.637 -3.771 -1.269 0.174 
Ecuador GSa_10 Epoxiconazole -3.154 -5.196 -1.111 2 0.637 -4.404 -1.903 0.112 
Ecuador GSa_10 Propiconazole -2.429 -4.471 -0.386 2 0.637 -3.679 -1.178 0.186 
Ecuador GSa_13 Difenoconazole -2.283 -4.326 -0.241 3 0.520 -3.305 -1.262 0.205 
Ecuador GSa_13 Epoxiconazole -3.177 -5.219 -1.134 3 0.520 -4.198 -2.155 0.111 
Ecuador GSa_13 Propiconazole -1.786 -3.828 0.257 3 0.520 -2.807 -0.765 0.290 
Ecuador GSa_2 Difenoconazole -2.639 -4.682 -0.597 2 0.637 -3.890 -1.389 0.160 
Chapter 3 
120 
Country Isolate Fungicide 2Log(m) Lsed Used (n) Sem LMCI UMCI EC50  
Ecuador GSa_2 Epoxiconazole -2.945 -4.987 -0.902 2 0.637 -4.196 -1.694 0.130 
Ecuador GSa_2 Propiconazole -1.458 -3.500 0.584 2 0.637 -2.709 -0.207 0.364 
Ecuador GSa_4 Difenoconazole -3.568 -5.610 -1.526 1 0.901 -5.337 -1.799 0.084 
Ecuador GSa_4 Epoxiconazole -4.515 -6.557 -2.473 1 0.901 -6.284 -2.746 0.044 
Ecuador GSa_4 Propiconazole -2.394 -4.437 -0.352 1 0.901 -4.163 -0.626 0.190 
Ecuador GSaN_12 Difenoconazole -2.752 -4.794 -0.709 2 0.637 -4.003 -1.501 0.148 
Ecuador GSaN_12 Epoxiconazole -3.485 -5.528 -1.443 2 0.637 -4.736 -2.234 0.089 
Ecuador GSaN_12 Propiconazole -2.233 -4.276 -0.191 2 0.637 -3.484 -0.983 0.213 
Ecuador GSaN_83 Difenoconazole    0    
<0.004 
Ecuador GSaN_83 Epoxiconazole 
   
0 
   
<0.004 
Ecuador GSaN_83 Propiconazole    0    
<0.004 
Ecuador GSB_11 Difenoconazole -4.317 -6.359 -2.274 3 0.520 -5.338 -3.296 0.050 
Ecuador GSB_11 Epoxiconazole -4.309 -6.351 -2.266 3 0.520 -5.330 -3.287 0.050 
Ecuador GSB_11 Propiconazole -2.382 -4.425 -0.340 3 0.520 -3.403 -1.361 0.192 
Ecuador GSB_5 Difenoconazole -2.109 -4.152 -0.067 3 0.520 -3.130 -1.088 0.232 
Ecuador GSB_5 Epoxiconazole -2.795 -4.837 -0.752 3 0.520 -3.816 -1.773 0.144 
Ecuador GSB_5 Propiconazole -1.939 -3.981 0.103 3 0.520 -2.960 -0.918 0.261 
Ecuador GSB_7 Difenoconazole -0.308 -2.351 1.734 4 0.451 -1.193 0.576 0.808 
Ecuador GSB_7 Epoxiconazole -1.276 -3.318 0.767 4 0.451 -2.160 -0.391 0.413 
Ecuador GSB_7 Propiconazole 0.008 -2.034 2.051 4 0.451 -0.876 0.893 1.006 
Ecuador GSB_9 Difenoconazole -2.388 -4.430 -0.345 1 0.901 -4.157 -0.619 0.191 
Ecuador GSB_9 Epoxiconazole -3.401 -5.444 -1.359 1 0.901 -5.170 -1.632 0.095 
Ecuador GSB_9 Propiconazole -1.823 -3.866 0.219 1 0.901 -3.592 -0.054 0.283 
Ecuador GSN_1 Difenoconazole -1.368 -3.411 0.674 3 0.520 -2.389 -0.347 0.387 
Ecuador GSN_1 Epoxiconazole -2.376 -4.419 -0.334 3 0.520 -3.398 -1.355 0.193 
Ecuador GSN_1 Propiconazole -1.504 -3.547 0.538 3 0.520 -2.525 -0.483 0.353 
Ecuador GSN_19 Difenoconazole -3.582 -5.625 -1.540 1 0.901 -5.351 -1.813 0.083 
Ecuador GSN_19 Epoxiconazole -4.012 -6.055 -1.970 1 0.901 -5.781 -2.244 0.062 
Ecuador GSN_19 Propiconazole -2.069 -4.111 -0.027 1 0.901 -3.838 -0.300 0.238 
Colombia Guata_1 Difenoconazole 0.568 -1.474 2.611 2 0.637 -0.682 1.819 1.483 
Colombia Guata_1 Epoxiconazole -1.201 -3.244 0.841 2 0.637 -2.452 0.049 0.435 
Colombia Guata_1 Propiconazole -0.092 -2.134 1.951 2 0.637 -1.342 1.159 0.938 
Guadalupe GW_1 Difenoconazole -7.843 -9.885 -5.801 1 0.901 -9.612 -6.074 0.004 
Guadalupe GW_1 Epoxiconazole -7.688 -9.730 -5.645 1 0.901 -9.456 -5.919 0.005 
Guadalupe GW_1 Propiconazole -4.551 -6.593 -2.508 1 0.901 -6.320 -2.782 0.043 
Guadalupe GW_10 Difenoconazole -6.297 -8.339 -4.254 1 0.901 -8.065 -4.528 0.013 
Guadalupe GW_10 Epoxiconazole -5.262 -7.305 -3.220 1 0.901 -7.031 -3.494 0.026 
Guadalupe GW_10 Propiconazole -4.729 -6.772 -2.687 1 0.901 -6.498 -2.960 0.038 
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Guadalupe GW_11 Difenoconazole -7.367 -9.409 -5.325 1 0.901 -9.136 -5.598 0.006 
Guadalupe GW_11 Epoxiconazole -5.965 -8.007 -3.923 1 0.901 -7.734 -4.196 0.016 
Guadalupe GW_11 Propiconazole -5.523 -7.565 -3.480 1 0.901 -7.291 -3.754 0.022 
Guadalupe GW_12 Difenoconazole -5.574 -7.616 -3.531 1 0.901 -7.343 -3.805 0.021 
Guadalupe GW_12 Epoxiconazole -4.715 -6.758 -2.673 1 0.901 -6.484 -2.947 0.038 
Guadalupe GW_12 Propiconazole -4.447 -6.489 -2.405 1 0.901 -6.216 -2.678 0.046 
Guadalupe GW_14 Difenoconazole -7.475 -9.518 -5.433 1 0.901 -9.244 -5.706 0.006 
Guadalupe GW_14 Epoxiconazole -7.176 -9.219 -5.134 1 0.901 -8.945 -5.408 0.007 
Guadalupe GW_14 Propiconazole -6.277 -8.319 -4.234 1 0.901 -8.045 -4.508 0.013 
Guadalupe GW_15 Difenoconazole -7.554 -9.596 -5.511 1 0.901 -9.323 -5.785 0.005 
Guadalupe GW_15 Epoxiconazole -6.347 -8.390 -4.305 1 0.901 -8.116 -4.579 0.012 
Guadalupe GW_15 Propiconazole -6.279 -8.321 -4.237 1 0.901 -8.048 -4.510 0.013 
Guadalupe GW_16_8 Difenoconazole -7.067 -9.109 -5.024 1 0.901 -8.835 -5.298 0.007 
Guadalupe GW_16_8 Epoxiconazole -6.887 -8.930 -4.845 1 0.901 -8.656 -5.119 0.008 
Guadalupe GW_16_8 Propiconazole -6.260 -8.302 -4.217 1 0.901 -8.028 -4.491 0.013 
Guadalupe GW_16_9 Difenoconazole -6.098 -8.141 -4.056 1 0.901 -7.867 -4.330 0.015 
Guadalupe GW_16_9 Epoxiconazole -6.102 -8.145 -4.060 1 0.901 -7.871 -4.333 0.015 
Guadalupe GW_16_9 Propiconazole -5.195 -7.237 -3.152 1 0.901 -6.964 -3.426 0.027 
Guadalupe GW_2 Difenoconazole -7.575 -9.618 -5.533 1 0.901 -9.344 -5.807 0.005 
Guadalupe GW_2 Epoxiconazole 
   
0 
   
<0.004 
Guadalupe GW_2 Propiconazole -4.108 -6.151 -2.066 1 0.901 -5.877 -2.340 0.058 
Guadalupe GW_26 Difenoconazole -5.925 -7.968 -3.883 1 0.901 -7.694 -4.156 0.016 
Guadalupe GW_26 Epoxiconazole -5.795 -7.837 -3.752 1 0.901 -7.563 -4.026 0.018 
Guadalupe GW_26 Propiconazole -4.398 -6.440 -2.355 1 0.901 -6.166 -2.629 0.047 
Guadalupe GW_28 Difenoconazole -5.791 -7.834 -3.749 1 0.901 -7.560 -4.023 0.018 
Guadalupe GW_28 Epoxiconazole -6.090 -8.132 -4.048 1 0.901 -7.859 -4.321 0.015 
Guadalupe GW_28 Propiconazole -7.843 -9.885 -5.801 1 0.901 -9.612 -6.074 0.004 
Guadalupe GW_29 Difenoconazole -6.107 -8.149 -4.064 1 0.901 -7.876 -4.338 0.015 
Guadalupe GW_29 Epoxiconazole -6.169 -8.211 -4.126 1 0.901 -7.938 -4.400 0.014 
Guadalupe GW_29 Propiconazole -7.575 -9.618 -5.533 1 0.901 -9.344 -5.807 0.005 
Guadalupe GW_3 Difenoconazole -7.519 -9.562 -5.477 1 0.901 -9.288 -5.751 0.005 
Guadalupe GW_3 Epoxiconazole -6.206 -8.248 -4.163 1 0.901 -7.974 -4.437 0.014 
Guadalupe GW_3 Propiconazole -4.344 -6.387 -2.302 1 0.901 -6.113 -2.575 0.049 
Guadalupe GW_30 Difenoconazole -7.519 -9.561 -5.476 1 0.901 -9.288 -5.750 0.005 
Guadalupe GW_30 Epoxiconazole -6.755 -8.797 -4.712 1 0.901 -8.523 -4.986 0.009 
Guadalupe GW_30 Propiconazole -7.519 -9.562 -5.477 1 0.901 -9.288 -5.751 0.005 
Guadalupe GW_31 Difenoconazole -7.507 -9.549 -5.464 1 0.901 -9.276 -5.738 0.005 
Guadalupe GW_31 Epoxiconazole -6.478 -8.520 -4.435 1 0.901 -8.247 -4.709 0.011 
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Guadalupe GW_31 Propiconazole -6.105 -8.148 -4.063 1 0.901 -7.874 -4.337 0.015 
Guadalupe GW_33 Difenoconazole -7.581 -9.624 -5.539 1 0.901 -9.350 -5.812 0.005 
Guadalupe GW_33 Epoxiconazole -6.537 -8.579 -4.494 1 0.901 -8.306 -4.768 0.011 
Guadalupe GW_33 Propiconazole -5.219 -7.261 -3.177 1 0.901 -6.988 -3.450 0.027 
Guadalupe GW_34 Difenoconazole -5.128 -7.170 -3.085 1 0.901 -6.896 -3.359 0.029 
Guadalupe GW_34 Epoxiconazole -4.150 -6.193 -2.108 1 0.901 -5.919 -2.381 0.056 
Guadalupe GW_34 Propiconazole -5.362 -7.405 -3.320 1 0.901 -7.131 -3.594 0.024 
Guadalupe GW_35 Difenoconazole -6.356 -8.399 -4.314 1 0.901 -8.125 -4.588 0.012 
Guadalupe GW_35 Epoxiconazole -6.407 -8.449 -4.365 1 0.901 -8.176 -4.638 0.012 
Guadalupe GW_35 Propiconazole -5.285 -7.328 -3.243 1 0.901 -7.054 -3.517 0.026 
Guadalupe GW_36 Difenoconazole -5.652 -7.694 -3.610 1 0.901 -7.421 -3.883 0.020 
Guadalupe GW_36 Epoxiconazole -5.835 -7.878 -3.793 1 0.901 -7.604 -4.066 0.018 
Guadalupe GW_36 Propiconazole -6.412 -8.454 -4.369 1 0.901 -8.180 -4.643 0.012 
Guadalupe GW_39 Difenoconazole -6.131 -8.173 -4.088 1 0.901 -7.899 -4.362 0.014 
Guadalupe GW_39 Epoxiconazole -6.216 -8.258 -4.173 1 0.901 -7.984 -4.447 0.013 
Guadalupe GW_39 Propiconazole -6.297 -8.339 -4.254 1 0.901 -8.065 -4.528 0.013 
Guadalupe GW_4 Difenoconazole -6.105 -8.148 -4.063 1 0.901 -7.874 -4.337 0.015 
Guadalupe GW_4 Epoxiconazole -6.219 -8.262 -4.177 1 0.901 -7.988 -4.451 0.013 
Guadalupe GW_4 Propiconazole -5.335 -7.377 -3.292 1 0.901 -7.103 -3.566 0.025 
Guadalupe GW_41 Difenoconazole -5.188 -7.231 -3.146 1 0.901 -6.957 -3.419 0.027 
Guadalupe GW_41 Epoxiconazole -5.440 -7.483 -3.398 1 0.901 -7.209 -3.672 0.023 
Guadalupe GW_41 Propiconazole -7.367 -9.409 -5.325 1 0.901 -9.136 -5.598 0.006 
Guadalupe GW_42 Difenoconazole -4.383 -6.426 -2.341 1 0.901 -6.152 -2.614 0.048 
Guadalupe GW_42 Epoxiconazole -6.083 -8.125 -4.041 1 0.901 -7.852 -4.314 0.015 
Guadalupe GW_42 Propiconazole -5.574 -7.616 -3.531 1 0.901 -7.343 -3.805 0.021 
Guadalupe GW_43 Difenoconazole -5.224 -7.266 -3.181 1 0.901 -6.993 -3.455 0.027 
Guadalupe GW_43 Epoxiconazole -5.074 -7.116 -3.032 1 0.901 -6.843 -3.305 0.030 
Guadalupe GW_43 Propiconazole -7.475 -9.518 -5.433 1 0.901 -9.244 -5.706 0.006 
Guadalupe GW_44 Difenoconazole -5.930 -7.972 -3.887 1 0.901 -7.699 -4.161 0.016 
Guadalupe GW_44 Epoxiconazole -5.755 -7.798 -3.713 1 0.901 -7.524 -3.987 0.019 
Guadalupe GW_44 Propiconazole -7.554 -9.596 -5.511 1 0.901 -9.323 -5.785 0.005 
Guadalupe GW_46 Difenoconazole -4.042 -6.084 -2.000 1 0.901 -5.811 -2.273 0.061 
Guadalupe GW_46 Epoxiconazole -3.598 -5.640 -1.555 1 0.901 -5.367 -1.829 0.083 
Guadalupe GW_46 Propiconazole -7.067 -9.109 -5.024 1 0.901 -8.835 -5.298 0.007 
Guadalupe GW_5 Difenoconazole -5.219 -7.261 -3.177 1 0.901 -6.988 -3.450 0.027 
Guadalupe GW_5 Epoxiconazole -5.808 -7.850 -3.766 1 0.901 -7.577 -4.039 0.018 
Guadalupe GW_5 Propiconazole -5.354 -7.396 -3.311 1 0.901 -7.122 -3.585 0.024 
Guadalupe GW_6 Difenoconazole -5.362 -7.405 -3.320 1 0.901 -7.131 -3.594 0.024 
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Guadalupe GW_6 Epoxiconazole -4.458 -6.501 -2.416 1 0.901 -6.227 -2.690 0.045 
Guadalupe GW_6 Propiconazole -5.284 -7.326 -3.241 1 0.901 -7.053 -3.515 0.026 
Guadalupe GW_7 Difenoconazole -5.285 -7.328 -3.243 1 0.901 -7.054 -3.517 0.026 
Guadalupe GW_7 Epoxiconazole -6.257 -8.300 -4.215 1 0.901 -8.026 -4.489 0.013 
Guadalupe GW_7 Propiconazole -5.640 -7.682 -3.598 1 0.901 -7.409 -3.871 0.020 
Guadalupe GW_8 Difenoconazole -6.412 -8.454 -4.369 1 0.901 -8.180 -4.643 0.012 
Guadalupe GW_8 Epoxiconazole -6.216 -8.258 -4.174 1 0.901 -7.985 -4.447 0.013 
Guadalupe GW_8 Propiconazole -5.607 -7.649 -3.565 1 0.901 -7.376 -3.838 0.021 
Colombia Horizonte_1 Difenoconazole -0.207 -2.250 1.835 1 0.901 -1.976 1.561 0.866 
Colombia Horizonte_1 Epoxiconazole -1.262 -3.305 0.780 1 0.901 -3.031 0.506 0.417 
Colombia Horizonte_1 Propiconazole -0.978 -3.020 1.065 1 0.901 -2.747 0.791 0.508 
Colombia Horizonte_3 Difenoconazole 2.822 0.780 4.865 1 0.901 1.054 4.591 7.074 
Colombia Horizonte_3 Epoxiconazole 1.677 -0.365 3.719 3 0.520 0.656 2.698 3.198 
Colombia Horizonte_3 Propiconazole 3.025 0.983 5.067 3 0.520 2.004 4.046 8.139 
Colombia Horizonte_4 Difenoconazole 1.691 -0.351 3.733 5 0.403 0.900 2.482 3.229 
Colombia Horizonte_4 Epoxiconazole -0.712 -2.754 1.331 6 0.368 -1.434 0.011 0.611 
Colombia Horizonte_4 Propiconazole 1.623 -0.419 3.665 6 0.368 0.901 2.345 3.080 
Colombia Llorona_1 Difenoconazole -7.529 -9.571 -5.487 1 0.901 -9.298 -5.760 0.005 
Colombia Llorona_1 Epoxiconazole -5.891 -7.933 -3.849 1 0.901 -7.660 -4.122 0.017 
Colombia Llorona_1 Propiconazole -5.690 -7.732 -3.648 1 0.901 -7.459 -3.921 0.019 
Colombia Llorona_2 Difenoconazole -7.355 -9.398 -5.313 1 0.901 -9.124 -5.587 0.006 
Colombia Llorona_2 Epoxiconazole -6.152 -8.195 -4.110 1 0.901 -7.921 -4.383 0.014 
Colombia Llorona_2 Propiconazole -5.827 -7.869 -3.785 1 0.901 -7.596 -4.058 0.018 
Colombia Luisa Fernanda_1 Difenoconazole 3.310 1.268 5.352 1 0.901 1.541 5.079 9.917 
Colombia Luisa Fernanda_1 Epoxiconazole 2.524 0.481 4.566 1 0.901 0.755 4.293 5.751 
Colombia Luisa Fernanda_1 Propiconazole 3.070 1.027 5.112 1 0.901 1.301 4.839 8.396 
Colombia Luisa Fernanda_10 Difenoconazole 0.624 -1.419 2.666 1 0.901 -1.145 2.393 1.541 
Colombia Luisa Fernanda_10 Epoxiconazole -1.036 -3.079 1.006 1 0.901 -2.805 0.733 0.488 
Colombia Luisa Fernanda_10 Propiconazole 1.150 -0.892 3.193 1 0.901 -0.619 2.919 2.220 
Colombia Luisa Fernanda_2 Difenoconazole 2.656 0.614 4.699 1 0.901 0.888 4.425 6.305 
Colombia Luisa Fernanda_2 Epoxiconazole 0.261 -1.781 2.304 1 0.901 -1.507 2.030 1.199 
Colombia Luisa Fernanda_2 Propiconazole 1.594 -0.449 3.636 1 0.901 -0.175 3.362 3.018 
Colombia Luisa Fernanda_4 Difenoconazole 2.793 0.751 4.836 1 0.901 1.025 4.562 6.932 
Colombia Luisa Fernanda_4 Epoxiconazole 1.032 -1.011 3.074 1 0.901 -0.737 2.800 2.044 
Colombia Luisa Fernanda_4 Propiconazole 2.688 0.645 4.730 1 0.901 0.919 4.456 6.442 
Colombia Luisa Fernanda_5 Difenoconazole 2.160 0.117 4.202 1 0.901 0.391 3.929 4.469 
Colombia Luisa Fernanda_5 Epoxiconazole 0.320 -1.723 2.362 1 0.901 -1.449 2.088 1.248 
Colombia Luisa Fernanda_5 Propiconazole 0.996 -1.046 3.038 1 0.901 -0.773 2.765 1.995 
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Philippines M52_1 Difenoconazole -1.608 -3.651 0.434 3 0.520 -2.630 -0.587 0.328 
Philippines M52_1 Epoxiconazole -2.494 -4.536 -0.452 3 0.520 -3.515 -1.473 0.177 
Philippines M52_1 Propiconazole -0.366 -2.408 1.676 3 0.520 -1.387 0.655 0.776 
Philippines M52_10 Difenoconazole -1.375 -3.417 0.668 3 0.520 -2.396 -0.354 0.386 
Philippines M52_10 Epoxiconazole -2.045 -4.087 -0.002 3 0.520 -3.066 -1.024 0.242 
Philippines M52_10 Propiconazole 0.189 -1.853 2.231 3 0.520 -0.832 1.210 1.140 
Philippines M52_11 Difenoconazole -0.860 -2.903 1.182 1 0.901 -2.629 0.908 0.551 
Philippines M52_11 Epoxiconazole -1.940 -3.982 0.102 1 0.901 -3.709 -0.171 0.261 
Philippines M52_11 Propiconazole 1.021 -1.022 3.063 1 0.901 -0.748 2.789 2.029 
Philippines M52_12 Difenoconazole -0.940 -2.982 1.103 1 0.901 -2.709 0.829 0.521 
Philippines M52_12 Epoxiconazole -0.249 -2.292 1.793 1 0.901 -2.018 1.519 0.841 
Philippines M52_12 Propiconazole 1.965 -0.077 4.008 1 0.901 0.196 3.734 3.905 
Philippines M52_13 Difenoconazole 1.302 -0.741 3.344 1 0.901 -0.467 3.071 2.465 
Philippines M52_13 Epoxiconazole -0.020 -2.063 2.022 1 0.901 -1.789 1.748 0.986 
Philippines M52_13 Propiconazole 2.421 0.378 4.463 1 0.901 0.652 4.190 5.354 
Philippines M52_14 Difenoconazole -0.389 -2.431 1.654 3 0.520 -1.410 0.632 0.764 
Philippines M52_14 Epoxiconazole -0.536 -2.579 1.506 3 0.520 -1.557 0.485 0.690 
Philippines M52_14 Propiconazole -0.707 -2.750 1.335 3 0.520 -1.729 0.314 0.612 
Philippines M52_15 Difenoconazole 0.965 -1.077 3.007 1 0.901 -0.804 2.734 1.952 
Philippines M52_15 Epoxiconazole 1.924 -0.118 3.966 1 0.901 0.155 3.693 3.795 
Philippines M52_15 Propiconazole 1.088 -0.954 3.131 1 0.901 -0.680 2.857 2.126 
Philippines M52_16 Difenoconazole 1.192 -0.850 3.235 1 0.901 -0.576 2.961 2.285 
Philippines M52_16 Epoxiconazole 1.605 -0.437 3.647 1 0.901 -0.164 3.374 3.042 
Philippines M52_16 Propiconazole 0.855 -1.187 2.897 1 0.901 -0.914 2.624 1.809 
Philippines M52_17 Difenoconazole -1.720 -3.763 0.322 1 0.901 -3.489 0.048 0.303 
Philippines M52_17 Epoxiconazole -1.059 -3.101 0.984 1 0.901 -2.828 0.710 0.480 
Philippines M52_17 Propiconazole -0.750 -2.792 1.292 1 0.901 -2.519 1.019 0.595 
Philippines M52_18 Difenoconazole -1.716 -3.758 0.327 1 0.901 -3.484 0.053 0.304 
Philippines M52_18 Epoxiconazole -0.885 -2.927 1.157 1 0.901 -2.654 0.884 0.542 
Philippines M52_18 Propiconazole 0.295 -1.748 2.337 1 0.901 -1.474 2.064 1.227 
Philippines M52_19 Difenoconazole -2.285 -4.328 -0.243 1 0.901 -4.054 -0.517 0.205 
Philippines M52_19 Epoxiconazole -1.321 -3.363 0.722 1 0.901 -3.089 0.448 0.400 
Philippines M52_19 Propiconazole -0.390 -2.433 1.652 1 0.901 -2.159 1.378 0.763 
Philippines M52_2 Difenoconazole -0.187 -2.230 1.855 1 0.901 -1.956 1.582 0.878 
Philippines M52_2 Epoxiconazole 0.526 -1.516 2.568 1 0.901 -1.243 2.295 1.440 
Philippines M52_2 Propiconazole 0.374 -1.668 2.416 1 0.901 -1.395 2.143 1.296 
Philippines M52_20 Difenoconazole -1.552 -3.595 0.490 1 0.901 -3.321 0.217 0.341 
Philippines M52_20 Epoxiconazole -0.052 -2.094 1.991 1 0.901 -1.821 1.717 0.965 
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Philippines M52_20 Propiconazole -2.591 -4.634 -0.549 1 0.901 -4.360 -0.823 0.166 
Philippines M52_21 Difenoconazole -1.144 -3.187 0.898 1 0.901 -2.913 0.624 0.452 
Philippines M52_21 Epoxiconazole -2.409 -4.451 -0.366 1 0.901 -4.177 -0.640 0.188 
Philippines M52_21 Propiconazole -3.341 -5.384 -1.299 1 0.901 -5.110 -1.573 0.099 
Philippines M52_22 Difenoconazole 0.853 -1.190 2.895 4 0.451 -0.032 1.737 1.806 
Philippines M52_22 Epoxiconazole -0.309 -2.351 1.734 4 0.451 -1.193 0.576 0.807 
Philippines M52_22 Propiconazole 0.428 -1.614 2.470 4 0.451 -0.456 1.312 1.345 
Philippines M52_23 Difenoconazole -0.972 -3.015 1.070 1 0.901 -2.741 0.797 0.510 
Philippines M52_23 Epoxiconazole -1.187 -3.230 0.855 1 0.901 -2.956 0.581 0.439 
Philippines M52_23 Propiconazole 1.488 -0.555 3.530 1 0.901 -0.281 3.256 2.804 
Philippines M52_24 Difenoconazole -2.185 -4.227 -0.142 3 0.520 -3.206 -1.163 0.220 
Philippines M52_24 Epoxiconazole -2.978 -5.020 -0.935 3 0.520 -3.999 -1.957 0.127 
Philippines M52_24 Propiconazole 0.297 -1.746 2.339 3 0.520 -0.725 1.318 1.228 
Philippines M52_25 Difenoconazole -3.422 -5.465 -1.380 1 0.901 -5.191 -1.653 0.093 
Philippines M52_25 Epoxiconazole -2.997 -5.039 -0.954 1 0.901 -4.765 -1.228 0.125 
Philippines M52_25 Propiconazole -0.749 -2.792 1.293 1 0.901 -2.518 1.019 0.595 
Philippines M52_3 Difenoconazole -0.147 -2.190 1.895 3 0.520 -1.168 0.874 0.903 
Philippines M52_3 Epoxiconazole -1.199 -3.242 0.843 3 0.520 -2.221 -0.178 0.435 
Philippines M52_3 Propiconazole 1.194 -0.849 3.236 3 0.520 0.172 2.215 2.287 
Philippines M52_35 Difenoconazole -1.329 -3.372 0.713 1 0.901 -3.098 0.439 0.398 
Philippines M52_35 Epoxiconazole -1.409 -3.452 0.633 1 0.901 -3.178 0.360 0.377 
Philippines M52_35 Propiconazole -0.418 -2.460 1.624 1 0.901 -2.187 1.351 0.748 
Philippines M52_37 Difenoconazole -0.516 -2.559 1.526 1 0.901 -2.285 1.252 0.699 
Philippines M52_37 Epoxiconazole -1.499 -3.541 0.544 1 0.901 -3.267 0.270 0.354 
Philippines M52_37 Propiconazole 1.280 -0.762 3.323 1 0.901 -0.488 3.049 2.429 
Philippines M52_4 Difenoconazole -2.077 -4.119 -0.034 3 0.520 -3.098 -1.055 0.237 
Philippines M52_4 Epoxiconazole -2.745 -4.787 -0.702 3 0.520 -3.766 -1.723 0.149 
Philippines M52_4 Propiconazole -0.703 -2.746 1.339 3 0.520 -1.725 0.318 0.614 
Philippines M52_5 Difenoconazole -3.341 -5.384 -1.299 1 0.901 -5.110 -1.573 0.099 
Philippines M52_5 Epoxiconazole -2.482 -4.525 -0.440 1 0.901 -4.251 -0.714 0.179 
Philippines M52_5 Propiconazole -0.795 -2.837 1.248 1 0.901 -2.564 0.974 0.576 
Philippines M52_6 Difenoconazole -2.575 -4.618 -0.533 1 0.901 -4.344 -0.807 0.168 
Philippines M52_6 Epoxiconazole -2.368 -4.411 -0.326 1 0.901 -4.137 -0.599 0.194 
Philippines M52_6 Propiconazole 0.041 -2.001 2.084 1 0.901 -1.727 1.810 1.029 
Philippines M52_7 Difenoconazole 1.488 -0.555 3.530 1 0.901 -0.281 3.256 2.804 
Philippines M52_7 Epoxiconazole 1.259 -0.783 3.301 1 0.901 -0.510 3.028 2.393 
Philippines M52_7 Propiconazole -0.213 -2.255 1.830 1 0.901 -1.981 1.556 0.863 
Philippines M52_8 Difenoconazole 2.918 0.875 4.960 1 0.901 1.149 4.686 7.556 
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Philippines M52_8 Epoxiconazole 3.036 0.993 5.078 1 0.901 1.267 4.804 8.200 
Philippines M52_8 Propiconazole 2.864 0.821 4.906 1 0.901 1.095 4.633 7.279 
Philippines M52_9 Difenoconazole -0.936 -2.978 1.107 3 0.520 -1.957 0.086 0.523 
Philippines M52_9 Epoxiconazole -1.572 -3.615 0.470 3 0.520 -2.593 -0.551 0.336 
Philippines M52_9 Propiconazole -0.578 -2.620 1.465 3 0.520 -1.599 0.443 0.670 
Martinique Ma26_10 Difenoconazole -6.217 -8.260 -4.175 1 0.901 -7.986 -4.449 0.013 
Martinique Ma26_10 Epoxiconazole -5.364 -7.407 -3.322 1 0.901 -7.133 -3.595 0.024 
Martinique Ma26_10 Propiconazole -7.507 -9.549 -5.464 1 0.901 -9.276 -5.738 0.005 
Martinique Ma26_11 Difenoconazole -4.795 -6.837 -2.752 1 0.901 -6.563 -3.026 0.036 
Martinique Ma26_11 Epoxiconazole -4.482 -6.524 -2.439 1 0.901 -6.251 -2.713 0.045 
Martinique Ma26_11 Propiconazole -7.581 -9.624 -5.539 1 0.901 -9.350 -5.812 0.005 
Martinique Ma26_13 Difenoconazole -5.904 -7.946 -3.861 1 0.901 -7.673 -4.135 0.017 
Martinique Ma26_13 Epoxiconazole -4.239 -6.282 -2.197 1 0.901 -6.008 -2.470 0.053 
Martinique Ma26_13 Propiconazole -5.128 -7.170 -3.085 1 0.901 -6.896 -3.359 0.029 
Martinique Ma26_14 Difenoconazole -4.665 -6.707 -2.623 1 0.901 -6.434 -2.896 0.039 
Martinique Ma26_14 Epoxiconazole -4.324 -6.367 -2.282 1 0.901 -6.093 -2.556 0.050 
Martinique Ma26_14 Propiconazole -6.356 -8.399 -4.314 1 0.901 -8.125 -4.588 0.012 
Martinique Ma26_16 Difenoconazole -5.119 -7.162 -3.077 1 0.901 -6.888 -3.350 0.029 
Martinique Ma26_16 Epoxiconazole -5.117 -7.159 -3.075 1 0.901 -6.886 -3.348 0.029 
Martinique Ma26_16 Propiconazole -5.652 -7.694 -3.610 1 0.901 -7.421 -3.883 0.020 
Martinique Ma26_17 Difenoconazole -6.059 -8.101 -4.016 1 0.901 -7.828 -4.290 0.015 
Martinique Ma26_17 Epoxiconazole -5.941 -7.983 -3.898 1 0.901 -7.709 -4.172 0.016 
Martinique Ma26_17 Propiconazole -6.131 -8.173 -4.088 1 0.901 -7.899 -4.362 0.014 
Martinique Ma26_18 Difenoconazole -3.792 -5.834 -1.750 1 0.901 -5.561 -2.023 0.072 
Martinique Ma26_18 Epoxiconazole -4.828 -6.870 -2.785 1 0.901 -6.596 -3.059 0.035 
Martinique Ma26_18 Propiconazole -5.188 -7.231 -3.146 1 0.901 -6.957 -3.419 0.027 
Martinique Ma26_19 Difenoconazole -4.073 -6.115 -2.030 1 0.901 -5.841 -2.304 0.059 
Martinique Ma26_19 Epoxiconazole -4.368 -6.410 -2.326 1 0.901 -6.137 -2.599 0.048 
Martinique Ma26_19 Propiconazole -4.383 -6.426 -2.341 1 0.901 -6.152 -2.614 0.048 
Martinique Ma26_2 Difenoconazole -4.538 -6.580 -2.495 1 0.901 -6.307 -2.769 0.043 
Martinique Ma26_2 Epoxiconazole -5.349 -7.392 -3.307 1 0.901 -7.118 -3.581 0.025 
Martinique Ma26_2 Propiconazole -6.098 -8.141 -4.056 1 0.901 -7.867 -4.330 0.015 
Martinique Ma26_20 Difenoconazole -5.952 -7.994 -3.910 1 0.901 -7.721 -4.183 0.016 
Martinique Ma26_20 Epoxiconazole -4.913 -6.955 -2.870 1 0.901 -6.681 -3.144 0.033 
Martinique Ma26_20 Propiconazole -5.224 -7.266 -3.181 1 0.901 -6.993 -3.455 0.027 
Martinique Ma26_22 Difenoconazole -6.368 -8.410 -4.326 1 0.901 -8.137 -4.599 0.012 
Martinique Ma26_22 Epoxiconazole -4.713 -6.756 -2.671 1 0.901 -6.482 -2.944 0.038 
Martinique Ma26_22 Propiconazole -5.930 -7.972 -3.887 1 0.901 -7.699 -4.161 0.016 
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Martinique Ma26_23 Difenoconazole -7.622 -9.664 -5.579 1 0.901 -9.391 -5.853 0.005 
Martinique Ma26_23 Epoxiconazole -5.524 -7.566 -3.481 1 0.901 -7.292 -3.755 0.022 
Martinique Ma26_23 Propiconazole -4.042 -6.084 -2.000 1 0.901 -5.811 -2.273 0.061 
Martinique Ma26_24 Difenoconazole -6.088 -8.130 -4.045 1 0.901 -7.856 -4.319 0.015 
Martinique Ma26_24 Epoxiconazole -4.480 -6.522 -2.438 1 0.901 -6.249 -2.711 0.045 
Martinique Ma26_24 Propiconazole -4.538 -6.580 -2.495 1 0.901 -6.307 -2.769 0.043 
Martinique Ma26_25 Difenoconazole -5.510 -7.552 -3.467 1 0.901 -7.279 -3.741 0.022 
Martinique Ma26_25 Epoxiconazole -3.878 -5.921 -1.836 1 0.901 -5.647 -2.110 0.068 
Martinique Ma26_25 Propiconazole -3.544 -5.587 -1.502 1 0.901 -5.313 -1.775 0.086 
Martinique Ma26_26 Difenoconazole -5.309 -7.351 -3.267 1 0.901 -7.078 -3.540 0.025 
Martinique Ma26_26 Epoxiconazole -5.619 -7.661 -3.576 1 0.901 -7.387 -3.850 0.020 
Martinique Ma26_26 Propiconazole -6.273 -8.316 -4.231 1 0.901 -8.042 -4.505 0.013 
Martinique Ma26_27 Difenoconazole -4.498 -6.540 -2.455 1 0.901 -6.267 -2.729 0.044 
Martinique Ma26_27 Epoxiconazole -4.282 -6.324 -2.240 1 0.901 -6.051 -2.513 0.051 
Martinique Ma26_27 Propiconazole    0    
<0.004 
Martinique Ma26_28 Difenoconazole -4.061 -6.104 -2.019 1 0.901 -5.830 -2.293 0.060 
Martinique Ma26_28 Epoxiconazole -4.760 -6.803 -2.718 1 0.901 -6.529 -2.992 0.037 
Martinique Ma26_28 Propiconazole -4.918 -6.961 -2.876 1 0.901 -6.687 -3.150 0.033 
Martinique Ma26_29 Difenoconazole -7.167 -9.209 -5.124 1 0.901 -8.936 -5.398 0.007 
Martinique Ma26_29 Epoxiconazole -6.262 -8.305 -4.220 1 0.901 -8.031 -4.493 0.013 
Martinique Ma26_29 Propiconazole -6.217 -8.260 -4.175 1 0.901 -7.986 -4.449 0.013 
Martinique Ma26_3 Difenoconazole -3.544 -5.587 -1.502 1 0.901 -5.313 -1.775 0.086 
Martinique Ma26_3 Epoxiconazole -3.572 -5.614 -1.529 1 0.901 -5.340 -1.803 0.084 
Martinique Ma26_3 Propiconazole -5.925 -7.968 -3.883 1 0.901 -7.694 -4.156 0.016 
Martinique Ma26_30 Difenoconazole -7.535 -9.577 -5.492 1 0.901 -9.304 -5.766 0.005 
Martinique Ma26_30 Epoxiconazole -7.014 -9.057 -4.972 1 0.901 -8.783 -5.246 0.008 
Martinique Ma26_30 Propiconazole -6.888 -8.930 -4.845 1 0.901 -8.657 -5.119 0.008 
Martinique Ma26_32 Difenoconazole -7.695 -9.737 -5.653 1 0.901 -9.464 -5.926 0.005 
Martinique Ma26_32 Epoxiconazole -7.626 -9.668 -5.583 1 0.901 -9.394 -5.857 0.005 
Martinique Ma26_32 Propiconazole -6.320 -8.362 -4.277 1 0.901 -8.088 -4.551 0.013 
Martinique Ma26_33 Difenoconazole -6.134 -8.177 -4.092 1 0.901 -7.903 -4.366 0.014 
Martinique Ma26_33 Epoxiconazole -3.337 -5.380 -1.295 1 0.901 -5.106 -1.568 0.099 
Martinique Ma26_33 Propiconazole -5.193 -7.235 -3.151 1 0.901 -6.962 -3.424 0.027 
Martinique Ma26_35 Difenoconazole -6.077 -8.120 -4.035 1 0.901 -7.846 -4.308 0.015 
Martinique Ma26_35 Epoxiconazole -4.648 -6.691 -2.606 1 0.901 -6.417 -2.880 0.040 
Martinique Ma26_35 Propiconazole -6.640 -8.682 -4.597 1 0.901 -8.409 -4.871 0.010 
Martinique Ma26_36 Difenoconazole -4.120 -6.163 -2.078 1 0.901 -5.889 -2.352 0.057 
Martinique Ma26_36 Epoxiconazole -4.333 -6.376 -2.291 1 0.901 -6.102 -2.565 0.050 
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Martinique Ma26_36 Propiconazole -4.521 -6.564 -2.479 1 0.901 -6.290 -2.752 0.044 
Martinique Ma26_37 Difenoconazole -6.129 -8.172 -4.087 1 0.901 -7.898 -4.360 0.014 
Martinique Ma26_37 Epoxiconazole -5.831 -7.873 -3.788 1 0.901 -7.600 -4.062 0.018 
Martinique Ma26_37 Propiconazole -5.406 -7.449 -3.364 1 0.901 -7.175 -3.637 0.024 
Martinique Ma26_40 Difenoconazole -7.507 -9.549 -5.465 1 0.901 -9.276 -5.738 0.005 
Martinique Ma26_40 Epoxiconazole -7.264 -9.307 -5.222 1 0.901 -9.033 -5.496 0.007 
Martinique Ma26_40 Propiconazole -6.197 -8.240 -4.155 1 0.901 -7.966 -4.428 0.014 
Martinique Ma26_5 Difenoconazole -6.273 -8.316 -4.231 1 0.901 -8.042 -4.505 0.013 
Martinique Ma26_5 Epoxiconazole -6.122 -8.165 -4.080 1 0.901 -7.891 -4.354 0.014 
Martinique Ma26_5 Propiconazole -5.791 -7.834 -3.749 1 0.901 -7.560 -4.023 0.018 
Martinique Ma26_7 Difenoconazole    0    
<0.004 
Martinique Ma26_7 Epoxiconazole 
   
0 
   
<0.004 
Martinique Ma26_7 Propiconazole -6.107 -8.149 -4.064 1 0.901 -7.876 -4.338 0.015 
Martinique Ma26_9 Difenoconazole -4.918 -6.961 -2.876 1 0.901 -6.687 -3.150 0.033 
Martinique Ma26_9 Epoxiconazole -4.460 -6.502 -2.417 1 0.901 -6.228 -2.691 0.045 
Martinique Ma26_9 Propiconazole -7.519 -9.561 -5.476 1 0.901 -9.288 -5.750 0.005 
Martinique Ma27_1 Difenoconazole -7.695 -9.737 -5.652 1 0.901 -9.464 -5.926 0.005 
Martinique Ma27_1 Epoxiconazole -6.193 -8.235 -4.150 1 0.901 -7.962 -4.424 0.014 
Martinique Ma27_1 Propiconazole -6.314 -8.356 -4.272 1 0.901 -8.083 -4.545 0.013 
Martinique Ma27_11 Difenoconazole -7.594 -9.636 -5.551 1 0.901 -9.362 -5.825 0.005 
Martinique Ma27_11 Epoxiconazole -6.857 -8.899 -4.814 1 0.901 -8.626 -5.088 0.009 
Martinique Ma27_11 Propiconazole -6.070 -8.113 -4.028 1 0.901 -7.839 -4.301 0.015 
Martinique Ma27_12 Difenoconazole -7.602 -9.645 -5.560 1 0.901 -9.371 -5.834 0.005 
Martinique Ma27_12 Epoxiconazole -6.785 -8.827 -4.742 1 0.901 -8.553 -5.016 0.009 
Martinique Ma27_12 Propiconazole -6.624 -8.666 -4.581 1 0.901 -8.392 -4.855 0.010 
Martinique Ma27_13 Difenoconazole -5.488 -7.530 -3.445 1 0.901 -7.257 -3.719 0.022 
Martinique Ma27_13 Epoxiconazole -5.134 -7.177 -3.092 1 0.901 -6.903 -3.365 0.028 
Martinique Ma27_13 Propiconazole -5.471 -7.513 -3.429 1 0.901 -7.240 -3.702 0.023 
Martinique Ma27_14 Difenoconazole -6.011 -8.053 -3.968 1 0.901 -7.780 -4.242 0.016 
Martinique Ma27_14 Epoxiconazole -5.749 -7.792 -3.707 1 0.901 -7.518 -3.981 0.019 
Martinique Ma27_14 Propiconazole -5.589 -7.632 -3.547 1 0.901 -7.358 -3.821 0.021 
Martinique Ma27_16 Difenoconazole -7.286 -9.328 -5.244 1 0.901 -9.055 -5.517 0.006 
Martinique Ma27_16 Epoxiconazole -6.910 -8.952 -4.868 1 0.901 -8.679 -5.141 0.008 
Martinique Ma27_16 Propiconazole -6.484 -8.527 -4.442 1 0.901 -8.253 -4.716 0.011 
Martinique Ma27_17 Difenoconazole -7.813 -9.856 -5.771 1 0.901 -9.582 -6.044 0.004 
Martinique Ma27_17 Epoxiconazole -7.459 -9.501 -5.416 1 0.901 -9.227 -5.690 0.006 
Martinique Ma27_17 Propiconazole -6.124 -8.166 -4.081 1 0.901 -7.893 -4.355 0.014 
Martinique Ma27_19 Difenoconazole -7.733 -9.775 -5.690 1 0.901 -9.501 -5.964 0.005 
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Martinique Ma27_19 Epoxiconazole -7.207 -9.250 -5.165 1 0.901 -8.976 -5.438 0.007 
Martinique Ma27_19 Propiconazole -6.192 -8.234 -4.149 1 0.901 -7.960 -4.423 0.014 
Martinique Ma27_22 Difenoconazole    0    
<0.004 
Martinique Ma27_22 Epoxiconazole -7.821 -9.864 -5.779 1 0.901 -9.590 -6.053 0.004 
Martinique Ma27_22 Propiconazole -7.775 -9.817 -5.733 1 0.901 -9.544 -6.006 0.005 
Martinique Ma27_5 Difenoconazole -6.055 -8.097 -4.012 1 0.901 -7.824 -4.286 0.015 
Martinique Ma27_5 Epoxiconazole -6.189 -8.231 -4.146 1 0.901 -7.958 -4.420 0.014 
Martinique Ma27_5 Propiconazole -4.731 -6.773 -2.688 1 0.901 -6.499 -2.962 0.038 
Martinique Ma27_6 Difenoconazole -7.795 -9.837 -5.753 1 0.901 -9.564 -6.026 0.005 
Martinique Ma27_6 Epoxiconazole -7.510 -9.553 -5.468 2 0.637 -8.761 -6.260 0.005 
Martinique Ma27_6 Propiconazole -6.764 -8.806 -4.722 2 0.637 -8.015 -5.513 0.009 
Martinique Ma27_7 Difenoconazole -5.848 -7.890 -3.805 1 0.901 -7.616 -4.079 0.017 
Martinique Ma27_7 Epoxiconazole -5.484 -7.526 -3.441 1 0.901 -7.253 -3.715 0.022 
Martinique Ma27_7 Propiconazole -5.933 -7.976 -3.891 1 0.901 -7.702 -4.165 0.016 
Martinique Ma27_9 Difenoconazole -5.000 -7.042 -2.957 1 0.901 -6.769 -3.231 0.031 
Martinique Ma27_9 Epoxiconazole -4.451 -6.493 -2.408 1 0.901 -6.220 -2.682 0.046 
Martinique Ma27_9 Propiconazole -4.642 -6.684 -2.600 1 0.901 -6.411 -2.873 0.040 
Colombia Montecristo_3 Difenoconazole 2.065 0.023 4.108 1 0.901 0.296 3.834 4.185 
Colombia Montecristo_3 Epoxiconazole -0.109 -2.151 1.934 1 0.901 -1.877 1.660 0.927 
Colombia Montecristo_3 Propiconazole 1.152 -0.890 3.195 1 0.901 -0.616 2.921 2.223 
Colombia Montecristo_4 Difenoconazole 2.295 0.253 4.338 3 0.520 1.274 3.317 4.909 
Colombia Montecristo_4 Epoxiconazole 0.779 -1.263 2.822 3 0.520 -0.242 1.801 1.716 
Colombia Montecristo_4 Propiconazole 1.843 -0.199 3.886 3 0.520 0.822 2.865 3.589 
Colombia Montecristo_5 Difenoconazole 2.396 0.353 4.438 3 0.520 1.374 3.417 5.262 
Colombia Montecristo_5 Epoxiconazole 1.260 -0.783 3.302 3 0.520 0.239 2.281 2.394 
Colombia Montecristo_5 Propiconazole 2.194 0.151 4.236 3 0.520 1.172 3.215 4.575 
Colombia Montecristo_7 Difenoconazole 2.949 0.907 4.992 1 0.901 1.181 4.718 7.724 
Colombia Montecristo_7 Epoxiconazole 0.963 -1.080 3.005 1 0.901 -0.806 2.731 1.949 
Colombia Montecristo_7 Propiconazole 1.452 -0.590 3.495 1 0.901 -0.316 3.221 2.737 
Dominican Rep. O_1 Difenoconazole 1.518 -0.525 3.560 3 0.520 0.496 2.539 2.863 
Dominican Rep. O_1 Epoxiconazole 0.651 -1.392 2.693 3 0.520 -0.371 1.672 1.570 
Dominican Rep. O_1 Propiconazole 1.587 -0.455 3.629 3 0.520 0.566 2.608 3.004 
Dominican Rep. O_2 Difenoconazole 0.497 -1.546 2.539 3 0.520 -0.524 1.518 1.411 
Dominican Rep. O_2 Epoxiconazole -0.347 -2.390 1.695 3 0.520 -1.369 0.674 0.786 
Dominican Rep. O_2 Propiconazole 0.427 -1.616 2.469 3 0.520 -0.594 1.448 1.344 
Dominican Rep. O_3 Difenoconazole 0.694 -1.349 2.736 3 0.520 -0.328 1.715 1.617 
Dominican Rep. O_3 Epoxiconazole 0.365 -1.677 2.408 3 0.520 -0.656 1.387 1.288 
Dominican Rep. O_3 Propiconazole 1.732 -0.311 3.774 3 0.520 0.710 2.753 3.321 
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Dominican Rep. O_4 Difenoconazole 1.125 -0.918 3.167 3 0.520 0.104 2.146 2.181 
Dominican Rep. O_4 Epoxiconazole 0.577 -1.465 2.620 3 0.520 -0.444 1.599 1.492 
Dominican Rep. O_4 Propiconazole 0.702 -1.341 2.744 3 0.520 -0.320 1.723 1.626 
Dominican Rep. O_5 Difenoconazole -0.790 -2.832 1.253 3 0.520 -1.811 0.231 0.578 
Dominican Rep. O_5 Epoxiconazole -0.819 -2.861 1.223 3 0.520 -1.840 0.202 0.567 
Dominican Rep. O_5 Propiconazole -0.168 -2.211 1.874 3 0.520 -1.189 0.853 0.890 
Ecuador OCM_11 Difenoconazole -2.367 -4.409 -0.325 4 0.451 -3.251 -1.483 0.194 
Ecuador OCM_11 Epoxiconazole -3.530 -5.572 -1.487 4 0.451 -4.414 -2.645 0.087 
Ecuador OCM_11 Propiconazole -1.846 -3.889 0.196 4 0.451 -2.731 -0.962 0.278 
Ecuador OCM_12 Difenoconazole -0.234 -2.277 1.808 4 0.451 -1.119 0.650 0.850 
Ecuador OCM_12 Epoxiconazole -1.808 -3.850 0.234 4 0.451 -2.692 -0.924 0.286 
Ecuador OCM_12 Propiconazole 0.458 -1.584 2.501 4 0.451 -0.426 1.343 1.374 
Ecuador OCM_15 Difenoconazole 0.361 -1.681 2.403 1 0.901 -1.408 2.130 1.284 
Ecuador OCM_15 Epoxiconazole -0.463 -2.505 1.580 1 0.901 -2.231 1.306 0.726 
Ecuador OCM_15 Propiconazole 0.519 -1.523 2.562 1 0.901 -1.249 2.288 1.433 
Ecuador OCM_20 Difenoconazole -1.296 -3.339 0.746 1 0.901 -3.065 0.473 0.407 
Ecuador OCM_20 Epoxiconazole -1.342 -3.384 0.700 1 0.901 -3.111 0.427 0.394 
Ecuador OCM_20 Propiconazole -0.181 -2.223 1.862 1 0.901 -1.949 1.588 0.882 
Ecuador OCM_26 Difenoconazole -1.820 -3.862 0.222 1 0.901 -3.589 -0.051 0.283 
Ecuador OCM_26 Epoxiconazole -1.489 -3.532 0.553 1 0.901 -3.258 0.280 0.356 
Ecuador OCM_26 Propiconazole -0.367 -2.409 1.675 1 0.901 -2.136 1.402 0.775 
Ecuador OCM_6 Difenoconazole -1.373 -3.415 0.670 3 0.520 -2.394 -0.351 0.386 
Ecuador OCM_6 Epoxiconazole -2.894 -4.936 -0.852 3 0.520 -3.915 -1.873 0.135 
Ecuador OCM_6 Propiconazole -1.489 -3.531 0.554 3 0.520 -2.510 -0.467 0.356 
Ecuador ONM_20 Difenoconazole 0.602 -1.440 2.645 1 0.901 -1.166 2.371 1.518 
Ecuador ONM_20 Epoxiconazole -0.829 -2.872 1.213 1 0.901 -2.598 0.939 0.563 
Ecuador ONM_20 Propiconazole -0.665 -2.708 1.377 1 0.901 -2.434 1.104 0.631 
Ecuador ONM_9 Difenoconazole -0.660 -2.702 1.383 1 0.901 -2.428 1.109 0.633 
Ecuador ONM_9 Epoxiconazole -0.052 -2.095 1.990 1 0.901 -1.821 1.716 0.964 
Ecuador ONM_9 Propiconazole 0.029 -2.013 2.072 1 0.901 -1.740 1.798 1.020 
Ecuador ONP_2 Difenoconazole -1.741 -3.783 0.301 1 0.901 -3.510 0.028 0.299 
Ecuador ONP_2 Epoxiconazole -1.959 -4.002 0.083 1 0.901 -3.728 -0.191 0.257 
Ecuador ONP_2 Propiconazole -0.361 -2.404 1.681 1 0.901 -2.130 1.408 0.779 
Ecuador ONS_34 Difenoconazole -2.449 -4.491 -0.407 1 0.901 -4.218 -0.680 0.183 
Ecuador ONS_34 Epoxiconazole -2.419 -4.461 -0.376 1 0.901 -4.187 -0.650 0.187 
Ecuador ONS_34 Propiconazole -1.886 -3.929 0.156 1 0.901 -3.655 -0.117 0.271 
Ecuador ONS_51 Difenoconazole -1.737 -3.779 0.306 1 0.901 -3.505 0.032 0.300 
Ecuador ONS_51 Epoxiconazole -1.367 -3.410 0.675 1 0.901 -3.136 0.402 0.388 
Global analysis of the sensitivity to azole  
131 
Country Isolate Fungicide 2Log(m) Lsed Used (n) Sem LMCI UMCI EC50  
Ecuador ONS_51 Propiconazole 0.437 -1.606 2.479 1 0.901 -1.332 2.205 1.353 
Ecuador ONS_8 Difenoconazole 0.848 -1.195 2.890 1 0.901 -0.921 2.616 1.799 
Ecuador ONS_8 Epoxiconazole -0.467 -2.509 1.576 1 0.901 -2.236 1.302 0.724 
Ecuador ONS_8 Propiconazole 1.164 -0.879 3.206 1 0.901 -0.605 2.932 2.240 
Ecuador Osa_19 Difenoconazole 0.901 -1.142 2.943 1 0.901 -0.868 2.669 1.867 
Ecuador Osa_19 Epoxiconazole -0.898 -2.940 1.144 1 0.901 -2.667 0.871 0.537 
Ecuador Osa_19 Propiconazole 0.925 -1.118 2.967 1 0.901 -0.844 2.694 1.898 
Ecuador Osa_20 Difenoconazole -1.155 -3.198 0.887 1 0.901 -2.924 0.613 0.449 
Ecuador Osa_20 Epoxiconazole -1.111 -3.153 0.931 1 0.901 -2.880 0.658 0.463 
Ecuador Osa_20 Propiconazole 0.770 -1.272 2.813 1 0.901 -0.998 2.539 1.706 
Ecuador Osa_22 Difenoconazole -1.973 -4.015 0.070 1 0.901 -3.742 -0.204 0.255 
Ecuador Osa_22 Epoxiconazole -1.708 -3.750 0.335 1 0.901 -3.477 0.061 0.306 
Ecuador Osa_22 Propiconazole 0.798 -1.244 2.841 1 0.901 -0.970 2.567 1.739 
Ecuador Osa_23 Difenoconazole -1.606 -3.648 0.437 1 0.901 -3.375 0.163 0.329 
Ecuador Osa_23 Epoxiconazole -1.896 -3.938 0.147 1 0.901 -3.664 -0.127 0.269 
Ecuador Osa_23 Propiconazole -0.314 -2.356 1.729 1 0.901 -2.082 1.455 0.805 
Ecuador Osa_25 Difenoconazole -1.347 -3.390 0.695 1 0.901 -3.116 0.421 0.393 
Ecuador Osa_25 Epoxiconazole -1.002 -3.045 1.040 1 0.901 -2.771 0.766 0.499 
Ecuador Osa_25 Propiconazole 0.051 -1.991 2.094 1 0.901 -1.718 1.820 1.036 
Ecuador Osa_31 Difenoconazole -1.931 -3.973 0.111 1 0.901 -3.700 -0.162 0.262 
Ecuador Osa_31 Epoxiconazole -2.716 -4.758 -0.673 1 0.901 -4.484 -0.947 0.152 
Ecuador Osa_31 Propiconazole -0.836 -2.879 1.206 1 0.901 -2.605 0.933 0.560 
Ecuador Osa_32 Difenoconazole -1.047 -3.089 0.996 1 0.901 -2.815 0.722 0.484 
Ecuador Osa_32 Epoxiconazole -1.326 -3.369 0.716 1 0.901 -3.095 0.442 0.399 
Ecuador Osa_32 Propiconazole -1.402 -3.445 0.640 1 0.901 -3.171 0.367 0.378 
Ecuador OSSR_13 Difenoconazole -2.526 -4.568 -0.483 1 0.901 -4.295 -0.757 0.174 
Ecuador OSSR_13 Epoxiconazole -1.745 -3.787 0.297 1 0.901 -3.514 0.024 0.298 
Ecuador OSSR_13 Propiconazole -0.509 -2.552 1.533 1 0.901 -2.278 1.260 0.703 
Ecuador OSSR_35 Difenoconazole -2.000 -4.042 0.043 1 0.901 -3.769 -0.231 0.250 
Ecuador OSSR_35 Epoxiconazole -1.106 -3.148 0.937 1 0.901 -2.874 0.663 0.465 
Ecuador OSSR_35 Propiconazole -0.103 -2.145 1.940 1 0.901 -1.871 1.666 0.931 
Ecuador OSSR_36 Difenoconazole -0.897 -2.939 1.145 3 0.520 -1.918 0.124 0.537 
Ecuador OSSR_36 Epoxiconazole -1.838 -3.881 0.204 3 0.520 -2.859 -0.817 0.280 
Ecuador OSSR_36 Propiconazole -1.118 -3.160 0.925 3 0.520 -2.139 -0.097 0.461 
Ecuador OSSR_51 Difenoconazole -1.632 -3.675 0.410 1 0.901 -3.401 0.136 0.323 
Ecuador OSSR_51 Epoxiconazole -0.887 -2.929 1.156 1 0.901 -2.655 0.882 0.541 
Ecuador OSSR_51 Propiconazole -0.082 -2.124 1.960 1 0.901 -1.851 1.687 0.945 
Ecuador OSSR_87 Difenoconazole -1.882 -3.924 0.160 1 0.901 -3.651 -0.113 0.271 
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Ecuador OSSR_87 Epoxiconazole -1.197 -3.240 0.845 1 0.901 -2.966 0.571 0.436 
Ecuador OSSR_87 Propiconazole 0.213 -1.829 2.256 1 0.901 -1.555 1.982 1.159 
Ecuador OSSR_96 Difenoconazole 0.637 -1.406 2.679 1 0.901 -1.132 2.406 1.555 
Ecuador OSSR_96 Epoxiconazole -0.992 -3.035 1.050 1 0.901 -2.761 0.776 0.503 
Ecuador OSSR_96 Propiconazole -1.204 -3.246 0.839 1 0.901 -2.973 0.565 0.434 
Cameroon P0S_14 Difenoconazole 0.761 -1.281 2.803 3 0.520 -0.260 1.782 1.695 
Cameroon P0S_14 Epoxiconazole 0.068 -1.975 2.110 3 0.520 -0.954 1.089 1.048 
Cameroon P0S_14 Propiconazole 0.844 -1.199 2.886 3 0.520 -0.177 1.865 1.795 
Cameroon P0S_16 Difenoconazole -6.640 -8.682 -4.598 3 0.520 -7.661 -5.619 0.010 
Cameroon P0S_16 Epoxiconazole -6.086 -8.128 -4.043 3 0.520 -7.107 -5.065 0.015 
Cameroon P0S_16 Propiconazole -4.583 -6.626 -2.541 3 0.520 -5.604 -3.562 0.042 
Cameroon P0S_18b Difenoconazole -0.483 -2.525 1.559 3 0.520 -1.504 0.538 0.715 
Cameroon P0S_18b Epoxiconazole -0.596 -2.639 1.446 3 0.520 -1.617 0.425 0.661 
Cameroon P0S_18b Propiconazole 0.486 -1.556 2.529 3 0.520 -0.535 1.508 1.401 
Cameroon P0S_22a Difenoconazole    0    
<0.004 
Cameroon P0S_22a Epoxiconazole -7.805 -9.847 -5.762 2 0.637 -9.056 -6.554 0.004 
Cameroon P0S_22a Propiconazole -7.305 -9.347 -5.262 2 0.637 -8.556 -6.054 0.006 
Cameroon P0S_22b Difenoconazole -7.699 -9.741 -5.657 2 0.637 -8.950 -6.448 0.005 
Cameroon P0S_22b Epoxiconazole -7.233 -9.275 -5.191 3 0.520 -8.254 -6.212 0.007 
Cameroon P0S_22b Propiconazole -6.458 -8.501 -4.416 3 0.520 -7.479 -5.437 0.011 
Cameroon P0S_29 Difenoconazole 0.969 -1.073 3.012 3 0.520 -0.052 1.990 1.958 
Cameroon P0S_29 Epoxiconazole -0.456 -2.498 1.587 3 0.520 -1.477 0.565 0.729 
Cameroon P0S_29 Propiconazole 0.988 -1.055 3.030 3 0.520 -0.033 2.009 1.983 
Cameroon P0S_38 Difenoconazole -1.112 -3.154 0.930 3 0.520 -2.133 -0.091 0.463 
Cameroon P0S_38 Epoxiconazole -1.373 -3.415 0.670 3 0.520 -2.394 -0.351 0.386 
Cameroon P0S_38 Propiconazole -0.425 -2.468 1.617 3 0.520 -1.447 0.596 0.745 
Cameroon P0S_53 Difenoconazole -3.381 -5.423 -1.338 1 0.901 -5.150 -1.612 0.096 
Cameroon P0S_53 Epoxiconazole -3.211 -5.253 -1.169 1 0.901 -4.980 -1.442 0.108 
Cameroon P0S_53 Propiconazole -1.276 -3.318 0.767 1 0.901 -3.045 0.493 0.413 
Cameroon P0S_54 Difenoconazole -0.684 -2.726 1.358 3 0.520 -1.705 0.337 0.622 
Cameroon P0S_54 Epoxiconazole -1.226 -3.269 0.816 3 0.520 -2.248 -0.205 0.427 
Cameroon P0S_54 Propiconazole -0.081 -2.123 1.962 3 0.520 -1.102 0.940 0.946 
Cameroon P0S_58b Difenoconazole -2.398 -4.440 -0.355 2 0.637 -3.648 -1.147 0.190 
Cameroon P0S_58b Epoxiconazole -3.748 -5.791 -1.706 2 0.637 -4.999 -2.498 0.074 
Cameroon P0S_58b Propiconazole -1.363 -3.406 0.679 2 0.637 -2.614 -0.112 0.389 
Cameroon P0S_59a Difenoconazole -0.864 -2.906 1.179 3 0.520 -1.885 0.158 0.550 
Cameroon P0S_59a Epoxiconazole -2.936 -4.978 -0.894 3 0.520 -3.957 -1.915 0.131 
Cameroon P0S_59a Propiconazole -0.429 -2.471 1.613 3 0.520 -1.450 0.592 0.743 
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Cameroon P0S_59b Difenoconazole -4.828 -6.871 -2.786 3 0.520 -5.850 -3.807 0.035 
Cameroon P0S_59b Epoxiconazole -4.622 -6.664 -2.579 3 0.520 -5.643 -3.600 0.041 
Cameroon P0S_59b Propiconazole -2.174 -4.216 -0.131 3 0.520 -3.195 -1.152 0.222 
Cameroon P0S_7a Difenoconazole -2.327 -4.369 -0.284 3 0.520 -3.348 -1.306 0.199 
Cameroon P0S_7a Epoxiconazole -2.747 -4.789 -0.705 3 0.520 -3.768 -1.726 0.149 
Cameroon P0S_7a Propiconazole -1.344 -3.387 0.698 3 0.520 -2.365 -0.323 0.394 
Cameroon P0S_72 Difenoconazole 0.939 -1.103 2.981 3 0.520 -0.082 1.960 1.917 
Cameroon P0S_72 Epoxiconazole 0.207 -1.835 2.250 3 0.520 -0.814 1.229 1.155 
Cameroon P0S_72 Propiconazole 0.387 -1.655 2.430 3 0.520 -0.634 1.408 1.308 
Cameroon P0S_76a Difenoconazole -2.352 -4.394 -0.309 3 0.520 -3.373 -1.330 0.196 
Cameroon P0S_76a Epoxiconazole -2.448 -4.490 -0.405 3 0.520 -3.469 -1.427 0.183 
Cameroon P0S_76a Propiconazole -1.095 -3.137 0.947 3 0.520 -2.116 -0.074 0.468 
Cameroon P0S_84a Difenoconazole -6.566 -8.608 -4.523 3 0.520 -7.587 -5.545 0.011 
Cameroon P0S_84a Epoxiconazole -5.884 -7.926 -3.841 3 0.520 -6.905 -4.863 0.017 
Cameroon P0S_84a Propiconazole -5.681 -7.724 -3.639 3 0.520 -6.703 -4.660 0.019 
Cameroon P0S_84b Difenoconazole -1.435 -3.477 0.607 3 0.520 -2.456 -0.414 0.370 
Cameroon P0S_84b Epoxiconazole -1.574 -3.617 0.468 3 0.520 -2.596 -0.553 0.336 
Cameroon P0S_84b Propiconazole -0.694 -2.737 1.348 3 0.520 -1.715 0.327 0.618 
Cameroon P0S_9 Difenoconazole -3.224 -5.266 -1.181 3 0.520 -4.245 -2.202 0.107 
Cameroon P0S_9 Epoxiconazole -3.225 -5.268 -1.183 3 0.520 -4.246 -2.204 0.107 
Cameroon P0S_9 Propiconazole -1.565 -3.608 0.477 3 0.520 -2.586 -0.544 0.338 
Cameroon P0S_91 Difenoconazole -4.178 -6.221 -2.136 3 0.520 -5.200 -3.157 0.055 
Cameroon P0S_91 Epoxiconazole -4.097 -6.140 -2.055 3 0.520 -5.118 -3.076 0.058 
Cameroon P0S_91 Propiconazole -2.414 -4.456 -0.372 3 0.520 -3.435 -1.393 0.188 
Cameroon P2S_14 Difenoconazole 0.436 -1.606 2.478 2 0.637 -0.815 1.687 1.353 
Cameroon P2S_14 Epoxiconazole 0.037 -2.005 2.080 3 0.520 -0.984 1.059 1.026 
Cameroon P2S_14 Propiconazole 1.231 -0.812 3.273 3 0.520 0.210 2.252 2.347 
Cameroon P2S_16 Difenoconazole -0.989 -3.031 1.054 3 0.520 -2.010 0.033 0.504 
Cameroon P2S_16 Epoxiconazole -1.566 -3.609 0.476 3 0.520 -2.587 -0.545 0.338 
Cameroon P2S_16 Propiconazole -0.487 -2.530 1.555 3 0.520 -1.509 0.534 0.713 
Cameroon P2S_19 Difenoconazole -0.577 -2.619 1.466 3 0.520 -1.598 0.444 0.670 
Cameroon P2S_19 Epoxiconazole -1.118 -3.160 0.924 3 0.520 -2.139 -0.097 0.461 
Cameroon P2S_19 Propiconazole 0.408 -1.634 2.451 3 0.520 -0.613 1.430 1.327 
Cameroon P2S_20 Difenoconazole -0.542 -2.584 1.501 3 0.520 -1.563 0.479 0.687 
Cameroon P2S_20 Epoxiconazole -0.119 -2.161 1.924 3 0.520 -1.140 0.903 0.921 
Cameroon P2S_20 Propiconazole 0.316 -1.727 2.358 3 0.520 -0.705 1.337 1.245 
Cameroon P2S_24 Difenoconazole -0.368 -2.411 1.674 3 0.520 -1.390 0.653 0.775 
Cameroon P2S_24 Epoxiconazole -1.718 -3.761 0.324 3 0.520 -2.740 -0.697 0.304 
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Cameroon P2S_24 Propiconazole 0.593 -1.449 2.636 3 0.520 -0.428 1.614 1.509 
Cameroon P2S_25 Difenoconazole -1.657 -3.699 0.386 3 0.520 -2.678 -0.636 0.317 
Cameroon P2S_25 Epoxiconazole -1.708 -3.751 0.334 3 0.520 -2.730 -0.687 0.306 
Cameroon P2S_25 Propiconazole -0.372 -2.415 1.670 3 0.520 -1.394 0.649 0.772 
Cameroon P2S_31 Difenoconazole -0.650 -2.693 1.392 3 0.520 -1.672 0.371 0.637 
Cameroon P2S_31 Epoxiconazole -1.261 -3.304 0.781 3 0.520 -2.282 -0.240 0.417 
Cameroon P2S_31 Propiconazole 0.207 -1.836 2.249 3 0.520 -0.815 1.228 1.154 
Cameroon P2S_37 Difenoconazole -0.856 -2.898 1.187 3 0.520 -1.877 0.166 0.553 
Cameroon P2S_37 Epoxiconazole -1.794 -3.837 0.248 3 0.520 -2.816 -0.773 0.288 
Cameroon P2S_37 Propiconazole -0.020 -2.063 2.022 3 0.520 -1.041 1.001 0.986 
Cameroon P2S_40 Difenoconazole -0.484 -2.527 1.558 3 0.520 -1.506 0.537 0.715 
Cameroon P2S_40 Epoxiconazole -1.025 -3.067 1.018 3 0.520 -2.046 -0.004 0.491 
Cameroon P2S_40 Propiconazole 0.056 -1.987 2.098 3 0.520 -0.966 1.077 1.039 
Cameroon P2S_41 Difenoconazole 0.163 -1.879 2.206 3 0.520 -0.858 1.185 1.120 
Cameroon P2S_41 Epoxiconazole -0.738 -2.781 1.304 3 0.520 -1.760 0.283 0.599 
Cameroon P2S_41 Propiconazole 0.725 -1.318 2.767 3 0.520 -0.296 1.746 1.653 
Cameroon P2S_42 Difenoconazole -0.896 -2.939 1.146 3 0.520 -1.917 0.125 0.537 
Cameroon P2S_42 Epoxiconazole -0.764 -2.806 1.279 3 0.520 -1.785 0.257 0.589 
Cameroon P2S_42 Propiconazole 0.267 -1.775 2.310 3 0.520 -0.754 1.289 1.204 
Cameroon P2S_44 Difenoconazole -1.025 -3.068 1.017 3 0.520 -2.047 -0.004 0.491 
Cameroon P2S_44 Epoxiconazole -1.571 -3.613 0.472 3 0.520 -2.592 -0.549 0.337 
Cameroon P2S_44 Propiconazole -0.541 -2.583 1.502 3 0.520 -1.562 0.480 0.687 
Cameroon P2S_47 Difenoconazole 0.603 -1.439 2.646 3 0.520 -0.418 1.624 1.519 
Cameroon P2S_47 Epoxiconazole 0.244 -1.799 2.286 3 0.520 -0.778 1.265 1.184 
Cameroon P2S_47 Propiconazole 0.467 -1.575 2.509 3 0.520 -0.554 1.488 1.382 
Cameroon P2S_62 Difenoconazole -0.733 -2.775 1.310 3 0.520 -1.754 0.288 0.602 
Cameroon P2S_62 Epoxiconazole -1.742 -3.785 0.300 3 0.520 -2.763 -0.721 0.299 
Cameroon P2S_62 Propiconazole -0.474 -2.517 1.568 3 0.520 -1.496 0.547 0.720 
Cameroon P2S_64 Difenoconazole -1.384 -3.427 0.658 3 0.520 -2.405 -0.363 0.383 
Cameroon P2S_64 Epoxiconazole 0.437 -1.605 2.480 3 0.520 -0.584 1.459 1.354 
Cameroon P2S_64 Propiconazole 0.994 -1.048 3.037 3 0.520 -0.027 2.016 1.992 
Cameroon P2S_68 Difenoconazole -2.009 -4.051 0.033 3 0.520 -3.030 -0.988 0.248 
Cameroon P2S_68 Epoxiconazole -2.366 -4.409 -0.324 3 0.520 -3.388 -1.345 0.194 
Cameroon P2S_68 Propiconazole -0.606 -2.649 1.436 3 0.520 -1.627 0.415 0.657 
Cameroon P2S_7 Difenoconazole -0.704 -2.746 1.339 3 0.520 -1.725 0.318 0.614 
Cameroon P2S_7 Epoxiconazole -0.882 -2.925 1.160 3 0.520 -1.903 0.139 0.543 
Cameroon P2S_7 Propiconazole -0.167 -2.209 1.876 3 0.520 -1.188 0.854 0.891 
Cameroon P2S_78 Difenoconazole 0.130 -1.913 2.172 3 0.520 -0.891 1.151 1.094 
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Cameroon P2S_78 Epoxiconazole -0.429 -2.472 1.613 3 0.520 -1.450 0.592 0.743 
Cameroon P2S_78 Propiconazole 0.219 -1.824 2.261 3 0.520 -0.803 1.240 1.164 
Cameroon P2S_79 Difenoconazole -0.327 -2.369 1.715 3 0.520 -1.348 0.694 0.797 
Cameroon P2S_79 Epoxiconazole -0.672 -2.715 1.370 3 0.520 -1.694 0.349 0.627 
Cameroon P2S_79 Propiconazole 0.926 -1.117 2.968 3 0.520 -0.095 1.947 1.900 
Cameroon P2S_81 Difenoconazole -1.620 -3.663 0.422 3 0.520 -2.642 -0.599 0.325 
Cameroon P2S_81 Epoxiconazole -1.752 -3.794 0.291 3 0.520 -2.773 -0.730 0.297 
Cameroon P2S_81 Propiconazole -0.909 -2.952 1.133 3 0.520 -1.931 0.112 0.532 
Cameroon P2S_X Difenoconazole -0.819 -2.862 1.223 3 0.520 -1.841 0.202 0.567 
Cameroon P2S_X Epoxiconazole -1.568 -3.611 0.474 3 0.520 -2.590 -0.547 0.337 
Cameroon P2S_X Propiconazole -0.342 -2.385 1.700 3 0.520 -1.363 0.679 0.789 
Cameroon P4S_1 Difenoconazole 1.029 -1.013 3.071 3 0.520 0.008 2.050 2.041 
Cameroon P4S_1 Epoxiconazole 0.699 -1.344 2.741 3 0.520 -0.323 1.720 1.623 
Cameroon P4S_1 Propiconazole 1.134 -0.909 3.176 3 0.520 0.113 2.155 2.194 
Cameroon P4S_13 Difenoconazole 0.190 -1.852 2.233 3 0.520 -0.831 1.212 1.141 
Cameroon P4S_13 Epoxiconazole -0.036 -2.079 2.006 3 0.520 -1.058 0.985 0.975 
Cameroon P4S_13 Propiconazole -0.305 -2.348 1.737 3 0.520 -1.326 0.716 0.809 
Cameroon P4S_16 Difenoconazole -0.100 -2.143 1.942 3 0.520 -1.121 0.921 0.933 
Cameroon P4S_16 Epoxiconazole -0.247 -2.289 1.795 3 0.520 -1.268 0.774 0.843 
Cameroon P4S_16 Propiconazole 0.194 -1.848 2.237 3 0.520 -0.827 1.215 1.144 
Cameroon P4S_19 Difenoconazole -0.775 -2.818 1.267 3 0.520 -1.796 0.246 0.584 
Cameroon P4S_19 Epoxiconazole -1.059 -3.101 0.984 3 0.520 -2.080 -0.037 0.480 
Cameroon P4S_19 Propiconazole 0.465 -1.578 2.507 3 0.520 -0.557 1.486 1.380 
Cameroon P4S_22 Difenoconazole 0.491 -1.551 2.533 3 0.520 -0.530 1.512 1.405 
Cameroon P4S_22 Epoxiconazole 0.137 -1.905 2.180 3 0.520 -0.884 1.159 1.100 
Cameroon P4S_22 Propiconazole 0.819 -1.224 2.861 3 0.520 -0.202 1.840 1.764 
Cameroon P4S_24 Difenoconazole -0.884 -2.926 1.159 3 0.520 -1.905 0.137 0.542 
Cameroon P4S_24 Epoxiconazole -0.913 -2.956 1.129 3 0.520 -1.934 0.108 0.531 
Cameroon P4S_24 Propiconazole 0.586 -1.456 2.628 3 0.520 -0.435 1.607 1.501 
Cameroon P4S_28 Difenoconazole -1.059 -3.101 0.983 3 0.520 -2.080 -0.038 0.480 
Cameroon P4S_28 Epoxiconazole -1.226 -3.269 0.816 3 0.520 -2.248 -0.205 0.427 
Cameroon P4S_28 Propiconazole 0.066 -1.977 2.108 3 0.520 -0.955 1.087 1.047 
Cameroon P4S_33 Difenoconazole -0.028 -2.071 2.014 3 0.520 -1.049 0.993 0.981 
Cameroon P4S_33 Epoxiconazole -0.217 -2.259 1.826 3 0.520 -1.238 0.804 0.860 
Cameroon P4S_33 Propiconazole 0.363 -1.680 2.405 3 0.520 -0.659 1.384 1.286 
Cameroon P4S_38 Difenoconazole -1.139 -3.181 0.904 3 0.520 -2.160 -0.118 0.454 
Cameroon P4S_38 Epoxiconazole -1.534 -3.577 0.508 3 0.520 -2.556 -0.513 0.345 
Cameroon P4S_38 Propiconazole -0.884 -2.926 1.159 3 0.520 -1.905 0.137 0.542 
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Cameroon P4S_42 Difenoconazole -0.864 -2.906 1.179 3 0.520 -1.885 0.157 0.549 
Cameroon P4S_42 Epoxiconazole -1.112 -3.154 0.930 3 0.520 -2.133 -0.091 0.463 
Cameroon P4S_42 Propiconazole 0.431 -1.611 2.473 3 0.520 -0.590 1.452 1.348 
Cameroon P4S_47 Difenoconazole -2.116 -4.159 -0.074 3 0.520 -3.138 -1.095 0.231 
Cameroon P4S_47 Epoxiconazole -3.368 -5.411 -1.326 3 0.520 -4.389 -2.347 0.097 
Cameroon P4S_47 Propiconazole -1.386 -3.429 0.656 3 0.520 -2.408 -0.365 0.382 
Cameroon P4S_5 Difenoconazole 0.016 -2.026 2.059 3 0.520 -1.005 1.037 1.011 
Cameroon P4S_5 Epoxiconazole 0.290 -1.752 2.332 3 0.520 -0.731 1.311 1.223 
Cameroon P4S_5 Propiconazole 0.796 -1.246 2.839 3 0.520 -0.225 1.818 1.737 
Cameroon P4S_51 Difenoconazole -1.419 -3.461 0.623 3 0.520 -2.440 -0.398 0.374 
Cameroon P4S_51 Epoxiconazole -1.591 -3.634 0.451 3 0.520 -2.612 -0.570 0.332 
Cameroon P4S_51 Propiconazole 0.152 -1.891 2.194 3 0.520 -0.870 1.173 1.111 
Cameroon P4S_53 Difenoconazole -1.521 -3.564 0.521 3 0.520 -2.542 -0.500 0.348 
Cameroon P4S_53 Epoxiconazole -1.313 -3.355 0.730 3 0.520 -2.334 -0.291 0.403 
Cameroon P4S_53 Propiconazole -0.607 -2.650 1.435 3 0.520 -1.628 0.414 0.656 
Cameroon P4S_58 Difenoconazole -0.795 -2.837 1.248 3 0.520 -1.816 0.226 0.576 
Cameroon P4S_58 Epoxiconazole -0.899 -2.941 1.144 3 0.520 -1.920 0.122 0.536 
Cameroon P4S_58 Propiconazole 0.179 -1.864 2.221 3 0.520 -0.842 1.200 1.132 
Cameroon P4S_60a Difenoconazole -1.033 -3.075 1.010 2 0.637 -2.284 0.218 0.489 
Cameroon P4S_60a Epoxiconazole -1.050 -3.092 0.993 2 0.637 -2.300 0.201 0.483 
Cameroon P4S_60a Propiconazole 0.129 -1.913 2.172 2 0.637 -1.121 1.380 1.094 
Cameroon P4S_60b Difenoconazole -0.833 -2.875 1.210 3 0.520 -1.854 0.189 0.562 
Cameroon P4S_60b Epoxiconazole -0.731 -2.773 1.311 3 0.520 -1.752 0.290 0.603 
Cameroon P4S_60b Propiconazole 0.112 -1.930 2.154 3 0.520 -0.909 1.133 1.081 
Cameroon P4S_64 Difenoconazole 2.736 0.694 4.778 3 0.520 1.715 3.757 6.663 
Cameroon P4S_64 Epoxiconazole 1.965 -0.078 4.007 3 0.520 0.944 2.986 3.904 
Cameroon P4S_64 Propiconazole 2.966 0.924 5.009 2 0.637 1.716 4.217 7.816 
Cameroon P4S_65 Difenoconazole 0.322 -1.720 2.364 3 0.520 -0.699 1.343 1.250 
Cameroon P4S_65 Epoxiconazole 0.375 -1.667 2.418 3 0.520 -0.646 1.397 1.297 
Cameroon P4S_65 Propiconazole 0.439 -1.603 2.482 3 0.520 -0.582 1.460 1.356 
Cameroon P4S_7a Difenoconazole 0.251 -1.792 2.293 3 0.520 -0.771 1.272 1.190 
Cameroon P4S_7a Epoxiconazole -0.705 -2.747 1.338 3 0.520 -1.726 0.316 0.614 
Cameroon P4S_7a Propiconazole 0.675 -1.368 2.717 3 0.520 -0.347 1.696 1.596 
Cameroon P4S_7b Difenoconazole 0.247 -1.795 2.290 3 0.520 -0.774 1.269 1.187 
Cameroon P4S_7b Epoxiconazole 0.077 -1.965 2.120 3 0.520 -0.944 1.098 1.055 
Cameroon P4S_7b Propiconazole 0.859 -1.184 2.901 3 0.520 -0.162 1.880 1.814 
Cameroon P4S_72 Difenoconazole -0.574 -2.617 1.468 3 0.520 -1.595 0.447 0.672 
Cameroon P4S_72 Epoxiconazole -0.942 -2.985 1.100 3 0.520 -1.964 0.079 0.520 
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Cameroon P4S_72 Propiconazole 0.441 -1.601 2.484 3 0.520 -0.580 1.462 1.358 
Cameroon P4S_78 Difenoconazole 0.932 -1.110 2.975 2 0.637 -0.318 2.183 1.908 
Cameroon P4S_78 Epoxiconazole -1.108 -3.150 0.935 1 0.901 -2.877 0.661 0.464 
Cameroon P4S_78 Propiconazole 0.794 -1.248 2.836 2 0.637 -0.457 2.045 1.734 
Cameroon P4S_81 Difenoconazole -1.347 -3.390 0.695 1 0.901 -3.116 0.421 1.264 
Cameroon P4S_81 Epoxiconazole -1.831 -3.874 0.211 1 0.901 -3.600 -0.063 0.706 
Cameroon P4S_81 Propiconazole -0.086 -2.129 1.956 1 0.901 -1.855 1.683 1.778 
Colombia Paraguay_1 Difenoconazole 2.741 0.699 4.784 1 0.901 0.972 4.510 6.686 
Colombia Paraguay_1 Epoxiconazole -1.272 -3.314 0.771 1 0.901 -3.040 0.497 0.414 
Colombia Paraguay_1 Propiconazole 0.200 -1.843 2.242 1 0.901 -1.569 1.968 1.148 
Colombia Pinos_1 Difenoconazole 0.385 -1.658 2.427 1 0.901 -1.384 2.154 1.306 
Colombia Pinos_1 Epoxiconazole -1.303 -3.345 0.740 1 0.901 -3.071 0.466 0.405 
Colombia Pinos_1 Propiconazole -0.245 -2.287 1.798 1 0.901 -2.014 1.524 0.844 
Colombia Raices_1 Difenoconazole 1.518 -0.524 3.560 2 0.637 0.267 2.769 2.864 
Colombia Raices_1 Epoxiconazole 1.164 -0.879 3.206 2 0.637 -0.087 2.414 2.240 
Colombia Raices_1 Propiconazole 1.994 -0.049 4.036 3 0.520 0.972 3.015 3.983 
Colombia Raices_2 Difenoconazole    0    
>10.24 
Colombia Raices_2 Epoxiconazole 2.510 0.467 4.552 1 0.901 0.741 4.279 5.696 
Colombia Raices_2 Propiconazole 3.286 1.244 5.329 1 0.901 1.518 5.055 9.757 
Colombia Raices_4 Difenoconazole 2.701 0.658 4.743 1 0.901 0.932 4.469 6.501 
Colombia Raices_4 Epoxiconazole 1.576 -0.467 3.618 1 0.901 -0.193 3.344 2.981 
Colombia Raices_4 Propiconazole 1.931 -0.111 3.974 1 0.901 0.162 3.700 3.814 
Colombia Raices_5 Difenoconazole 3.091 1.048 5.133 1 0.901 1.322 4.860 8.520 
Colombia Raices_5 Epoxiconazole 0.990 -1.052 3.033 1 0.901 -0.778 2.759 1.987 
Colombia Raices_5 Propiconazole 2.734 0.692 4.777 1 0.901 0.966 4.503 6.655 
Colombia Raices_6 Difenoconazole 2.602 0.559 4.644 1 0.901 0.833 4.371 6.071 
Colombia Raices_6 Epoxiconazole 1.509 -0.533 3.551 1 0.901 -0.260 3.278 2.846 
Colombia Raices_6 Propiconazole    0    
>10.24 
Ecuador RCM_14 Difenoconazole -0.769 -2.811 1.273 1 0.901 -2.538 1.000 0.587 
Ecuador RCM_14 Epoxiconazole 0.750 -1.292 2.793 1 0.901 -1.018 2.519 1.682 
Ecuador RCM_14 Propiconazole 0.644 -1.398 2.686 1 0.901 -1.125 2.413 1.563 
Ecuador RCM_15 Difenoconazole -2.268 -4.310 -0.225 2 0.637 -3.518 -1.017 0.208 
Ecuador RCM_15 Epoxiconazole -2.270 -4.312 -0.228 2 0.637 -3.521 -1.019 0.207 
Ecuador RCM_15 Propiconazole -1.865 -3.907 0.178 2 0.637 -3.115 -0.614 0.275 
Ecuador RCM_16 Difenoconazole -2.408 -4.450 -0.365 2 0.637 -3.658 -1.157 0.188 
Ecuador RCM_16 Epoxiconazole -4.044 -6.086 -2.001 2 0.637 -5.294 -2.793 0.061 
Ecuador RCM_16 Propiconazole -2.232 -4.275 -0.190 2 0.637 -3.483 -0.981 0.213 
Ecuador RCQS_16 Difenoconazole 1.216 -0.826 3.259 3 0.520 0.195 2.238 2.324 
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Ecuador RCQS_16 Epoxiconazole -0.086 -2.128 1.957 3 0.520 -1.107 0.936 0.942 
Ecuador RCQS_16 Propiconazole 1.465 -0.577 3.508 3 0.520 0.444 2.486 2.761 
Ecuador RCQS_19 Difenoconazole 2.365 0.323 4.408 1 0.901 0.596 4.134 5.152 
Ecuador RCQS_19 Epoxiconazole 2.169 0.127 4.212 1 0.901 0.401 3.938 4.498 
Ecuador RCQS_19 Propiconazole -0.860 -2.903 1.182 1 0.901 -2.629 0.908 0.551 
Ecuador RCQS_3 Difenoconazole 0.380 -1.663 2.422 5 0.403 -0.411 1.171 1.301 
Ecuador RCQS_3 Epoxiconazole -0.119 -2.161 1.924 5 0.403 -0.910 0.672 0.921 
Ecuador RCQS_3 Propiconazole 1.557 -0.486 3.599 5 0.403 0.766 2.348 2.942 
Colombia Rena_1 Difenoconazole -0.350 -2.392 1.693 1 0.901 -2.118 1.419 0.785 
Colombia Rena_1 Epoxiconazole 0.679 -1.364 2.721 1 0.901 -1.090 2.447 1.601 
Colombia Rena_1 Propiconazole 0.813 -1.229 2.856 1 0.901 -0.956 2.582 1.757 
Ecuador RNB_13 Difenoconazole -0.082 -2.125 1.960 1 0.901 -1.851 1.687 0.945 
Ecuador RNB_13 Epoxiconazole 2.493 0.451 4.536 1 0.901 0.724 4.262 5.630 
Ecuador RNB_13 Propiconazole 0.366 -1.677 2.408 1 0.901 -1.403 2.135 1.289 
Ecuador RNB_18 Difenoconazole 0.569 -1.474 2.611 1 0.901 -1.200 2.337 1.483 
Ecuador RNB_18 Epoxiconazole 0.302 -1.740 2.345 1 0.901 -1.466 2.071 1.233 
Ecuador RNB_18 Propiconazole -0.193 -2.235 1.850 1 0.901 -1.962 1.576 0.875 
Ecuador RNB_19 Difenoconazole -1.735 -3.778 0.307 1 0.901 -3.504 0.034 0.300 
Ecuador RNB_19 Epoxiconazole -2.605 -4.647 -0.563 1 0.901 -4.374 -0.836 0.164 
Ecuador RNB_19 Propiconazole -1.289 -3.331 0.753 1 0.901 -3.058 0.480 0.409 
Ecuador RNVE_10 Difenoconazole 0.680 -1.362 2.723 1 0.901 -1.089 2.449 1.602 
Ecuador RNVE_10 Epoxiconazole 1.358 -0.684 3.400 1 0.901 -0.411 3.127 2.563 
Ecuador RNVE_10 Propiconazole 2.094 0.052 4.136 1 0.901 0.325 3.863 4.269 
Ecuador RNVP_4 Difenoconazole -0.709 -2.751 1.333 1 0.901 -2.478 1.060 0.612 
Ecuador RNVP_4 Epoxiconazole 1.189 -0.853 3.232 1 0.901 -0.579 2.958 2.280 
Ecuador RNVP_4 Propiconazole 0.336 -1.707 2.378 1 0.901 -1.433 2.104 1.262 
Ecuador RNVP_8 Difenoconazole 1.045 -0.998 3.087 1 0.901 -0.724 2.814 2.063 
Ecuador RNVP_8 Epoxiconazole -0.187 -2.229 1.855 1 0.901 -1.956 1.582 0.878 
Ecuador RNVP_8 Propiconazole -0.016 -2.059 2.026 1 0.901 -1.785 1.753 0.989 
Ecuador RSaB_14 Difenoconazole -7.446 -9.488 -5.403 1 0.901 -9.214 -5.677 0.006 
Ecuador RSaB_14 Epoxiconazole 
   
0 
   
<0.004 
Ecuador RSaB_14 Propiconazole -7.835 -9.878 -5.793 1 0.901 -9.604 -6.067 0.004 
Ecuador RSaB_36 Difenoconazole -1.903 -3.945 0.139 1 0.901 -3.672 -0.134 0.267 
Ecuador RSaB_36 Epoxiconazole -2.078 -4.120 -0.035 1 0.901 -3.846 -0.309 0.237 
Ecuador RSaB_36 Propiconazole -2.001 -4.044 0.041 1 0.901 -3.770 -0.232 0.250 
Ecuador RSaB_37 Difenoconazole -1.856 -3.899 0.186 1 0.901 -3.625 -0.088 0.276 
Ecuador RSaB_37 Epoxiconazole -2.226 -4.268 -0.184 1 0.901 -3.995 -0.457 0.214 
Ecuador RSaB_37 Propiconazole -1.026 -3.068 1.017 1 0.901 -2.794 0.743 0.491 
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Ecuador RSaB_6 Difenoconazole -4.783 -6.825 -2.740 1 0.901 -6.551 -3.014 0.036 
Ecuador RSaB_6 Epoxiconazole -5.627 -7.670 -3.585 1 0.901 -7.396 -3.859 0.020 
Ecuador RSaB_6 Propiconazole -3.542 -5.584 -1.499 1 0.901 -5.311 -1.773 0.086 
Ecuador RSaV_6 Difenoconazole -6.074 -8.117 -4.032 1 0.901 -7.843 -4.306 0.015 
Ecuador RSaV_6 Epoxiconazole -4.036 -6.078 -1.993 1 0.901 -5.804 -2.267 0.061 
Ecuador RSaV_6 Propiconazole -4.243 -6.286 -2.201 1 0.901 -6.012 -2.475 0.053 
Ecuador RSaV_7 Difenoconazole -2.583 -4.625 -0.540 1 0.901 -4.351 -0.814 0.167 
Ecuador RSaV_7 Epoxiconazole -1.842 -3.884 0.200 1 0.901 -3.611 -0.073 0.279 
Ecuador RSaV_7 Propiconazole -0.489 -2.531 1.553 1 0.901 -2.258 1.280 0.712 
Ecuador RSaV_8 Difenoconazole -7.000 -9.042 -4.957 3 0.520 -8.021 -5.979 0.008 
Ecuador RSaV_8 Epoxiconazole -5.919 -7.961 -3.877 3 0.520 -6.940 -4.898 0.017 
Ecuador RSaV_8 Propiconazole -5.581 -7.623 -3.538 3 0.520 -6.602 -4.559 0.021 
Ecuador RSP_1 Difenoconazole -2.791 -4.833 -0.748 1 0.901 -4.560 -1.022 0.145 
Ecuador RSP_1 Epoxiconazole -3.746 -5.789 -1.704 1 0.901 -5.515 -1.978 0.075 
Ecuador RSP_1 Propiconazole -2.329 -4.371 -0.286 1 0.901 -4.097 -0.560 0.199 
Ecuador RSP_11 Difenoconazole -2.221 -4.263 -0.179 1 0.901 -3.990 -0.452 0.214 
Ecuador RSP_11 Epoxiconazole -3.497 -5.539 -1.454 1 0.901 -5.265 -1.728 0.089 
Ecuador RSP_11 Propiconazole -1.711 -3.754 0.331 1 0.901 -3.480 0.058 0.305 
Ecuador RSP_2 Difenoconazole -2.571 -4.614 -0.529 3 0.520 -3.592 -1.550 0.168 
Ecuador RSP_2 Epoxiconazole -2.872 -4.915 -0.830 3 0.520 -3.893 -1.851 0.137 
Ecuador RSP_2 Propiconazole -1.668 -3.711 0.374 3 0.520 -2.689 -0.647 0.315 
Ecuador RSP_3 Difenoconazole 0.387 -1.655 2.429 1 0.901 -1.382 2.156 1.308 
Ecuador RSP_3 Epoxiconazole 0.573 -1.469 2.616 1 0.901 -1.196 2.342 1.488 
Ecuador RSP_3 Propiconazole 0.914 -1.129 2.956 1 0.901 -0.855 2.682 1.884 
Ecuador RSSB_16 Difenoconazole -1.414 -3.457 0.628 1 0.901 -3.183 0.355 0.375 
Ecuador RSSB_16 Epoxiconazole -0.676 -2.718 1.367 1 0.901 -2.444 1.093 0.626 
Ecuador RSSB_16 Propiconazole 0.051 -1.991 2.094 1 0.901 -1.717 1.820 1.036 
Ecuador RSSB_22 Difenoconazole -1.947 -3.989 0.095 3 0.520 -2.968 -0.926 0.259 
Ecuador RSSB_22 Epoxiconazole -2.827 -4.869 -0.785 3 0.520 -3.848 -1.806 0.141 
Ecuador RSSB_22 Propiconazole -0.923 -2.965 1.119 3 0.520 -1.944 0.098 0.527 
Ecuador RSSM_6 Difenoconazole -1.898 -3.940 0.145 3 0.520 -2.919 -0.877 0.268 
Ecuador RSSM_6 Epoxiconazole -2.650 -4.693 -0.608 3 0.520 -3.671 -1.629 0.159 
Ecuador RSSM_6 Propiconazole -0.923 -2.966 1.119 3 0.520 -1.945 0.098 0.527 
Colombia Salvis_1 Difenoconazole 0.272 -1.770 2.314 1 0.901 -1.497 2.041 1.208 
Colombia Salvis_1 Epoxiconazole -1.625 -3.667 0.417 1 0.901 -3.394 0.144 0.324 
Colombia Salvis_1 Propiconazole -1.560 -3.603 0.482 1 0.901 -3.329 0.208 0.339 
Colombia Santillana_1 Difenoconazole 0.413 -1.629 2.456 1 0.901 -1.355 2.182 1.332 
Colombia Santillana_1 Epoxiconazole -0.297 -2.339 1.746 1 0.901 -2.066 1.472 0.814 
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Colombia Santillana_1 Propiconazole -0.083 -2.125 1.960 1 0.901 -1.851 1.686 0.944 
Colombia Santillana_12 Difenoconazole 2.706 0.664 4.749 1 0.901 0.937 4.475 6.526 
Colombia Santillana_12 Epoxiconazole 0.718 -1.324 2.761 1 0.901 -1.050 2.487 1.645 
Colombia Santillana_12 Propiconazole 0.920 -1.123 2.962 1 0.901 -0.849 2.688 1.892 
Colombia Santillana_13 Difenoconazole 3.149 1.106 5.191 3 0.520 2.127 4.170 8.868 
Colombia Santillana_13 Epoxiconazole 0.992 -1.050 3.034 3 0.520 -0.029 2.013 1.989 
Colombia Santillana_13 Propiconazole 2.429 0.386 4.471 3 0.520 1.408 3.450 5.384 
Colombia Santillana_2 Difenoconazole 1.756 -0.286 3.799 3 0.520 0.735 2.777 3.378 
Colombia Santillana_2 Epoxiconazole 0.158 -1.885 2.200 3 0.520 -0.863 1.179 1.116 
Colombia Santillana_2 Propiconazole 1.001 -1.041 3.044 3 0.520 -0.020 2.023 2.002 
Colombia Santillana_3 Difenoconazole 0.725 -1.317 2.767 1 0.901 -1.044 2.494 1.653 
Colombia Santillana_3 Epoxiconazole -1.607 -3.649 0.436 1 0.901 -3.376 0.162 0.328 
Colombia Santillana_3 Propiconazole 0.852 -1.190 2.895 1 0.901 -0.916 2.621 1.805 
Colombia Santillana_4 Difenoconazole 2.200 0.158 4.243 2 0.637 0.950 3.451 4.596 
Colombia Santillana_4 Epoxiconazole -0.080 -2.122 1.963 2 0.637 -1.330 1.171 0.946 
Colombia Santillana_4 Propiconazole 0.541 -1.501 2.584 2 0.637 -0.709 1.792 1.455 
Colombia Santillana_5 Difenoconazole    0    
>10.24 
Colombia Santillana_5 Epoxiconazole 2.999 0.957 5.042 1 0.901 1.231 4.768 7.996 
Colombia Santillana_5 Propiconazole    0    
>10.24 
Colombia Santillana_6 Difenoconazole 
   
0 
   
>10.24 
Colombia Santillana_6 Epoxiconazole 2.729 0.687 4.772 1 0.901 0.960 4.498 6.631 
Colombia Santillana_6 Propiconazole 2.135 0.093 4.178 1 0.901 0.367 3.904 4.393 
Colombia Sierra_1 Difenoconazole 0.945 -1.098 2.987 1 0.901 -0.824 2.713 1.925 
Colombia Sierra_1 Epoxiconazole 0.717 -1.325 2.760 1 0.901 -1.052 2.486 1.644 
Colombia Sierra_1 Propiconazole 1.078 -0.965 3.120 1 0.901 -0.691 2.847 2.111 
Costa Rica SPM2_1 Difenoconazole 1.410 -0.632 3.453 4 0.451 0.526 2.295 2.658 
Costa Rica SPM2_1 Epoxiconazole 0.724 -1.319 2.766 4 0.451 -0.161 1.608 1.651 
Costa Rica SPM2_1 Propiconazole 1.486 -0.556 3.529 4 0.451 0.602 2.371 2.801 
Costa Rica SPM2_11 Difenoconazole 1.746 -0.296 3.789 2 0.637 0.495 2.997 3.355 
Costa Rica SPM2_11 Epoxiconazole 0.597 -1.445 2.640 2 0.637 -0.654 1.848 1.513 
Costa Rica SPM2_11 Propiconazole 1.575 -0.468 3.617 2 0.637 0.324 2.826 2.979 
Costa Rica SPM2_2 Difenoconazole 0.677 -1.366 2.719 4 0.451 -0.208 1.561 1.599 
Costa Rica SPM2_2 Epoxiconazole 0.072 -1.970 2.115 4 0.451 -0.812 0.957 1.051 
Costa Rica SPM2_2 Propiconazole 0.404 -1.639 2.446 4 0.451 -0.481 1.288 1.323 
Costa Rica SPM2_3 Difenoconazole 1.514 -0.529 3.556 4 0.451 0.629 2.398 2.855 
Costa Rica SPM2_3 Epoxiconazole 0.587 -1.455 2.630 4 0.451 -0.297 1.472 1.502 
Costa Rica SPM2_3 Propiconazole 0.811 -1.231 2.853 4 0.451 -0.073 1.695 1.755 
Costa Rica SPM2_4 Difenoconazole 1.834 -0.208 3.877 4 0.451 0.950 2.719 3.566 
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Costa Rica SPM2_4 Epoxiconazole 0.524 -1.519 2.566 4 0.451 -0.361 1.408 1.438 
Costa Rica SPM2_4 Propiconazole 1.796 -0.246 3.838 4 0.451 0.912 2.680 3.472 
Costa Rica SPM2_5 Difenoconazole 2.240 0.197 4.282 2 0.637 0.989 3.490 4.722 
Costa Rica SPM2_5 Epoxiconazole 1.938 -0.105 3.980 2 0.637 0.687 3.188 3.831 
Costa Rica SPM2_5 Propiconazole 2.229 0.187 4.271 2 0.637 0.978 3.480 4.688 
Costa Rica SPM2_6 Difenoconazole 1.506 -0.536 3.548 2 0.637 0.255 2.757 2.840 
Costa Rica SPM2_6 Epoxiconazole 1.149 -0.893 3.192 2 0.637 -0.101 2.400 2.218 
Costa Rica SPM2_6 Propiconazole 1.402 -0.640 3.444 2 0.637 0.151 2.653 2.643 
Costa Rica SPM2_7 Difenoconazole 1.578 -0.464 3.621 2 0.637 0.328 2.829 2.986 
Costa Rica SPM2_7 Epoxiconazole 1.332 -0.711 3.374 2 0.637 0.081 2.582 2.517 
Costa Rica SPM2_7 Propiconazole 1.091 -0.951 3.133 2 0.637 -0.160 2.342 2.130 
Costa Rica SPM2_8 Difenoconazole 1.214 -0.828 3.257 2 0.637 -0.037 2.465 2.320 
Costa Rica SPM2_8 Epoxiconazole -0.011 -2.053 2.032 2 0.637 -1.261 1.240 0.993 
Costa Rica SPM2_8 Propiconazole 0.229 -1.814 2.271 2 0.637 -1.022 1.479 1.172 
Costa Rica SPM2_9 Difenoconazole 2.267 0.225 4.310 2 0.637 1.016 3.518 4.814 
Costa Rica SPM2_9 Epoxiconazole 1.800 -0.242 3.842 2 0.637 0.549 3.051 3.482 
Costa Rica SPM2_9 Propiconazole 2.200 0.158 4.243 2 0.637 0.949 3.451 4.595 
Costa Rica SPM3_1 Difenoconazole 
   
0 
   
>10.24 
Costa Rica SPM3_1 Epoxiconazole 3.013 0.970 5.055 1 0.901 1.244 4.781 8.071 
Costa Rica SPM3_1 Propiconazole 2.945 0.903 4.988 1 0.901 1.176 4.714 7.702 
Costa Rica SPM3_2 Difenoconazole 2.892 0.849 4.934 1 0.901 1.123 4.660 7.420 
Costa Rica SPM3_2 Epoxiconazole 1.508 -0.535 3.550 1 0.901 -0.261 3.277 2.844 
Costa Rica SPM3_2 Propiconazole 1.428 -0.614 3.471 1 0.901 -0.340 3.197 2.691 
Costa Rica SPM4_1 Difenoconazole 3.331 1.289 5.374 1 0.901 1.563 5.100 10.066 
Costa Rica SPM4_1 Epoxiconazole 
   
0 
   
>10.24 
Costa Rica SPM4_1 Propiconazole    0    
>10.24 
Costa Rica SPM4_10 Difenoconazole 
   
0 
   
>10.24 
Costa Rica SPM4_10 Epoxiconazole 2.855 0.813 4.898 1 0.901 1.087 4.624 7.236 
Costa Rica SPM4_10 Propiconazole 
   
0 
   
>10.24 
Costa Rica SPM4_11 Difenoconazole 2.834 0.791 4.876 1 0.901 1.065 4.602 7.128 
Costa Rica SPM4_11 Epoxiconazole 2.459 0.416 4.501 1 0.901 0.690 4.228 5.498 
Costa Rica SPM4_11 Propiconazole 2.450 0.408 4.493 1 0.901 0.682 4.219 5.466 
Costa Rica SPM4_12 Difenoconazole 3.202 1.160 5.244 1 0.901 1.433 4.971 9.203 
Costa Rica SPM4_12 Epoxiconazole 2.369 0.326 4.411 1 0.901 0.600 4.137 5.164 
Costa Rica SPM4_12 Propiconazole 3.098 1.056 5.141 1 0.901 1.330 4.867 8.565 
Costa Rica SPM4_13 Difenoconazole 1.182 -0.860 3.224 1 0.901 -0.587 2.951 2.269 
Costa Rica SPM4_13 Epoxiconazole 0.475 -1.567 2.518 1 0.901 -1.293 2.244 1.390 
Costa Rica SPM4_13 Propiconazole 2.217 0.175 4.260 1 0.901 0.449 3.986 4.651 
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Costa Rica SPM4_14 Difenoconazole 0.855 -1.187 2.898 1 0.901 -0.913 2.624 1.809 
Costa Rica SPM4_14 Epoxiconazole 0.475 -1.567 2.518 1 0.901 -1.293 2.244 1.390 
Costa Rica SPM4_14 Propiconazole 2.402 0.360 4.445 1 0.901 0.633 4.171 5.286 
Costa Rica SPM4_15 Difenoconazole 
   
0 
   
>10.24 
Costa Rica SPM4_15 Epoxiconazole 2.885 0.842 4.927 1 0.901 1.116 4.653 7.385 
Costa Rica SPM4_15 Propiconazole 
   
0 
   
>10.24 
Costa Rica SPM4_2 Difenoconazole 3.064 1.021 5.106 1 0.901 1.295 4.832 8.361 
Costa Rica SPM4_2 Epoxiconazole 2.411 0.368 4.453 1 0.901 0.642 4.179 5.317 
Costa Rica SPM4_2 Propiconazole 3.045 1.003 5.088 1 0.901 1.277 4.814 8.255 
Costa Rica SPM4_3 Difenoconazole 
   
0 
   
>10.24 
Costa Rica SPM4_3 Epoxiconazole 2.739 0.696 4.781 1 0.901 0.970 4.507 6.674 
Costa Rica SPM4_3 Propiconazole 
   
0 
   
>10.24 
Costa Rica SPM4_4 Difenoconazole 2.742 0.700 4.785 1 0.901 0.974 4.511 6.692 
Costa Rica SPM4_4 Epoxiconazole 2.574 0.531 4.616 1 0.901 0.805 4.342 5.953 
Costa Rica SPM4_4 Propiconazole 2.849 0.807 4.892 1 0.901 1.080 4.618 7.206 
Costa Rica SPM4_5 Difenoconazole 1.808 -0.235 3.850 1 0.901 0.039 3.576 3.501 
Costa Rica SPM4_5 Epoxiconazole 1.150 -0.893 3.192 1 0.901 -0.619 2.918 2.218 
Costa Rica SPM4_5 Propiconazole 1.226 -0.816 3.269 1 0.901 -0.543 2.995 2.339 
Costa Rica SPM4_6 Difenoconazole 2.743 0.700 4.785 1 0.901 0.974 4.511 6.693 
Costa Rica SPM4_6 Epoxiconazole 2.419 0.377 4.462 1 0.901 0.651 4.188 5.349 
Costa Rica SPM4_6 Propiconazole 3.065 1.022 5.107 1 0.901 1.296 4.833 8.367 
Costa Rica SPM4_7 Difenoconazole 3.077 1.035 5.120 1 0.901 1.308 4.846 8.440 
Costa Rica SPM4_7 Epoxiconazole 
   
0 
   
>10.24 
Costa Rica SPM4_7 Propiconazole 2.329 0.286 4.371 1 0.901 0.560 4.097 5.023 
Costa Rica SPM4_8 Difenoconazole 3.245 1.203 5.288 1 0.901 1.477 5.014 9.482 
Costa Rica SPM4_8 Epoxiconazole 1.289 -0.754 3.331 1 0.901 -0.480 3.057 2.443 
Costa Rica SPM4_8 Propiconazole 2.457 0.415 4.500 1 0.901 0.689 4.226 5.492 
Costa Rica SPM4_9 Difenoconazole 1.193 -0.850 3.235 1 0.901 -0.576 2.962 2.286 
Costa Rica SPM4_9 Epoxiconazole 0.724 -1.318 2.766 1 0.901 -1.045 2.493 1.652 
Costa Rica SPM4_9 Propiconazole 0.908 -1.135 2.950 1 0.901 -0.861 2.676 1.876 
Costa Rica SPM5_1 Difenoconazole -0.161 -2.203 1.881 3 0.520 -1.182 0.860 0.894 
Costa Rica SPM5_1 Epoxiconazole -0.742 -2.784 1.301 3 0.520 -1.763 0.280 0.598 
Costa Rica SPM5_1 Propiconazole 1.087 -0.956 3.129 3 0.520 0.065 2.108 2.124 
Costa Rica SPM5_2 Difenoconazole 2.635 0.593 4.678 1 0.901 0.866 4.404 6.212 
Costa Rica SPM5_2 Epoxiconazole 1.166 -0.877 3.208 1 0.901 -0.603 2.935 2.244 
Costa Rica SPM5_2 Propiconazole 1.239 -0.804 3.281 1 0.901 -0.530 3.008 2.360 
Costa Rica SPM5_3 Difenoconazole 
   
0 
   
>10.24 
Costa Rica SPM5_3 Epoxiconazole 1.849 -0.194 3.891 1 0.901 0.080 3.617 3.601 
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Costa Rica SPM5_3 Propiconazole    0    
>10.24 
Costa Rica SPM6_1 Difenoconazole 2.984 0.941 5.026 3 0.520 1.962 4.005 7.910 
Costa Rica SPM6_1 Epoxiconazole 2.153 0.111 4.196 3 0.520 1.132 3.174 4.448 
Costa Rica SPM6_1 Propiconazole 2.482 0.440 4.525 3 0.520 1.461 3.504 5.588 
Costa Rica SPM6_10 Difenoconazole    0    
>10.24 
Costa Rica SPM6_10 Epoxiconazole 2.537 0.495 4.580 1 0.901 0.768 4.306 5.804 
Costa Rica SPM6_10 Propiconazole    0    
>10.24 
Costa Rica SPM6_11 Difenoconazole 
   
0 
   
>10.24 
Costa Rica SPM6_11 Epoxiconazole 1.024 -1.018 3.066 1 0.901 -0.745 2.793 2.034 
Costa Rica SPM6_11 Propiconazole 2.740 0.698 4.782 1 0.901 0.971 4.509 6.681 
Costa Rica SPM6_12 Difenoconazole    0    
>10.24 
Costa Rica SPM6_12 Epoxiconazole 3.252 1.209 5.294 1 0.901 1.483 5.020 9.525 
Costa Rica SPM6_12 Propiconazole    0    
>10.24 
Costa Rica SPM6_13 Difenoconazole 2.970 0.928 5.013 1 0.901 1.202 4.739 7.837 
Costa Rica SPM6_13 Epoxiconazole 2.664 0.622 4.707 1 0.901 0.895 4.433 6.339 
Costa Rica SPM6_13 Propiconazole 0.953 -1.090 2.995 1 0.901 -0.816 2.722 1.936 
Costa Rica SPM6_14 Difenoconazole    0    
>10.24 
Costa Rica SPM6_14 Epoxiconazole 2.745 0.702 4.787 1 0.901 0.976 4.513 6.702 
Costa Rica SPM6_14 Propiconazole 2.796 0.753 4.838 1 0.901 1.027 4.564 6.943 
Costa Rica SPM6_15 Difenoconazole 
   
0 
   
>10.24 
Costa Rica SPM6_15 Epoxiconazole 2.474 0.431 4.516 1 0.901 0.705 4.242 5.554 
Costa Rica SPM6_15 Propiconazole 2.809 0.766 4.851 1 0.901 1.040 4.577 7.006 
Costa Rica SPM6_2 Difenoconazole 2.634 0.591 4.676 1 0.901 0.865 4.402 6.206 
Costa Rica SPM6_2 Epoxiconazole 1.011 -1.032 3.053 1 0.901 -0.758 2.779 2.015 
Costa Rica SPM6_2 Propiconazole 2.675 0.632 4.717 1 0.901 0.906 4.443 6.385 
Costa Rica SPM6_3 Difenoconazole    0    
>10.24 
Costa Rica SPM6_3 Epoxiconazole 
   
0 
   
>10.24 
Costa Rica SPM6_3 Propiconazole    0    
>10.24 
Costa Rica SPM6_4 Difenoconazole 
   
0 
   
>10.24 
Costa Rica SPM6_4 Epoxiconazole 2.998 0.956 5.041 1 0.901 1.229 4.767 7.990 
Costa Rica SPM6_4 Propiconazole 
   
0 
   
>10.24 
Costa Rica SPM6_5 Difenoconazole 2.811 0.769 4.854 1 0.901 1.043 4.580 7.019 
Costa Rica SPM6_5 Epoxiconazole 1.149 -0.894 3.191 1 0.901 -0.620 2.917 2.217 
Costa Rica SPM6_5 Propiconazole 2.733 0.691 4.776 1 0.901 0.965 4.502 6.650 
Costa Rica SPM6_6 Difenoconazole 1.703 -0.339 3.745 1 0.901 -0.066 3.472 3.256 
Costa Rica SPM6_6 Epoxiconazole 0.454 -1.588 2.497 1 0.901 -1.314 2.223 1.370 
Costa Rica SPM6_6 Propiconazole 0.785 -1.257 2.828 1 0.901 -0.984 2.554 1.723 
Costa Rica SPM6_7 Difenoconazole    0    
>10.24 
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Costa Rica SPM6_7 Epoxiconazole 1.651 -0.391 3.693 1 0.901 -0.118 3.420 3.141 
Costa Rica SPM6_7 Propiconazole 2.879 0.837 4.921 1 0.901 1.110 4.648 7.356 
Costa Rica SPM6_8 Difenoconazole    0    
>10.24 
Costa Rica SPM6_8 Epoxiconazole 3.188 1.146 5.231 1 0.901 1.420 4.957 9.117 
Costa Rica SPM6_8 Propiconazole    0    
>10.24 
Costa Rica SPM6_9 Difenoconazole 
   
0 
   
>10.24 
Costa Rica SPM6_9 Epoxiconazole 2.170 0.127 4.212 1 0.901 0.401 3.938 4.499 
Costa Rica SPM6_9 Propiconazole 2.764 0.722 4.806 1 0.901 0.995 4.533 6.793 
Costa Rica SPM7_1 Difenoconazole 2.066 0.024 4.108 2 0.637 0.815 3.317 4.187 
Costa Rica SPM7_1 Epoxiconazole 0.686 -1.356 2.729 3 0.520 -0.335 1.707 1.609 
Costa Rica SPM7_1 Propiconazole 2.366 0.324 4.409 3 0.520 1.345 3.387 5.156 
Costa Rica SPM7_2 Difenoconazole 2.624 0.582 4.666 1 0.901 0.855 4.393 6.164 
Costa Rica SPM7_2 Epoxiconazole 1.273 -0.770 3.315 1 0.901 -0.496 3.041 2.416 
Costa Rica SPM7_2 Propiconazole 1.583 -0.460 3.625 1 0.901 -0.186 3.352 2.996 
Costa Rica SPM7_3 Difenoconazole 1.389 -0.654 3.431 1 0.901 -0.380 3.158 2.619 
Costa Rica SPM7_3 Epoxiconazole 1.182 -0.860 3.225 1 0.901 -0.587 2.951 2.269 
Costa Rica SPM7_3 Propiconazole 1.217 -0.825 3.260 1 0.901 -0.551 2.986 2.325 
Costa Rica SPM7_4 Difenoconazole 2.670 0.627 4.712 1 0.901 0.901 4.439 6.363 
Costa Rica SPM7_4 Epoxiconazole 1.092 -0.951 3.134 1 0.901 -0.677 2.861 2.132 
Costa Rica SPM7_4 Propiconazole 2.634 0.592 4.676 1 0.901 0.865 4.403 6.207 
Colombia StaI_4 Difenoconazole 2.830 0.788 4.873 1 0.901 1.062 4.599 7.113 
Colombia StaI_4 Epoxiconazole 0.794 -1.249 2.836 1 0.901 -0.975 2.562 1.734 
Colombia StaI_4 Propiconazole 2.886 0.844 4.928 1 0.901 1.117 4.655 7.392 
Philippines T52_1 Difenoconazole 2.467 0.424 4.509 2 0.637 1.216 3.717 5.528 
Philippines T52_1 Epoxiconazole 0.887 -1.156 2.929 3 0.520 -0.135 1.908 1.849 
Philippines T52_1 Propiconazole 1.179 -0.864 3.221 2 0.637 -0.072 2.430 2.264 
Philippines T52_10 Difenoconazole 2.407 0.364 4.449 3 0.520 1.385 3.428 5.302 
Philippines T52_10 Epoxiconazole 1.890 -0.152 3.933 4 0.451 1.006 2.775 3.707 
Philippines T52_10 Propiconazole 2.225 0.183 4.268 4 0.451 1.341 3.110 4.676 
Philippines T52_12 Difenoconazole 3.094 1.052 5.137 1 0.901 1.326 4.863 8.541 
Philippines T52_12 Epoxiconazole 
   
0 
   
>10.24 
Philippines T52_12 Propiconazole 2.720 0.678 4.763 1 0.901 0.951 4.489 6.590 
Philippines T52_13 Difenoconazole 2.154 0.112 4.197 3 0.520 1.133 3.176 4.452 
Philippines T52_13 Epoxiconazole 2.138 0.095 4.180 3 0.520 1.117 3.159 4.401 
Philippines T52_13 Propiconazole 2.946 0.903 4.988 3 0.520 1.925 3.967 7.705 
Philippines T52_14 Difenoconazole    0    
>10.24 
Philippines T52_14 Epoxiconazole 
   
0 
   
>10.24 
Philippines T52_14 Propiconazole    0    
>10.24 
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Philippines T52_15 Difenoconazole 2.590 0.548 4.632 3 0.520 1.569 3.611 6.021 
Philippines T52_15 Epoxiconazole 2.857 0.815 4.899 2 0.637 1.606 4.108 7.245 
Philippines T52_15 Propiconazole 2.329 0.287 4.372 4 0.451 1.445 3.214 5.025 
Philippines T52_16 Difenoconazole 3.185 1.143 5.227 1 0.901 1.416 4.954 9.095 
Philippines T52_16 Epoxiconazole 2.786 0.744 4.828 1 0.901 1.017 4.555 6.897 
Philippines T52_16 Propiconazole 2.805 0.763 4.847 1 0.901 1.036 4.574 6.989 
Philippines T52_17 Difenoconazole    0    
>10.24 
Philippines T52_17 Epoxiconazole 
   
0 
   
>10.24 
Philippines T52_17 Propiconazole    0    
>10.24 
Philippines T52_18 Difenoconazole 
   
0 
   
>10.24 
Philippines T52_18 Epoxiconazole 3.095 1.053 5.137 1 0.901 1.326 4.864 8.544 
Philippines T52_18 Propiconazole 2.538 0.495 4.580 1 0.901 0.769 4.306 5.807 
Philippines T52_19 Difenoconazole 2.869 0.827 4.912 1 0.901 1.101 4.638 7.307 
Philippines T52_19 Epoxiconazole 3.016 0.974 5.058 1 0.901 1.247 4.785 8.089 
Philippines T52_19 Propiconazole 1.668 -0.374 3.710 1 0.901 -0.101 3.437 3.178 
Philippines T52_2 Difenoconazole 3.327 1.285 5.369 1 0.901 1.558 5.096 10.035 
Philippines T52_2 Epoxiconazole 1.285 -0.758 3.327 2 0.637 0.034 2.535 2.436 
Philippines T52_2 Propiconazole 3.136 1.094 5.178 2 0.637 1.885 4.387 8.791 
Philippines T52_20 Difenoconazole 2.609 0.567 4.652 1 0.901 0.840 4.378 6.101 
Philippines T52_20 Epoxiconazole 2.298 0.255 4.340 1 0.901 0.529 4.066 4.917 
Philippines T52_20 Propiconazole 2.566 0.524 4.608 1 0.901 0.797 4.335 5.922 
Philippines T52_21 Difenoconazole 2.904 0.862 4.946 1 0.901 1.135 4.673 7.485 
Philippines T52_21 Epoxiconazole 
   
0 
   
>10.24 
Philippines T52_21 Propiconazole 2.912 0.869 4.954 1 0.901 1.143 4.681 7.525 
Philippines T52_22 Difenoconazole 2.815 0.772 4.857 4 0.451 1.930 3.699 7.035 
Philippines T52_22 Epoxiconazole 1.735 -0.308 3.777 6 0.368 1.012 2.457 3.328 
Philippines T52_22 Propiconazole 3.067 1.024 5.109 5 0.403 2.276 3.858 8.379 
Philippines T52_23 Difenoconazole -0.064 -2.107 1.978 3 0.520 -1.085 0.957 0.956 
Philippines T52_23 Epoxiconazole 0.115 -1.928 2.157 3 0.520 -0.907 1.136 1.083 
Philippines T52_23 Propiconazole -0.558 -2.600 1.484 2 0.637 -1.809 0.693 0.679 
Philippines T52_3 Difenoconazole 3.255 1.212 5.297 1 0.901 1.486 5.023 9.544 
Philippines T52_3 Epoxiconazole 2.678 0.636 4.721 1 0.901 0.910 4.447 6.402 
Philippines T52_3 Propiconazole 0.693 -1.350 2.735 1 0.901 -1.076 2.462 1.616 
Philippines T52_36 Difenoconazole 1.438 -0.605 3.480 1 0.901 -0.331 3.207 2.709 
Philippines T52_36 Epoxiconazole 1.295 -0.748 3.337 1 0.901 -0.474 3.063 2.453 
Philippines T52_36 Propiconazole 0.218 -1.825 2.260 1 0.901 -1.551 1.987 1.163 
Philippines T52_4 Difenoconazole 
   
0 
   
>10.24 
Philippines T52_4 Epoxiconazole    0    
>10.24 
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Philippines T52_4 Propiconazole    0    
>10.24 
Philippines T52_5 Difenoconazole 3.353 1.311 5.396 1 0.901 1.585 5.122 10.220 
Philippines T52_5 Epoxiconazole 3.085 1.042 5.127 2 0.637 1.834 4.335 8.484 
Philippines T52_5 Propiconazole 2.694 0.651 4.736 3 0.520 1.673 3.715 6.470 
Philippines T52_6 Difenoconazole    0    
>10.24 
Philippines T52_6 Epoxiconazole 2.874 0.832 4.916 1 0.901 1.105 4.643 7.331 
Philippines T52_6 Propiconazole    0    
>10.24 
Philippines T52_7 Difenoconazole 2.539 0.496 4.581 1 0.901 0.770 4.307 5.810 
Philippines T52_7 Epoxiconazole 2.689 0.646 4.731 1 0.901 0.920 4.458 6.448 
Philippines T52_7 Propiconazole 
   
0 
   
>10.24 
Philippines T52_8 Difenoconazole 2.920 0.877 4.962 3 0.520 1.898 3.941 7.567 
Philippines T52_8 Epoxiconazole 1.343 -0.699 3.386 3 0.520 0.322 2.365 2.538 
Philippines T52_8 Propiconazole 1.974 -0.068 4.016 3 0.520 0.953 2.995 3.929 
Philippines T52_9 Difenoconazole 
   
0 
   
>10.24 
Philippines T52_9 Epoxiconazole    0    
>10.24 
Philippines T52_9 Propiconazole 
   
0 
   
>10.24 
Colombia Tamaca_1 Difenoconazole 0.165 -1.877 2.208 1 0.901 -1.603 1.934 1.121 
Colombia Tamaca_1 Epoxiconazole -1.102 -3.145 0.940 1 0.901 -2.871 0.666 0.466 
Colombia Tamaca_1 Propiconazole 0.387 -1.655 2.430 1 0.901 -1.381 2.156 1.308 
Colombia Teresa_1 Difenoconazole 2.790 0.748 4.832 1 0.901 1.021 4.559 6.916 
Colombia Teresa_1 Epoxiconazole -3.510 -5.553 -1.468 1 0.901 -5.279 -1.742 0.088 
Colombia Teresa_1 Propiconazole 0.634 -1.408 2.676 1 0.901 -1.135 2.403 1.552 
Colombia Teresa_2 Difenoconazole -0.313 -2.356 1.729 1 0.901 -2.082 1.455 0.805 
Colombia Teresa_2 Epoxiconazole -0.914 -2.956 1.129 1 0.901 -2.683 0.855 0.531 
Colombia Teresa_2 Propiconazole 0.130 -1.913 2.172 1 0.901 -1.639 1.898 1.094 
Colombia Teresa_3 Difenoconazole -0.534 -2.576 1.508 3 0.520 -1.555 0.487 0.691 
Colombia Teresa_3 Epoxiconazole 0.333 -1.710 2.375 3 0.520 -0.688 1.354 1.259 
Colombia Teresa_3 Propiconazole 1.954 -0.089 3.996 3 0.520 0.933 2.975 3.874 
Colombia Toscana_12 Difenoconazole 2.554 0.511 4.596 1 0.901 0.785 4.322 5.871 
Colombia Toscana_12 Epoxiconazole 0.910 -1.132 2.952 1 0.901 -0.859 2.679 1.879 
Colombia Toscana_12 Propiconazole 2.562 0.520 4.604 1 0.901 0.793 4.331 5.906 
Colombia Toscana_2 Difenoconazole 1.833 -0.209 3.876 1 0.901 0.065 3.602 3.564 
Colombia Toscana_2 Epoxiconazole 1.905 -0.138 3.947 1 0.901 0.136 3.673 3.744 
Colombia Toscana_2 Propiconazole 2.684 0.642 4.727 1 0.901 0.915 4.453 6.427 
Colombia Toscana_3 Difenoconazole 1.113 -0.929 3.156 1 0.901 -0.656 2.882 2.163 
Colombia Toscana_3 Epoxiconazole -0.004 -2.047 2.038 1 0.901 -1.773 1.765 0.997 
Colombia Toscana_3 Propiconazole 0.938 -1.104 2.981 1 0.901 -0.830 2.707 1.916 
Colombia Toscana_4 Difenoconazole -1.668 -3.710 0.375 1 0.901 -3.436 0.101 0.315 
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Colombia Toscana_4 Epoxiconazole -3.667 -5.709 -1.625 1 0.901 -5.436 -1.898 0.079 
Colombia Toscana_4 Propiconazole -0.678 -2.721 1.364 1 0.901 -2.447 1.090 0.625 
Colombia Toscana_5 Difenoconazole 1.264 -0.778 3.306 1 0.901 -0.505 3.033 2.402 
Colombia Toscana_5 Epoxiconazole 0.231 -1.811 2.273 1 0.901 -1.538 2.000 1.174 
Colombia Toscana_5 Propiconazole 2.777 0.735 4.820 1 0.901 1.009 4.546 6.856 
Colombia Toscana_6 Difenoconazole 2.207 0.165 4.249 1 0.901 0.438 3.976 4.617 
Colombia Toscana_6 Epoxiconazole 0.001 -2.041 2.044 1 0.901 -1.767 1.770 1.001 
Colombia Toscana_6 Propiconazole 0.911 -1.131 2.954 1 0.901 -0.858 2.680 1.881 
Colombia Toscana_7 Difenoconazole 1.125 -0.918 3.167 1 0.901 -0.644 2.893 2.181 
Colombia Toscana_7 Epoxiconazole -0.654 -2.696 1.388 1 0.901 -2.423 1.115 0.636 
Colombia Toscana_7 Propiconazole 1.021 -1.022 3.063 1 0.901 -0.748 2.789 2.029 
Colombia Toscana_8 Difenoconazole 1.950 -0.092 3.993 4 0.451 1.066 2.835 3.864 
Colombia Toscana_8 Epoxiconazole 1.081 -0.961 3.124 4 0.451 0.197 1.966 2.116 
Colombia Toscana_8 Propiconazole 2.356 0.314 4.399 4 0.451 1.472 3.241 5.120 
Philippines U22_1 Difenoconazole 0.385 -1.657 2.428 2 0.637 -0.865 1.636 1.306 
Philippines U22_1 Epoxiconazole 0.449 -1.593 2.491 2 0.637 -0.802 1.700 1.365 
Philippines U22_1 Propiconazole 0.772 -1.270 2.814 2 0.637 -0.479 2.023 1.708 
Philippines U22_10 Difenoconazole 0.935 -1.107 2.978 1 0.901 -0.834 2.704 1.912 
Philippines U22_10 Epoxiconazole 0.603 -1.440 2.645 1 0.901 -1.166 2.371 1.518 
Philippines U22_10 Propiconazole 0.586 -1.457 2.628 1 0.901 -1.183 2.354 1.501 
Philippines U22_11 Difenoconazole 2.389 0.347 4.432 1 0.901 0.620 4.158 5.239 
Philippines U22_11 Epoxiconazole 0.350 -1.692 2.392 1 0.901 -1.419 2.119 1.274 
Philippines U22_11 Propiconazole 1.315 -0.727 3.357 1 0.901 -0.454 3.084 2.488 
Philippines U22_12 Difenoconazole 1.485 -0.558 3.527 1 0.901 -0.284 3.254 2.799 
Philippines U22_12 Epoxiconazole 1.371 -0.671 3.413 1 0.901 -0.398 3.140 2.586 
Philippines U22_12 Propiconazole 1.428 -0.614 3.470 1 0.901 -0.341 3.197 2.691 
Philippines U22_13 Difenoconazole 2.650 0.608 4.692 1 0.901 0.881 4.419 6.277 
Philippines U22_13 Epoxiconazole 2.443 0.401 4.486 1 0.901 0.675 4.212 5.439 
Philippines U22_13 Propiconazole 0.539 -1.503 2.582 1 0.901 -1.230 2.308 1.453 
Philippines U22_14 Difenoconazole -1.134 -3.176 0.909 1 0.901 -2.902 0.635 0.456 
Philippines U22_14 Epoxiconazole -1.709 -3.751 0.334 1 0.901 -3.477 0.060 0.306 
Philippines U22_14 Propiconazole -0.812 -2.854 1.230 1 0.901 -2.581 0.957 0.570 
Philippines U22_15 Difenoconazole 0.370 -1.673 2.412 1 0.901 -1.399 2.138 1.292 
Philippines U22_15 Epoxiconazole -0.493 -2.535 1.549 1 0.901 -2.262 1.276 0.711 
Philippines U22_15 Propiconazole 0.938 -1.104 2.980 1 0.901 -0.831 2.707 1.916 
Philippines U22_16 Difenoconazole 2.790 0.748 4.832 1 0.901 1.021 4.559 6.916 
Philippines U22_16 Epoxiconazole 2.168 0.125 4.210 1 0.901 0.399 3.936 4.493 
Philippines U22_16 Propiconazole 1.417 -0.625 3.460 1 0.901 -0.352 3.186 2.671 
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Philippines U22_17 Difenoconazole -0.501 -2.544 1.541 1 0.901 -2.270 1.267 0.706 
Philippines U22_17 Epoxiconazole -0.875 -2.917 1.168 1 0.901 -2.644 0.894 0.545 
Philippines U22_17 Propiconazole 0.364 -1.678 2.407 1 0.901 -1.405 2.133 1.287 
Philippines U22_18 Difenoconazole 1.764 -0.278 3.806 1 0.901 -0.005 3.533 3.397 
Philippines U22_18 Epoxiconazole 1.250 -0.792 3.292 1 0.901 -0.519 3.019 2.379 
Philippines U22_18 Propiconazole 0.715 -1.328 2.757 1 0.901 -1.054 2.483 1.641 
Philippines U22_19 Difenoconazole -1.072 -3.114 0.971 1 0.901 -2.840 0.697 0.476 
Philippines U22_19 Epoxiconazole -1.731 -3.773 0.311 1 0.901 -3.500 0.038 0.301 
Philippines U22_19 Propiconazole -1.186 -3.229 0.856 1 0.901 -2.955 0.582 0.439 
Philippines U22_2 Difenoconazole 1.067 -0.976 3.109 3 0.520 0.046 2.088 2.095 
Philippines U22_2 Epoxiconazole 0.663 -1.380 2.705 3 0.520 -0.359 1.684 1.583 
Philippines U22_2 Propiconazole 1.377 -0.665 3.420 3 0.520 0.356 2.399 2.598 
Philippines U22_20 Difenoconazole 2.201 0.158 4.243 1 0.901 0.432 3.970 4.598 
Philippines U22_20 Epoxiconazole 1.826 -0.216 3.869 1 0.901 0.058 3.595 3.546 
Philippines U22_20 Propiconazole 0.624 -1.419 2.666 1 0.901 -1.145 2.393 1.541 
Philippines U22_21 Difenoconazole 1.357 -0.685 3.400 1 0.901 -0.411 3.126 2.562 
Philippines U22_21 Epoxiconazole 1.426 -0.616 3.469 1 0.901 -0.343 3.195 2.687 
Philippines U22_21 Propiconazole 0.853 -1.189 2.895 1 0.901 -0.916 2.622 1.806 
Philippines U22_22 Difenoconazole 0.607 -1.435 2.649 1 0.901 -1.162 2.376 1.523 
Philippines U22_22 Epoxiconazole 0.633 -1.409 2.676 1 0.901 -1.136 2.402 1.551 
Philippines U22_22 Propiconazole 0.693 -1.350 2.735 1 0.901 -1.076 2.462 1.616 
Philippines U22_3 Difenoconazole -0.356 -2.398 1.686 3 0.520 -1.377 0.665 0.781 
Philippines U22_3 Epoxiconazole -1.241 -3.284 0.801 3 0.520 -2.262 -0.220 0.423 
Philippines U22_3 Propiconazole -0.888 -2.930 1.154 3 0.520 -1.909 0.133 0.540 
Philippines U22_4 Difenoconazole -1.549 -3.592 0.493 3 0.520 -2.570 -0.528 0.342 
Philippines U22_4 Epoxiconazole -1.701 -3.743 0.341 3 0.520 -2.722 -0.680 0.308 
Philippines U22_4 Propiconazole -0.418 -2.460 1.625 3 0.520 -1.439 0.604 0.749 
Philippines U22_5 Difenoconazole -1.508 -3.550 0.534 3 0.520 -2.529 -0.487 0.352 
Philippines U22_5 Epoxiconazole -1.690 -3.732 0.353 3 0.520 -2.711 -0.668 0.310 
Philippines U22_5 Propiconazole -0.849 -2.892 1.193 3 0.520 -1.871 0.172 0.555 
Philippines U22_6 Difenoconazole -1.012 -3.054 1.031 3 0.520 -2.033 0.009 0.496 
Philippines U22_6 Epoxiconazole -1.462 -3.504 0.581 3 0.520 -2.483 -0.441 0.363 
Philippines U22_6 Propiconazole -0.257 -2.299 1.786 3 0.520 -1.278 0.764 0.837 
Philippines U22_7 Difenoconazole 0.199 -1.843 2.242 1 0.901 -1.570 1.968 1.148 
Philippines U22_7 Epoxiconazole -0.334 -2.376 1.708 1 0.901 -2.103 1.435 0.793 
Philippines U22_7 Propiconazole 0.454 -1.589 2.496 1 0.901 -1.315 2.222 1.369 
Philippines U22_8 Difenoconazole 2.816 0.773 4.858 1 0.901 1.047 4.584 7.040 
Philippines U22_8 Epoxiconazole 2.738 0.696 4.781 1 0.901 0.970 4.507 6.674 
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Philippines U22_8 Propiconazole 2.517 0.474 4.559 1 0.901 0.748 4.285 5.722 
Philippines U22_9 Difenoconazole -0.638 -2.681 1.404 1 0.901 -2.407 1.131 0.643 
Philippines U22_9 Epoxiconazole -1.394 -3.437 0.648 1 0.901 -3.163 0.374 0.380 
Philippines U22_9 Propiconazole 0.233 -1.810 2.275 1 0.901 -1.536 2.001 1.175 
Colombia Universalia_1 Difenoconazole -3.646 -5.688 -1.603 1 0.901 -5.414 -1.877 0.080 
Colombia Universalia_1 Epoxiconazole -5.279 -7.321 -3.236 1 0.901 -7.047 -3.510 0.026 
Colombia Universalia_1 Propiconazole -2.090 -4.133 -0.048 1 0.901 -3.859 -0.321 0.235 
Colombia Universalia_2 Difenoconazole -5.315 -7.357 -3.273 1 0.901 -7.084 -3.546 0.025 
Colombia Universalia_2 Epoxiconazole -1.665 -3.708 0.377 1 0.901 -3.434 0.104 0.315 
Colombia Universalia_2 Propiconazole 1.311 -0.731 3.353 1 0.901 -0.458 3.080 2.481 
Colombia Universalia_3 Difenoconazole 2.804 0.762 4.847 2 0.637 1.554 4.055 6.985 
Colombia Universalia_3 Epoxiconazole 1.479 -0.564 3.521 3 0.520 0.458 2.500 2.787 
Colombia Universalia_3 Propiconazole 0.995 -1.047 3.037 2 0.637 -0.256 2.246 1.993 
Colombia Vega_1 Difenoconazole 1.015 -1.027 3.058 1 0.901 -0.754 2.784 2.021 
Colombia Vega_1 Epoxiconazole 0.716 -1.326 2.759 1 0.901 -1.052 2.485 1.643 
Colombia Vega_1 Propiconazole 2.497 0.454 4.539 1 0.901 0.728 4.266 5.644 
Colombia Victoria Difenoconazole 2.199 0.157 4.242 1 0.901 0.431 3.968 4.593 
Colombia Victoria Epoxiconazole 1.846 -0.197 3.888 1 0.901 0.077 3.614 3.594 
Colombia Victoria Propiconazole -0.437 -2.480 1.605 1 0.901 -2.206 1.332 0.739 
Cameroon X02_4 Difenoconazole -7.663 -9.706 -5.621 3 0.520 -8.685 -6.642 0.005 
Cameroon X02_4 Epoxiconazole -6.968 -9.010 -4.925 3 0.520 -7.989 -5.946 0.008 
Cameroon X02_4 Propiconazole -6.547 -8.589 -4.504 3 0.520 -7.568 -5.525 0.011 
Cameroon X03_2 Difenoconazole -7.644 -9.686 -5.601 2 0.637 -8.895 -6.393 0.005 
Cameroon X03_2 Epoxiconazole -7.437 -9.480 -5.395 3 0.520 -8.459 -6.416 0.006 
Cameroon X03_2 Propiconazole -6.835 -8.877 -4.793 3 0.520 -7.856 -5.814 0.009 
Cameroon X04_2 Difenoconazole -7.966 -10.008 -5.923 3 0.520 -8.987 -6.945 0.004 
Cameroon X04_2 Epoxiconazole -7.199 -9.242 -5.157 3 0.520 -8.221 -6.178 0.007 
Cameroon X04_2 Propiconazole -6.418 -8.460 -4.375 3 0.520 -7.439 -5.397 0.012 
Cameroon X04_5 Difenoconazole -7.562 -9.604 -5.520 2 0.637 -8.813 -6.311 0.005 
Cameroon X04_5 Epoxiconazole -6.609 -8.651 -4.566 2 0.637 -7.859 -5.358 0.010 
Cameroon X04_5 Propiconazole -6.119 -8.161 -4.077 2 0.637 -7.370 -4.868 0.014 
Cameroon X05_3 Difenoconazole -7.163 -9.205 -5.120 3 0.520 -8.184 -6.141 0.007 
Cameroon X05_3 Epoxiconazole -6.844 -8.886 -4.801 3 0.520 -7.865 -5.822 0.009 
Cameroon X05_3 Propiconazole -6.264 -8.306 -4.221 3 0.520 -7.285 -5.242 0.013 
Cameroon X05_5 Difenoconazole -7.506 -9.548 -5.463 4 0.451 -8.390 -6.621 0.006 
Cameroon X05_5 Epoxiconazole -7.065 -9.107 -5.022 4 0.451 -7.949 -6.180 0.007 
Cameroon X05_5 Propiconazole -6.011 -8.053 -3.968 4 0.451 -6.895 -5.126 0.016 
Cameroon X07_2 Difenoconazole -7.270 -9.312 -5.227 2 0.637 -8.520 -6.019 0.006 
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Cameroon X07_2 Epoxiconazole -6.550 -8.592 -4.507 3 0.520 -7.571 -5.529 0.011 
Cameroon X07_2 Propiconazole -6.004 -8.047 -3.962 3 0.520 -7.026 -4.983 0.016 
Cameroon X08_1 Difenoconazole -7.644 -9.686 -5.601 2 0.637 -8.895 -6.393 0.005 
Cameroon X08_1 Epoxiconazole -6.060 -8.103 -4.018 3 0.520 -7.081 -5.039 0.015 
Cameroon X08_1 Propiconazole -6.015 -8.058 -3.973 3 0.520 -7.036 -4.994 0.015 
Cameroon X08_2 Difenoconazole -7.644 -9.686 -5.601 2 0.637 -8.895 -6.393 0.005 
Cameroon X08_2 Epoxiconazole -6.835 -8.877 -4.793 3 0.520 -7.856 -5.814 0.009 
Cameroon X08_2 Propiconazole -6.117 -8.159 -4.074 3 0.520 -7.138 -5.096 0.014 
Cameroon X13_3 Difenoconazole -7.576 -9.618 -5.533 3 0.520 -8.597 -6.555 0.005 
Cameroon X13_3 Epoxiconazole -6.676 -8.719 -4.634 3 0.520 -7.697 -5.655 0.010 
Cameroon X13_3 Propiconazole -6.428 -8.470 -4.385 3 0.520 -7.449 -5.406 0.012 
Cameroon X14_3 Difenoconazole -7.512 -9.555 -5.470 2 0.637 -8.763 -6.262 0.005 
Cameroon X14_3 Epoxiconazole -6.815 -8.858 -4.773 3 0.520 -7.837 -5.794 0.009 
Cameroon X14_3 Propiconazole -5.968 -8.010 -3.925 3 0.520 -6.989 -4.946 0.016 
Cameroon X14_4 Difenoconazole -7.663 -9.706 -5.621 3 0.520 -8.685 -6.642 0.005 
Cameroon X14_4 Epoxiconazole -6.745 -8.788 -4.703 3 0.520 -7.766 -5.724 0.009 
Cameroon X14_4 Propiconazole -6.366 -8.408 -4.324 3 0.520 -7.387 -5.345 0.012 
Cameroon X14_5 Difenoconazole -7.104 -9.146 -5.062 3 0.520 -8.125 -6.083 0.007 
Cameroon X14_5 Epoxiconazole -5.340 -7.382 -3.297 3 0.520 -6.361 -4.319 0.025 
Cameroon X14_5 Propiconazole -5.152 -7.194 -3.109 3 0.520 -6.173 -4.131 0.028 
Cameroon X16_1 Difenoconazole -7.413 -9.455 -5.371 3 0.520 -8.434 -6.392 0.006 
Cameroon X16_1 Epoxiconazole -6.260 -8.302 -4.218 3 0.520 -7.281 -5.239 0.013 
Cameroon X16_1 Propiconazole -5.858 -7.901 -3.816 3 0.520 -6.880 -4.837 0.017 
Cameroon X16_3 Difenoconazole -6.629 -8.671 -4.586 3 0.520 -7.650 -5.607 0.010 
Cameroon X16_3 Epoxiconazole -4.915 -6.958 -2.873 3 0.520 -5.936 -3.894 0.033 
Cameroon X16_3 Propiconazole -4.269 -6.311 -2.227 3 0.520 -5.290 -3.248 0.052 
Cameroon X18_10 Difenoconazole -7.792 -9.834 -5.749 2 0.637 -9.042 -6.541 0.005 
Cameroon X18_10 Epoxiconazole -6.945 -8.988 -4.903 2 0.637 -8.196 -5.694 0.008 
Cameroon X18_10 Propiconazole -6.592 -8.634 -4.549 3 0.520 -7.613 -5.571 0.010 
Cameroon X18_5 Difenoconazole -7.170 -9.212 -5.127 3 0.520 -8.191 -6.149 0.007 
Cameroon X18_5 Epoxiconazole -5.869 -7.912 -3.827 3 0.520 -6.890 -4.848 0.017 
Cameroon X18_5 Propiconazole -5.652 -7.694 -3.609 3 0.520 -6.673 -4.630 0.020 
Cameroon X18_7 Difenoconazole -7.134 -9.176 -5.091 2 0.637 -8.385 -5.883 0.007 
Cameroon X18_7 Epoxiconazole -6.606 -8.649 -4.564 3 0.520 -7.627 -5.585 0.010 
Cameroon X18_7 Propiconazole -5.607 -7.650 -3.565 3 0.520 -6.629 -4.586 0.021 
Cameroon X18_8 Difenoconazole -7.341 -9.383 -5.299 3 0.520 -8.362 -6.320 0.006 
Cameroon X18_8 Epoxiconazole -6.613 -8.655 -4.571 3 0.520 -7.634 -5.592 0.010 
Cameroon X18_8 Propiconazole -5.849 -7.892 -3.807 3 0.520 -6.870 -4.828 0.017 
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Cameroon X19_1 Difenoconazole -7.291 -9.333 -5.248 3 0.520 -8.312 -6.270 0.006 
Cameroon X19_1 Epoxiconazole -6.446 -8.488 -4.403 3 0.520 -7.467 -5.425 0.011 
Cameroon X19_1 Propiconazole -5.961 -8.003 -3.918 3 0.520 -6.982 -4.940 0.016 
Cameroon X19_3 Difenoconazole -7.644 -9.686 -5.601 1 0.901 -9.413 -5.875 0.005 
Cameroon X19_3 Epoxiconazole -7.663 -9.706 -5.621 3 0.520 -8.685 -6.642 0.005 
Cameroon X19_3 Propiconazole -7.556 -9.599 -5.514 3 0.520 -8.577 -6.535 0.005 
Cameroon X23_2 Difenoconazole -7.519 -9.561 -5.476 2 0.637 -8.769 -6.268 0.005 
Cameroon X23_2 Epoxiconazole -7.242 -9.284 -5.199 3 0.520 -8.263 -6.221 0.007 
Cameroon X23_2 Propiconazole -6.237 -8.279 -4.195 3 0.520 -7.258 -5.216 0.013 
Cameroon X23_3 Difenoconazole -7.151 -9.193 -5.109 3 0.520 -8.172 -6.130 0.007 
Cameroon X23_3 Epoxiconazole -5.791 -7.833 -3.749 3 0.520 -6.812 -4.770 0.018 
Cameroon X23_3 Propiconazole -5.415 -7.458 -3.373 3 0.520 -6.436 -4.394 0.023 
Cameroon X24_2 Difenoconazole -7.412 -9.454 -5.369 3 0.520 -8.433 -6.391 0.006 
Cameroon X24_2 Epoxiconazole -6.628 -8.671 -4.586 3 0.520 -7.649 -5.607 0.010 
Cameroon X24_2 Propiconazole -6.120 -8.162 -4.077 3 0.520 -7.141 -5.099 0.014 
Cameroon X26_7 Difenoconazole -7.184 -9.227 -5.142 3 0.520 -8.206 -6.163 0.007 
Cameroon X26_7 Epoxiconazole -6.487 -8.529 -4.444 3 0.520 -7.508 -5.466 0.011 
Cameroon X26_7 Propiconazole -5.858 -7.900 -3.815 3 0.520 -6.879 -4.836 0.017 
Costa Rica ZentM1_1 Difenoconazole 0.767 -1.275 2.809 3 0.520 -0.254 1.788 1.702 
Costa Rica ZentM1_1 Epoxiconazole 0.278 -1.764 2.321 3 0.520 -0.743 1.299 1.213 
Costa Rica ZentM1_1 Propiconazole 1.575 -0.468 3.617 3 0.520 0.554 2.596 2.979 
Costa Rica ZentM1_2 Difenoconazole -0.848 -2.891 1.194 3 0.520 -1.870 0.173 0.555 
Costa Rica ZentM1_2 Epoxiconazole -1.206 -3.249 0.836 3 0.520 -2.227 -0.185 0.433 
Costa Rica ZentM1_2 Propiconazole -1.561 -3.603 0.482 3 0.520 -2.582 -0.540 0.339 
Costa Rica ZentM2_2 Difenoconazole 0.577 -1.466 2.619 3 0.520 -0.445 1.598 1.491 
Costa Rica ZentM2_2 Epoxiconazole 0.078 -1.964 2.120 3 0.520 -0.943 1.099 1.055 
Costa Rica ZentM2_2 Propiconazole 0.321 -1.721 2.364 3 0.520 -0.700 1.343 1.250 
Colombia Zurrambay_1 Difenoconazole -4.212 -6.254 -2.169 1 0.901 -5.981 -2.443 0.054 
Colombia Zurrambay_1 Epoxiconazole -4.818 -6.860 -2.775 1 0.901 -6.586 -3.049 0.035 
Colombia Zurrambay_1 Propiconazole -3.603 -5.645 -1.561 1 0.901 -5.372 -1.834 0.082 
Colombia Zurrambay_2 Difenoconazole -5.990 -8.033 -3.948 1 0.901 -7.759 -4.222 0.016 
Colombia Zurrambay_2 Epoxiconazole -4.760 -6.803 -2.718 1 0.901 -6.529 -2.991 0.037 
Colombia Zurrambay_2 Propiconazole -4.597 -6.640 -2.555 1 0.901 -6.366 -2.829 0.041 
Colombia Zurrambay_3 Difenoconazole -5.651 -7.694 -3.609 1 0.901 -7.420 -3.883 0.020 
Colombia Zurrambay_3 Epoxiconazole -4.652 -6.694 -2.609 1 0.901 -6.421 -2.883 0.040 
Colombia Zurrambay_3 Propiconazole -4.010 -6.052 -1.968 1 0.901 -5.779 -2.241 0.062 
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Table S2. Description of the Pseudocercospora fijiensis population EC50 values. Minimum, 
maximum, average and standard deviation per country and the percentage of the sensitivity trait 
are indicated. The sensitivity trait was characterized by arbitrary thresholds. Average EC50 
values higher than 1 mg.L-1were labelled “resistant”, 0.1 to 0.99 mg.L-1 “tolerant” and lower 
than 0.1 mg.L-1 as “sensitive”.  
*Resistance categories: S=Sensitive, T=Tolerant, R=Resistant 
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Table S4. Substitutions in the Pseudocercospora fijiensis CYP51 protein. The position of the 
reference codon, the reference sequence and the mutations in the Pfcyp51 gene are indicated.  
 
 
 
 
 
 
 
 
  
Substitution Reference sequence 
Position from start 
codon 
Alternative mutations found 
T18I ACA 53 bp ATA non 
A19E GCG 56 bp GAG non 
Y58F TAC 174 bp TTC non 
I70M ATC 210 bp ATG non 
D71E GAC 213 bp GAA non 
V106D GTC 318 bp GAC non 
V116L GTC 348 bp CTC non 
Y136F TAC 408 bp TTC TTT 
K171R AAA 513 bp AGA non 
V260L GTC 780 bp CTC non 
I264T ATC 792 bp ACC non 
A313G GCT 939 bp GGT non 
H380N CAT 1140 bp AAT non 
A381G GCT 1143 bp GGT non 
R418G CGA 1254 bp GGA non 
A446S GCA 1338 bp TCA non 
D460E GAT 1380 bp GAA non 
D460V GAT 1380 bp GTT non 
Y461D TAC 1383 bp GAC non 
Y461N TAC 1383 bp AAC non 
Y461S TAC 1383 bp TCC non 
Δ(Y461) TAC 1383 bp --- non 
G462A GGC 1386 bp GCC non 
G462D GGC 1386 bp GAC non 
Y463D TAT 1389 bp GAT non 
Y463H TAT 1389 bp CAT non 
Y463N TAT 1389 bp AAT non 
Y463S TAT 1389 bp TCT non 
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Table S5. Characteristics of the amino acid changes in the enzyme 14α demethylase 
sequences of Pseudocercospora fijiensis isolates. 
 
Position Variant Amino acid Group 
Characteristic Hydrophobic Index* 
pH2 pH7 pH2 pH7 
T18 Wild type Threonine Neutral – polar side chain Neutral Neutral 13 13 
I18 Mutant Isoleucine Hydrophobic aliphatic Very Hydrophobic Very Hydrophobic 100 99 
A19 Wild type Alanine Hydrophobic aliphatic Hydrophobic Hydrophobic 47 41 
E19 Mutant Glutamic acid Acidic Neutral Hydrophilic 8 -31 
Y58 Wild type Tyrosine Hydrophobic aromatic Hydrophobic Hydrophobic 49 63 
F58 Mutant Phenylalanine Hydrophobic aromatic Very Hydrophobic Very Hydrophobic 92 100 
I70 Wild type Isoleucine Hydrophobic aliphatic Very Hydrophobic Very Hydrophobic 100 99 
M70 Mutant Methionine Neutral – polar side chain Very Hydrophobic Very Hydrophobic 74 74 
D71 Wild type Aspartic Acid Acidic Neutral Hydrophilic -18 -55 
E71 Mutant Glutamic acid Acidic Neutral Hydrophilic 8 -31 
V106 Wild type Valine Hydrophobic aliphatic Very Hydrophobic Very Hydrophobic 79 76 
D106 Mutant Aspartic Acid Acidic Neutral Hydrophilic -18 -55 
V116 Wild type Valine Hydrophobic aliphatic Very Hydrophobic Very Hydrophobic 79 76 
L116 Mutant Leucine Hydrophobic aliphatic Very Hydrophobic Very Hydrophobic 100 97 
Y136 Wild type Tyrosine Hydrophobic aromatic Hydrophobic Hydrophobic 49 63 
F136 Mutant Phenylalanine Hydrophobic aromatic Very Hydrophobic Very Hydrophobic 92 100 
K171 Wild type Lysine Basic Hydrophilic Hydrophilic -37 -23 
R171 Mutant Arginine Basic Hydrophilic Hydrophilic -26 -14 
V260 Wild type Valine Hydrophobic aliphatic Very Hydrophobic Very Hydrophobic 79 76 
L260 Mutant Leucine Hydrophobic aliphatic Very Hydrophobic Very Hydrophobic 100 97 
I264 Wild type Isoleucine Hydrophobic aliphatic Very Hydrophobic Very Hydrophobic 100 99 
T264 Mutant Threonine Neutral – polar side chain Neutral Neutral 13 13 
A313 Wild type Alanine Hydrophobic aliphatic Hydrophobic Hydrophobic 47 41 
G313 Mutant Glycine Unique Neutral Neutral 0 0 
H380 Wild type Histidine Basic Hydrophobic Neutral -42 8 
N380 Mutant Asparagine Neutral – polar side chain Hydrophilic Hydrophilic -41 -28 
A381 Wild type Alanine Hydrophobic aliphatic Hydrophobic Hydrophobic 47 41 
G381 Mutant Glycine Unique Neutral Neutral 0 0 
R418 Wild type Arginine Basic Hydrophilic Hydrophilic -26 -14 
G418 Mutant Glycine Unique Neutral Neutral 0 0 
A446 Wild type Alanine Hydrophobic aliphatic Hydrophobic Hydrophobic 47 41 
S446 Mutant Serine Neutral – polar side chain Neutral Neutral -7 -5 
D460 Wild type Aspartic Acid Acidic Neutral Hydrophilic -18 -55 
E460 Mutant Glutamic acid Acidic Neutral Hydrophilic 8 -31 
V460 Mutant Valine Hydrophobic aliphatic Very Hydrophobic Very Hydrophobic 79 76 
Y461 Wild type Tyrosine Hydrophobic aromatic Hydrophobic Hydrophobic 49 63 
D461 Mutant Aspartic Acid Acidic Neutral Hydrophilic -18 -55 
N461 Mutant Asparagine Neutral – polar side chain Hydrophilic Hydrophilic -41 -28 
S461 Mutant Serine Neutral – polar side chain Neutral Neutral -7 -5 
Δ461 Mutant non non non non non Non 
Y463 Wild type Tyrosine Hydrophobic aromatic Hydrophobic Hydrophobic 49 63 
D463 Mutant Aspartic Acid Acidic Neutral Hydrophilic -18 -55 
N463 Mutant Asparagine Neutral – polar side chain Hydrophilic Hydrophilic -41 -28 
S463 Mutant Serine Neutral – polar side chain Neutral Neutral -7 -5 
*pH2 values normalized from Sereda et al 1994 (Sereda et al. 1994), pH7 values from 
Monera et al 1995 (Monera et al. 1995). 
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Table S6. YASARA CYP51 hybrid models quality Z-scores. The score includes floppy 
terminal tails. Values close to +1 are consider optimal (in green), negative values close to 0 are 
consider good (in Blue) and values close to -1 are consider satisfactory (in yellow).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hybrid models 
 
C86 Bo_1 CaM10_21 Z14_16 M52_10 M52_22 CaM10_6 
Check type Quality Z-score 
Dihedrals 0.427 0.305 0.429 0.129 0.156 0.268 0.416 
Packing 1D -0.286 0.116 -0.279 0.163 0.04 0.117 -0.412 
Packing 3D -1.087 -1.083 -1.268 -1.132 -1.21 -1.057 -1.287 
Overall -0.555 -0.414 -0.636 -0.444 -0.524 -0.407 -0.699 
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Figure S1. A. Banana plant infected with Pseudocercospora. fijiensis in a greenhouse 
experiment. The plant shows the typical symptom of the disease, elliptical necrotic lesions with 
water-soaked border and a chlorotic yellow halo. B. Symptoms of naturally infected banana 
plants in the field. 
 
A 
B 
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Figure S2. Plots of the Finlay-Wilkinson model (FW) describing the interaction between the 
three fungicides (model: yijk = Fungicidei + bj x Isolatej + εijk or yijk = Isolatei + bj x Fungicidej 
+ εijk.) in 592 isolates of Pseudocercospora fijiensis. A) Individual strains 2Log EC50 raw data 
(3 repeats) of the three DMI. B) Fitted 2Log EC50 mean data. Sensitive and resistant threshold 
are show in blue and red dashes lines, respectively. Indicated in black dots are the isolates of 
which the Pfcyp51 gene is sequenced. General difference between fungicides exist where 
isolates reacts proportionally by the EC50. Nonetheless the main effects of isolate still describe 
nearly 92% of the variation in EC50 found. 
1 mg.L-1 
0.1 mg.L-1 
A) 
B) 
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Figure S3. Plot of the 2Log mean EC50 values distribution of the frequency of all 
Pseudocercospora fijiensis isolates and their interaction with each DMI fungicide: A) 
difenoconazole, B) epoxiconazole and C) propiconazole. The thresholds grouping criteria is 
coloured green for sensitivity, yellow for tolerance and red for resistance. 
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Figure S4. Calculated EC50 means of the tested Pseudocercospora fijiensis isolates with 
fungicide concentration up to 40.96 mg.L-1. The dashed line represents the threshold value (1 
mg.L-1) for DMI resistant isolates.  
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Figure S5. Predicted interaction of propiconazole in the binding site of Pseudocercospora 
fijiensis CYP51. Amino acid residues in the active site are shown in green. The heme group’s 
carbon atoms are depicted in magenta and the propiconazole carbon atoms are shown in cyan. 
Hydrogen atoms are coloured in light grey, oxygen in red and nitrogen in blue. The iron atom 
is also depicted in magenta in the heme group. Interaction forces are shown in blue (cation-π), 
pink or red (π - π) lines.  
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Summary  
Black Sigatoka is one of the most important disease in bananas and plantains and the 
most relevant economically. Black Sigatoka is caused by the dothideomycete fungus 
Pseudocercospora fijiensis, previously known as Mycosphaerella fijiensis. Disease control is 
mainly obtained through the application of fungicides, including the lanosterol demethylation-
inhibitors (DMIs). The continued use of DMI has triggered the appearance of novel genotypes, 
displaying reduced sensitivity to this class of fungicides. So far the phenotype of these isolates 
was found to be linked to the presence of non-synonymous point mutations in the target gene 
encoding the lanosterol 14α-demethylase enzyme (Pfcyp51). In this study, we identify a 19 
base pairs (bp) repeat element in the promoter region (103 bp upstream the coding region) of 
the Pfcyp51gene, whose copy number correlates positively with increased resistance to DMIs. 
A PCR-based assay was developed to characterize four field populations of P. fijiensis in Costa 
Rica for the presence and copy numbers of repeated elements within the Pfcyp51 promoter. 
Additionally, functional analyses - including promoter swapping - showed that the presence 
of the repeat element proportionally upregulates Pfcyp51 expression which consequently 
decreases sensitivity to the DMIs in vivo. This study provides important information on the 
genetic mechanisms that confer reduced sensitivity to azole fungicides and might offer a tool 
for optimizing the use of azoles in disease management of black Sigatoka. 
 
Introduction 
 Black Sigatoka, caused by the ascomycete Pseudocercospora fijiensis (Morelet) 
Deighton (1976), (synonym, Mycosphaerella fijiensis Morelet (1969)), is one of the most 
devastating and economically significant diseases for export bananas and plantains. Disease 
management of black Sigatoka is mainly based on the application of fungicides, in which 
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single-sites plays an important role. However, the high level of sexual reproduction of this 
fungus favours the generation and maintenance of highly diverse populations with a broad 
base-line sensitivity towards fungicides (Arango Isaza et al., 2016; Conde-Ferráez et al., 2007; 
Hayden and Carlier, 2003; Rivas et al., 2004; Romero and Sutton, 1997). As a result, fungicide 
resistance develops frequently and spreads rapidly, particularly when pathogen populations 
are under strong selection pressure (Arango et al. 2016; Ware et al. 2006). This situation has 
contributed to a dramatic increase in the number of fungicide applications, which can tally up 
to over 50 applications (12 azoles applications) per year in some banana export countries 
(Chong et al. 2016b; FRAC 2010; Lapeyre et al. 2010a; Martínez-Bolaños et al. 2012). This 
can dramatically  increase production costs by as high as  30% (Marín et al., 2003) and 
additionally poses a threat to occupational health and the environment. It is thus imperative to 
understand the mechanisms by which resistance towards DMIs develops in order to enable 
adequate long-term disease management strategies with optimized chemical input. 
Azoles fungicides have been used against black Sigatoka as early as 1987, but became 
widely used since 1991 when propiconazole, one of the currently prominent lanosterol 14-
demethylation inhibitors (DMIs), was introduce in the market (Chong et al. 2016a; Romero & 
Sutton 1997) (Chong et al., 2016a; Romero and Sutton, 1997). Currently, several DMI 
fungicides, such difenoconazole, bitertanol, and epoxiconazole are commonly used in spray 
programs (Chong et al., 2016a). DMI fungicides act as inhibitors of the CYP51 enzyme 
involved in the 14α-demethylation of the ergosterol precursor eburicol (24-methylene-24, 25-
dihydrolanosterol). Ergosterol regulates cellular membranes fluidity and permeability, and is 
essential for cell viability (Lepesheva and Waterman, 2011). Resistance or reduced sensitivity 
for most single-site fungicides developed rapidly in P. fijiensis after introduction of 
strobilurins, benzimidazoles, and DMI for disease control in banana production (Arango et al., 
2016; Amil et al., 2007; Cañas-Gutiérrez et al., 2009, 2006; Romero and Sutton, 1997). 
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Previous studies on P. fijiensis revealed the correlation between resistance to propiconazole 
and point mutations in the Pfcyp51 gene, which caused amino acid (aa) substitutions 
surrounding the Substrate Recognition Site (SRS) at positions Y136, A313, Y461 and Y463 
(Cañas-Gutiérrez et al., 2009; Chong et al., 2016b). Prior to this work, aa substitutions were 
the only described mechanisms for shifting sensitivity to azoles in P. fijiensis. Here, we report 
the presence and analysis of a repetitive element in the promoter region of Pfcyp51 gene from 
P. fijiensis field strains that are resistant to propiconazole. Specifically, we have studied the 
presence and copy number of these elements in 239 field isolates that were collected in Costa 
Rican banana plantations with and without fungicide applications, and compared them with 
control isolates originating from Ecuador, Asia and Africa. This comparison enabled us to 
establish positive correlation between the presence and copy number of the elements in the 
Pfcyp51 promoter, on one hand, and its overexpression and reduced fungicide sensitivity, on 
the other. The influence of promoter inserts, on increased target expression and reduced azole 
sensitivity was experimentally corroborated by using promoter swaps between propiconazole, 
difenoconazole and epoxiconazole sensitive and resistant P. fijiensis strains. These promoter 
inserts upstream of the Pfcyp51 gene represent an additional resistance mechanism in P. 
fijiensis. 
 
Materials and methods 
Pseudocercospora fijiensis strains  
 A set of 25 monoascosporic P. fijiensis strains from Africa, Asia and Latin America, was 
used for fungicide sensitivity assays. Eight of the Latin-American strains were collected in 
Ecuador and 11 strains in Costa Rica. The larger set of Costa Rican strains was from four 
different banana plantations: Cartagena (Ca), Zent (Z), San Pablo (SP) and San Carlos (ZTSC) 
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(Arango et al., 2016). The former three are frequently sprayed with fungicides, whereas the 
San Carlos is a plantain growing area with low P. fijiensis incidence, hence fungicides are not 
required for disease control. We consider the P. fijiensis population from this area as a wt 
population. Strains were obtained from CORBANA (Costa Rica), CIBE-ESPOL (Ecuador) 
and CBS-KNAW Fungal Biodiversity Centre (Africa and Asia). 
 
Determination of in vitro sensitivity to azole fungicides  
The fungicides propiconazole and difenoconazole were provided by Syngenta Crop 
Protection AG, Basel, Switzerland. Epoxiconazole was obtained from Sigma (Sigma Aldrich, 
Missouri, USA). All compounds were technical grade quality and were kept in 100x stock 
solutions, either in methanol or DMSO. When applied to the culture medium the final 
concentration of the solvents was <1% (v/v). For the initial in vitro sensitivity assays the final 
concentrations tested for propiconazole were 10, 5.62, 3.16, 1.78, 1.0, 0.56, and 0.31 mg·L-1. 
Subsequently, to evaluate sensitive strains more accurately, lower concentrations of fungicides 
were included in the assays (10.24, 2.56, 0.64, 0.16, 0.04, 0.016, 0.004, 0 mg·L-1) and exploited 
to evaluate the performance of P. fijiensis transformants in the presence of propiconazole, 
difenoconazole and epoxiconazole.  
Fungicide sensitivity of each strain was determined by calculating the 50% inhibitory 
concentration (EC50). Quantitative analysis of fungal growth, was determined by the 96 -well 
microtiter plate dilution assay (Peláez et al. 2006) with some modifications. Fifty microliters 
of a 1x105 mycelial parts/mL solution from each strain were inoculated in 200 l potato 
dextrose broth medium per well of a 96-well polystyrene, flat bottom, transparent, plate 
(Corning, USA; cat. # 3370). Plates were incubated at 25 ºC in an incubator (Elbanton, 
Kerkdriel, Netherlands) for seven days before mycelial growth was measured. Each 
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concentration was tested in duplicate per strain, and per plate four blank controls were present. 
Individual plates were considered as one biological replicate, and tests were performed in 
triplicate. Absorbance was initially measured at 620 nm in a TECAN A5082 plate reader 
(Männedorf, Switzerland), but due to the variation of mycelial colours over the strains as well 
as the different colony morphologies, we eventually monitored growth at an absorbance of 
690 nm in an Infinite® M200 PRO reader (TECAN, Männedorf, Switzerland), which enabled 
measuring higher sensitivities. The read design per well was settled at room temperature, 
leaving a border of 1,000 m, a bandwidth of 9 m, circle-filled reads of 25 read points (5x5), 
and each read point was measured 5 times. Read averages were plotted against dpi and 
compared with the other strains and controls. The fungicide sensitivity of transformants and 
control strains was determined by the aforementioned 96-well polystyrene plates. Sealed 
plates were maintained at 27 ºC in an incubator (Elbanton, Kerkdriel, Netherlands) in darkness 
and fungal growth was evaluated 10 days post inoculation (dpi). Plates were evaluated at 690 
nm, while covered to reduce contamination. 
 
Pfcyp51 gene and promoter amplification and sequencing  
 To amplify the Pfcyp51 gene and the promoter region, specific primers located 
at the first repeat element and 22 bp upstream of the open reading frame (ORF) were used: 
CYP51_Pfijien_F1 (5’-AAGGTCATATCGCAGG-3’) and CYP51_Pfijien_R1 (5’-
GAATGTTATCGTGTGACA-3’). A basic PCR mix was prepared and the PCR program 
consisted of 5 min. of denaturation at 94 °C followed by 34 cycles of 30 sec. at 94 °C, 30 
sec. of annealing at 55 °C and 90 sec. of extension at 68 °C. An additional extension step 
of 7 min. at 72 °C was performed at the end. DNA sequencing of the gene was performed 
at Macrogen (Seoul, Korea) and by the Genomics facility of Wageningen University and 
Research Centre (WUR), directly using the PCR products. In order to obtain the entire 
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sequence of the gene and the promoter region four primers were used in the sequencing 
reactions: CYP51_Pfijien_F2 (5’-ACAGAAACATCACCTCC-3’), CYP51_Pfijien_F3 (5’-
ATTGCTTCACTTTCATCC-3’), CYP51_Pfijien_F4 (5’-CTCTACCACGATCTCGAC-3’) and 
CYP51_Pfijien_R2 (5’-GATATGGATATAGTTGTC-3’). The obtained sequences were 
assembled in contigs per strain using CLC DNA Workbench software (CLC bio, Aarhus, 
Denmark) and the ORF was translated to aa and the protein sequences were aligned using 
the ClustalW plug in. The sequence alignments allowed the identification of mutations. 
 
Pfcyp51 gene expression analysis 
 Extraction of total RNA was carried out with mycelia of P. fijiensis isolates grown 
for 10 days in liquid PDB using the Qiagen RNA extraction plus mini kit (QIAGEN Inc., 
Valencia, USA). The integrity of the RNA was checked using agarose gel electrophoresis and 
the concentration was determined by measuring absorbance at 260 nm in a nanodrop 
spectrophotometer (Thermo scientific, Wilmington, USA). Expression analysis was 
performed by quantitative real time -PCR (qRT-PCR) using primers QRTCYP-forward: (5’-
CGCCAGTATTCGGCACAGATGTCG-3’) and QRTCYP-reverse: (5’-
TAACGTAGGACTGGAGGGCGGA-3’), which amplify a fragment of 89 bp of the Pfcyp51 
gene and primers QRTACT-forward: (5’-TCCGTCCTTGGTCTCGAATCTGGT-3’) and 
QRTACT-reverse: (5’-TGCATACGGTCGGAGATACCTGGA-3’), which amplify a 
fragment 146 bp of the P. fijiensis actin gene that was used to normalize the expression. 
Quantitative RT-PCR reactions were performed using 20 ng of total RNA per strain in an 
Applied Biosystems ABI 7500 thermocycler (Waltham, USA) using the Applied Biosystems 
Power SYBR® Green RNA-to-CT™ 1-Step Kit, according to the manufactures instructions. 
The delta-delta Ct method was used - with the actin gene as the endogenous control - to 
determine the level of Pfcyp51 gene expression (Livak & Schmittgen 2001). 
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Analysis of promoter repeats of Pfcyp51 gene in four Costa Rican P. fijiensis 
populations 
Genomic DNA (gDNA) of 225 P. fijiensis isolates from the four Costa Rican 
populations was analysed; 82 from the Cartagena population, 43 from the San Pablo 
population, 84 from the Zent population, and 16 from the San Carlos wt population. PCR 
fragments were amplified from gDNA using the specific primer pair, P._fijiensis_repeats_F 
(5’-TCTCGTACGATAGCACCTGCCCA-3’) and P._fijiensis_repeats_R (5’-
TGTTGGTGTAGGGGGTTAGGCCA-3’) that was designed to amplify the promoter region 
of Pfcyp51. PCR conditions comprised 2 min. at 95 °C, 30 cycles of 30 sec. denaturation at 95 
°C, 30 sec. of annealing at 68 °C, and 2 min. of extension at 72 °C with an additional extension 
step of 10 min. at 72 °C at the end of the reaction. PCR products were visualized and evaluated 
on a 1% agarose gels and eleven isolates were selected for sequencing and subsequent analysis 
of promoter and coding sequences. Different repeated elements were aligned and a weblogo 
consensus sequence was generated (Crooks et al. 2004) to graph nucleotide conservation 
within the elements. 
 
Promoter swapping  
We performed a promoter swapping experiment to test the effect of promoter repeats 
on Pfcyp51 expression and henceforward on sensitivity to several azole fungicides. The 
Pfcyp51 donor promoter for homologous recombination was obtained from the resistant strain 
Ca5_16. The recombination construct pPROM_CYP51_Ca5_16 comprised an upstream 2,024 
bp fragment (the PfCyp51 gene has an antisense position in the genome), obtained by using 
primers 5-CYP-Prom Fwd (5´-GGGGACAACTTTGTATAGAAAAGTTGAGGATATCAAGCACGCAC-3´) 
and Rev (5´-GGGGACTGCTTTTTTGTACAAACTTGGAAGAGAAACGGACTCCA-3´), which was 
cloned in front of a cassette with the hygromycin (hph) resistance gene and the green 
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fluorescent protein (gfp) gene, followed by the upstream region of 1,737 bp obtained with 
primers 3-CYP-Prom Fwd (5´- GGGGACAGCTTTCTTGTACAAAGTGGGAATGAGCATTTGAGAGC-
3´) and Rev (5´-GGGGACAACTTTGTATAATAAAGTTAATACTAGCGGAGGTTCG-3´), containing the 
promoter region of strain Ca5_16, which has six promoter repeats. Transformations were 
performed by Agrobacterium tumefaciens mediated transformation (Díaz-Trujillo et al. 
2016b) using the sensitive P. fijiensis strain E22, with a single repeat element and no mutations 
in the coding region. The promoter length of 250 GFP labelled transformants was compared 
with the promoter length of the resistant donor Ca5_16 and the sensitive recipient E22 strains. 
Transformants with a Ca5_16 sized promoter are considered to be homologous recombinants, 
hence promoter swapped transformants, which were subsequently analysed for the integration 
site using PCR of a 2,629 bp amplicon using primers PROM-HR-3´ Fwd (5´-
TGAGCATTTGAGAGC-3´) and Rev (5´-TTATGATCGCCTCCAAGC-3´) located in the 
cassette and the Pfcyp51 ORF, respectively. 
 
Results  
In vitro sensitivity to propiconazole 
The P. fijiensis isolates that were tested for sensitivity to the azole fungicides were 
classified in three groups; strains with (1) EC50 values of ≤0.10 mg.L-1 were marked sensitive; 
(2) EC50 values between 0.10 to 0.90 mg.L
-1 were consider tolerant and (3) those with EC50 
values ≥1.0 mg.L-1 were consider resistant (Figure 1 and Table 1). Among the 25 isolates tested 
for sensitivity to propiconazole, 7 were sensitive, 14 moderately resistant and four were 
resistant. Clear cross-resistance was observed, since all isolates showed similar EC50 values 
(data not shown). In general, strains coming from banana plantations in Costa Rica and 
Ecuador displayed higher EC50 values compared to strains coming from Africa or Asia. Also 
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strains originating from frequently (>50/year) sprayed plantations (Chong et al., 2016a; De 
Lapeyre De Bellaire et al., 2010), such as Cartagena, showed significantly reduced sensitivities 
to the fungicides, contrary to strains coming from regions not subjected to fungicide 
applications (Figure 1, Table 1).  
 
 
 
 
Figure 1. Sensitivity of Pseudocercospora fijiensis strains to propiconazole. The sensitivity 
thresholds are marked with dotted lines. Sensitive strains from different origin are inhibited at 
very low concentrations (green bars). The other strains were obtained from various banana 
plantations in Ecuador (E, RS, SaR, RN and GS) and Costa Rica (Ca and Z) where black 
Sigatoka disease is controlled through frequent fungicide applications. Tolerant 
Pseudocercospora fijiensis isolates are shown in orange. The “Ca” strains originate from the 
Costa Rican Cartagena banana plantation, which is frequently sprayed with fungicides, and 
they display the lowest level of sensitivity (blue bars). 
 
 
 
 
 
 
 
 
 
-8
-7
-6
-5
-4
-3
-2
-1
0
1
2
3
C
_8
6
*
E_
2
2
X
8
4
7
X
8
4
9
X
8
4
6
X
8
5
1
X
8
4
5
R
S_
13
Z4
_1
4
Z8
_1
7
Z4
_1
6
Sa
R
_2
Z8
_1
8
Z4
_1
1
Z8
_1
2
Z4
_7
Sa
R
_5
R
N
_
3
R
N
_
5
G
S_
1
0
G
S_
4
 C
a6
_1
1
C
a5
_
1
6
C
a1
_
5
C
a1
0
_
13
2
Lo
g 
EC
5
0
(m
g.
L-
1
)
Pseudocercospora fijiensis isolates
Chapter 4 
188 
 
T
a
b
le
 1
. 
O
ri
g
in
 a
n
d
 c
h
ar
ac
te
ri
st
ic
s 
o
f 
th
e 
P
fc
yp
5
1
 g
en
e 
a
n
d
 i
ts
 p
ro
m
o
te
r 
in
 2
5
 P
se
u
d
o
ce
rc
o
sp
o
ra
 f
ij
ie
n
si
s 
st
ra
in
s 
u
se
d
 i
n
 t
h
is
 s
tu
d
y
, 
in
c
lu
d
in
g
 
th
e
ir
 s
e
n
si
ti
v
it
y
 t
o
 p
ro
p
ic
o
n
az
o
le
 (
E
C
5
0
) 
 
A new resistance mechanism in Pseudocercospora fijiensis 
 189 
Resistant Pseudocercospora fijiensis strains always contain repetitive elements in the 
Pfcyp51 promoter  
 Closer examination of the promoter of the Pfcyp51 gene revealed that sensitive 
isolates contain a 19 bp promoter element “TAAATCTCGTACGATAGCA” (Figure 2). This 
element is present as a single element in the CIRAD86 reference and originally located a few 
nucleotides downstream in the promoter MYCFIscaffold_7:2121794 – 2121813, (-122 bp 
upstream of the Pfcyp51 start codon).  
A detailed analysis of the promoter of the resistant strains identify a region of high 
variation, with insertions starting at position at 2,121,774 of scaffold 7 in the genome sequence 
of the reference strain (Pseudocercospora fijiensis v2.0, JGI), ~103 bp upstream of the start 
codon of Pfcyp51 (antisense direction). Some isolates contain a partial construction of the 
element in their insertions, while others have a modified element due to a few additional 
nucleotides. Additional to the 19 bp element of a partial construction element of 16 bp 
(TAAAATCTCGTACGAT) and a modify element of 20 bp 
(TAAAATCTCGTACGATAGCA), were also present. For example, in highly resistant strains 
Ca1_5, Ca5_16, Ca6_11, and Ca10_13 (Figure 2) this element is repeated up to six times (four 
fully conserved and one partial, mostly in tandem insertion) and three tandem times in the 
tolerant P. fijiensis strains Z8_12 and Z8_18. DNA sequence analysis of the most resistant 
strains from Costa Rica (Ca5_16, Ca6_11 and Ca10_13), revealed that these contain identical 
mutations in the coding region of the Pfcyp51 gene, and that the length of the insertion in the 
promoter reach 100 bp (Table 1).  
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Figure 2. Sequence logo of the Pfcyp51 promoter repeat element. Sequences of all repeat 
elements were aligned and used to generate a sequence logo using the WebLogo website 
(http://weblogo.berkeley.edu/logo.cgi). The logo displays the frequency of the nucleotides 
within the three different repeated elements with 16, 19 or 20 bp that we observed in the 
promoter. Nucleotide frequency is scaled relative to the information content (measure of 
conservation) at each position. The positions 3-16 are most characteristic for the repeat 
element. 
 
Repetitive elements in the promoter of Pfcyp51 upregulate its expression 
In order to test whether Pfcyp51 gene expression is affected by the presence of 
repetitive element, we performed quantitative real time RT-PCR on total RNA from mycelia, 
normalized to the expression of the actin gene, Pfact. Pseudocercospora fijiensis strains 
Ca5_16, Ca6_11 and Ca10_13, which have six repetitive units in their promoter, have a five-
fold increase in Pfcyp51 gene expression as compared to strains E22 and CIRAD86, that have 
only one (Figure 3). In contrast, no significant difference was found between the control strains 
and P. fijiensis strain Z8_12, with three units. The up-regulation of Pfcyp51 was constitutive 
and independent of addition of propiconazole in the culture medium (data not shown). 
 
High frequency of the repetitive element in reduce sensitive strains from Costa Rican 
banana plantations 
To identify the copy number of the repetitive element present in the promoter of 
Pfcyp51, we performed PCR analysis on 225 isolates originating from four banana plantations 
in Costa Rica that were previously studied (Arango et al., 2016): three plantations (Cartagena, 
Zent and San Pablo) with intensive fungicide applications and one plantation (wild type; wt) 
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(ZTSC) that has not received any fungicide applications. Examination of the amplicon sizes 
by gel electrophoresis revealed banding patterns that correspond to two, three and six promoter 
repeats (Figure 4A). 
 
Figure 3. Relative expression of the Pfcyp51 gene in six Pseudocercospora fijiensis strains 
carrying different numbers of the promoter element. Relative expression was normalized with 
the P. fijiensis actin gene. Numbers on top of each bar stand for the number of promoter 
element present. Reference isolate CIRAD86 (C86) is shown in green. Data represent averages 
of three biological repetitions with each at least three technical replicates (error bars indicate 
standard variations). 
 
Amongst P. fijiensis populations collected from fungicide treated plantation, the 
Cartagena population was dominated by isolates containing six Pfcyp51 copies of the element, 
(50 out of 82) followed by isolates with two copies (29 out of 82), isolates carrying the unique 
element were the least represented (3 out of 82). In contrast, Zent population was dominated 
by strains carrying the unique element (59 out of 84) but isolates containing two and six 
promoter repeats were also found (11 and 14 out of 84 respectively). San Pablo population 
was dominated by isolates carrying three promoter repeats (23 out of 43), this genotype was 
not observed in the Cartagena and Zent populations, followed by isolates with six (10 out of 
23), one (8 out of 23) and two (2 out of 23) promoter repeats. In contrast, the population from 
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untreated plantations exclusively contained strains with just one 19 bp element in the Pfcyp51 
promoter (Figure 4B). 
 
 
Figure 4. Screening for the Pfcyp51 promoter repeats in Pseudocercospora fijiensis strains 
from four Costa Rican populations. A) Example of PCR amplification of Pfcyp51 promoter in 
isolates from different populations. Isolate CIRAD86 (C86) was used as indicative control for 
the presence of one promoter element, Z8.12 as control with three element repeats and Ca5_16 
as control of six element repeats. The number of elements repeated in each control sample is 
showed above the corresponding band. The other strains originate from banana plantations 
under fungicide disease management and represent various promoter length variants as 
controls. B) Distribution of the number of Pfcyp51 promoter inserts within Costa Rican 
populations of Pseudocercospora fijiensis, based on 225 PCR amplifications. 
 
Subsequent sequence analysis revealed that the promoter insertions were 100 (six 
elements), 59 (three elements) or 42 bp (two elements) in length. Most repetitive elements are 
inserted at 103 bp upstream of the start codon of the Pfcyp51 gene. As mention before some 
isolates contain a partial construction of the element in their insertions, while others have a 
modified element due to a few additional nucleotides comprising three different alternatives 
(element of 20 bp, 19 bp, or 16 bp). Elements of 20 bp and 19 bp only differ in one nucleotide 
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an extra adenine, whereas the 16 bp element represents a shorter version of the 19 bp insert 
(Figure 5). The 19 bp element was found alone in isolates with one, two and three copies, 
whereas in isolates with six copies of the repetitive element, the 19 bp element was 
accompanied by the 20 bp and 16 bp variants present as single units. Hence, the 19 bp element 
is the commonest insertion across all isolates analysed (Figure 2). 
 
 
Figure 5. Alignment of the promoter region of the Pfcyp51 gene of Pseudocercospora fijiensis 
strains from the Zent (Z), Cartagena (Ca), San Pablo (SP) and the wt San Carlos (ZTSC) 
banana plantations in Costa Rica. Isolate CIRAD86 (C86) is the reference wt isolate. The 
normal element present in all isolate at position -122 bp is shown in green arrows. The different 
repeated insertions found in some P. fijiensis isolates are shown in red. 
 
Analysis of the Pfcyp51 coding sequence 
As expected, sequence analyses of different isolates revealed the presence of non-
synonymous mutations in the coding region of Pfcyp51. These resulted in the amino acid (aa) 
changes Y136F, A313G, Y463D/H/N that were previously reported and linked to sensitivity 
loss for propiconazole (Cañas-Gutiérrez et al., 2009). In addition, nine not previously 
described aa changes (T18I, Y58F, V106D, V116L, K171R, A381G, A446S, G462A, and 
Y463S) were detected (Table 1). In all isolates T18I and V106D were identified. Excluding 
these, the most frequent aa changes were A313G and Y463N/D/S/H, present in 44% and 66% 
of the analysed isolates, respectively. These were often found in combination with Y136F and 
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A381G. The most frequent haplotype amongst the 25 isolates was T18I, V106D, Y136F, 
A313G, Y463D/N/S, which was found present in combination with two, three or six copies of 
the repetitive element and accounts for 30% of the isolates. In addition, several other 
combinations of aa substitutions were observed in the analysed cohort of P. fijiensis strains, 
including A313G - Y463S/H/D/N, G381A - G462A, Y136F - Y463D, Y136F - A381G - 
Y463D, and K171R - A446S.  
 
Functional analysis of the Pfcyp51 promoter insertions  
We discovered a range of promoter insertions exclusively in P. fijiensis populations 
from treated banana plantations. The promoter insertions, in particular the six repeats insertion 
was shown to confer enhanced expression of Pfcyp51. The strains carrying the insertions 
display reduced sensitivity to DMI fungicides but, also carry Pfcyp51 mutations in the coding 
sequence which is the most common mechanism for conferring shifted sensitivities to these 
fungicides. To disentangle the relation between both mutations in the coding sequence and the 
promoter insertions, we introduced the Pfcyp51 promoter from the resistant P. fijiensis strain 
Ca5_16, (Costa Rica, Table 1) which has six repetitive elements into the sensitive wt E22 
strain from Ecuador (Table 1). Transformation of P. fijiensis strain E22 resulted in 250 green 
fluorescent protein (GFP) and hygromycine (HGH) positive transformants (Figure 6A). The 
transformants were PCR characterized to identify strains with the six repeat elements promoter 
region inserted at the correct integration site from ectopic transformants (Figure 6B). Two 
independent transformants, Swap26 and Swap121 (Figure 6C), showing the Ca5_16 promoter 
amplicon (Figure 6B) and positive for the correct integration site (Figure 6C) were selected 
for further analyses. Subsequently, we performed qRT-PCR analyses on Swap26 and Swap121 
along with the P. fijiensis control strains comprising the recipient wt strain E22 and the wt 
resistant strains Ca5_16 and Ca10_13 and an ectopic transformant.  
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Figure 6. Transformation design for Pfcyp51 promoter swap strains of Pseudocercospora 
fijiensis. A) Strain Ca5_16 is the Pfcyp51 promoter donor (slashed area) in the 
3´recombination fragment together with 5´fragment (crossed out area) was amplified with 
CYP-Prom primers and ligated to a cassette with the HGH and GFP markers into construct 
pPROM_CYP51_Ca5_16. This construct was inserted into the P. fijiensis recipient E22 
sensitive strain, containing a single promoter element (dotted area). After Agrobacterium-
mediated transformation and selection for gfp tagged strains, homologous recombination sites 
were amplified with PROM-HR-3´primers to detect and characterize promoter swapped 
transformants. B) The promoter lengths of positive GFP tagged transformants was amplified 
and compared with the donor and the wt recipient strain. Transformant Swap 26 is shown as 
an example of a true promoter replacement transformant, which show a similar amplicon as 
the donor strain. Ectopic transformants possess the promoter fragment of both the donor and 
the recipient strain, respectively, whereas untransformed strains only show the wt-sized 
amplicon. C) Verification of swapping by amplification of the 2,629 bp cassette between the 
homologous recombination sites and the Pfcyp51coding region using primers PROM-HR-3´. 
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Consistent with previous results, the resistant strains Ca5_16 and Ca10_13 express 
Pfcyp51 at a higher level than the E22 recipient strain. Moreover, the expression of Pfcyp51 
was significantly increased in both Swap26 and Swap121 compared to E22 and the ectopic 
strain. The expression phenotype of both Swap26 and Swap121 was not significantly different 
from that of the resistant donor strain Ca5_16 (Figure 8A). Hence, these results prove that 
replacing the Pfcyp51 promoter from a resistant strain to a sensitive strain results in over 
expression of Pfcyp51.  
To determine whether the observed effect was independent of azole fungicides we 
challenged the transformants with difenoconazole, epoxiconazole and propiconazole, and 
calculated the EC50. A consistent pattern of growth was observed on the plates. The resistant 
Ca10_13 strain up to concentration of 2.56 mg·L-1 of difenoconazole or epoxiconazole, and 
10 mg·L-1 of propiconazole. The sensitive strain E22 and the ectopic transformant only grew 
up to concentration of 0.016 mg·L-1 of difenoconazole and 0.04 mg·L-1 of epoxiconazole or 
propiconazole. The Swap26 and Swap121 transformants grew at least on fourfold higher 
concentrations as compared to the sensitive wt strain E22. The ectopic transformant, displayed 
similar sensitivity to E22 regardless of the fungicide used (Figure 8B and 8C; Table 2). For 
difenoconazole, transformants Sawp26 and Sawp121 displayed a twofold and over fourfold 
(4,25) increment of EC50 compared to the sensitive E22 strain, whereas the resistant strain 
Ca10_13 was 703-fold more resistant. For epoxiconazole, Swap26 displayed a 4.48-fold 
reduction in sensitivity, while Swap121 displayed a slightly higher shift of 8.36-fold. By 
contrast the resistant strain Ca10_13 was 185.84-fold less sensitive to epoxiconazole than wt 
strain E22. The EC50 value for propiconazole of this strain was 4.65- and 5.23-fold higher 
compared to Swap26 and Swap121, respectively. The resistant strain Ca10_13 was 217.42-
fold less sensitive in comparison with wt E22 (the resistant strain Ca5_16 was not analysed at 
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this point due to contamination). Overall this data confirms the contribution of promoter 
modifications in the overall sensitivity shift to the azoles in P. fijiensis. 
 
Table 2. Means of EC50 values
1 (mg.L-1) of the Pseudocercospora fijiensis promoter swapped 
transformants Swap26 and Swap121 and various control strains to three azole fungicides.  
 
1Data represent at least three independent biological replicates with each two technical 
repeats. 
 
 
 
Figure 7. Configuration of the Pfcyp51 promoter of the Pseudocercospora fijiensis strains 
used for transformation and the recombinant individuals. The promoter region is represented 
at the left as a blue line with different coloured boxes. Green boxes represent the 19 bp 
promoter repeat element. Blue and orange boxes represent alteration of 20 bp and 16 bp 
element respectively. Rectangular boxes at the right represent the coding region. The sensitive 
wt configuration is depicted in green and the resistant donor (resistant wt) configuration is 
shown in blue. Vertical lines –with aa substitutions - in these blue and green rectangular boxes 
represent mutations in the coding region. 
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Figure 8. In vitro sensitivity of the promoter swapped Pseudocercospora fijiensis 
transformants Swap26 and Swap121 vs. various control strains. (A) The relative expression 
(normalized with the expression in wt sensitive donor strain E_22) of Pfcyp51 in Swap26 and 
Swap121, the wt E22 and the resistant strain (Ca10_13) with identical promoter and coding 
region as donor strain (Ca5_16) as well as the ectopic control strain (Ectopic 34). Data 
represent the averages of three replications. (B) Fungicide sensitivity assays of Swap26 and 
Swap121 and the ectopic, wt resistant (Ca10_13) and recipient (E_22) controls to 0 – 10.24 
ppm of difenoconazole, epoxiconazole and propiconazole at 10 days post inoculation (pictures 
are representative for three independent repetitions). (C) Graphical interpretation of the 
fungicide sensitivity assays shown in (B).  
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Discussion  
 
 Management of crop diseases is commonly based on an integrated approach making 
use of combined breeding for host resistance, agronomic measurements and crop protection 
agents whenever necessary (Matthews et al. 2014). Due to the overall P. fijiensis susceptibility 
and ubiquity of “Cavendish” clones, which represent over 90% of the global banana trade, 
disease control in banana is almost entirely relying on crop protection agents and prophylaxis 
measures. Despite the use, under particular conditions, of forecast and disease monitoring as 
decision support systems, accompanied with prophylaxis measures as leaf surgery and 
removal of infected material to reduce the inoculum potential, the cornerstone for P. fijiensis 
control remains chemical crop protection (Chong et al., 2016a). Consequently, the selection 
pressure on the pathogen has been enormous, which resulted in the appearance of fungicide 
resistant populations. This urges for a better understanding of the nature and development of 
resistance. 
Known mechanisms of resistance against azole fungicides include non-synonymous 
point mutations in the cyp51 coding region, overexpression of the gene and the overexpression 
of membrane efflux pumps (Ma et al., 2006; Stergiopoulos et al., 2002). A number of 
mutations in the cyp51 gene that are linked to DMI resistance are shared across diverse species 
and some are linked to a specific azole (reviewed by Becher and Wirsel, 2012). In the case of 
P. fijiensis, the presence of mutations in the Pfcyp51 gene was related to propiconazole 
resistance (Cañas-Gutiérrez et al., 2009). In the present work we have focused on the promoter 
region as an important determinant for Pfcyp51 gene expression, and describe the 
identification of a 19 bp repetitive element, whose presence upregulates Pfcyp51 expression 
and leads to reduced DMI sensitivity. Our data represent the first report of targeted genetic 
manipulation in P. fijiensis, and the first description of a modified promoter resulting in the 
Chapter 4 
200 
over expression of Pfcyp51 and contributing to reduced DMI sensitivity, thereby constituting 
a new mechanism of DMI resistance in this organism. 
We observed a broad sensitivity range among the different P. fijiensis strains to the 
tested DMI fungicides with a clear connection between geographical origin of the strains and 
reduced sensitivity to these compounds. This is in agreement with previous work showing that 
the majority of resistant strains was isolated from countries where the banana production is 
economically very important, such as Costa Rica and Ecuador, and where fungicide 
application frequencies are very high (Aguilar-Barragan et al. 2014; Amil et al. 2007; Arango 
et al. 2016; Chong et al. 2016b; Marín et al. 2003). 
The majority of P. fijiensis isolates from the Zent population were tolerant, whereas 
the strains from the Cartagena population were amongst the most resistant encountered in this 
study. Interestingly, sensitive strains were still found in these heavily treated plantations and, 
more surprisingly, some strains from the non-treated ZTSC population showed tolerance or 
resistance (Chong et al., 2016a). Despite this pattern was observed in very small portion of 
these populations, it raises questions about the underlying mechanisms. We tentatively 
propose that this could be due to a low frequency gene flow according to the stratified dispersal 
combination with the relatively narrow spatial scale of ascospore distribution (Rieux et al., 
2014, 2013) for the approximately 100km distance between ZTSC and the other locations 
(Arango et al., 2016). 
 Pseudocercospora fijiensis populations in banana plantations in Costa Rica that are 
frequently sprayed with fungicides comprise a plethora of genotypes with diverse mutations 
in the coding region of the Pfcyp51 gene (Chong et al., 2016b). Some of these mutations were 
previously reported in Colombian P. fijiensis populations and were related with resistance to 
propiconazole (Cañas-Gutiérrez et al., 2009) as well as to other azoles in Zymoseptoria tritici, 
Candida albicans, and Aspergillus fumigatus (Akins and Sobel, 2009; Cools et al., 2013; 
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Mellado et al., 2007). These aa changes are all located at the SRS (Alvarez-Rueda et al. 2011; 
Becher & Wirsel 2012; Morio et al. 2010; Mullins et al. 2011). 
One of the most frequent aa substitutions found in our work, Y136F, was previously 
reported for Blumeria graminis (Wyand & Brown 2005), and for C. albicans (Morio et al. 
2010). Changes in the Ca5_16 and Ca10_13 strains are equivalent to Y137F, A379G and Y461 
in Z. tritici, which are related to different and highly resistant azole phenotypes (Leroux & 
Walker 2011; Stammler et al. 2009). The substitution Y137F is close to the azole docking site, 
A379 forms part of the secondary structure adjacent to the cavity, and Y461 is located at the 
heme end(Mullins et al., 2011). For many of the isolates we eventually had only DNA 
available, as P. fijiensis isolates are hard to maintain, hence there was no possibility to examine 
for the DMI sensitivity phenotypes in all the haplotypes. However, this will be addressed in a 
wider study in the future (Chong et al., 2016b).  
 Unexpectedly, we found that in addition to the Pfcyp51 coding region mutations, the 
majority of the P. fijiensis strains from the Costa Rican Cartagena population contain a 100 bp 
insertion in the promoter region. These insertions are composed of six copies of a repetitive 
element, whereas a single copy of this element is present in all sensitive strains. Strains with 
reduced sensitivity have usually two, three or more copies of this element. Changes in the 
promoter region of the cyp51 gene have been described in other fungi, such as truncated 
derivatives of a LINE-like retrotransposon in Blumeriella jaappi (Ma et al., 2006), a MITE-
like transposon named PdMLE1 in Penicillium digitatum (Sun et al. 2013), a larger transposon 
of 1.8 kb in A. fumigatus (Albarrag et al., 2011; Verweij et al., 2013) and transcription factors 
binding site in V. inaequalis (Villani et al., 2016). More detailed studies would be required in 
P. fijiensis to decipher whether the insertions we observed corresponds to the movements of a 
transposon sequence or whether the Pfcyp51 expression might also be regulated by 
transposons. However, unlike previous reports of promoter insertions with a 199 bp to 5.6 kb-
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sequence transposon, the promoter insertion in Pfcyp51 is a repeated merely 19 bp fragment, 
reaching only 100 bp in length, even shorter than insertions in Venturia inaequalis (Schnabel 
and Jones, 2001; Villani et al., 2016) and Z. tritici (Cools et al., 2012), where transposons were 
not reported. In other organisms e.g. E. coli, overexpression of a desired gene was achieved 
by tandem repeats of core promoter sequences called “MCPtacs” (Li et al., 2012).  
Repeated elements in the ERG11 promoter sequence from Z. tritici, were suggested 
to have appeared after the initial mutations in the coding region. In this way, a larger 
accumulation of mutations could be avoided, that would compromise the activity of the 
enzyme (Cools et al. 2012; Leroux & Walker 2011), but however, contribute further to 
sensitivity reduction. Possibly, this also applies to P. fijiensis, for which we did not find 
tolerant or resistant isolates with insertions in the promoter and no mutations within the coding 
region. Isolates from wild populations lacked promoter insertions, but - occasionally - 
possessed mutations within the coding region. Thus far, we do not have any indication for 
promoter insertions being driven by sexual recombination (Chong et al., 2016c). 
We studied the regulatory nature of the inserted sequences in P. fijiensis in silico and 
show that the 19 bp (TAAATCTCGTACGATAGCA) repetitive element is the most common 
feature. Using a targeted reverse genetics approach in P. fijiensis we for the first time could 
validate that the presence of six copies of this element in the Pfcyp51 promoter increases the 
expression of Pfcyp51 at least five-fold, compared to wt strains and those with one or three 
elements of tolerant phenotypes. Previously, Cañas-Gutiérrez et al. (2009) were unable to 
show such expression in experiments with P. fijiensis in response to propiconazole and 
considered it either a non-existent or unimportant mechanism in this fungus. However, this 
can be explained by a smaller data set and the fact that those strains had a much higher 
sensitivity than the strains in our study. Hence, we now propose that promoter repeats 
constitute a genetic adaptation mechanism to the high selective pressure imposed on P. fijiensis 
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by the repeated use of different DMI fungicides, particularly since this same phenomenon has 
been observed in various geographically discontinuous populations, including the Philippines, 
Cameroon, Colombia and Costa Rica (Chong et al., 2016b). 
Within population, we identified a clear genetic diversity in the number of promoter 
repeats. The frequency of strains with more repeats was higher in banana plantations with up 
to 8 DMI cycles sprayed, such as Cartagena, Zent and San Pablo. Strikingly, all isolates from 
the untreated San Carlos plantation contained the single 19 bp element present in sensitive 
wild isolate around the world. These data provide additional evidence that the promoter 
insertions constitute an adaptation mechanism to fungicide applications in banana plantations.  
Even though P. fijiensis is a difficult fungus to transform (Díaz-Trujillo et al. 2016b), 
and despite site specific recombinations levels seem to be very low, promoter swapping was 
successfully applied in our study. The introduction of the promoter from a resistant P. fijiensis 
strain into a sensitive isolate by site specific recombination resulted in a transformant with 
increased expression of Pfcyp51, and consequently reduced sensitivity to three azole 
fungicides, as a result of the promoter replacement. The Swap26 and Swap121 transformants 
were at least four times less sensitive than the recipient wt strain E22, but not as resistant as 
the resistant strains Ca10_13 or the donor strain Ca5_16 which were both carrying similar 
(Y136F and Y463D) mutations in the coding region. From our results it is expected that the 
reverse experiment, swapping the promoter from the resistant strain for a wild type promoter 
should lead to reduced resistance. Finally swapping the wt Pfcyp51 gene into a resistant strain 
but keeping the insertions might reveal differential genetic backgrounds between sensitive and 
resistant strains that might contributed to the sensitivity. The combination of both mechanisms: 
1) overexpression conferred by promoter insertions and 2) target mutation likely explain most 
of the shift towards DMIs.  
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DMIs are and will likely remain a cornerstone for global black Sigatoka disease 
management. However, the risks of bad practices and too frequent applications are 
considerable since they exert a significant selection pressure on P. fijiensis populations, 
turning these increasingly more resistant. Hence, DMI applications are, may lose their 
competitive advantage compared to other less environmentally friendly compounds. The 
practical spin-off of this study is that we now can use a simple PCR assay to monitor, evaluate 
and predict reduced DMI sensitivity in P. fijiensis field populations.  
Evidently, DMIs are under pressure due to resistance and therefore increasingly being 
studied in various fungal pathogens, including P. fijiensis. This fosters efforts into the research 
and development for novel chemistry for efficient black Sigatoka control, although alternative 
products, such as the strobilurins and Succinate Dehydrogenase Inhibitors (SDHIs), are also 
prone to resistance development (Arango et al. 2016; Scalliet et al. 2012). Therefore, disease 
management should embark on the availability of resistant banana germplasms. Nonetheless, 
disregarding of which banana cultivars dominate the export trade, fungicide resistance 
monitoring and the strict adoption of use recommendations of the products is an absolute 
necessity. 
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Abstract 
The haploid fungus Pseudocercospora fijiensis causes black Sigatoka in banana and is chiefly 
controlled by extensive fungicide applications, threatening occupational health and the 
environment. The 14α-Demethylase Inhibitors (DMIs) are important disease control agents, but 
they lose sensitivity in a rather gradual fashion, suggesting an underlying polygenic genetic 
mechanism. Evidence found thus far suggests that P. fijiensis cyp51 gene is the single 
responsible factor for sensitivity loss in the field. In this study we performed molecular analysis, 
including the construction of genetic maps, to better understand the mechanisms involved in 
DMI resistance in P. fijiensis. Two different DMI resistant P. fijiensis strains were crossed with 
a sensitive strain. Analysis of the inheritance of DMI resistance in the two F1 populations 
revealed a strong bimodal distribution, indicative of a single major responsible gene. Based on 
the bimodal distribution, the causal factor was genetically mapped as a single factor, using 
DArTseq markers and DMI-sensitivity scorings of both F1 populations. This results in the 
generation a genetic linkage maps for each population. Both maps indicated a similar genetic 
region on the resistant parents harbouring the responsible factor for DMI resistance. Full 
agreement was found for genetic markers in either population, underlining the robustness of the 
approach. The two maps indicated a similar genetic region where the Pfcyp51 gene is found. 
Sequence analyses of the Pfcyp51 gene of the F1 populations also revealed a matching bimodal 
distribution with the DMI resistant. Amino acid substitutions in P. fijiensis CYP51 enzyme of 
the resistant progeny were previously correlated with the loss of DMI sensitivity. In addition, 
the resistant progeny inherited a Pfcyp51 gene promoter insertion, composed of a repeat element 
with a palindromic core, also previously correlated with increased gene expression. This genetic 
approach confirms that Pfcyp51 is the single explanatory gene for reduced sensitivity to DMI 
fungicides in the analysed P. fijiensis isolates.
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Introduction  
The dothideomycete fungus Pseudocercospora fijiensis (previously Mycosphaerella 
fijiensis) is the causal agent of black Sigatoka, a major global threat to banana crops that is 
responsible for serious economic losses in banana production and provokes major negative 
environmental impacts due to the current control strategies (Chong et al. 2016a). 
Contemporary disease control is mainly achieved by the application of systemic fungicides of 
which the most commonly used fungicides belong to the 14α-Demethylase Inhibitors (DMIs) 
group. DMI are single target fungicides, hence, sensitive to resistance development. Fungicide 
application frequencies for black Sigatoka management are extensive and DMIs are important 
constituents of the spray schedules, which have not only serious negative environmental and 
social impacts, but also contribute to the development of resistance in the pathogen populations 
(Beaglehole et al. 2003; Guzmán et al. 2013; Marín et al. 2003). In general, most 
microorganisms adapt to fungicides by the selection of individuals with modulated genetic 
information. Commonly observed genetic mechanisms resulting in reduced DMI sensitivity in 
P. fijiensis are point mutations in and overexpression of 14α-demethylase that is encoded by 
the Pfcyp51 gene (Bolton et al. 2016; Cañas et al. 2009; Chong et al. 2010; Chong et al. 2016b; 
Churchill 2011a; Díaz-Trujillo et al. 2016a; Lepesheva & Waterman 2004). 
Abrupt loss of fungicide efficacy in the field is usually considered to be monogenic, 
resulting from mutations in a single major gene. As a result, the pathogen subpopulation 
carrying the mutation(s) becomes dominant and higher fungicide concentrations do not enable 
improved disease management, also indicated as qualitative resistance. The resistance to 
strobilurins in various plant pathogenic fungi, including P. fijiensis, illustrates this observation 
(Arango et al. 2016). In contrast, quantitative and hence, gradually shifting reduced 
sensitivities are enabled by the interaction of a number of different genes (Dyer et al. 2000). 
DMI resistance mechanisms in fungi have a quantitative polygenic nature. In Candida 
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albicans, Aspergillus fumigatus and Zymoseptoria tritici DMI resistance involves 
modification of sterol biosynthesis and increased expression of membrane transporters, e.g. 
ATP-binding cassette transporters and major facilitators, resulting in modified fungicide efflux 
that leads to reduced efficacy (Cools et al. 2013; Cowen 2008). All current evidence in P. 
fijiensis points to Pfcyp51 as a major factor responsible for reduced sensitivity to DMIs. 
However, the loss of sensitivity to DMIs in the field has been gradual in nature (Cañas et al. 
2009; Marín et al. 2003) and a recent study revealed extraordinary high EC50 values in some 
strains, questioning whether changes in the Pfcyp51 gene are the only underlying genetic 
mechanism (Chong et al. 2016b). Hence, additional quantitative genetic components may exist 
that directly or indirectly modulate resistance. 
P. fijiensis has a bipolar heterothallic mating system (Conde-Ferraez et al. 2007), 
which facilitates genetic studies by crossing strains with opposite mating types (Arango et al. 
2016; Kema 2009). Recently, a genetic linkage map for P. fijiensis was generated to support 
genome assembly, but specific mapping studies on fungal characteristics have not been 
accomplished (Arango et al., 2016). The aim of the present study was to unravel the genetic 
basis for reduced sensitivity towards DMI’s fungicides in P. fijiensis by objective genetic 
mapping using Diversity Array Technology (DArTs) markers that also were used to generate 
a new genome assembly. Contrary to our expectations, progeny analyses provided strong 
evidence that DMI resistance in P. fijiensis is solely based on Pfcyp51 modulation and not on 
other previously reported mechanisms such as increased efflux (Becher & Wirsel 2012; Cools 
et al. 2013; Leroux & Walker 2011). Despite increasing and accumulating data on fungicide 
resistance in fugal human and plant pathogens (Chowdhary et al. 2013; Cools & Fraaije 2013; 
Cools et al. 2013; Eddouzi et al. 2013; Guzmán et al. 2013; Hollomon 2015; Sun et al. 2013; 
Verweij et al. 2013; Villani et al. 2016), our study is the first genetic analysis to map the 
underlying genetic factors for reduced DMI efficacy.  
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Materials and methods 
Fungal isolation 
 Banana leaves with black Sigatoka symptoms were collected from untreated field plots on 
the island of Bohol, Philippines, and from the commercial Cartagena plantation in Costa Rica 
that is weekly sprayed with fungicides (Chong et al. 2016b). Infected leaf pieces (~2x3 cm) 
with mature necrotic lesions were retrieved and stapled to a circular 90 mm diameter filter 
paper (Whatman 113, Little Chalfont, UK). Filter papers containing four or five leaf pieces 
were incubated for 48 hours in humid chambers (sealed plastic container with humid cotton) 
and subsequently soaked in water for five minutes. The excess of water was blotted with paper 
towel and the filter papers were placed on the lid of inverted petri dishes filled with 1% water 
agar. The drop in relative humidity facilitates the discharge of ascospores and single spore 
isolates were recovered with a needle after one-night incubation at 4°C in a refrigerator and 
transferred to Petri dishes with potato dextrose agar (PDA) medium that were incubated at 
27°C in the dark for three weeks. 
 
Inoculum preparation 
To prepare inoculum, a piece of mycelium (~0.5 cm2) from a mono-ascosporic P. 
fijiensis colony (three to four weeks old) grown on PDA was blended for 20 seconds at 6,000 
rpm in an Ultra Turrax Tube Drive machine using a sterile DT-20 tube (Tube with rotor stator 
element, IKA, Staufen, Germany) in 15 ml of distilled water (Peláez et al. 2006). The mycelial 
fragments were filtered through a Steriflip Vacuum-driven Filtration System (100 µm, 
Millipore, Billerica, USA) and counted with a Kova glasstic slide 10 with a grids coverslip 
microscope slide (Kova, California, USA) and the suspensions were diluted to a final 
concentration of approximately 5x105 mycelial fragments.ml-1.  
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Microtiter experiments and analyses  
From the abovementioned mycelium solution, a 50 µl aliquot was transferred to each 
well of a 96-well microtiter plate (Corning 96-well Flat Bottom Transparent Polystyrene 
uncoated, Corning, USA) that were filled with 200 μl potato dextrose broth (PDB) medium 
with antifungal compounds. Seven compound concentrations were tested with two technical 
repetitions per strain. All experiments were repeated three times. The samples were incubated 
in the dark at 27°C for 10 days to allow the mycelium to grow. Subsequently, the microtiter 
plates were analysed in the Infinite® 200 PRO machine branch (TEKAN, Switzerland) at 
room temperature (~20°C), without cover, at a wavelength of 690 nm with multiple reads per 
well in a 5x5 circle-filled form to determine mycelium proliferation by optical density. The 
bandwidth was 9 µm with five flashes per read that started 1 mm from the well wall to prevent 
border effects. 
 
Fungicide compounds 
The fungicides propiconazole, difenoconazole and epoxiconazole were provided by 
Syngenta Crop Protection AG (Basel, Switzerland), were of technical grade quality and 
maintained as stock solution in DMSO (propiconazole and difenoconazole at 50,000x and 
epoxiconazole at 20,000x). The final testing concentrations for all compounds were 0; 0,004; 
0,016; 0,04; 0,16; 0,64; 2,56 and 10,24 mg.L-1 with 1% DMSO. The sensitivity ranges for the 
compounds were established by calculating the 50% effective concentration (EC50) by plotting 
the growth profiles based on OD readings. Monotone regression spline functions (Ramsay 
1988) were applied to fit the curve profiles using GenStat 18th Edition software (VSN 
International, Hemel Hempstead, UK). The EC50 thresholds for categorizing P. fijiensis 
isolates as either DMI resistant or sensitive were arbitrary chosen based on the cluster analysis 
of the Least Standard error of the Differences (LSD) of the 2log EC50 individual means in each 
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population. The selected EC50 thresholds were: resistant isolates >1 mg.L
-1 and sensitive 
isolates ≤ 0.2 mg.L-1 
 
Crosses between sensitive and resistant P. fijiensis strains 
Five DMI resistant mono-ascosporic P. fijiensis field isolates from Costa Rica (CaM10_16, 
CaM10_6, CaM7_19, CaM7_10 and CaM10_21), maintained in the Plant Research 
International collection were selected for crosses with the mono-ascosporic wild type strain 
Bo_1 (Bohol, Philippines, Table 1). The isolates were crossed shortly after the first sensitivity 
assay to avoid loss of sexual fitness as experienced in numerous other tries for developing P. 
fijiensis mapping populations (no more than two sub-cultivation steps). The mating type locus 
(mat) configuration was determined using the mat1-1 primers Mat1F (5’-
CATGAGCACGCTGCAGCAAG-3’) and Mat1R (5’-
GTAGCAGTGGTTGACCAGGTCAT-3’) and the mat1-2 primers Mat2F (5’-
GGCGCTCCGGCAAATCTTC-3’) and Mat2R (5’-CTTCTCGGATGGCTTGCGTG-3’) 
(Arzanlou et al. 2010). The PCR reaction was performed using Roche Taq DNA polymerase 
with a standard mix containing 10 ng of gDNA according to the following protocol: 94°C for 
4 min., then 30 cycles 30 sec. at 94°C, 40 sec. at 62°C and 40 sec. at 72°C, followed by a final 
extension step for 7 min. at 72°C. As Mat determinations by PCR were not conclusive, we 
eventually decided to use the Bo_1 isolate as common parent in five pairings, which we 
expected to be no less than 40% successful due to the bipolar heterothallic mating system of 
P. fijiensis (Conde-Ferraez et al. 2007). We, therefore prepared 15 ml of mycelium solution - 
as described above - of each parental strain and then mixed the sensitive P. fijiensis strain 
Bo_1 in a 1:1 ratio with each of the other aforementioned Costa Rican strains, hence in total 
five mixtures, which were incubated overnight at 27°C to recover from blending. The next day 
the inoculum mixtures were atomized on individual “Cavendish” banana plants, variety Grand 
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Nain, using a spray device (#0267-6, Preval®, Chicago, USA) at both sides of the leaves until 
run-off. Each plant was six months old to ensure large leaves with more surface area for disease 
development. After inoculation, plants were maintained in the greenhouse for 14 weeks with 
the following growth regime: light (>300 µmol m-2 s-1) period of ~12 hours; day/night 
temperatures of 28°C/25°C with a relative humidity >90%. First necrosis and mature spots 
appeared around 65 days after inoculation (dai) and starting from that day, leaf pieces with the 
mature reproductive lesions were taken for ascospore discharge as described above. The first 
set of spores was observed and collected 73 days after inoculation from two crosses (Table 1) 
and 100 ascospores were isolated from each cross for further analyses. 
 
Table 1. Crossing Pseudocercospora fijiensis. The DMI sensitive strain (Bo_1), mating type 
mat1-1, was crossed to five mat1-2 DMIs resistant strains (CaM10_16, CaM10_6, CaM7_19, 
CaM10_21) and one mat1-1 resistant strain (CaM7_10). Crosses were performed directly after 
the preliminary sensitive assay to avoid possible loss of sexual fitness due to sub-cultivation. 
 
Cross  DMI sensitive parent 1 
Propiconazole 
EC50 average 
score (mg.L-1) 
DMI resistant parent 2 
Propiconazole 
EC50 average 
score (mg.L-1) 
Progeny 
N1 
Bo_1 0.020 
CaM10_16 5.730 No progeny 
N2 CaM10_6 11.750 
Successful 
cross 
N3 CaM7_19 5.125 No progeny 
N4 CaM7_10 2.205 
Incompatible 
cross* 
N5 CaM10_21 6.349 
Successful 
cross 
* The mat gene configuration was unknown in the moment of the cross experiment.  
 
DArTseq marker generation  
A set of 98 isolates from each population was genotyped using DArTseq technology 
(www.diversityarrays.com). DNA samples were processed as described previously with few 
modifications (Kilian et al. 2012). The technology was optimized for P. fijiensis by using two 
restriction enzymes, i.e. PstI and MseI, rather than PstI only. The Restriction Enzyme (RE) 
overhangs differed from one another, allowing ligation of RE-site specific adaptors. The PstI-
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compatible adapter was designed to include Illumina flow cell attachment sequence, the 
sequencing primer sequence and a “staggered”, varying length barcode region, similar to the 
sequence reported by Elshire (Elshire et al. 2011). The reverse adapter contained the flow cell 
attachment region and a MseI-compatible overhang sequence. Only “mixed fragments” (PstI-
MseI) were effectively amplified by PCR. Equimolar amounts of amplification products from 
each sample of the 96-well microtiter plate were bulked and applied to c-Bot (Illumina) bridge 
PCR followed by sequencing on an Illumina Hiseq2000. Each generated marker had a 
sequence length of 68 bp. Sequences generated from each lane were processed using 
proprietary DArT analytical pipelines (Kilian et al. 2012). In the primary pipeline the fastq 
files were processed to filter away poor quality sequences, applying more stringent selection 
criteria to the barcode region compared to the rest of the sequence. In that way the assignments 
of the sequences to specific samples carried in the “barcode split” steps were very reliable. 
Approximately 2,000,000 sequences per barcode/sample were identified and used in marker 
calling. Identical sequences were collapsed into “fastqcoll files” and a second pipeline was 
followed for further quality selection criteria as described (Kilian et al. 2012). Finally, the 
scored markers (presence/absence of restriction fragments) were represented in a 0/1 binary 
matrix to be used in the calculation of the genetic similarity.  
 
Genetic linkage maps  
Approximately 5,400 DArTseq markers were generated for the segregating F1 
populations N2 and N5 (Table 1). As the DMI sensitivity trait showed a clear bimodal 
distribution (sensitive versus resistant), this trait was integrated as phenotypic marker in both 
genetic maps. The markers were filtered based on their co-segregation with the sensitivity trait 
and those with close linkage (<10cM) to the trait were selected for the construction of a linkage 
group to identify the genetic region of the responsible gene. The linkage group markers were 
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sorted with the genetic mapping software JoinMap 4.1 (Stam 1993) and, according to the 
positions of the recombination events, the strains were sorted to identify the chromosomal 
region harboring the sensitivity gene. Subsequently, the genetic map was linked to the physical 
map by aligning the DNA sequences of the DArTseq markers to the P. fijiensis CIRAD 86 
reference genome version 2.0 (http://fungi.ensembl.org/Pseudocercospora_fijiensis_cirad86/Info/Index). 
 
Pfcyp51 sequencing  
 The Pfcyp51 genes of a total of 193 isolates from both populations (98 strains from 
N2 and 95 strains from N5) were sequenced. To amplify the Pfcyp51 gene, specific primers 
were used: CYP51_Pfijien_F1 (5’-AAGGTCATATCGCAGG-3’) and CYP51_Pfijien_R1 
(5’-GAATGTTATCGTGTGACA-3’). A standard PCR mix was used in the following 
program; initiation with a 5 min. denaturation at 94°C followed by 35 cycles of 30 sec. 
denaturation at 94°C, 30 sec. annealing at 55°C and 90 sec. extension at 68°C with a final 
round of seven min. extension at 72°C. The DNA sequencing of the Pfcyp51 amplicons was 
directly performed on the PCR products (Macrogen Europe, Amsterdam, The Netherlands). 
Full sequence coverage was obtained by using four primers: CYP51_Mfijien_F2 (5’-
ACAGAAACATCACCTCC-3’, CYP51_Mfijien_F3 (5’-ATTGCTTCACTTTCATCC-3’), 
CYP51_Mfijien_F4 (5’-CTCTACCACGATCTCGAC-3’) and CYP51_Mfijien_R2 (5’-
GATATGGATATAGTTGTC-3’). The obtained Pfcyp51 sequences were assembled per strain 
in contigs (SeqMan application software Lasergene v8, DNASTAR®, Madison, USA) and 
aligned to gene model MYCFIDRAFT_30715 of the reference genome (P. fijiensis CIRAD 
86, genome version 2.0, (Arango et al. 2016)), using the CLC Genomic Workbench software 
(version 7.5.2, CLC Bio-Qiagen, Aarhus, Denmark).  
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Results  
Progeny generation and DMI segregation  
 Successful crosses were accomplished after two experimental failures where we 
empirically determined the critical number of sub-cultivations of the parental strains, which 
should not be more than two in order to maintain sexual fitness. Among the five evaluated 
crosses, four combinations produced mature lesions at 65 dai, but ascospores were only 
discharged from N2 and N5 at 73 dai (Table 1). Other crosses failed, apparently due to 
identical mat genotypes. A total of 200 progeny isolates was characterized for DMI sensitivity 
using epoxiconazole, propiconazole and difenoconazole (Table 2).  
The segregation ratios for sensitivity versus resistance of the N2 and N5 progenies 
were 47:53 and 44:56, respectively, according to an expected 1:1 ratio for a single gene 
inheritance. Hence, examination of the sensitivity response in both F1 populations revealed a 
clear bimodal distribution (Figure 1, Figures S1 and S2). Despite these bimodal distributions, 
four strains (N2_21, N2_89, N5_1, and N5_57) had an intermediate response to the tested 
DMIs (Figure 1). These four strains were included in the mapping generation. Based on the 
sequence analyses, only N5_1 was regarded as resistant, whereas the others were considered 
sensitive. The average EC50 scores for each strain are shown in the Table S2. 
 
Genetic linkage maps 
We used the DArTseq markers to construct two linkage maps. From population N2, 
53 markers were selected with 17 markers in coupling phase to resistance and 36 markers in 
coupling phase to sensitivity to DMIs (Figure S4a and Table S1). The markers were clustered 
in seven groups based on their segregation patterns. Thirty-three of the markers were placed 
onto scaffold 7 of the physical map of P. fijiensis (Table S1). The recombination events for 
the seven groups in the N2 population are shown in the right panel of Figure 2. From 53 
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markers, 21 fully co-segregated with sensitivity to the DMIs. Markers 12410413 and 
12405280 were identified as the flanking markers of the sensitivity trait with physical positions 
scaffold_7:1,779,092 bp and scaffold_7:2,130,447 bp, respectively, and a physical distance of 
351,355 bp. 
 
 
 
Table 2. Summary of the EC50 data for DMIs for the two Pseudocercospora fijiensis mapping 
populations N2 and N5. Indicated are the highest (Max) and lowest (Min) values that were 
obtained in the discretely segregating sensitive or resistant groups as well as their average 
values, the percentage of strains in each category and the average resistance factor (RF) of the 
resistant segregants.  
 
1Sensitivity trait: S= sensitive, R= resistant.  
2Four strains showed intermediate phenotypes.  
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Figure 1. Segregation of DMI sensitivity in the Pseudocercospora fijiensis mapping population 
N2 and N5. Histograms of the 2log average EC50 data per fungicide are shown for each 
population. Resistant and sensitive strains show the same sensitivity response to all three DMI 
fungicides respectively. A minority of the progeny isolates showed intermediate phenotypes in 
some fungicides (EC50 thresholds between resistant >1 mg.L
-1, Intermediates from 0.2 – 1 mg.L-
1 and sensitive ≤0.2.mg.L-1).The Bin range was based on the lower and upper intervals of the 
standard error of the difference of the 2Log means. The EC50 positions of the parental strains 
are marked with triangles. Least Significant Difference (LSD) values are shown above the 
histograms.  
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From population N5, 41 markers were selected with eight markers in coupling phase with 
resistance and 33 markers in coupling phase with sensitivity to the tested DMIs (Figure S4b 
and Table S1). The markers were clustered in three groups by their genetic distance, of which 
27 placed on scaffold 7. All recombination events for the N5 population are shown in the left 
panel of Figure 2. From the 41 markers, 32 fully co-segregate with sensitivity to the tested 
DMIs. Markers 12397726 and 12399875 were identified as the flanking markers with positions 
scaffold_7:1,879,787 bp and scaffold_7:2,175,183 bp, respectively, and a physical distance of 
295,396 bp.  
The order of the genetic markers in both the N2 and N5 populations was in full agreement 
(Figure 2). The N2 and N5 populations share 38 markers and 17 markers from both maps show 
inconsistencies or low coverage scores, which were therefore omitted from place them in the 
reference physical map. Markers with inconsistences between the physical and the genetic maps 
are markers 12412057 on scaffold_7 - but in a displace position - 12,412,405 on scaffold_27, 
marker 12397704 on scaffold_6 and marker 12410210 on scaffold_5. Since they co-segregated 
with the groups of markers close to or in the area carrying the sensitivity locus, we assume there 
are either differences between the sequences of the CIRAD86 reference genome and the 
parental/progeny isolates or there are a few errors in their positioning on the physical map. The 
positions of all markers are indicated in Figure 2 and a summary of the information is compiled 
in Table S1 and Figure S4. Based on the flanking markers, there is an overlapping region for 
the N2 and N5 populations of 250,660 bp between scaffold_7:1,879,787 (marker 12397726) 
and scaffold_7:2,130,447 (marker 12405280). This genetic window harbours 53 putative genes 
among which is Pfcyp51, located at scaffold_7:2,119,919-2,121,685 (Figure 2, Figure S5, Table 
S3). 
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Figure 2. Integration of the Pseudocercospora fijiensis N2 (left) and N5 (right) genetic linkage 
maps with the physical map (Partial Scaffold_7) of the genomic reference P. fijiensis CIRAD86 
(middle; Mycosphaerella fijiensis version 2.0). The genetic map was generated using DArTseq 
markers. The sensitive trait is taken as phenotypic marker in the genetic map (marker in yellow). 
The number of recombinations between the markers is indicated between the linkage groups. 
Markers perfectly co-segregating with the sensitivity trait are indicated in blue, with the direct 
flanking markers depicted in red for both populations. The area of the co-segregating markers 
for each population is presented as a light blue line and the overlapping region is depicted in 
yellow on the physical map. The genetic and the physical map are linked for each marker by 
arrows. The flanking markers are indicated in red while the remaining markers are printed in 
black. Genetically linked markers without a position in the physical region are indicated with a 
question mark (?) and unpositioned markers are placed with a light blue dashed line. The 
position of Pfcyp51 is marked in bold letters with a yellow triangle and is represented by a 
yellow box.   
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Molecular analyses of the Pfcyp51 configuration in the N2 and N5 progenies 
Analysis of the Pfcyp51 gene, including the promoter, revealed that all P. fijiensis progeny 
strains only had parental genotypes. Resistant strains carried the Pfcyp51 gene encoding protein 
modifications T18I and V106D, which have no DMI phenotypic consequences, and three other 
substitutions related to DMI resistant describe in Figure 3, whereas all sensitive isolates were 
identical to the wild type genotype of the parental strain Bo_1, lacking any insertion in the 
promoter region and a Pfcyp51 sequence encoding the non-phenotypical T18I, V106D and 
A446S amino acid (aa) modifications compared with the reference sequence of P. fijiensis 
CIRAD86 (Table S2). However, all resistant progenies from either population contained a 103 
bp promoter insertion located 94 bp upstream of the reference Pfcyp51 start codon. The 
insertion is accompanied with an 18 bp substitution “GGACCACTCGAACATCAC”. 
(reference position MYCFIscaffold_7:2121783, Mycosphaerella fijiensis v2.0, JGI) and is 
composed of repeated elements interspersed with non-repeated sequences. The repeated 
element is described in Chong et al. (2016) (Chong et al. 2016b) and possesses a palindromic 
core. In total, three exact copies and a single modified copy of this element – from here 
identified as element A - are present in the insertion. The modified copy (A*) carries an 
additional one bp substitution, resulting in the sequence “TAAAATCTCGTACGATAGCA. 
All sensitive isolates have only one A element in their promoter (Chong et al., 2016; Figure 2). 
So, when taking into account this single A element in wt Bo_1, resistant progeny isolates 
contained five A copies (Figure 3 and Figure S3).  
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Figure 3. Schematic visualization of the Pfcyp51 gene configuration derived from the 
Pseudocercospora fijiensis crossing partners and segregating progenies, based on the expressed 
phenotypes towards three DMI fungicides. All progeny isolates exclusively showed parental 
genotypes. Resistant isolates have promoter insertions while sensitive isolates have no 
insertions. Mutations in the coding domain are marked with colored lines and the resulting aa 
substitutions.  
 
All resistant progeny isolates from the N2 population share Pfcyp51 substitutions resulting 
in the aa modifications Y136F, A313G and Y463D originating from their resistant parent 
CaM10_6 (Figure 2 and Table S2). The resistant progeny from the N5 population have 
substitutions resulting in the aa changes H380N, A381G and Y463D, originating from the 
parental resistant strain CaM10_21 (Figure 3 and Table S2). All Pfcyp51 sequences from 
parents and progenies of both the N2 and N5 populations showed a perfect match with the 
segregating phenotypes (sensitive: resistant = 1:1, Table S2). From the aforementioned four 
strains with intermediate behaviour, strains N2_21, N2_89 and N5_57 contained the Pfcyp51 
sequence of the sensitive parent and isolate N5_1 had the configuration of the resistant parent. 
Hence, their phenotypes were either scoring errors or caused by other genomic modifications. 
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Discussion  
Disease management in agricultural crops largely depends of two crucial factors: host 
resistance and crop protection agents. As Cavendish bananas are highly susceptible to P. 
fijiensis and represent 85% of the global trade, there is essentially one option left for disease 
control, i.e. fungicides. This has huge implications for overall management. One important 
implication is for the disease, with an imminent risk for the selection of increasingly resistant 
P. fijiensis populations. Another important implication is on the occupational health of 
thousands of workers in banana plantations and the environmental issues due to the precarious 
tropical landscapes where bananas are usually produced (Risède et al. 2010). The latter issue 
results in significant water contaminations (van Wendel de Joode et al. 2016) as well as the risk 
of non-target hits, which for instance is considered to be the reasons of increasing fungicide 
resistance in Aspergillus fumigatus to medical azoles (Chowdhary et al. 2013). On top of that, 
the increasing loss of DMI efficacy resulted in higher frequency of contact fungicide that are 
more hazardous to the environment (Chong et al. 2016a; Guzmán et al. 2013; Pereira et al. 
2014; van Wendel de Joode et al. 2016). Hence, a thorough analysis of DMI resistance in P. 
fijiensis is both necessary and urgent to raise awareness of spending more efforts to develop 
new banana germplasm with resistance to black Sigatoka (Chong et al. 2016a; Guzmán et al. 
2013; Risède et al. 2010; Stergiopoulos et al. 2014; Stergiopoulos et al. 2010). However, this 
will take considerable time and hence altered strategies for the use of fungicides are required 
and necessitate scrutinizing the current disease control practice and its consequences. Without 
doubt, black Sigatoka disease is the most costly disease of global banana production with an 
estimated cost of at least US $1000.ha-1 in most environments (Arias et al. 2003). After 
describing the global landscape of DMI resistance in P. fijiensis (Chong et al. 2016b) as well 
as the mechanistic proof of its mechanism (Díaz-Trujillo et al. 2016a), we decided to perform 
an unbiased genetic analysis to identify any other underlying factors for the resistance to DMIs 
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in P. fijiensis. Therefore, we generated two new high marker density genetic linkage maps after 
crossing sensitive and resistant P. fijiensis isolates. These crosses were not at all routine, 
required a pragmatic approach compared to previous reports (Manzo-Sanchez et al. 2008), and 
eventually resulted in two mapping populations. This classic genetic approach in combination 
with state of the art DArTseq molecular markers technology provided novel and key 
information to understand the development of DMI resistance and, hence, is the basis for 
optimizing their use for disease management. 
 
Pseudocercospora fijiensis mating  
One of the most challenging tasks in the present study was to perform the P. fijiensis 
crosses. First we were not able to unequivocally determine the mating type of each isolate, 
which previously also appeared difficult (Arzanlou et al. 2010), despite the fact that we earlier 
cloned the P. fijiensis mat genes (Conde-Ferraez et al. 2007). Our pragmatic approach is similar 
to the protocol being used for the related dothideomycete wheat pathogen Zymoseptoria tritici 
(Goodwin et al. 2011; Kema et al. 1996; Wittenberg et al. 2009). Recent genome data show 
that sub-culturing fungal isolates frequently results in chromosome loss (Johnson et al. 2001; 
Rodríguez et al. 2006), and hence it is conceivable that our failures to successfully cross P. 
fijiensis is related to the number of sub-cultivations of each candidate parent (Saleh et al. 2012). 
The moment we reduced these to maximally two – and essentially determined the DMI 
phenotype of the parents in retrospect – crosses proved to be successful, resulting in viable and 
sufficient progeny strains for formal genetic analyses. Hence, we conclude that subsequent sub-
cultivation steps affect sexual fitness, although we do not know whether this has to do with the 
loss of essential chromosomes. Alteration of fungal properties by sub-cultivation not only 
affects mating but also for instance pathogenicity observed by Krokene and Solheim in the blue-
stain fungus Ceratocystis polonica (Krokene & Solheim 2001) and by Kashino et al. in 
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Paracoccidioides brasiliensis (Kashino et al. 1990). Krokene and Solheim also observed 
alterations in the ability to grow under oxygen-deficient and reduction in growth rate in C. 
polonica (Krokene & Solheim 2001).  
 
Sensitivity tests results  
Despite the bimodal distribution into sensitive and resistant progeny, the wide range 
of EC50 values’ in each group was substantial and awaits further explanation as various strains 
exceeded the thresholds that were recently established for sensitivity based on global population 
analyses (Chong et al. 2016b). We, therefore, adopted another threshold in this experiment as 
it is conceivable that the chosen fungicide doses limited the precise determination of EC50 
concentrations, especially at low concentrations. Potentially, other individual factors such as 
minor fungicide resistance genes, or genes related to stress responses or growth rates are 
involved. Nonetheless, the DMI response difference between sensitive and resistant isolates 
was clear and separates them into two major and discrete groups with an approximate 
differential resistance factor of approximately 100 (Table 2), resulting in a 1:1 segregation, 
indicating a single causal gene for DMI sensitivity in P. fijiensis. 
 
Genetic linkage maps 
By using the DMI phenotypes and progeny genotypes in a mapping approach we show 
that azole sensitivity in the two segregating P. fijiensis populations is due to a single major 
gene, Pfcyp51. Since no evidence was observed for the presence of any other sensitive genetic 
region in either progeny, this strongly supports the presence of the Pfcyp51 gene as the single 
explanatory factor for DMI sensitivity. The progeny was no different when compared to the 
parents, despite the quantitative expression of DMI sensitivity (Cañas et al. 2009; Chong et al. 
2016b; Dyer et al. 2000). In only four progeny isolates an alternative explanation seems 
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appropriate, but was not apparent from the generated data set and might equally be due to 
experimental error due to e.g. age or density of P. fijiensis cultures.  
The genetic window explaining DMI sensitivity contained 53 genes, of which the 
majority lack any functional clue. Predicted gene Id96804 encodes a putative transcription 
factor, which might regulate expression of (minor) genes that contribute to DMI resistance and 
predicted gene Id86816 encodes a putative transporter that might facilitate increased efflux 
(Stergiopoulos et al. 2002; Zwiers 2002) (Table S3). However, the overruling factor seems to 
be Pfcyp51 that also maps to this exact region (Figure 2 and S4) and which accords with its 
importance in other – related – fungi (Cools et al. 2013) as well as with the accumulating 
evidence that recently became available (Cañas et al. 2009; Chong et al. 2010; Chong et al. 
2016b; Díaz-Trujillo et al. 2016a). Therefore, despite the presence of other genes in the mapped 
genomic region, we propose that modifications of the Pfcyp51 gene and its promoter are the 
driving molecular force for DMI fungicide resistance. 
 
Molecular analysis of the Pfcyp51 configuration in F1 progenies 
Common mechanisms described for the loss of sensitivity to DMIs are increased efflux 
of the fungicides from the cells (Cools et al. 2013; Leroux et al. 2010), adaptation and 
overexpression of the fungicide target gene (Bolton et al. 2016; Chong et al. 2016b; Cools et 
al. 2012; Díaz-Trujillo et al. 2016a; Villani et al. 2016) and cellular alterations that reduce the 
toxicity of the fungicides, such as modulation of the targeted biosynthesis pathway (Cowen 
2008). Recently, we showed that modulation of the promoter and coding domain of Pfcyp51 
explains reduced DMI sensitivity (Chong et al. 2016b; Díaz-Trujillo et al. 2016a). Other fungal 
species, such as Candida albicans and Aspergillus graminearum, accommodate more than one 
of these mechanisms (Akins & Sobel 2009; Becher & Wirsel 2012; Cowen 2008). Our data 
suggests that in P. fijiensis modification and consistent alteration in the promoter region of the 
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Pfcyp51 are the most plausible causes of the reduced sensitivity to DMIs. The current study 
underscores these observation as our unbiased linkage approach did not map any additional 
contributing factor to DMI sensitivity; none of the sensitive strains contained substitutions 
Y136F, A313G, H380N, A381G or Y463D or insertions in the promoter region of Pfcyp51, 
which were previously correlated with reduced efficacy in DMIs (Cañas et al. 2009; Chong et 
al. 2016b; Díaz-Trujillo et al. 2016a). Since there were no recombination events close to the 
Pfcyp51 gene, we also conclude that sexual reproduction apparently does not contribute to the 
important Pfcyp51 promoter modulations, which therefore awaits further mechanistic 
explanations.  
Interestingly, the overall sensitivity loss in population N2 was higher than in N5. 
Based on the similarity of the promoter configuration we assume that the expression of the gene 
is comparable (Table 2). Therefore, the sensitivity difference might be explained by the non-
synonymous mutations present in the Pfcyp51 gene (Figure 2). Resistant progeny from N2 
harbour aa substitutions Y136F, A313G and Y463D, while those in N5 comprise H380N, 
A381G and Y463D. The differentiating substitutions at positions 136 and 313 are particularly 
important since these are located in the substrate binding site (Cañas et al. 2009; Chong et al. 
2016b).  
Unlike other single site fungicide interactions, CYP51 substitutions often affect 
individual, or a subset of DMIs compounds, with generally incomplete cross-resistance across 
the whole class (Cools et al., 2013). This particular mode of interaction of the CYP51 protein 
can explain the unusual behaviour and the steep increase of DMI resistance in the banana 
plantations. It is likely that the quantitative resistance response – as observed for DMI resistance 
in the field - is due to an accumulation of different Pfcyp51 non-synonymous mutations in 
response to the apparent selection pressure, which also and alternatively can be due to a 
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dramatic synergistic and epistatic effect explained by Pfcyp51 overexpression under high 
selection pressure (Díaz-Trujillo et al. 2016a). 
In comparison with the DMI resistance mechanisms present in other fungi (Becher & 
Wirsel 2012; Cools et al. 2013) it is at least remarkable that we have exclusively identified a 
role for Pfcyp51 in DMI sensitivity. The lack of alternative quantitative mechanisms might 
indicate that we are just at the beginning of P. fijiensis DMI resistance development, illustrative 
for the recent development in DMI resistance in Latin America. Common DMI resistance 
mechanisms in other fungi include increased fungicide efflux or alternative ergosterol synthesis 
pathways (Cools et al. 2013; Cowen 2008) may therefore become more common in the future 
if the fitness penalty for these mechanisms is sufficiently low (Cools et al. 2013; Cowen 2008). 
However, this largely depends on future application of DMI fungicides. The current situation 
on reduced DMI efficacy has already resulted in a fall-back strategy avoiding DMIs and 
increased use of protectants and mineral oil (Chong et al. 2016a). 
Our data have not shown any modulating effect of sexual reproduction on Pfcyp51, 
but the versatility of the fungus through an almost continuous production of offspring 
throughout the year is undeniable. Current spraying practices likely significantly contributed to 
the accumulation and actually fixation of strobilurin resistance, as was recently explained in 
Zymoseptoria tritici (Aouini 2016). This should - evidently - be a huge concern for the banana 
industry since the maximum number of fungicide applications seems to have plateaued and thus 
the efficacy of the treatments could be on the verge of breaking. In other species there are few 
indications that a temporal suspension of DMI applications results in a subsequent decrease of 
resistant isolates due to fitness penalty and stability restrains in the Pfcyp51 gene (Chowdhary 
et al. 2013; Lendenmann et al. 2015; Verweij et al. 2013), although in a limited number of 
cases this strategy was shown to be functional (Latin, 2011, Cowen, 2008). As stated above, 
resistance breeding, but also the introduction of biological control measures and the 
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development of alternative non-DMI fungicides are considered as the most promising options 
for a more balanced and hence sustainable black Sigatoka management. 
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Figure S1. Plots of the calculated EC50 values and residuals of the interaction of the 
Pseudocercospora fijiensis segregating N2 population with the three DMI fungicides. A) 
difenoconazole, B) epoxiconazole and C) propiconazole. 
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Figure S2. Plots of the calculated EC50 values and residuals of the interaction of the 
Pseudocercospora fijiensis segregating N5 population with the three DMI fungicides. A) 
difenoconazole, B) epoxiconazole and C) propiconazole 
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Figure S3. Analysis of the insertions in the promoter region of Pfcyp51 gene in 
Pseudocercospora fijiensis progeny strains in both the N2 and N5 mapping populations. The 
promoter modifications start at -94 bp upstream of the Pfcyp51 start codon of the reference 
sequence. Element “A” is shown in blue boxes together with the arrangement of the palindromic 
sequence TCGTACGA shown in green boxes. Element “A*” is shown in red as a partial 
construction of element “A” in purple. Negative values in the right bottom represent the 
positions from the beginning of the insertion related to the start codon of the gene.
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Figure S4. Pseudocercospora fijiensis strains sorted according to the positions of the 
recombination events in the chromosomal region harbouring the Pfcyp51 sensitivity gene. A) 
Mapping population N2 and B) Mapping population N5. The markers descending from the 
highly sensitive parent are coded “a” and shown in light red boxes, whereas the chromosomal 
segments inherited from the resistant parent genotype are coded “b” and shown in light green 
boxes. The unknown values are represented by dashes in grey boxes (-). The DArTseq markers 
fully co-segregating with sensitivity are shown in light blue with the sensitivity trait shown in 
yellow. The flanking markers are shown in red.  
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General discussion  
 
Fungicides are currently key tools for disease control. Among the fungicides, 
triazoles (azoles) belonging to the group of demethylation inhibitors (DMIs) are ubiquitous 
compounds for the control of human and plant diseases (Chowdhary et al. 2013; Cools et al. 
2013; Ploetz et al. 2015; Verweij et al. 2013). Black Sigatoka control in banana, caused by 
Pseudocercospora fijiensis, relies on intensive application of triazoles in fungicide mixtures, 
next to cultural measures such as deleafing (Cañas et al. 2009; Marín et al. 2003; Pérez 2006). 
Although the disease is still manageable, the appearance and spread of resistant strains is 
alarming (Cañas et al. 2009; Churchill 2011b; Ploetz et al. 2015). The single target DMIs 
fungicides, targeting the 14α-demethylase enzyme, together with the sexual reproduction of 
P. fijiensis have greatly contributed to this phenomenon. The increasing problem of reduced 
efficacy of DMI fungicides to P. fijiensis urges for understanding of the underlying 
developmental mechanisms to ensure successful future control strategies based on similar and 
new chemistries. While resistance monitoring measures are generally applied in banana farms 
worldwide, the methods are outdated and key genetic information is hardly available, which 
translates into uncertainty and routine fungicide application rather than into decision support 
mechanisms. The aim of this thesis was, therefore, to elucidate the molecular mechanisms of 
reduced efficacy to DMI fungicides in P. fijiensis. 
 
DMI fungicides selective pressure  
For years, the DMI baseline sensitivity in most banana producing countries is 
continuously rising. Marín et al., (2003) reported an average EC50 for propiconazole of 0.15 
mg.L-1 with a maximum value of 0.5 mg.L-1 in Costa Rican populations. In 2009, our study 
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revealed an increase in the propiconazole EC50 values to an average of 1.10 mg.L
-1 with a 
maximum value of 1.53 mg.L-1 for four resistant Costa Rican isolates (Chapter 3, (Díaz-
Trujillo et al. 2016a)). A subsequent analysis of 107 P. fijiensis isolates from 2014 showed 
again an increase in resistance with an EC50 average of 5.8 mg.L
-1 and a maximum value of 
18.4 mg.L-1 for propiconazole (Chapter 2, (Chong et al. 2016b)). These data revealed an ~40-
fold increase of the EC50 over a decade, which was gradual and hence, predictable. Costa Rica 
has a long history of fungicide use in black Sigatoka management (Marín et al. 2003) and the 
DMI baseline sensitivity shift correlates with the increasing amounts of fungicides being used. 
The number of fungicide applications raised from 30 in the 90’s up to 50 treatments by 2007 
and are still rising (Lapeyre et al. 2010a). The results from the Costa Rican isolates are 
representative for the selective pressure role exerted by DMIs fungicides on the pathogen 
population. In this thesis we elaborated on the DMIs sensitivity baseline for P. fijiensis isolates 
representing populations from various countries. Unfortunately, documentation on the 
development of DMI sensitivity, in combination with the number of application is frequently 
lacking. Nonetheless, populations derived from countries with a (long) history of DMI 
applications are generally resistant. In contrast, P. fijiensis populations from areas without 
fungicide applications are generally sensitive. Exemplary are indigenous areas such as Bohol, 
Philippines, or the San Pablo area of Costa Rica as well as the sensitive populations from the 
most recently colonized areas, Martinique and Guadalupe (Guzmán et al. 2013; Ioos et al. 
2011). This latter case raises questions about their origin. As stated in Chapter 2, in order for 
all isolates in these populations to be sensitive they should fit one of the two following 
hypotheses: (1) the islands were colonized by wild type (wt) P. fijiensis populations that had 
not undergone DMI selection pressure or (2) the islands were colonized by P. fijiensis 
populations that had undergone DMI selection pressure, but they reverted to wild type 
populations due to the lack of DMI selective pressure. The latter case supports the fitness costs 
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theory where DMI resistance is accompanied with a fitness penalty, which is rapidly lost in 
the absence of selective pressure. This phenomena was observed for Magnaporthe oryzae and 
Cercospora beticola but remained unnoticed for many others fungi (Hollomon 2015). 
Moreover, the isolates from Martinique and Guadalupe are closely related to the Latin 
American population, which might support hypothesis 2. However, in both island the selective 
pressure exist since DMI are used to control yellow Sigatoka. Besides, this population are also 
sensitive to other fungicides, namely strobilurins (QoI) and benzimidazoles (MBC) (data not 
shown) thus, the favoured hypothesis is that these islands were colonized by wt P. fijiensis 
isolates. We, therefore, consider the fitness hypothesis unlikely for P. fijiensis, particularly 
since we have identified wt strains in other non-sprayed areas such as San Carlos (Arango et 
al. 2016) in Costa Rica and Bohol in the Philippines as well as in Cameroon, Colombia, and 
Ecuador (Chapter 2). Nevertheless, it is worth mentioning that our research was limited to just 
a few isolates from these populations, hence analyses on more isolates and further genetic 
studies are required to conclusively elucidate this matter. 
The role of selection exerted by DMI fungicides on P. fijiensis population is 
highlighted in Chapter 2 and 3 of this thesis in which we studied the genetic and phenotypic 
response of a global panel of P. fijiensis isolates to DMIs. The global panel strain from 
countries with a wide diversity in the intensity of DMI fungicide applications. This allowed us 
to compare the effects of fungicide application on DMI efficacy, i.e. the distribution of 
resistant and sensitive P. fijiensis strains and to analyse the underlying genetic background. 
Consequently, most resistant strains were collected from countries where banana production 
is important, which suffer from black Sigatoka disease and hence are exposed to a high 
fungicide application frequency. This information enables us now to predict, based on the 
number of fungicide application cycles and the country origin, the level of DMI sensitivity. 
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We show that DMI resistance in P. fijiensis correlates with specific changes in the Pfcyp51 
gene.  
 
CYP51 structure and DMI resistance  
The accumulation of modifications in the CYP51 protein tends to confer reduced 
efficacy of DMI fungicides in several organisms (Cools et al. 2013). A high degree of 
polymorphisms in CYP51 was previously reported for Tapesia acuformis and T. yallundae 
(Albertini et al. 2003). We also identified a high degree of polymorphisms in P. fijiensis with 
60 different Pfcyp51 genotypes resulting in 28 different amino acid (aa) substitutions in the 
resulting protein. Among these, aa substitutions resulting in A19E, I70M, D71E, V260L, 
I264T, H380N, R418G, D460E, D460V, Y461N, Y461S, ΔY461 and G462D were hitherto 
unpublished in P. fijiensis. However, not all of these substitutions correlate with DMI 
resistance. Surprisingly, we identified sensitive isolates carrying three aa CYP51 
modifications, which apparently might represent natural random mutations, although some 
could be compensatory substitutions. Substitutions T18I and A446S had an additive (EC50) 
effect in tolerant and resistant isolates. Additive compensatory substitutions were nicely 
illustrated by aa changes in Zymoseptoria tritici - the Septoria tritici blotch pathogen of wheat 
- since the main substitution for fungicide resistance was enzymatically lethal as corroborated 
by complementation experiments in Saccharomyces cerevisiae (Becher & Wirsel 2012). 
Future studies in fungi showing reduced efficacy to DMIs should elaborate on the role of 
substitutions outside the catalytic core of the CYP51 protein. 
The effect of DMI applications on genetic changes of P. fijiensis is exemplified by 
key mutations in the Pfcyp51 gene. Especially CYP51 substitution A313G, and to a lesser 
extend Y136F, H380N, Y463D and D460V correlate with DMI resistance (Chapter 2). 
Equivalent substitutions in CYP51 of other fungi confirm their vital role in azole resistance 
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(Albertini et al. 2003; Cools et al. 2013; Délye et al. 1997; Lupetti et al. 2002). The importance 
of substitutions located in or near the core of CYP51 was highlighted by CYP51 modelling 
and fungicide docking experiments (Chapter 2). According to Mullins et al. (2011) DMI 
resistance due to modulation of the CYP51 enzyme occurs in the following order: (1) 
obstruction or loss of interaction due to residue substitution; (2) constriction of the binding 
cavity to block the access of azoles; and (3) enlargement of the binding cavity to prevent 
interactions between key residues and the active ingredient (Mullins et al. 2011). Interestingly, 
CYP51 modelling and propiconazole docking experiments confirmed all these options. 
Substitutions at positions 136, 313, 380, 381 affect the core of the protein in the substrate 
recognition site (SRS) and fulfil Mullins first statement. Modulations at positions 460 to 463, 
not located in the SRS, compromise the three-dimensional structure of the protein resulting in 
an affinity change due to significant distance and angle changes around position 524 to 526 
(SRS6) (Chapter 2). Similar observations were made for the deletion of Y461 affecting the 
active site (Chapter 2). Position 125, at the entrance of the channel to the active site of the 
protein, was modified in all resistant strains, resulting in constriction of the binding cavity or 
enlargement of the binding cavity. Either affects the protein affinity for the active ingredient 
of the fungicide (Mullins et al. 2011). This knowledge can now be applied in protein 
modelling, anticipating on specific substitutions, and the effect on binding of azole fungicides 
and hence, act as a prediction tool in order to develop azole based compounds de novo. 
Interestingly, the P. fijiensis reference strain CIRAD86 that was used to generate the 
first linkage map (Manzo-Sanchez et al. 2008) that was also used and improved in a recent 
whole genome sequencing project (Kema 2009), is the only strain among 268 isolates that 
encodes a valine instead of aspartic acid at position 106 in CYP51 (Chapter 2). Since South 
East Asia is the proposed centre of origin (Carlier et al. 1996; Halkett et al. 2010; Hayden et 
al. 2003; Rivas et al. 2004b) and CIRAD86 originates from Cameroon, we concluded that 
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substitution D106V is a rare event that exclusively occurred in CIRAD86 rather than the 
reverse substitution in all other strains. The proposed additive role of D106V, as stated in 
Chapter 2, is most likely a statistical artefact based on another (other) mutation(s) in the 
reference strain. Due to the fact that all resistant strains possess this variant, the statistical 
variance of V106D + A313G is, with 11.8, slightly higher than the threshold of 10. However, 
this is likely a statistical artefact as the interaction was preferred by the algorithm, probably 
by the presence of the resistant substitution A313G rather than V106D. This highlights two 
important issues: first, one should always consider biology for final decisions to avoid miss-
interpretation based on probability; secondly, although the CIRAD86 genome has been a 
priceless tool for our studies, there is an urgent need for sequencing many more P. fijiensis 
isolates, preferably using strains from the centre of origin, to better understand overall genetic 
diversity. 
 
Discovery of Pfcyp51 promoter insertions and their role in reduced 
efficacy of DMIs 
Whether aa substitutions are the main mechanism for reduced DMI efficacy is 
addressed in Chapter 3. For the first time we observed overexpression of the target Pfcyp51 
gene, apparently through (repeated) insertions of a Pfcyp51 promoter localized sequence. The 
inserted sequences are composed of a particular repeat element (Chapter 2 and 3), which are 
widely shared among tolerant and resistant strains, whereas it was absent from all sensitive 
strains. The presence of these insertions and their number, positively correlate with DMIs 
fungicide resistance (Chapter 2). Since their discovery in Costa Rica populations (Chapter 3), 
other populations were identified with similar insertions (Chapter 2). In a previous study, the 
role of this mechanism was thought to be negligible since overexpression of the Pfcyp51 gene 
in propiconazole resistant isolates from Colombia was not observed (Cañas et al. 2009). There 
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are however, many possible reasons why overexpression was not (yet) observed: firstly, the 
propiconazole resistance level was still much lower than we observed for resistant strains 
(Chapter 2 and 3); and secondly, the Colombian set of isolates analysed by Cañas-Gutierrez 
(2009) was smaller. It is plausible that the frequency of strains, sampled in 2008, with 
insertions, was negligible or even not-existing (Cañas-Gutierrez 2009). In contrast, among the 
2012 Colombian derived P. fijiensis strains, 24 out of 34 resistant strains contained a promoter 
insertion (70%). This rapid increase, between 2008 to 2012, in both EC50 values and promoter 
insertion frequency correlated with the constant selection pressure of DMI fungicide 
applications with an average of 6.8 cycles per year (6.8 from a total of 30 fungicide 
applications) from 2008 to 2012 (Vicente Rey, Augura, personal communication). These data 
could be used to extrapolate the critical DMI selection pressure for the appearance of a 
particular resistant mechanism within a given population. Such a tool would be very useful for 
the management and improvement of diseases control strategies.  
Inserts as observed in Pfcyp51 promoters are commonly observed in other fungal 
species (Cools et al. 2012; Hamamoto et al. 2000; Ma et al. 2006; Mellado et al. 2007; 
Schnabel & Jones 2000; Snelders et al. 2012; Villani et al. 2016). Nevertheless, they 
differentiate greatly between species based on their size, sequence, position and nature. 
Clearly, they are the result of independent events, raising important questions about their 
origin. Some insertions are considered to be remains from transposable element activity. These 
can contain powerful promoter sequences whose footprints could be the observed insertions 
(Cools et al., 2013). The repeats identified in P. fijiensis can be categorized as mini-satellite 
like structures (>14 bp), as found by Espley et al. (2009) in the promoter of MYB10 
overexpressed in red flesh apples (Espley et al. 2009). The expansion mechanism of mini-
satellites is suggested to result from recombination (Espley et al. 2009). Nonetheless, mini-
satellite like structures have been related to miniature inverted-repeat transposable elements 
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(Espley et al. 2009; Lu et al. 2008). Since the Pfcyp51 gene is 8.7 kb away from the nearest 
recombination point (Chapter 4), it is unlikely that recombination is the key player in the 
Pfcyp51 repeat element expansion and also, there is no clear evidence for miniature inverted-
repeat transposable elements, and hence, the origin of these repeats remains unknown. 
The P. fijiensis repeat element’s central core is a palindromic motif. These motifs are 
frequently annotated as cis-elements, an important group of regulators in eukaryotes (Knox & 
Keller 2015). It is well known that many transcription factors (TF) bind palindromic sequences 
with high affinity (Narlikar & Hartemink 2006; Qian et al. 2006). Interestingly, we observed 
that these elements negatively regulate fungicide efficacy: an increasing number of repeat 
elements, particularly with the number of palindromic sequences, reduced the efficacy 
(Chapter 2 and 3). Finally, the promoter swapping transformation experiments described in 
Chapter 3 proved that the causality of these insertions: insertion in the Pfcyp51 promoter both 
increased the gene’s expression as well as azole resistance. This is consistent with observations 
in Venturia inaequalis where overexpression of the cyp51 confers differential resistance to 
difenoconazole (Villani et al. 2016). However, the increase of DMI resistance in the P. fijiensis 
mutants was not as high as in the resistant wt strain (Chapter 3) since that strain also possessed 
aa modulations in the target Pfcyp51 gene. So, overexpression synergizes the effect of 
accompanying effective target site mutations. All these observations are consistent with results 
from Z. tritici, where promoter insertions were suggested to occur after target site mutations 
and also prevented further accumulation of such mutations as this would eventually 
compromise the enzymatic activity and stability of the protein (Leroux and Walker, 2011). 
Finally, in Chapter 2 the statistical analyses on the role of promoter insertions in reduced DMI 
efficacy revealed that they are not the main explanatory component, but important add-ons to 
key target site mutations. 
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One of the main upcoming questions for P. fijiensis is what molecular machinery 
drives this increase of repeat elements? Whole genome sequence methodology can shed light 
to their origin, but except for the palindromic sequence, no general lead was found. Therefore, 
we hypothesize that these palindromes are essential for further repeat amplification. One 
possible mechanism to study the role of the element and its palindromic core is DNA-protein 
hybridization. In particular, yeast one hybrid has been a useful DNA-protein hybridization 
system to find transcription factors (Ota et al. 2014). We could try using the Pfcyp51 promoter 
as a capture probe in a genome-wide mapping of promoter-anchored interactions through 
HiCap methodologies for the identification of regulatory interactors as this is based on 
modified chromosome conformation capture followed by a sequence-capture of promoter 
containing fragments, resulting in a high-resolution map of promoter-anchored interactions 
(Sahlen et al. 2015). Finally, to elucidate more basic elements in fungal promoters, cap 
analysis of gene expression (CAGE) technology can be used to detect transcriptional start 
site(s) (TSS) and the expression levels by utilizing 5’ cDNA tags and PCR (Kurosawa et al. 
2011). 
 
Classical genetic analysis to unequivocally identify and map genomic 
regions involved in DMIs resistance  
The aim of Chapter 4 was to elucidate the genetic nature of reduced DMI efficacy by 
genetic mapping using segregating P. fijiensis populations from crosses between isolates with 
major differences in DMI sensitivity. We, therefore, generated, phenotyped and genotyped 
two mapping population and constructed two linkage maps using Diversity Array Technology 
(DArT) markers. As discussed earlier in Chapter 4, a gradual shift from sensitivity to resistance 
is usually based on the interaction of many genes, often referred to as quantitative or polygenic 
resistance (Dyer et al. 2000). The DMI resistance mechanism was characterized as polygenic 
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for Candida albicans, A. fumigatus and Z. tritici (Cools et al. 2013; Cowen 2008). Also, 
reduced DMI sensitivity for P. fijiensis in the field has been gradual in nature (Cañas et al. 
2009; Marín et al. 2003). Nevertheless, the evidence presented in this thesis points at Pfcyp51 
as the single major gene involved and hence, the quantitative expression of the phenomenon 
seems to be largely due to the various modulations of the CYP51 protein and the binding of 
various active ingredients. 
The first evidence of a monogenic cause in P. fijiensis was the correlation of the 
Pfcyp51 changes with reduced DMIs efficacy as described in Chapter 2. The second evidence 
is the clear distinct 1:1 segregation for DMI sensitivity and analogous Pfcyp51 modifications 
in the P. fijiensis mapping populations described in Chapter 4. Thirdly, the genetic maps 
revealed one genetic region harbouring Pfcyp51 as the single most important candidate gene. 
Nonetheless, subtle variations were observed between individuals with the same Pfcyp51 
genotype configuration. We, therefore, cannot exclude modifying factors for DMI sensitivity, 
including physiological factors such as colony age, growth ratios and other stress factors.  
 
Modernizing monitoring  
Hitherto, DMI efficacy is monitored by germ tube lengths measurement and 
germination ratios of P. fijiensis ascospores. Though technically simple, it does not provide 
any insight in the underlying mechanisms and hence, DNA based methodologies are preferred 
to further precise and modernize monitoring strategies. Rapid molecular monitoring tools such 
as PCR-based technologies reduce the required timeframe for an adequate response to any 
disease. For DMI efficacy monitoring we could develop a quick molecular test focusing on 
the presence of important substitutions in PfCYP51, e.g. position 313, 136 and 463. We have 
shown that a simple PCR, which is based on the variable number of the insertions, indicates 
the presence of Pfcyp51promoter repeats, suggesting the potentially reducing sensitivity levels 
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in natural P. fijiensis populations (Chapter 3) for instance in Costa Rican populations (Díaz-
Trujillo et al. 2016a). Ideally, such test should be run directly on leaf tissue, which would 
further the implementation of technology revealing the genomic basis of DMI resistance in P. 
fijiensis strains. The generation of the two genetic maps based on DMI sensitivity (Chapter 4) 
also contributed significantly to the identification of molecular markers and candidates genes 
involved in DMI sensitivity for further studies (Chong et al. 2016c). These should include 
quantification of DNA/RNA species enabling the ratio of resistant vs. wt genotype(s) in natural 
population (Singh & Mustapha 2013).  
 
Concluding remarks 
In conclusion, the proven monogenic basis of DMI sensitivity in P. fijiensis has an apparent 
quantitative phenotypic expression, which in many systems is considered to result from a 
polygenically controlled mechanism (Cools & Fraaije 2013; Cools et al. 2013; Dyer et al. 
2000). How can we reconcile such a seemingly contrasting observation? Interestingly as noted 
in Chapter 2, each of the Pfcyp51 mutations contributes to resistance, but does not confer full 
DMI resistance as it seems to depend on the balance between catalytic activity of the CYP51 
protein and the active ingredient of the fungicide. Another phenomenon is that a particular 
substitution affects individual, or subsets of DMIs compounds, but is insufficient for cross-
resistance to the whole class of fungicides (Cools et al., 2013), which was nicely illustrated in 
Venturia inaequalis with differential resistance to difenoconazole and myclobutanil (Villani 
et al. 2016). In theory, each (surviving) mutation in the CYP51 protein will be based on the 
interaction with the DMIs applied in the field. However, this is insufficient for full resistance 
against the array of fungicides.  
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Figure 1. Schematic representation of CYP51 interaction with DMI fungicides in 
Pseudocercospora fijiensis based on Cowen et al (2008) cyp51 illustration. A) Normal 
membrane integrity and ergosterol pathway. B) Scheme of the effect of DMI fungicides on the 
membrane integrity and the ergosterol pathway. Accumulation of 14 α-methylergosta-
8,24(28)-dien-3 β, 6 α-diol will stop development and cause cell death (Lupetti et al. 2002; 
Shapiro et al. 2011). C) Modulated CYP51 reduces the affinity for the interaction with DMI 
fungicides and thereby their efficacy, hence increasing amounts of fungicide are needed for 
disease control. D) Increased expression of CYP51 overcomes increasing amounts of 
fungicides. This increment of enzymatic active units causes a synergistic effect with the 
reduced affinity towards the fungicide, resulting in a further amplification of resistance. In 
comparison with scenario (C) an increases of fungicide doses from ten times or more will be 
required for effective disease control (D).  
 
 
The discovered Pfcyp51 overexpression mechanism is the latest novelty in an 
important research area. Overexpression is unavoidable to maintain catalytic activity under 
the mutational pressure at and around the catalytic site (Figure 1). Finally, we hypothesize that 
in the near future additional mechanisms will appear, such as the increased exclusion of 
fungicides from the intracellular compartments as observed before in other DMI stressed fungi 
(Cowen 2008). Potentially, the occurrence of this mechanism in P. fijiensis might provoke a 
non-gradual increase in DMI resistance, which cannot be counteracted by increased fungicide 
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applications and hitherto practiced (Chapter 2). This stresses the need for novel mode of action 
fungicides (moa’s) or control strategies to manage black Sigatoka disease in the future. The 
knowledge of the current distribution, evolution and impact of the resistance in the field is 
therefore an invaluable data source for the future control of this important banana disease. 
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Summary  
Pseudocercospora fijiensis is the causal agent of black Sigatoka which is the most 
serious leaf defoliation disease on Musa spp. (bananas and plantains). Many plantain and 
banana species are susceptible to black Sigatoka including the exporting Cavendish cultivars. 
Leaf defoliation results in significant yield loses and premature ripening of banana fruit, which 
is a serious problem for the banana exporting industry. The main control measure of black 
Sigatoka involves frequent fungicide application with a very high environmental and 
economic burden. Among these fungicides, the azole chemical family is one of the most 
frequently used fungicides for the control of the disease. Azole fungicides belong to the sterol 
demethylation-inhibitors (DMIs) that target the lanosterol 14α-demethylase enzyme (CYP51). 
One of the major problems in black Sigatoka control has been the excessive and unplanned 
use of the DMI fungicide applications in many banana farms worldwide. This uncurbed use 
of the fungicide resulted in DMI resistance in pathogen population. Over time, resistance 
levels have increased to such an extent that the number of fungicide application cycles is now 
near maximum level. The reduction of sensitivity in P. fijiensis to currently used DMIs has 
been gradual in nature, suggesting a polygenic control (Cañas et al. 2009). Nevertheless, 
genetic evidence described in this thesis suggests that Pfcyp51 is the single major factor 
responsible for the sensitivity loss in the field. Our study is the first global analysis of DMI 
fungicide resistance in P. fijiensis, provides a lead to understand DMI sensitivity reduction, 
enables the development of better black Sigatoka management strategies, but also calls for 
more sustainable solutions of this unparalleled banana threat. 
Chapter 1 describes the importance of the banana fruit as commodity and staple food 
worldwide and the impact of black Sigatoka on its cultivation. It introduces the subject of the 
thesis, the problem of the resistance to DMIs in the control of black Sigatoka and describes 
lifestyle features of the causal agent P. fijiensis, the history of fungicide control of the disease, 
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the impact that DMI fungicides exerted in the population of this species and concludes with 
the set-up of the thesis.  
Chapter 2 provides an historical treatise of black Sigatoka management – primarily 
in Costa Rica – including the strategies that were developed and applied. It concludes with a 
critical evaluation of the current practice and the required changes.  
 Chapter 3 describes an extensive worldwide phenotypic and genotypic survey of P. 
fijiensis resistance to DMI fungicides. The sensitivity of a set of 592 field isolates collected 
from various banana production zones in Colombia, Costa Rica, the Dominican Republic, 
Ecuador, the Philippines, Guadalupe, Martinique and Cameroon was tested. The sequence 
analyses of the 14α-demethylase enzyme CYP51 encoding the Pfcyp51 gene in 266 isolates 
showed a wide suite of modulations. Insertions of a 19 base pairs (bp) element found in the 
promoter region of the Pfcyp51 gene were described and the correlation between these changes 
in the Pfcyp51 gene and promoter and the increase in azole resistance was established. In 
addition, the contribution of the main CYP51 amino acid substitutions through the elucidation 
of seven in silico protein models was evaluated.  
 Chapter 4 describes the de-novo identification of a 19 bp element found in the 
promoter region of the Pfcyp51 gene. Evidence strongly suggested that insertion of this 
element in the promoter - up to 6 copies - of resistant strains causes over expression of the 
Pfcyp51 gene in comparison to strains that contain one element. PCR based assays were used 
to analyse the presence of the repeat element in four P. fijiensis populations of Costa Rica and 
some isolates from Ecuador, Africa and South East Asia. Promoter swap transformation 
experiments were used to analyse the role of the repeat element in the expression of the 
Pfcyp51 gene. This identified the repeat element as a novel component that, together with 
mutations in the Pfcyp51 open reading frame, are responsible for higher levels of resistance 
against azole fungicides.  
 Chapter 5 describes the generation of two F1 P. fijiensis progenies for the 
construction of two genetic maps that identifies the region encoding for DMI fungicide 
resistance using DArTseq technology. Full agreement was found between the genetic markers 
in either population, underlining the robustness of the approach. This genetic tool was essential 
to identify the genetic region that determines the resistant to DMI fungicides in the species 
and strongly supports the hypothesis that the Pfcyp51 gene is the single major determinant of 
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resistance towards DMI fungicides in P. fijiensis. The mapped region comprises 250,660 bp 
and contains 53 putative genes, including the Pfcyp51 gene, which is the most plausible 
candidate as the driving molecular force for the resistance to DMI fungicides based on our and 
others’ findings.  
Chapter 6 discusses the experimental outcomes obtained in the thesis and describes 
them in a broader framework. It highlights the compelling evidence that modulation of the 
promoter and the coding gene sequence of Pfcyp51 correlate with the observed azole 
sensitivity. Finally, the impact and implications of these findings are discussed for future 
disease control strategies. 
 
  
Summary 
278 
Resumen 
Pseudocercospora fijiensis es el agente causal de la Sigatoka negra, la enfermedad 
foliar más grave de Musa spp. (bananos y plátanos). Muchas especies de plátano y banano son 
susceptibles a la Sigatoka negra incluyendo los cultivares de exportación Cavendish. La 
defoliación que causa la enfermedad resulta en una reducción significativa de la producción y 
la maduración prematura de la fruta, que es un serio problema para la industria exportadora de 
banano. La principal medida de control de la enfermedad implica la aplicación frecuente de 
fungicidas con un impacto ambiental y económico muy alto. Entre los fungicidas usados para 
el control de la enfermedad, los triazoles son uno de los fungicidas más utilizados. Los azoles 
pertenecen al grupo de compuestos inhibidores de la des-metilación del esterol (DMIs). Estos 
fungicidas pertenecientes al grupo DMI que actúan directamente en la inhibición de la enzima 
lanosterol 14α-desmetilasa (CYP51). Uno de los principales problemas en el control de la 
Sigatoka negra ha sido el uso excesivo y no planificado de las aplicaciones de fungicidas DMI 
en muchas fincas de banano alrededor del mundo. Este uso desordenado de los fungicidas ha 
dado lugar a la aparición de resistencia a los DMI en las poblaciones del patógeno. Con el 
tiempo, los niveles de resistencia han aumentado a tal medida que el número de ciclos de 
aplicación de fungicidas están cerca del nivel máximo. La pérdida de sensibilidad de P. 
fijiensis a los DMI que se utilizan actualmente ha sido gradual, esto aparentemente sugeriría 
que la resistencia a los DMI es de naturaleza poligénica. Sin embargo, la evidencia genética 
encontrada en esta tesis sugiere que el gen cyp51 es el principal y único responsable de la 
pérdida de sensibilidad en el campo. Este estudio es el primer análisis global de la resistencia 
a los fungicidas DMI en P. fijiensis y; ofrece pistas para entender la reducción de la 
sensibilidad a los DMI. La información obtenida en este trabajo nos permitirá el desarrollo de 
mejores estrategias de manejo de la Sigatoka negra, pero al mismo tiempo nos muestra la 
necesidad de la búsqueda de soluciones más sostenibles para lidiar con esta amenaza sin 
precedentes al cultivo del banano. 
El capítulo 1 describe la importancia de la fruta del banano como bien de exportación 
y como alimento básico a nivel mundial, mostrándonos el impacto que la Sigatoka negra ejerce 
en su cultivo. Nos introduce el tema de la tesis, el problema de la resistencia a DMIs en el 
control de la Sigatoka negra. Describe las características del estilo de vida del agente causal 
P. fijiensis, la historia del control de la enfermedad y el impacto que ejercen los fungicidas 
DMI en la población de la especie y concluye mostrando la estructura de la tesis. 
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El capítulo 2 provee una disertación histórica del manejo de la Sigatoka negra – 
principalmente en Costa Rica – incluyendo las estrategias que han sido desarrolladas y 
aplicadas a través del tiempo. Concluye con una evaluación critica del presente manejo de la 
enfermedad y de los cambios que se necesitan para futuro.  
El capítulo 3 Describe un análisis fenotípico y genotípico mundial de la resistencia 
de P. fijiensis a los fungicidas DMIs. En el capítulo 2 se examinó la sensibilidad de un conjunto 
de 592 aislados del campo recogidos de diferentes zonas de producción bananera en Colombia, 
Costa Rica, República Dominicana, Ecuador, Filipinas, Guadalupe, Martinica y Camerún. El 
análisis de la secuencia del gen Pfcyp51 que codifica la enzima 14α-desmetilasa CYP51 en 
266 aislamientos mostraron una amplia gama de variaciones. Se describe también las 
inserciones de un elemento de 19 pares de bases (pb) que se descubrió en la región promotora 
del gen Pfcyp51. Se estableció la correlación entre los cambios en el gen Pfcyp51 y su 
promotor con el aumento de la resistencia a los azoles. Además, se evaluó la contribución de 
las principales sustituciones en los aminoácidos de la CYP51 a través de la elucidación de 7 
modelos computacionales de proteínas. 
El capítulo 4 describe por primera vez la identificación de un elemento de 19 pares 
de bases (pb) en la región promotora del gen Pfcyp51. La evidencia sugiere fuertemente que 
insertos de hasta 6 copias de este elemento en el promotor de cepas resistentes proporcionar 
sobre-expresión al gen en comparación con las cepas que contienen un elemento. Ensayos 
basados en PCR se utilizaron para analizar la presencia del elemento repetido en cuatro 
poblaciones de P. fijiensis de Costa Rica y en algunos aislados de Ecuador, África y el Sudeste 
Asiático. Experimentos de transformación de intercambio del promotor se utilizaron para 
analizar el papel de este elemento repetido en la expresión del gen Pfcyp51. Estos 
experimentos nos permitieron identificar a este nuevo elemento repetido como un componente 
que junto con las mutaciones en la región codificante del Pfcyp51 son responsables de niveles 
superiores de resistencia contra los fungicidas azólicos. 
El capítulo 5 describe la generación de dos progenies F1 de P. fijiensis para la 
construcción de dos mapas genéticos basados en la resistencia a los fungicidas DMI. La 
tecnología DArTseq se utilizó para generar un mapa de ligamiento genético para ambas 
poblaciones. Se encontró total acuerdo entre los marcadores genéticos de ambas poblaciones, 
lo que subraya la solidez del enfoque. Esta herramienta genética fue esencial para identificar 
la región genética que determina la resistencia a los fungicidas DMI en la especie y apoya 
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firmemente la hipótesis de que el gen cyp51 es el único importante determinante de la 
resistencia a fungicidas DMI en P. fijiensis. Esta región genética de 250.660 pb contiene 53 
genes putativos que incluyen el gen cyp51 que base en los hallazgos de otros autores y los 
nuestros es el candidato más plausible como la fuerza molecular que determina la resistencia 
a los fungicidas DMIs.  
El capítulo 6 analiza los resultados experimentales obtenidos en la tesis y los describe 
desde una perspectiva más amplia. Este capítulo resalta la evidencia convincente de que la 
modulación de la secuencia del promotor y la región codificante del gen cyp51 se correlaciona 
con la perdida de sensibilidad observada en azoles. Finalmente, se discute el impacto y las 
implicaciones de estos hallazgos en las futuras estrategias para el control de enfermedades.
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Samenvatting 
 
Pseudocercospora fijiensis is de veroorzaker van black Sigatoka (of zwarte blad strepenziekte), 
de schadelijkste bladvlekkenziekte van het geslacht Musa dat ook bananen en bakbananen 
omvat. Vele soorten zijn vatbaar voor black Sigatoka, inclusief de “Cavendish” export 
variëteiten. Bladschade veroorzaakt belangrijke opbrengstverliezen en vroegtijdige afrijping 
van bananen, een belangrijke schadepost voor de exportindustrie. De belangrijkste 
beheersmethode voor black Sigatoka betreft het frequent bespuiten van plantages met 
fungiciden die een grote milieukundige en economische belasting vormen. Onder deze 
fungiciden omvat de chemische familie van de azolen de meest gebruikte werkzame stoffen om 
de ziekte te bestrijden. Azolen vallen onder de sterol demethylase remmers (DMIs) die het 14α-
demethylase enzym (CYP51) blokkeren. Eén van de grootste problemen bij de bestrijding van 
black Sigatoka vormt de buitensporige en regelmatige toepassing van fungiciden op vele 
bananenplantages rondom de wereld. Het ongebreidelde gebruik van fungiciden heeft 
bijgedragen aan het ontstaan van populaties met een hoog niveau van DMI-resistentie. 
Gedurende de tijd is deze resistentie zodanig toegenomen dat het maximum aantal toepassingen 
in bereikt. Het verlies van gevoeligheid voor DMIs in P. fijiensis is gradueel ontstaan en dat 
geeft de indruk van een eigenschap die polygeen wordt gereguleerd. Desniettegenstaande blijkt 
in dit proefschrift dat het Pfcyp51 gen uitsluitend verantwoordelijk is voor dit verlies onder 
veldomstandigheden. Onze studie omvat de eerste wereldwijde analyse van fungicideresistentie 
tegen DMIs in P. fijiensis, voorziet in een leidend principe om deze ontwikkeling te begrijpen, 
maakt het daarmee mogelijk om betere beheerstrategieën voor black Sigatoka te ontwerpen en 
roept op tot een duurzame oplossing voor deze ongeëvenaarde bedreiging van de bananenteelt.  
 
In Hoofdstuk 1 wordt het belang van banaan als fruit en voedselgewas beschreven alsmede het 
effect van black Sigatoka op de wereldwijde teelt van banaan en wordt het thema van dit 
proefschrift omschreven: fungicide resistentie tegen DMIs. Het beschrijft de levenscyclus en 
kenmerken van het pathogene organisme P. fijiensis, alsmede de geschiedenis van het gebruik 
van fungiciden en het effect van DMIs op natuurlijke populaties van de soort en wordt 
afgesloten met de opzet van het proefschrift. 
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In Hoofdstuk 2 wordt een historisch overzicht beschreven van de bestrijding van black 
Sigatoka – met name in Costa Rica - en welke strategieën daarbij werden ontwikkeld en ingezet. 
Het sluit af met een kritische analyse van deze praktijk en de gewenste veranderingen. 
 
Hoofdstuk 3 beschrijft een uitvoerige wereldwijde phenotypering en genotypering van 
resistentie tegen DMIs in P. fijiensis. De gevoeligheid van 592 veldisolaten - afkomstig uit 
verschillende productiegebieden in Colombia, Costa Rica, de Dominicaanse Republiek, 
Ecuador, de Filippijnen, Guadeloupe, Martinique en Kameroen – tegen DMIs werd bepaald. 
Uit sequentieanalyses van het gen dat het 14α-demethylase enzym CYP51 codeert, Pfcyp51, in 
266 isolaten komt een grote variatie naar voren. Daarbij werden ook inserties van een 19 bp 
fragment in de promotor van het gen gevonden en beschreven. De correlatie tussen deze 
veranderingen in de promotor en de toenemende resistentie tegen azolen was daarbij een 
opvallende constatering. Daarnaast werd het effect van de modulering van het CYP51 eiwit 
door diverse mutaties geëvalueerd door gebruik te maken van in-silico eiwitmodellen. 
 
Hoofdstuk 4 beschrijft een de-novo identificatie van een 19 bp element dat werd gevonden in 
de promotor van het Pfcyp51 gen. De meervoudige - tot zes kopieën - insertie van dit fragment 
in de promotor in resistente stammen leidt tot overexpressie van het Pfcyp51 gen in vergelijking 
met isolaten die slecht één fragment in de promotor hebben. Een op PCR gebaseerde test werd 
gebruikt om de aanwezigheid van deze fragmenten in veldpopulaties uit Costa Rica en enige 
isolaten uit Ecuador, Afrika en Zuidoost Azië te onderzoeken. Transformatie experimenten 
waarbij de promotoren tussen gevoelige en resistente isolaten werden omgewisseld 
demonstreerden de rol van promotorinserties in de expressie van het Pfcyp51 gen. Hiermee 
werd het geïnserteerde fragment als een nieuwe component van fungicideresistentie beschreven 
dat tezamen met mutaties in het coderende Pfcyp51 gebied verantwoordelijk is voor de 
toenemende fungicideresistentie tegen azolen. 
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Hoofdstuk 5 beschrijft het maken van twee F1 populaties van P. fijiensis die werden gebruikt 
om twee genetisch kaarten te maken van het gebied dat codeert voor DMI-fungicideresistentie 
en dat met DArT-technologie werd gekarteerd. Daarbij werd een volledige overeenkomst 
geconstateerd tussen de merkers in beide populaties die de robuustheid van de gehanteerde 
methoden onderstreepte. Deze benadering was essentieel om het gebied dat DMI-resistentie 
codeert in kaart te brengen en bevestigde de hypothese dat het Pfcyp51 gen de bepalende factor 
is voor DMI-fungicideresistentie in P. fijiensis. Het gekarteerde gebied omvat 250,660 bp en 
bevat 53 mogelijke genen, waaronder Pfcyp51, als de belangrijkste kandidaat en de drijvende 
kracht achter de resistentie tegen DMIs in ons onderzoek en dat van anderen. 
 
Hoofdstuk 6 is een algemene discussie over de uitkomsten van dit onderzoek en beschrijft deze 
in een breder kader. Hierbij wordt op overtuigende wijze aangetoond dat modulering van de 
promotor en het coderende gebied van Pfcyp51 bepalend is voor en correleert met de 
waargenomen gevoeligheid voor azolen. Tenslotte worden het effect en de implicaties van dit 
onderzoek bediscussieerd ten aanzien van toekomstige beheersstrategieën van de ziekte.  
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